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Abstract 
Sarcopenia is characterised by a decrease in muscle specific force that can only partially be 
attributed to 1nuscle atrophy. Changes in fiber type composition of 1nuscle have also been 
observed in humans with age. Additionally, it is suggested that excitation contraction coupling 
(EC coupling) is i1npaired in aging by uncoupling of the two Ca2+ channels facilitating EC 
coupling, the dihydropyridine receptor (DHPR) and the ryanodine receptor (RyRl ), perhaps due 
to a decrease in expression of the DHPR a 15 subunit which has been de1nonstrated in rodents. 
Changes in DHPR ~la subunit expression have also been reported in aging mice but not 
investigated in humans. The 12kDa FK506 binding protein (FKBP12) stabilizes RyRl in the 
closed state. Its dissociation fro1n RyRl causes a " leaky" channel and decreased EC coupling. 
Furthennore, RyRl has two variably spliced regions, ASI and ASII, thought to be 
developmentally regulated. The ASI region, which lies close to a DHPR ~l a binding site, affects 
EC coupling. The juvenile isoform (ASI(-)RyRl) shows enhanced Ca2+ release during EC 
coupling and its overexpression is linked to myopathy in myotonic dystrophy. Regeneration in 
aging muscle due to increased denervation and reinnervation can give rise to i1nmature muscle 
fibers with higher levels of the juvenile isoforms of some proteins. 
Therefore the aim of this study was to investigate the fiber type distribution as well as levels of 
RyRl, DHPR a 15, ~la, and FKBP12 in aged human muscle from 42 donors (aged 40-90yr) 
undergoing knee (vastus medialis) and hip replacements (gluteus 1ninimus and gluteus medius). 
The levels of ASI splice variant transcripts in the muscle were investigated using RT-PCR. 
Furthermore, the effect of the addition of ~la to recombinant ASI splice variant channels in lipid 
bilayers was investigated. 
Vastus 1nedialis was predominantly fast twitch, whereas gluteus 1ninimus and gluteus medius 
were predo1ninantly slow twitch fibers. Contrary to expectation, age affected fiber type 
composition differently in the three human muscles. Also, contrary to rodent studies, no 
significant difference in the hun1an expression levels of the RyRl , DHPR a 15 and ~l a or FKBPJ 2 
with age was found . The ASI( + )RyRl :ASI(-)RyRl ratio showed no significant change with 
age, however, an unexpected strong correlation between the fiber type and splice variant was 
found. In muscle with a high fraction of slow-twitch fibers , ASI(-)RyRl predominates and vice 
versa. This novel finding suggests the ASI splice variants are fiber type specific rather than 
developmentally regulated . Finally, novel lipid bilayer results showed that ASI(+)RyRl was 
activated more by 1 0nM ~ la than ASI(-)RyRl , but was similarly activated by 50nM ~l a 
indicating a higher affinity of ASI(+)RyRl for ~ la · 
Although no significant difference in expression levels of EC coupling proteins with age in 
humans was found , the di scovery of fiber type specificity in RyR 1 splice variants is important. 
This has not been shown before and provides a paradigm shift in understanding skeletal muscle 
changes in myotonic dystrophy. The discovery of different isoform affinities for ~I a 1nay explain 
differences between EC coupling in fast and slow twitch fibers and changes in EC coupling in 
myotonic dystrophy. 
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Chapter 1 
Chapter 1: Introduction 
Muscle is a dynamic and versatile tissue that plays an important part in the physiology of 
mammals. The 1nain function of muscle is to facilitate movement, but it also plays a role in 
metabolism and temperature homeostasis. 
The content of this chapter is mainly sourced from the following references unless otherwise 
referenced (Ganong 1997; Silverthorn 1998; Hille 2001; Sambrook 2001; Johnson and Byrne 
2003; Solo1non 2009; Marieb and Hoehn 2010; Hall and Guyton 2011; Kandel 2012). 
1.1 Overview of muscle tissue 
Mainmalians have three types of muscle tissue: smooth muscle, skeletal muscle and cardiac 
muscle. 
Smooth muscle is the primary muscle of internal organs and vessels. It has no striations due to 
the fact that it has a less organized arrangement of its contractile filaments. Muscle cells are 
elongated and are therefore referred to as muscle fibers. Smooth muscle fibers are variable in 
size (5-1 0µm in diameter; 30-200µm in length) and they have one central nucleus per muscle 
fiber. Smooth muscle is not under voluntary control. It is controlled J:,y autonomic 
innervations, but it can also contract spontaneously and is subject to endocrine modulation. Its 
contractions are slow and sustained and s1nooth muscle is resistant to fatigue. 
Cardiac muscle is found in the heart and makes up most of the heart walls. Its contractile 
filainents are arranged in a very organized way which gives it a banded appearance. Cardiac 
muscle is therefore referred to as striated muscle. Cardiac muscle fibers 1nostly have one central 
nucleus, but s01netimes there can be two. The fibers branch and fit together with tight junctions 
referred to as intercalated discs. Cardiac 1nuscle is also not under voluntary control and it is 
innervated by the autonomic nervous system, however, it can contract spontaneously and 
respond to endocrine input. It contracts at a steady rate determined by the heart ' s pacemaker, 
but is responsive to neural and endocrine modulation 
Skeletal muscle is attached the skeleton and facilitates movement, maintains posture and 
stabilizes joints. It is striated, but unlike cardiac muscle, it is under voluntary control. It can, 
however, be activated by reflexes as well. Skeletal muscle fibers are long cylindrical cells with 
multiple oval nuclei located just beneath the plasma membrane or sarcolemma. The fiber 
1 
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diameter ranges from 10-1 00~tm and fibers can be up to 30cm long. Healthy skeletal muscle 
doesn ' t contract spontaneously. It contracts in response to somatic motor neuron stimulus and 
is not directly modulated by the endocrine system. Skeletal muscle contraction can occur 
rapidly but it fatigues and cannot sustain continuous rapid contraction for an extended time. 
The range of pressure and force that skeletal muscle can produce is quite large and is therefore 
very adaptable in this regard. 
This study involves exclusively skeletal muscle and the introduction will therefore focus on this 
type of muscle. 
1.2 Gross anatomy of skeletal muscle 
Each muscle is a discrete organ made up of a several kinds of tissues. The 1nost predominant 
tissue is skeletal muscle, but there are also blood vessels, nerve fibers and substantial amounts 
of connective tissue present. 
1.2.1 Nerve and blood supply 
Generally each muscle is served by one nerve, an artery and one or more veins. These 
structures enter or exit near the middle of the 1nuscle and then branch liberally throughout the 
connective tissue sheaths. A nerve ending connects to each muscle fiber and controls its 
activity. Contracting muscle expends large amounts of energy and need an almost continuous 
delivery of oxygen and nutrients and the removal of metabolic waste that are produced in large 
quantities. It therefore has a rich blood supply 
1.2.2 Connective tissue sheaths 
Each individual muscle fiber is surrounded by a sheath of connective tissue referred to as the 
endomysium. It consists of fine areolar connective tissue. Within the muscle, the muscle fibers 
are grouped together in "bundles of sticks" called fascicles and each fascicle is surrounded by a 
fibrous connective tissue sheath referred to as the perimysium. Surrounding the whole muscle 
is another connective tissue sheath, the epimysium, consisting of dense irregular connective 
tissue (see Figure 1.1 ). Together, the connective tissue sheaths serve to support each cell and to 
reinforce the muscle as a whole, preventing damage during strong contractions. They are 
continuous with each other as well as the tendons that connect the muscle to the bone of the 
skeleton. As the muscle contracts and shortens the connective tissue sheaths and tendons 
transmit the pulling force to the bone thus facilitating movement of the skeleton. Not onlv do 
2 
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the sheaths contribute to the natural elasticity of muscle, they also serve as a corridor for blood 
vessels and nerve fibers entering and exiting the muscle. 
1.3 Microscopic anatomy of skeletal muscle 
Skeletal muscle fibers are long cylindrical cells with multiple oval nuclei just beneath the 
plasma membrane or sarcolemma. The cytoplasm of the skeletal muscle fiber is referred to as 
the sarcoplasm. It contains large amounts of glycosomes, which are granules of stored glycogen 
that provides glucose when needed. The sarcoplasm also contains myoglobin, which is a red 
pigment that can store oxygen. The usual organelles are present in skeletal muscle fibers, along 
with some organelles that are specialized for muscle ' s function e.g. myofibrils, sarcoplasmic 
reticulum and t-tubule network. 
1.3.1 Myofibrils 
Myofibrils are bundles of contractile and elastic proteins that carry out the work of contraction. 
They are rod like and run parallel to the fiber ' s length. Each myofibril is l-2µm in diameter and 
the bundles occupy most of the intracellular space, leaving little space for mitochondria and 
other organelles. In fact, myofibrils make up about 80% of the cellular volume. They contain 
the contractile elements of skeletal muscle cells, the sarcomere, which is formed by even 
smaller rod-like structures called myofiliments. 
When skeletal muscle is observed under a light microscope, a repeating series of light and dark 
bands is visible along the length of the myofibril. As mentioned previously, these repeating 
bands are referred to as striations and skeletal muscle as striated. The dark bands are called A 
bands (A stands for anisotropic because the proteins in this area scatter light unevenly under a 
polarizing microscope). The light bands are called I bands (I stand for isotropic because the 
proteins in this area reflects light uniformly under a polarizing microscope. Each dark A band 
has a lighter region in its mid-section called the H zone (H for "helle"; bright), which it tum is 
bisected by a dark line called the M line (M for "mittle"; middle) that is formed by the protein 
myomesin. The light bands also have a midline interruption, a darker area called the Z disc or Z 
line (Z stands for "zwischen"; between) (See Figure 1.2). 
The sarcomere is the region stretching from one Z disc to the next and encompasses an A band 
flanked by half an I band at each end. Within the myofibril, the sarcomeres are arranged end-to-
end and form the functional unit of muscle. 
3 
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The orderly arrangement of the contractile myofilaments, which are myosin and actin, give nse 
to the banding pattern. The myofilaments are organized by a subset of cytoskeleton proteins 
w hich include a.-actinin, myomesin, titin , obscurin, desmin and nebulin. 
"" . - - Ep1rnysium 
Ep imysium 
Fa scicle 
Perimysium 
Blood vessel 
Fascicle 
Endomysiu m 
Figure 1.1: Connective tissue sheaths of skeletal muscle (Marieb and Hoehn 20 I 0). 
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- -- -- - , 
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Figure 1.2: Microscopic anatomy of skeletal muscle (Marieb and Hoehn 20 I 0). 
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Figure 1.3 : Composition of thick and thin filaments (Marieb and Hoehn 2010) 
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Thick filaments extend the entire length of the A band. The thick filan1ents are about 16nm in 
diameter and are composed primarily of myosin. Various isoforms occur in different types of 
skeletal muscle fiber which will be discussed in the section dealing with skeletal muscle fiber 
types. Each myosin head consists of two heavy polypeptide chains that intertwine to form a 
long coiled tail and a pair of tadpole like heads as well as two lightweight polypeptide chains 
that are associated with the heavy chain of each head (four in total). Each thick filament 
contains about 3 00 myosin molecules bundled together in such a way that their heads are 
clustered together at the ends and their tails are in the central part of the thick filan1ent. The 
middle portion of the thick filament is therefore smooth, while the ends are studded with the 
staggered 1nyosin heads. At the point of attachment of the myosin heads, there is an elastic 
hinge region which allows the head to swivel. The myosin heads have actin and ATP binding 
sites and also contain ATPase enzymes. The myosin heads form cross-bridges with the thin 
filaments (See Figure 1.3). 
Thin filaments contain mostly actin and stretch across the I band and partway into the A band. 
They are 7-8nm thick. Actin has kidney shaped polypeptide subunits referred to as globular 
actin (G-actin). The active sites that bind myosin are located on G-actin and the subunits 
polymerize into long actin filaments referred to as fibrous actin (F-actin). The backbone of the 
thin filaments is formed by two intertwined actin filaments. Several other proteins that have a 
regulatory role are also found in thin filaments. Tropomyosin is one of them. It is a rod shaped 
protein that spiral about the actin core and helps stabilize it. The tropmnyosin 1nolecules are 
arranged end-to-end along the actin filament and in relaxed 1nuscle, tropo1nyosin blocks the 
1nyosin binding site on actin so that myosin cannot bind. Another regulatory protein found in 
thin filaments is troponin. Troponin is a globular three-polypeptide complex consisting of 
troponin I (Tnl), troponin T (TnT), and troponin C (TnC). Tnl is an inhibitory subunit that 
binds to actin. TnT binds to tropomyosin and helps position it on actin and TnC binds calcium 
ions (see Figure 1.3). 
The H zone of the A band appears less dense because the thin filaments do not extend into this 
region (see Figure 1.2). The M line in the center of the H zone is darker due to the presence of 
fine protein strands that hold adjacent thick filaments together. The Z disc is a coin shaped disc 
that consists mainly of the protein a-actinin and anchors the thin fila1nents. 
Elastic filaments consist of titin, a large elastic molecule that stretches from the Z disc to the 
thick filament and then runs parallel with the thick filainent (forming its core) to attach to the 
M line. It holds the thick filament in place, therefore maintaining the organization of the A 
band. It also helps the muscle to spring back into shape after being stretched. The I band 
spanning part of titin is extensible. It unfolds when the 1nuscle is stretched and recoils when the 
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tension is released. In the normal range of extension, titin does not resist stretching, but as it 
uncoils it stiffens. This helps the muscle to resist excessive stretching that would have pulled 
the sarcomeres apart (see Figure 1.2). 
N ebulin is an inelastic large protein that lies alongside the thin filaments and attaches to the Z 
disc, thereby helping to align the actin filaments (see Figure 1.4). The intermediate filament 
( desmin) that extends from the Z disc connects each myofibril to the next through the width of 
the fiber. The myofilaments are connected to the sarcomere and held in place at the Z discs and 
the M lines. 
Electron-microscopy of cross sections of the sarcomere show each thick filament is actually 
surrounded by a hexagonal arrangement of six thin filaments and each thin filament is enclosed 
by three thick filaments (see Figure 1.5). 
1.3.2 Dystrophin-glycoprotein complex 
The thin filaments are connected to the sarcolemma via a large protein, called dystrophin, which 
fonns a rod that connects the thin filainents to the sarcolemma via a protein complex referred to 
as the dystrophin-glycoprotein complex (see Figure 1.6). The integral components of the 
complex consist of dystrophin, the dystroglycan complex, the sarcoglycan complex, the 
dystrobrevin/syntrophin complex and sarcospan. An extracellular ligand, namely laminin-2, 
also forms part of the dystrophin-glycoprotein complex as well as intracellular binding partners 
(F-actin, syncoilin and filamin 2) and signaling molecules associated w ith the complex 
(cahnodulin, Grb2 and neuronal nitric oxide synthase - nNOS) (Ganong 1997; Rando 2001 ; 
Sciandra et al. 2003; Lapidos et al. 2004; Ervasti and Sonnemann 2008). 
The pri1nary role for the dystrophin-glycogen protein complex is the stabilization of the 
sarcolemma but it also plays a role in organizing molecules involved in cellular signaling 
(Rando 2001 ; Ervasti and Sonnemann 2008). 
1.3.3 Sliding filament theory of contraction 
The force created by contracting muscle is referred to as 1nuscle tension and the weight or force 
opposing the contraction is the load. Sir Andrew Huxley and Rolf Niedergerke discovered in 
1954, that the length of the A band of the sarcomeres in a myofibril remains constant during 
contraction (Huxley and Niedergerke 1954). They proposed the sliding filament theory of 
contraction which states that during contraction, the thin filaments slide past the thick filaments 
so that they overlap to a greater degree and in an energy requiring process (Huxley and 
Niedergerke 1954). 
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Figure 1.5: The 2D and 3D organization of the sarcomere (Silverthorn 2004). 
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Figure 1.6: The dystrophin-glycoprote in complex (Rando 2001 ). 
The s liding filament theory of contraction takes into account the fact that muscle does not 
always shorten during contraction. Muscle contraction can occur without creating movement, 
for example w hen we push against a wall. The tension generated in the muscle is directly 
proportional to the interaction between the thick and thin filaments (Huxley and Niedergerke 
1954). 
A myofibril at resting length has sarcomeres that have the ends of the thick and thin filaments 
over lapping sli ghtly. As the musc le contracts, the thick and thin filaments slide past each other 
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moving the Z discs of each sarcomere closer together. In the relaxed state, a sarcomere has a 
larger I band (thin filaments only) and an A band the length of the thick filament. As 
contraction proceeds, the sarcomere shortens. The Z discs move closer together, while the I 
band and H zone almost disappear. The changes occurring in the sarcomere are consistent with 
the sliding of the thin actin filaments along the thick myosin filaments as they move toward the 
M line in the middle of the sarcomere (Huxley and Niedergerke 1954) (see Figure 1.7). 
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Figure 1.7: Changes in the sarcomere during contraction 
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Skeletal muscle fibers contain two sets of intracellular tubules that participate in the regulation 
of contraction. They are the sarcoplasmic reticulum (SR) and transverse tubules (t-tubules) . 
The SR is a modified smooth endoplasmic reticulum and it surrounds the myofibril closely. 
Most of the tubules run longitudinally along the myofibril forming connecting branches in the H 
zone, others referred to as terminal cistemae form swollen perpendicular connections at the A 
band - I band junction (see Figure 1.8). The major function of the SR is to regulate 
intracellular levels of Ca2+. It stores Ca2+ and releases it upon stimulation for contraction. 
At each A band - I band junction, the sarcolemma forms invaginations that extends deep into 
the cell interior, forming elongated tubules referred to as transverse tubules (t-tubules). The 
effect of the presence of the t-tubule network is to increase the surface area of fiber. The lumen 
of the t-tubule is continuous with the extracellular matrix. T-tubules allow action potentials that 
originate on the cell surface to move rapidly into the interior of the muscle fiber thereby 
facilitating a quicker response time. A surface potential would only release Ca2+ at the surface 
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of the fiber and it would take the Ca2+ ions > 1000 times longer to reach the center of the fiber by 
diffusion through the cytosol than it would take the action potential traveling down the t-tubule 
membrane and releasing Ca2+ deep in the fiber. 
At-tubule encircles each sarcomere as it passes from one myofibril to the next. Along the 
length , the t-tubule is flanked by two terminal cisternae forming an intracellular junction called 
a triad (Franzini-Armstrong et al. 1999) ( see Figure 1.8). 
T-tubules Sarcolemma Mitochondria 
A 
Myofibril 
Thin filament Sarcolemma 
B 
Terminal cisternae 
Figure 1.8: T-tubul ar netwo rk and sarcoplasmic reticulum (SR). (A) The t-tubular network and sarcopl asmi c 
reti culum in relati on to the other internal structures of the muscl e fib er. (B) A closer view of th e arrangement of th e 
t-tubular network and the SR. Adapted from (S il verthorn 1998). 
1.3.4.1 Calcium release units 
The t-tubule flanked by two terminal cisternae, as mentioned above, is referred to as a triad , but 
that is not the only configuration between the t-tubules and SR. Sometimes the t-tubule is 
associated with only one tenninal cisterna, in which case, the junction is referred to as a dyad. 
When the SR form s a junction between the SR and the surface membrane, it is referred to as a 
10 
Chapter 1 
peripheral coupling. Triads, dyads and peripheral couplings are functionally equivalent and 
they are collectively referred to as calcium release units (CRUs) (Franzini-Armstrong et al. 
1999). In developing muscle and in the myotendinous junction of adult muscle fibers , pentads 
and heptads (two or three t-tubule elements with three or four elements of terminal cistemae 
closely alligned) can also be found (Yamashita et al. 2007). So CRUs are formed by apposed 
junctional domains of the sarcoplasmic reticulum and oft-tubules or sarcolemma. In skeletal 
muscle, the most common CRU is the triad. The CRU is essential for muscle function as it is 
the site of one of the steps in excitation contraction coupling (EC coupling) - the rapid release 
of calcium from the calcium store (SR) in response to the depolarization of the sarcolemma and 
t-tubules (Franzini-Armstrong 1973 ; Franzini-Armstrong and Jorgensen 1994; Flucher and 
Franzini-Armstrong 1996; Protasi et al. 1998; Franzini-Armstrong et al. 1999). The process of 
EC coupling will be discussed in further detail in Section 1.4.2. 
The electron micrograph of a triad showed in Figure 1.9 clearly shows the two terminal 
cistemae flanking the t-tubule in the center. There are also darker structures visible that span 
the gap between the t-tubule and the terminal cistemae (indicated by arrows). These darker 
structures were first referred to as foot structures but have since been shown to be the 
cytoplasmic assembly of the ryanodine receptor (RyR) (Kawamoto et al. 1986; Campbell et al. 
1987; Imagawa et al. 1987; Inui et al. 1987b; Lai et al. 1988). The RyR will be discussed in 
more detail in Section 1.5 
Figure 1.9: Electron micrograph of muscle from the hind legs of 
Rana pipiens showing the triad . Arrows indicate foot structures 
- adapted from (Franzini-Armstrong 1973). 
The RyR is one of many proteins involved in EC coupling. The depolarization of the t-tubular 
membrane has to be communicated to the RyR is some way. For this purpose the RyRl has 
recruited a voltage sensor in the t-tubular membrane in the form of an L-type voltage gated Ca2+ 
channel, the dihydropyridine receptor (DHPR). In skeletal muscle the communication between 
the DHPR and the RyR is a physical interaction with the signal communicated via 
conformational changes in the proteins . The DHPR will be discussed in more detail in Section 
1.6. 
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A further term used to describe this system is the "couplon" . A couplon is defined as a 
functional grouping of RYRs and DHPRs (and other SR proteins) which may act in concert 
during EC coupling. (Rios and Stern 1997; Stem et al. 1997). With this definition. a triad 
contains two couplons (one on either side of the t-tubule) and dyads and peripheral couplings 
are made up of one couplon. 
During development the formation of CRUs, the close association between SR and t-
tubules/sarcolemma, referred to as docking, is the first step (Franzini-Armstrong 2010). Small 
SR cistemae are docked at the sarcolemma before RyRs and DHPRs are detectable (Franzini-
Armstrong et al. 1991). There is evidence that the docking proteinjunctophilin is directly 
involved in this process (Takeshima et al. 2000). Docking occurs without the presence of any 
of the following proteins; RyRl (Takekura et al. 1995a), DHPR (Flucher et al. 1993 ; Felder et 
al. 2002), calsequestrin (Knollmann et al. 2006), triadin (Shen et al. 2007) and junctin (Franzini-
Armstrong 2010). Docking is an essential step for the assembly of CRUs in skeletal muscle, in 
the absence of junctophilin, expression of RyRl and DHPR is not sufficient to form CRUs 
(Takekura et al. 1995b ). 
Although the RyR and DHPRs have to be in close proximity to each other in order to interact, as 
shown above, each does not require the presence of the other to be retained in the CR Us . 
Another protein, perhaps junctophilin, must trap them within the CRU once they reach the site 
(Franzini-Armstrong 2010). Once within the CRU, the component proteins cluster into their 
characteristic assemblies. 
In mammalian skeletal muscle, the junctional gap is occupied by two rows of feet (RyRl s) 
therefore every foot has a side that faces the junctional gap and one facing the myofibril s 
(Franzini-Armstrong et al. 1999). Two geometrical factors are constant in all types of CRUs, 
the size of the junctional gap separating the SR from the t-tubule/sarcolemma (approximately 
the size of the foot) and the tight ordered clustering of feet. In skeletal muscle the Ry Rs are 
arranged in a tetragonal di sposition with a center-to-center distance of about 29nm. (Ferguson et 
al. 1984; Block et al. 1988; Saito et al. 1988; Franzini-Armstrong et al. 1999) 
1.3.4.2 The arrangement of RYRs and DHPR in the CR Us 
RyRl s. as stated above. form a two-rowed regular array in the CRUs with their comers 
overlapping. In skeletal muscle, the DHPRs are clustered into groups of four DHPRs (tetrads) 
overlaying every other RyR 1 (see Figure 1.10) (Ferguson et al. 1984; Block et al. 1988: 
Franzini-Annstrong and Kish 1995: Serysheva 2004). The fou r DHPRs making up the tetrad 
are arranged in such a way that they correspond to the four subunits of the RvRl . The fact that 
12 
Chapter 1 
tetrad formation is unique to skeletal muscle provides structural evidence supporting the 
mechanical nature of interaction between the DI-IPR and RyRl during EC coupling (Block et al. 
1988). Even though the RyR is not involved in targeting the DI-IPR to the CRU, tetrads only 
form in the presence of RyRl, suggesting that anchoring to RyRl is necessary for positioning 
DHPRs into tetrads (Protasi et al. 1998). 
Figure 1.10: Model of physical coupling between RyRl and DHPR in skeletal muscle based on freeze-fracture 
studies and using 3D reconstruction of two Ca2+ channels, generated by electron cryomicroscopy and single particle 
reconstruction. The model shows two arrays of Ry Rs overlaid by arrays of DHPRs grouped into tetrads. The scale 
bar represents 1 OOA. From (Serysheva 2004 ). 
How the RyRs that are not associated with DHPRs are activated during EC coupling is still not 
fully understood. One theory is that the Ca2+ released from the RyRs that are associated with 
the DHPRs activate the unassociated RyRs through a calcium induced calcium release (CICR) 
mechanism. There are, however, a few problems with this theory as the rate of Ca2+ release by 
CICR under physiological conditions is too low. This will be discussed in more detail in 
Section 1.4.2 that deals with EC coupling. Another theory involves the coordinated activities of 
multiple channels possibly though coupled gating. Coupled gating describes the simultaneous 
opening and closing of multiple RyR channels (Marx et al. 1998; Lehnart et al. 2003) that 
occurs through their physical contact at their comers and seems to be facilitated by FKBP 12 
(see Figure 1.10 and Section 1.4.2 and 1.5.3.2). 
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1.4 Physiology of skeletal muscle fibers 
1.4.1 The motor unit and neuromuscular junction 
1.4.1.1 The motor unit 
Every muscle is served by a motor nerve, which in turn consists of axons of up to hundreds of 
motor neurons whose cell bodies are clustered in a motor nucleus in the spinal cord or brain 
stem. The axon of each motor neuron exits the spinal cord through the ventral root or through a 
cranial nerve in the brain stem. It then runs in a peripheral nerve till it reaches the muscle. The 
axon branches when it reaches the muscle, to innervate the muscle fibers. 
A motor unit consists of a motor neuron and the muscle fibers it innervates. It is the basic 
fundamental unit through which the nervous system controls movement. The number of fibers 
that are innervated by a single motor neuron is referred to as the innervation nmnber. It varies 
with muscle type and function. In human skeletal muscle the range for average innervation 
number stretches from 5 ( eye muscles) to 1800 (leg muscles). Differences in innervation 
number reflect differences in average increment of force that occur when a motor unit is 
activated. It therefore gives an indication of the fineness of control of the muscle. The smaller 
the innervation number, the finer the control achieved by varying the number of motor units 
activated. The muscle fibers of a single motor unit are distributed throughout the muscle and 
fibers from different motor units are therefore intermingled. When a motor neuron transmits an 
action potential, all the muscle fibers it innervates contract and because they are spread 
throughout the muscle, it causes a weak contraction of the entire muscle. 
The force exerted by a muscle depends on the number of motor units activated, but it also 
depends on the properties of the active motor units. The relevant properties are: 
• Contraction speed 
• Maximal force 
• Fatigability 
These properties are assessed by examining the time course and force exerted by individual 
motor units in response to the number and rate of action potentials evoked. 
A motor unit's response to a single actio_n potential is referred to as a twitch (as is the response 
of one or all fibers in the muscle to one electrical stimulus) and the time it takes for the twitch to 
reach its peak force is the contraction time. The contraction time is measure of the contraction 
speed of fibers that make up a motor unit. A slow-twitch motor unit has a long contraction 
time ( e.g. 3 8ms in rat sole us muscle) and fast-twitch motor units have a shorter contraction time 
( e.g. 12ms in rat extensor digitorum longus, EDL muscle) (Close 1967). A rapid series of 
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action potentials cause overlapping twitches and is known as a tetanic contraction or tetanus. 
The force exerted during tetanus depends on the extent that the twitches overlap and summate 
and the innervation number. The force varies with the contraction time of the motor units 
involved as well as the frequency of the action potentials. Maximal force is reached at different 
action potential frequencies for fast- and slow-twitch motor units. Slow-twitch motor units 
produce small forces (e.g. 2.34-3.53N in rat soleus) (Larsson and Edstrom 1986), but are 
resistant to fatigue. These motor units are the first to be activated during voluntary contraction. 
On the other hand, fast-twitch motor units are the last to be activated, produce large forces ( e.g. 
11.9-15.0N in rat tibialis anterior - TA) (Larsson and Edstrom 1986) and are easy to fatigue. In 
a study of human motor units in toe extensors (EDL, extensor hallucis longis- EHL, extensor 
digitorum brevis - EDB) contraction forces of 6.3-78.1 mN were measured as well as an 
average contraction ti1ne of 74ms (range of 50-107ms) (Macefield et al. 1996). The order in 
which 1notor units are recruited is correlated with motor unit size ( size of motor neuron cell 
body, diameter and conducting velocity of motor neuron axon and amount of force muscle 
fibers can exert). 
1.4.1.2 The neuromuscular junction 
The branches of the axons from the motor neurons that form the motor units end in a number of 
terminals, each of which forms an elliptical neuromuscular junction (NMJ) along the surface of 
a single muscle fiber. Each muscle fiber has only one NMJ located approximately midway 
along its length. The axon terminal and muscle fiber are about 50nm apart, separated by the 
synaptic cleft and are situated in a shallow depression in the sarcolemma. At this point, the 
sarcole1nma is further invaginated into deep and regular folds , called post-junctional folds. The 
motor nerve terminal is specialized for the neurotransmitter, acetylcholine (ACh), release. 
Within the axon terminal are synaptic vesicles containing ACh that cluster adjacent to 
specialized structures of the presynaptic membrane, called active zones. A Ch receptors are 
highly concentrated, with a density of about 12000 receptors per µm2 (Shigemoto et al. 2010), 
close to the outennost part of the post-junctional fold. When the nerve impulse reaches the axon 
terminal, depolarization opens voltage gated Ca2+ channels on the presynaptic membrane, which 
triggers the fusion of the synaptic vesicles with the presynaptic 1nembrane and the release of 
ACh into synaptic cleft. ACh binds to ACh receptors on sarcolemma, which triggers 
depolarization of sarcolemina. A layer of connective tissue called basal lamina sheaths each 
muscle fiber and contains the enzyme acetylcholinesterase. After ACh binds to receptors, its 
effects are terminated by its enzymatic breakdown by acetylcholinesterase to acetate and 
choline. This prevents continued muscle fiber contractions in absence of additional nerve 
stimulation. 
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The binding of ACh to its ligand gated ACh receptors opens the ion channel which is permeable 
to a number of cations including Na+ and K+. When the ACh receptor opens, the resting 
membrane potential (-70 to -90mV) is close to the K+ equilibrium potential (-98mV) and far 
from the Na+ equilibrium potential (+67mV) and therefore the biggest driving force is on Na+ 
ions which move down their concentration gradient into the muscle fiber causing a local and 
transient depolarisation of the sarcolemma. Initially the depolarization is a local event ( end 
plate potential) but when depolarization reaches a threshold, an action potential is invoked 
which spreads in all directions across from the NMJ across the sarcolemma, opening voltage 
gated Na+ channels in adjacent areas of the sarcolemma and down the t-tubules. The Na+ 
channels inactivate and voltage gated K+ channels open allowing K+ to flow down its 
concentration gradient out of the fiber, reducing the membrane potential to a value near the K + 
equilibrium potential (repolarization). The repolarization occurs untill the resting membrane 
potential is restored, after which, the Na+ /K+ ATPase pump restores the ionic concentrations to 
resting levels by exchanging Na+ inside the fiber for K+ outside the fiber. 
1.4.2 Excitation contraction coupling 
The term EC coupling refers to the process whereby an action potential travelling along the 
sarcolemma and down the t-tubular membrane is converted into cross-bridge cycling and 
contraction of the muscle. However, it is also used more narrowly to describe the process 
occurring between sarcolemmal depolarization and Ca2+ release from the SR. Central to this 
process is the functional interaction between the DHPR in the t-tubular membrane and the RyR 
in the 1nembrane of the SR. EC coupling differs in skeletal muscle and in cardiac muscle. 
1.4.2.1 Skeletal muscle excitation contraction coupling 
When the action potential is propagated along the sarcole1nma and down the t-tubules, the 
change in the electrical field across the membrane caused by the movement of Na+ ions across 
the membrane causes the five to six positively charged residues that make up the voltage sensor 
in the DHPR to move outward under the influence of this electric field (Schneider and Chandler 
1973; Rios and Brum 1987; Tanabe et al. 1987; Numa et al. 1990; Serysheva 2004; Catterall 
2011 ). The movement of the charged residues causes a conformational change that is somehow 
relayed to the Ry Rs via a physical interaction (Tanabe et al. 1988; Numa et al. 1990: Paolini et 
al. 2004; Catterall 2011 ). The DHPR is a functional Ca2+ channel in itself and the charge 
1novement within this molecule changes, allowing the ion channel pore to enter an open state 
and Ca2- to enter the muscle fiber. This Ca2+ influx across the sarcolemma is smaJl and very 
slow (Lan1b and Walsh 1987; Field et al. 1988) and it is not necessary for EC coupling in adult 
vertebrate skeletal muscle (Rios and Pizarro 1991; Dulhunty 1992; Melzer et al. 1995). In fact 
skeletal type EC coupling can occur in the absence of extracellular Ca2_,_ . Interestingly, neonatal 
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vertebrate skeletal muscle is more like cardiac muscle as it requires the inflow of Ca2+ for full 
contraction (Dangain and Neering 1991 ; Melzer et al. 1995). The physical interaction between 
the DHPR and the RyR ( discussed in 1nore detail in Section 1.6) activates the RyR, which 
allows Ca2+ to be released into the cytoplasm resulting in muscle contraction (see Section 1.4.2). 
The Ca2+ released into the sarcoplasm is pumped back into the SR by the sarcoplasmic, 
endoplasmic Ca-ATPase (SERCA) that is located in the SR membrane. This lowers the 
cytoplasmic Ca2+ level allowing relaxation of the muscle fiber (see Figure 1.11). 
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Figure 1.11: A comparison between EC coupling in skeletal and cardiac muscle. In skeletal muscle (left panel), the 
DHPR sense the sarcolemmal depolarisation and transmit a conformational change to the RyRl causing the channel 
to open and release Ca2+ from the SR. Ca2+ influx through the DHPR is not required. RyRl channel snot associated 
with a DHPR tetrad may either be activated by Ca2+ release from a neighbouring RyRl or, more likely, by 
transmission of the conformational change through physical interactions between Ry RI within the array. In cardiac 
muscle (right panel), DHPRs are activated by sarcolemmal depolarization and allow Ca2+ influx into the cytoplasm. 
The Ca2+ entering the cell activate RyR2 channels allowing Ca2+ release from the SR. Neighbouring RyR2 channels 
may in turn be activated by Ca2+ flowing from the SR (Zissimopoulos and Lai 2007). 
The RyR and DHPR, as mentioned in Section 1.3 .4.2, are arranged in a very ordered way in the 
skeletal muscle CRU s. The DHPR forms tetrads and associates with every other RyRl in the 
CRU. The mechanism whereby the RyRs that are not associated with a DHPR tetrad are 
activated during EC coupling remains unclear with CICR as one possible theory and another 
theory that of a physical coupling between RyRl at the overlapping corners in the array. Ca2+ 
release induced by the direct action of Ca2+ through the voltage activated RyRl channel on 
neighbouring channels does not seem to significantly contribute to Ca2+ release during EC 
coupling as the rate of Ca2+ released by CICR under physiological conditions is too low (Endo 
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1984; Endo 2009). RyR inhibition by physiological lmM concentrations of Mg2+ also provides 
a stumbling block for CICR as Mg2+ inhibition is maintained in the presence of activating Ca2+ 
concentrations (Meissner 1994). The relief of Mg2+ inhibition is suggested as a fundamental 
part of EC coupling in response to signal transmission from the DHPR to RyR in skeletal 
muscle (Endo 1985; Lamb and Stephenson 1990; Lamb and Stephenson 1991). There is also 
evidence that Ca2+ activation of the RyRl is not necessary for the initiation of skeletal type EC 
coupling (O'Brien et al. 2002). Therefore the transmission of the EC coupling activation signal 
from the DHPR-associated RyRl s to their neighbouring DHPR-unassociated RyRl s probably 
occurs through a physical coupling. Image processing of electron micrographs of reconstituted 
RyRl arrays in vitro showed that adjacent RyRl tetramers are interlocked though domain 6 
located at the comer of the clamp region (see Section 1.5.1) (Yin et al. 2005a). RyRl channel 
recordings in lipid bilayer experiments show synchronous openings of 1nultiple channels, which 
suggests the occurrence of coupled gating (Marx et al. 1998; Marx et al.2001) . Coupled gating 
is consistent with intermolecular interactions occurring between physically interacting RyRl s in 
lipid bilayers. Coupled gating is not a unique feature of Ry Rs, as it has also been observed in 
IP3R (Dargan et al. 2002) and KcsA potassium channels (Molina et al. 2006). 
Ca2+ sparks are small, brief and highly localized releases of Ca2+ which can occur 
spontaneously, but at much higher frequencies during depolarisation and with voltage 
dependence similar to that of the activation ofCa2+ release (Baylor et al. 1983; Pape et al. 1995; 
Tsugorka et al. 1995; Klein et al. 1996). Numerous studies of intracellular Ca2+ signalling 
during EC coupling suggest that Ca2+ sparks are the basic unit events of physiological Ca2+ 
release (Cheng et al. 1993; Cannell et al. 1995; Klein et al. 1996). Each spark corresponds to a 
multiple RyRl-channel opening event and appears to have a preferred amplitude. This suggests 
that Ca2+ sparks involve a cohort of a specific number of RyR channels opening and closing in a 
coordinated synchronous 1nanner (Gonzalez et al. 2000; Rios et al. 2001 ). 
The proposed 1nechanis1n for coordinated activation of adjacent RyRl s in an array involves the 
following (see Figure 1.12) (Yin et al. 2005a; Yin et al. 2008). At rest, the DHPRs and RyRl 
are in the closed conformation. Upon depolarization of the sarcolemma and t-tubular 
1nembrane, there is a simultaneous 1novement of charge in the four DHPRs in one tetrad. The 
DHPR charge 1novement is transmitted to the directly associated RyRl and induces a 
conformational change and activation of the RyRl. This activation is transmitted to the RyRl s 
that are physically coupled to the activated RyRl in the array, inducing the111 to open 
synchronously. In thi s way, a single DHPR tetrad would be able to activate five RyRs 
synchronously (the RyRl associated with the DHPR and the four surrounding Ry Rs in the 
array), which is consistent with the proposed four to six activated RyRs requires to generate a 
s ingle ca2~ spark (Gonzalez et al. 2000; Rios et al. 2001 ). 
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Figure 1.12: Proposed mechanism of activation of Ca2+ release during a Ca2+ release event in skeletal muscle. In the resting state, the DHPRs (group of four black filled circles) and Ry Rs are in the 
closed state (left panel) . Upon depolarization of the sarcolemma, one tetrad is activated (group of four red stars) to produce a conformational change (middle panel). The DHPR conformational change 
is transmitted to the RyR 1 associated with the tetrad through a physical interaction and induces a conformational change and activation in the RyRl (yellow star). As the Ry Rs in the array are physically 
coupled, the conformational change would be instantly relayed to the neighbouring RyRl that are not associated with a tetrad, inducing them to open synchronously (right panel). Adapted from (Yin et 
al. 2005a). 
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1.4.2.2 Cardiac muscle excitation contraction coupling 
Cardiac EC coupling does not involve a physical interaction between the DHPR and the RyR. 
The activation of the cardiac isoform of the DHPR upon sarcolemmal and t-tubular membrane 
depolarization causes the Ca2+ channel pore to open, allowing Ca2+ to flow into the cytoplasm. 
The Ca2+ entering the cell binds to the RyR2 in the SR membrane , activating the RyR Ca2+ 
release channel and allowing Ca2+ to flow into the cytoplasm from the SR. There is 
approximately one-tenth as many DHPRs as RyR2s but that is all that is required to allow 
sufficient Ca2+ entry to activate all the RyR2s. The rise in cytoplasmic Ca2+ concentration 
activates the contractile proteins as with skeletal muscle. The Ca2+ is subsequently taken up into 
the SR by SERCA and extruded from the cell by the Na+/Ca2+ exchanger on the sarcolemma, 
allowing the muscle to relax (Lamb 2000; Zissimopoulos and Lai 2007). Cardiac muscle CRUs 
are mostly diads (Franzini-Armstrong 1999) and although the DHPR and RyR2 are in close 
proximity to each other, the DHPRs do not form tetrads but are randomly distributed with 
respect to the RyR2 arrays (Carl et al. 1995a; Sun et al. 1995; Protasi et al. 1996). An opening 
of a single cardiac DHPR channel triggers the calcium release from 4-6 RyR2 channels (Wang 
et al. 2001) (see Figure 1.11) . 
1.4.3 Cross-bridge cycling 
The sliding filament theory described in Section 1.3 .3 relies on mechanical work performed by 
the globular myosin heads and requires ATP for energy. The binding of the myosin head to the 
actin filament forms a cross bridge and the sequence of detachment, activation and attachment 
of myosin heads to actin filaments is referred to as cross-bridge cycling. Cross-bridge 
formation (attachment of 111yosin heads to actin) requires Ca2+. The active (myosin-binding) 
sites on the actin filament in a relaxed muscle fiber, when intracellular levels of calcium ions are 
low, are physically blocked by tropo1nyosin molecules. As Ca2+ levels rise, the ions bind to 
regulatory sites on troponin. Each troponin molecule can bind up to four Ca2+ ions. To aJlow 
availability of the active sites on the actin filament, troponin C must bind two calcium ions, 
change shape, and then roll tropomyosin into the groove of the actin helix, away from the 
myosin binding sites. Once binding sites on actin are exposed, cross bridge cycling can occur. 
Cross-bridge cycling is the series of events during which myosin heads pull thin filaments 
toward the centre of the sarcomere. Before the myosin head can bind to actin it binds to ATP. 
The A TPase activity of the myosin head cleaves the ATP but leaves the resulting ADP and 
phosphate ion (Pi) bound to the head. In this state, the head extends perpendicular toward the 
actin fila1nent ready to bind to the active sites on actin. Cross bridge cycling involves the 
following steps : 
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myofilament, fanning a cross bridge. 
Chapter 1 
• Step 2: The power stroke - ADP and Pi are released and the myosin head pivots and 
bends, changing to its bent, low energy shape. This results in the actin filament sliding 
toward the M line. 
• Step 3: Cross bridge detachment - After a new ATP molecule attaches to the myosin at 
the site where ADP was released, the link between myosin and actin weakens, and the 
myosin head detaches (the cross bridge "breaks"). 
• Step 4: Cocking of myosin head - As ATP is again hydrolysed to ADP and Pi, the 
myosin head returns to its pre-stroke high-energy or "cocked" position ready to bind to 
actin once more. 
Cross-bridge cycling and thus the sliding of the thin filament continues as long as the calcium 
signal and enough ATP are present. The force that a muscle fiber can exert depends on the 
nu1nber of cross-bridges formed and also the force produced by each cross-bridge. Both factors 
are influenced by the Ca2+ concentration in the cytoplasm, the amount of overlap between the 
thick and thin filaments and the velocity with which the filaments slide over each other. The 
release and uptake of Ca2+ in response to a single action potential occurs so quickly that there is 
not enough time for all the potential cross-bridges to form and therefore only some of them are 
formed. The peak force of a twitch is less that the maximal force of the muscle for this reason. 
Maximal force can be achieved only when a series of action potentials sustains the Ca2+ 
concentration in the cytoplasm, allowing for maximum cross bridge formation. 
When SERCA pumps the Ca2+ from the cytoplasm into the SR, troponin changes back to its 
original shape and tropomyosin moves back over the active sites, bloc~ing them from myosin. 
The contraction ends and the muscle fiber relax. Contracting muscle routinely shortens by 3 0-
35% of its total resting length, so each myosin cross bridge attaches and detaches many times 
during a single contraction and the actin filament does not slide backwards because there are 
always some myosin heads attached to actin. 
1.5 The ryanodine receptor 
Structures were observed in skeletal muscle in the early 1970s in electron micrographs as large 
electron dense masses (feet) spanning the junctional gap between the SR membrane and the t-
tubules (Franzini-Armstrong 1973) were later found to be RyRs. Intact RyR molecules were 
isolated and purified in skeletal muscle and the purified receptors incorporated into lipid 
bilayers as functional Ca2+ channels with characteristics identical to the Ca2+ release channels 
previously identified in the heavy SR (Kawamoto et al. 1986; Campbell et al. 1987; Imagawa et 
al. 1987; Inui et al. 1987b; Lai et al. 1987; Lai et al. 1988). The RyR gained its name because 
the plant alkaloid Ryanodine, found in the Ryania speciosa, a plant from Central and South 
America, binds to it very specifically. 
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Three isofo rms ofRyR are expressed in n1ammals: RyRl , RyR2 and RyR3. RyRl was first 
detected in skeletal muscle (Takeshi1na et al. 1989; Zorzato et al. 1990), RyR2 in cardiac 
muscles (Nakai et al. 1990; Otsu et al. 1990) and RyR3 was found in the brain (Haka1nata et al. 
1992). They are each encoded by a distinct gene (RYRl , RYR2 and RYR3), residing on three 
diffe rent chromosomes. RYRl is located on chromosome 19q 13 .2 and spans 104 exons, R YR2 
is located on chromosome lq43 and spans 102 exons and RYR3 is located on chromoso1ne 
15ql3.3-14 and spans 103 exons (Lanner et al. 2010). The three mam1nalian isoforms share 
about 70% homology (Hakamata et al. 1992) with the highest sequence identity present in the 
car boxy-terminal end (Hakainata et al. 1992; Zissimopoulos and Lai 2007). Three 1naj or 
regions of diversity are tenned D 1-3. D 1 lies between residues 4254 and 4631 in the skeletal 
sequence, D2 between residues 1342 and 1404 and D3 between residues 1872 and 1923. D2 is 
essential for the mechanical interaction between RyRl and DHPR (Sorrentino and Volpe 1993 ; 
Yainazawa et al. 1997; Perez et al. 20036). 
RyRl is predo1ninantly expressed in skeletal muscle (Takeshima et al. 1989; Zorzato et al. 
1990) but is also found in s1nooth muscle (Neylon et al. 1995) stomach, kidney, thymus (Nakai 
et al. 1990), cerebellar Purkinje cells, adrenal glands, ovaries and testis (Marks et al. 1989; 
Takeshi1na et al. 1989; Furuichi et al. 1994; Giannini et al. 1995; Ottini et al. 1996) as well as 
B-ly1nphocytes (Vukcevic et al. 2010). RyR2 is predo1ninantly expressed in cardiac muscle 
(Nakai et al. 1990; Ottini et al. 1996), but is also found to be the predominant isoform in the 
brain (Kuwaji1na et al. 1992; Lai et al. 1992a; Nakanishi et al. 1992; Sharp et al. 1993 ; Furuichi 
et al. 1994 ). RyR2 is also found in the stomach, kidney, adrenal glands, ovaries, thymus and 
lungs(Giannini et al. 1995). RyR3 is more widely expressed including in hippocampal neurons, 
thalamus, Purkinje cells, corpus striatum (Hakamata et al. 1992; Lai et al. 1992a; Furuichi et al. 
1994 ), skeletal muscle (Marks et al. 1989) ( especially during development (Conti et al. 2005 · 
Perez et al. 2005) and in the adult diaphragtn), smooth 1nuscle cell of the coronary vasculature 
lung, kidney, ilernn, jejunrnn, spleen, stomach, uterus, ureter, urinary bladder and oesophagus 
(Giannin i et al. 1992; Hakainata et al. 1992; Giannini et al. 1995; Neylon et al. 1995: Ottini et 
a l. 1996). 
Non-mammalian vertebrate (birds, a1nphibians, reptiles, fish) ske letal 1nuscle contain two RyR 
isoforms referred to as a and ~ (A irey et al. 1990; 0 I iv ares et al. 1991 ; Lai et al. 1992b; 
Murayama and Ogawa 1992; O'Brien et al. 1993). The ~-isofonn is homol ogous to RyR3 and 
the a-isofonn to RyR 1 (Oyamada et al. 1994; Giannini et al. 1995; Conti et al. 1996). The 
RyR 1 and RyR3 isoforms ( a and ~) are present in equal amounts in non-mammalian skeletal 
muscle with both isoforms found in the triads (Airey et al. ] 990: Olivares et al. 1991: Lai et al. 
1992b ). Although RyRJ is present in mammalian ske letal muscle and found in the triadic 
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microsomal fraction, it is present at a 20- to SO-fold lower concentrations (Ledbetter et al. 1994; 
Giannini et al. 1995; Takeshima et al. 1995; Conti et al. 1996). 
1.5.1 Structure 
The RyR is the largest known ion channel, with four subunits of about SOOkDa, it forms a 
homotetramer of about 2MDa. Because of its size and the fact that it is a membrane bound 
protein, a detailed atomic three dimensional structure is not available and the protein awaits 
crystallization. The structural information about the RyR that is available has been obtained 
with the use of cryo-electron microscopy (EM) (Radermacher et al. 1994; Serysheva et al. 199 5; 
Jeyakumar et al. 1998; Sharma et al. 1998; Wagenknecht and Samso 2002; Samso et al. 2005 ; 
Serysheva et al. 2005 ; Samso et al. 2006; Serysheva et al. 2008 ; Hamilton and Serysheva 2009; 
Samso et al. 2009), comparative modelling (Welch et al. 2004) and recently x-ray 
crystallography of sections of the RyR (Amador et al. 2009; Lobo and Van Petegem 2009; Tung 
et al. 2010). 
The RyR has a quatrefoil or cloverleaf-shaped structure when seen from above (i.e. looking 
down from the t-tubule membrane) and seen from the side has a mushroom shape with the 
cytoplasmic assembly forming the "cap" (27nm x 27nm x 12 nm) and the "stalk" made up of 
the smaller square shaped transmembrane assembly measuring about 12 x 12nm where it 
attaches to the cytoplasmic assembly and with a length of around 7nm (see Figure 1.13). The 
quatrefoil structure arises from the symmetrical arrangement of the four subunits. The 
cytoplasmic assembly consists of 15 distinct domains (1 , 2a, 2b, 3, 4, 5, 6, 7 a, 7b, 8a, 8b, 9, 10, 
11 and 12) per subunit that can be mapped onto morphological units called the clamp, handle, 
column and the central rim (see Figure 1.14). The clamp is found on the corners of the 
cytoplasmic assembly and is formed by domains 5, 7a, 7b, 8b, 9 and 10 from one subunit and 
domains 6 and 8a from the adjacent subunit. The clamps are connected through the handle that 
surrounded the central rim, which is connected to the transmembrane assembly via the column. 
The handle is formed by domains 3 and 4, the central rim by domains 1, 2a and 2b and the 
column by domains 11 and 12 (Serysheva et al. 2008). In bet\veen these domains are numerous 
cavities that facilitate interactions with solvent, small molecules and protein modulators. The 
molecule has the architecture of scaffolding that allows for mechanical linkage bet\veen the SR 
membrane and the t-tubules but also allow solutes (Ca2+) to flow through it easily . 
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Figure 1.13: Three dimensional reconstruction ofRyRlin the closed confirmation at a resolution of2 5-30A. 
Regions that differ between the open and closed states are shown in red. The structure is shown from the (a) top (view from cytoplasm), (b) the side view (b) and ( c) from the bottom (view from the SR lumen). The dashed circles 
indicate the clamp regions. The scale bar represents 1 00A. Adapted from (Serysheva 2004 ). 
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Figure 1.14: A 9.6A resolution cryo-EM map of the RyRl showing the numbering of the globular domains on the 
cytoplasmic assembly from (A) the top view (view from cytoplasm) and (B) the side view. The clamp. handle and 
column and central rim morphological units have also been indicated. (Serysheva et al. 2008) 
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The clamps undergo major conformational changes during the opening and closing of the 
channel (see Figures 1.13 and 1.15) (Serysheva 2004; Serysheva et al. 2008; Sainso et al. 2009) 
and are likely to participate in inter molecular interactions between neighbouring RyRs (Yin et 
al. 2005a; Yin et al. 2005b; Yin et al. 2008). They are also the sites of interactions with 
modulators (Wagenknecht et al. 1994; Wagenknecht et al. 1996; Wagenknecht et al. 1997; 
Samso and Wagenknecht 2002; Samso et al. 2006; Sharma et al. 2006). The transmembrane 
domain also undergoes conformational changes during the opening and closing of the channels 
as to be expected. It seems to undergo dilation and constriction quite like a camera diaphragm 
(Serysheva et al. 1999). The transmembrane assembly is rotated at 4 ° with respect to the 
cytoplasmic assembly during the open conformation of the channel (Orlova et al. 1996; 
Serysheva et al. 1999; Sharma et al. 2000). 
closed open 
Figure 1.15: 3D reconstructions of the RyRl in the closed (left) and in the open (right) stateat a resolution of 25-
30A. The clamp domains are marked with an asterisk and the presence and absence of a channel opening in the 
transmembrane regions with an arrow. The scale bar represents 100A. (Serysheva 2004) 
Hydropathy plots of the primary sequence of the RyRl indicates a large hydrophilic N-terminal 
region, which corresponds to the cytoplasmic assembly, and a smaller mostly hydrophobic C-
tenninal region which corresponds to the transmembrane assembly and with a sequence that is 
the most conserved among the RyR isoforms (Takeshima et al. 1989; Nakai et al. 1990; Otsu et 
al. 1990; Zorzato et al. 1990; Hakamata et al. 1992; Tunwell et al. 1996). Two topology 
models, of 4 transmembrane (TM) (Takeshima et al. 1989) or I 0TM segments (Zorzato et al. 
1990), were first proposed. Since then a lot of experimental work has been done (Marty et al. 
1994; Grunwald and Meissner 1995; Tunwell et al. 1996; Du et al. 2002; Du et al. 2004; Ludtke 
et al. 2005) and the latest model of the transmembrane topology is based on a revised I 0TM 
model and can be seen in Figure 1.16. The RyRl pore structure in the closed position resolved 
at 9 .6A (Ludtke et al. 2005) shows at least 5 a-helices within the membrane spam1ing region. 
The structure can be seen in Figure 1.17. Helix 1 is likely to correspond to Ml 0 and was 
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assigned as the inner, pore-lining helix with the gating hinge, whereas helix 2 likely corresponds 
to M9 or pore loop and contains a sequence analogous to the selectivity filter in K+ channels and 
is therefore possibly the selectivity filter for RyRl (Ludtke et al. 2005). 
Cytosol 
nmmm. 
llJllfilJJlfilJllfilJU 
Lumen 
Foot region 
Pore loop 
Figure 1.16: Model of the membrane topology of the RyR. The model is based on the l0TM model but revised with late experimental evidence. Hydrophobic sequences M5, M6, M8 and MIO span the membrane once. M7 is shown 
as a transmembrane hairpin and M4 resides parallel to the SR membrane on the cytoplasmic side. Hydrophobic domain M9 dips inside the lipid bilayer from the luminal side to form the pore loop and selectivity filter. The 
residues marked on the model correspond to rabbit RyRl. (Zissimopoulos and Lai 2007) 
SR lumen 
Figure 1.17: The putative helices in the RyRl membrane spanning region at a resolution of 9.6A. (A) Stereo view of 
the membrane spanning region view from the SR luminal side along the symmetry axis. The helices are shown in red (inner helix). green (pore helix). blue and purple. (B) Side view perpendicular to the symmetry axis showing tv,•o of 
the four subunits of RyRl with annotated helices showing the relative positions of the putative a helices within the SR membrane. The scale bar indicates 50A. (Ludtke et al. 2005) 
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The binding sites for two proteins that closely associates with the RyR and alter channel gating, 
namely calmodulin (CaM) and FKBP12 have been localized by cryo-EM. The differences in 
shape between the RyRl by itself and bound to the proteins were used to identify the binding 
sites (Wagenknecht et al. 1997) and the results showed that both CaM and FKBP 12 are situated 
further than 10nm away from the pore. This suggests that conformational changes can be 
transmitted over long distances between the binding sites and the channel pore. 
Two studies have solved high-resolution crystal structures (2.5A) of portions of the N-terminal 
region of the RyRl (Amador et al. 2009; Tung et al. 2010). The first study crystalized the N-
terminal 210 residues and the second study the N-terminal residues 1-559. The first 210 
residues were found to adopt a~ trefoil fold structure, and residues 1-559 were found to fold 
into three distinct domains that were arbitrarily termed A, B and C, farming a vestibule around 
the central rim of the channel. 
1.5.2 Interactions with other proteins 
The RyR serves as a scaffold for other proteins and cofactors and are often complexed with 
several accessory proteins to form an intricate multiprotein array. Apart from its interactions 
with the DHPR, the RyR's other binding partners include proteins such as FKBP12, calmodulin, 
junctin, triadin, calsequestrin and several kinases. 
The interactions between the DHPR and the RyRl will be discussed in the section dealing with 
the DHPR in more detail (Section 1.6). 
1.5.2.1 FKBP12 
FKBP stands for FK506 binding protein. The proteins form part-of the immunophilin fainily of 
highly conserved proteins that bind immunosuppressive drugs like rapamycin and FK5 06. 
FKBPs are named according to their molecular weight and are expressed in most tissues. They 
are involved in a number of biochemical processes such as protein folding, receptor signalling, 
protein trafficking and transcription (Lanner et al. 2010). FKBP12 and FKBP12.6 have been 
shown to physically interact with all three isoforms of RyR, but they have different expression 
levels in different tissues (Chelu et al. 2004). FKBP12 is sometimes referred to as calstabin 1 
and FKBP12.6 as calstabin 2. Both isoforms of FKBP have peptidyl-prolyl cis-trans isomerase 
activity and consists of 108 residues with 85% homology (Kay 1996). They have nearly 
identical structures as determined by X-ray crystallography (Michnick et al. 1991 ; Van Duyne et 
al. 1991 ; Deivanayagam et al. 2000). Co-immunoprecipitation and co-purification assays as 
well as GST-FKBP affinity chromatography have shown that RyRl binds both FKBP12 and 
FKBP12.6 with similar affinities (Collins 1991; Jayaraman et al. 1992; Timerman et al. 1995; 
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Timerman et al. 1996; Qi et al. 1998). Because FKBP12 is more abundant in skeletal muscle 
native RyRl is isolated as a complex with mostly FKBP12. 
FKBP12 binds to the RyRl with a stoichiometry of four FKBP12 molecules to one 
RyRltetramer with one FKBP12 molecule associated with each subunit ofRyRl (Jayaraman et 
al. 1992). Mutation analysis has shown three residues (Q3, Rl8 and M49) on FKBP12 to be 
important for the interaction with RyRl (Lee et al. 2004a), but that isomerase activity is not 
necessary for the interaction with RyRl (Timerman et al. 1995). The RyRl-FKBP12 
interaction is a high affinity, conformation sensitive, interaction. Strong FKBP12 binding 
occurs when RyRl is in its open state (Kd of about lnM), but the RyRl 's closed configuration 
enhances this binding even further (approximately 4-5 orders of magnitude) (Jones et al. 2005). 
The RyRl-FKBP12 interaction is unaffected by temperature or pH, but is sensitive to ionic 
strength (Mackrill et al. 2001). The binding site of FKBP12 to RyRl has been visualized with 
cryo-EM along the edge of the of the cytoplasmic assembly on domain 3 in the handle region 
about 12nm away from the channel entrance (Wagenknecht et al. 1997). A later study found 
two interaction sites between FKBP12 and RyRl (Samso et al. 2006). A portion of the ~-sheet 
of FKBP12 interacts with domain 9 and the intersection of domain 3, 5 and 9. Loop 87-90 of 
the FKBP12 molecule binds with domain 3 ofRyRl (see Figure 1.18). 
DOMAIN3 
loop 8-19 
Figure 1.18: Detail of the proposed interaction between RyRl and FKBP12. RyRl (green) is shown with FKBP12 (blue) and FK506 (gray). Interaction with domain 3, 5 and 9 can be seen (Samso et al . 2006). 
Functionally, FKBP12 stabilizes RyRlin the closed and open conformation. In the absence of 
FKBP 12 channels show an increased open probability with extended openings to 
subconductance levels (partial openings to less than the full current amplitude) as well as 
increased sensitivity to Ca2- or caffeine activation and reduced sensitivity to Mg2- inhibition 
(Timerman et al. 1993: Ahem et al. 1994: Brillantes et al. 1994: Mavrleitner et al. 1994 · 
Timerman et al. 1995: Ahem et al. 1997~ Barg et al. 1997; Qi et al. 1998). The subconductance 
levels are multiples of ¼ of the total conductance of the channel which might indicate that the 
8 
Chapter 1 
subunits can act semi-independently, but coordinate to allow maximum current amplitude 
(Franzini-Armstrong and Protasi 1997). 
The action of FKBP12 on RyRl is thought to maintain RyRl in the closed state at low cytosolic 
Ca2+ concentrations or after inactivation, and to stabilize the RyRl in a high conductance state 
during channel activation. This enables a steeply increasing and large cytosolic Ca2+ transient 
that is necessary for activation of contraction (Lehnart et al. 2003 ). An additional role for the 
FKBP12 ' s regulation of RyR activity is that of the facilitation of coupled gating. Coupled 
gating is the simultaneous opening and closing of multiple channels as opposed to independent 
stochastic gating of channels (Lehnart et al. 2003). Coupled gating depends on the close 
special organization of RyR complexes and is suggested to occur only in the presence of 
FKBP12. This mechanism has been suggested as way in which the RyRs that are not associated 
with DHPRs can be activated during skeletal type EC coupling (Marx et al. 1998; Lehnart et al. 
2003 ; Yin et al. 2005a; Yin et al. 2005b; Yin et al. 2008). 
1.5.2.2 Calsequestrin, triadin and junctin 
The efficiency of calcium release during EC coupling is dependent, among other things, upon 
the activity of RyRl and the amount of calcium stored in the SR. These two factors, however, 
are interdependent because the amount of calcium in the calcium store affects the activity of the 
RyRl , partially through the action of the calcium binding protein, calsequestrin (CSQ), in the 
lu1nen of the SR (Beard et al. 2002; Beard et al. 2005; Wei et al. 2006) and the activity of the 
RyRl in tum affects the level of calcium in the SR. 
CSQ has high capacity and low affinity for Ca2+ which makes it an efficient Ca2+ binding and 
storage protein (MacLennan and Wong 1971; Ikemoto et al. 1972; Beard et al. 2009a). The 
binding of Ca2+ to CSQ effectively allows the total Ca2+ concentration in the SR to be in excess 
of 201nM, while the free Ca2+ concentration remains at around lmM (MacLennan and Wong 
1971). CSQ undergoes conformational changes upon changes in Ca2+ concentration so that its 
conformation is highly dependent upon the Ca2+ concentration and ionic strength of its 
environment. It has the highest Ca2+ binding capacity as a polymer which occurs at Ca2+ 
concentrations > lmM (physiological free Ca2+ concentration in SR) (Fryer and Stephenson 
1996). CSQ has a C-terminal tail domain with a high density of acidic residues and forms a 
Ca2+ binding pocket when CSQ polymerises (Wang et al. 1998; Beard et al. 2009b). CSQ as a 
polymer is visible in electron micrographs as electron-dense material in the terminal cistemae of 
the SR anchored near the luminal face of the RyRl(Franzini-Armstrong 1999) 
Skeletal muscle has two isoforms of CSQ that are expressed and coded for by different genes 
(Scott et al. 1988; Fliegel et al. 1990). CSQl (skeletal isoform) is the only isoform expressed in 
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fast-twitch skeletal muscle (Biral et al. 1992; Damiani and Margreth 1994), while slow-twitch 
skeletal muscle also express CSQ2 ( cardiac isoform) as a minor transcript together with CSQ 1. 
The two isoforms share 86% homology (Fliegel et al. 1987; Scott et al. 1988). The major 
difference being in the C-terminal with CSQ2 having an extended, highly acidic C-terminal tail. 
Functionally, CSQl inhibits RyRl(Beard et al. 2002; Wei et al. 2009) and CSQ acts as a 
luminal Ca2+ sensor for RyR (Beard et al. 2004; Gyorke et al. 2004; Wei et al. 2006; Qin et al. 
2008) and is anchored to the junctional face of the SR membrane by its interactions with two 
integral SR proteins, triadin andjunctin (Guo and Campbell 1995; Zhang et al. 1997). 
Triadin and junctin are thought to be closely involved in the inhibitory interaction between 
CSQl and RyRl as this interaction is only seen when RyRl channels have triadin andjunctin 
associated (Beard et al. 2002; Wei et al. 2009). In the absence of triadin and junctin, CSQ 1 
enhances RyRl channel activity probably by binding directly to the RyRl (Szegedi et al. 1999· 
Beard et al. 2002), showing that the normal inhibitory action of CSQ 1 on RyRl requires the 
presence of triadin and j unctin. 
Triadin was originally identified by Caswell et al and Kim et al (Kim et al. 1990; Caswell et al. 
1991) and was isolated from skeletal muscle as a 95kDa membrane glycoprotein (Brandt et al. 
1990). At a later stage the primary sequence and structure of skeletal triadin was deduced from 
its cDNA sequence. An intrinsic membrane protein of about 705 residues was predicted 
containing a short cytoplasmic N-terminus, a single membrane-spanning domain, and a long 
intraluminal C-terminal domain (Knudson et al. 1993a; Knudson et al. 19936). There are 
multiple isoforms of triadin in both skeletal muscle and in cardiac muscle, but they are all 
encoded by a single gene (Trdn) and undergo alternative splicing give rise to the multiple 
isoforms (Knudson et al. 19936; Guo et al. 1996; Kobayashi and Jones 1999; Marty et al. 2000· 
Vassilopoulos et al. 2005). Skeletal muscle has four isoforms labelled according to their 
molecular weights (Trisk 95, 51 , 49 and 32). Trisk 95 is the predominant isoform in skeletal 
muscle (Caswell et al. 1991; Knudson et al. 1993a; Knudson et al. 19936; Marty et al. 1995· 
Taske et al. 1995; Kobayashi and Jones 1999; Thevenon et al. 2003; Shen et al. 2007). All of 
triadin ' s isoforms share identical sequences between residues 1-264, but have unique C-terminal 
regions. Triadin forms oligomers through disulphide bonds (Caswell et al. 1991 ,. 
Triadin interacts with RyRl through both the cytoplasmic and luminal domajns of triadin. The 
cytoplasmic binding site to RyR l involves residues 18-46 and is Ca2+ dependent (optimal Ca2 ... 
concentration < l 0µM) (Groh et al. 1999). The luminal RyRl binding site involves a triadin 
sequence of alternating positive and negative residues located between residues 210-224 known 
as the KEKE motif (Realini et al. 1994: Jones et al. 1995: Kobayashi et al. 2000: Lee et al. 
30 
Chapter 1 
2004b ). These KEKE residues interact with the RyRl at the most C-terminal luminal loop (M8-
Ml 0 loop) where three charged residues are important for the interaction (D4878, D4907 and 
E4908) (Guo and Campbell 1995; Lee et al. 2004b; Goonasekera et al. 2007). Trisk 49 and 32 
do not bind RyRl although they contain both the cytoplasmic binding domain and the KEKE 
motif (Vassilopoulos et al. 2005). 
Junctin is a 26kDa non-catalytic splice variant of the aspartate-~-hydroxylase gene. It is an 
integral membrane protein found in the junctional SR of both skeletal and cardiac muscle and 
has a structure similar to that of triadin. It has a short, 21 residue cytoplasmic N-terminal 
domain, a single transmembrane domain and a highly charged luminal domain which is highly 
enriched with KEKE motifs. It is not glycosylated and does not form disulphide-linked 
oligomers (Jones et al. 1995). Junctin binds to RyR and triadin through its luminal domain in a 
Ca2+ independent manner, but binding to CSQ is disrupted by either low or high Ca2+ 
concentrations (Zhang et al. 1997). The binding site for junctin on RyRl is different to that of 
triadin as mutating the three residues important for triadin binding does not abolish junctin 
binding to RyRl (Goonasekera et al. 2007). 
Because of junctin and triadin's structural similarity and the ability of both to interact with CSQ 
and RyRl, they were presumed to be functionally redundant and were clumped together as CSQ 
anchoring proteins. It has since been shown that triadin and junctin have independent functions 
in regulating RyRl. When triadin binding to RyRl is abolished by the mutation of the three 
RyRl residues important for its binding, EC coupling and Ca2+ release fro1n the SR are 
modified even thoughjunctin binding remains intact (Goonasekera et al. 2007). Trisk 95 
enhances [3H]ryanodine binding to recombinant RyR channels and triadin or junctin added 
independently to the luminal side of purified RyRl in planar lipi~ bilayer studies, each increase 
the open probability of the channel (Goonasekera et al. 2007; Wei et al. 2009). Wei et al also 
showed that junctin alone is responsible for normal CSQ 1 regulation of RyRl (Wei et al. 2009), 
however, there is mention of Ca2+ imaging studies in junctin-null mice showing nearly wild type 
phenotype with no significant alteration in skeletal SR content and a small but significant 
increase in resting cytoplasmic Ca2+ concentration (Perez 2011; Boncompagni et al. 2012). 
Another study by Yuan et al, however, found an increased SR content injunctin null 
cardiomyocytes (Yuan et al. 2009). Therefore junctin's role in the SR remains to be fully 
unveiled. Triadin-null myotubes show significant dysregulation of Ca2+ homeostasis indicating 
that triadin is a key functional component of Ca2+ homeostasis in skeletal muscle (Perez 2011 ; 
Boncompagni et al. 2012). 
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1.5.2.3 Calmodulin 
Calmodulin (CaM) is part of the EF-hand family of Ca2+ sensing proteins. It is a ubiquitous 
highly conserved protein of 17kDa with a high affinity for Ca2+. Calmodulin participates in a 
number of Ca2+ signalling processes that regulate various mechanisms including growth 
proliferation and movement. It has a dumbbell-shaped structure with N-terminal and C-terminal 
globular domains which are linked by a flexible linker. The N-terminal and C-terminal domains 
each contains two EF hand Ca2+ binding motifs. Calcium free calmodulin is referred to as 
apocalmodulin ( apo-CaM) and binding of Ca2+ causes conformational changes to the molecule 
(Porter Moore et al. 1999a; Chin and Means 2000; Zissimopoulos and Lai 2007). 
Calmodulin binds to all three RyR isoforms with nanomolar affinity both in its calcium bound 
and apo-CaM form (Porter Moore et al. 1999a; Fruen et al. 2000; Rodney et al. 2000; Balshaw 
et al. 2001; Yamaguchi et al. 2005). As with FKBP12, four CaM molecules bind to one RyR 
molecule ( one for each subunit) at high and low Ca2+ concentrations (Chen and MacLennan 
1994; Menegazzi et al. 1994; Yang et al. 1994; Tripathy et al. 1995). The CaM binding site 
involves residues 3614-3643 on the RyRl (rabbit sequence) (Takeshima et al. 1989; Porter 
Moore et al. 1999b; Yamaguchi et al. 2003; Zhang et al. 2003). The CaM/RyRl binding site has 
also been visualized by cryo-EM as with FKBP12 and is situated approximately 10nm from the 
putative channel pore in clefts formed by domains 3, 4 and 7 (Wagenknecht et al. 1997). Cryo-
EM studies found that Ca2+ -CaM and apo-CaM bind to overlapping but spatially distinct 
locations on the RyRl with the centres of mass of the two forms of CaM differing by 3-4nm 
(Wagenknecht et al. 1997; Samso and Wagenknecht 2002). However, a subsequent study 
employing FRET to investigate the binding of Ca2+-CaM and apo-CaM to the RyRl found no 
difference in Ca2+ -CaM and apo-CaM binding sites (Cornea et al. 2009). The different sites of 
binding have since been confirmed by cryo-EM using a mutated CaM with its four Ca2+ binding 
sites rendered incapable of binding Ca2+ (Huang et al. 2012). The different results obtained by 
FRET and cryo-EM may possibly be explained by the location of the fluorophores on CaM and 
how it changes its conformation upon binding to Ca2+ and further investigation is need to 
resolve this matter. 
CaM has a Ca2+-dependent biphasic effect of RyRl activity. CaM activates RyRl at low 
nanomolar Ca2+ levels, but at Ca2+ concentrations higher than 1 µM, it inhibits the RyRl 
(Meissner 1986; Smith et al. 1989; Fuentes et al. 1994; Tripathy et al. 1995; Rodney et al. 2000· 
Fruen et al. 2003). CaM binding to RyRl , however, is not essential for EC coupling as 
mutation of its binding site to RyRl did not affect voltage-induced calcium release (O'Connell 
et al. 2002). CaM does, however, bind to and regulate the DHPR a,15 calcium current so it may 
contribute to EC coupling through this interaction (Tang et al. 2002; Ohrtman et al. 2008). 
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Apart from CaM, a number of other EF-hand containing proteins have been shown to interact 
with RyR, including calumenin and S 1 00Al. S 1 00Al competes with CaM for the binding site 
on the RyR. The role for these proteins in vivo is, however, still not clear (Jung et al. 2006; 
Wright et al. 2008). 
1.5.2.4 Glutathione S-transferase (GST) 
Glutathione S-transferases are a major group of detoxification enzymes (Hayes and Pulford 
1995). Some of the members of this family have been shown to modulate RyR calcium release 
from skeletal and cardiac muscle. The effects thusfar defined are muscle specific with GSTs 
having a strong inhibitory action on RyR2 and a weaker activation of RyRl. The first member 
of the GST family shown to have an effect on RyR activity was the GST-omega class protein. 
Other members of the GST family examined were found to have similar actions to GST-omega. 
They include GSTAl-1 , the muscle specific GSTM2-2 and the CLIC2 (chloride intracellular 
channel type 2) protein (Dulhunty et al. 2001; Board et al. 2004; Dulhunty et al. 2005; Liu et al. 
2009). Modulation of Ry Rs is probably a ubiquitous function of the GST family but the muscle 
specific GSTM2-2, which is strongly expressed in skeletal and cardiac muscle is the most 
physiologically relevant GST in terms of RyR modulation. 
Structurally, GSTs have distinct N-terminal and C-terminal domains. The N-terminal domain 
forms a thioredoxin fold 1nade up of three a-helices and four anti parallel ~-strands. Most of the 
residues involved in glutathione (GSH) binding are found in this domain. The C-terminal 
--
domain has a bundle of five to six helices that are connected with unstructured loops. The 
overall fold of the C-terminal domain is conserved but it is generally more variable than the N-
terminal domain thereby allowing different substrates to be accommodated by different 
isoforms (Dulhunty et al. 2011 ). 
As stated above, the general modulation of GSTs on cytoplasmic side of Ry Rs involves the 
inhibition of RyR2 and activating RyRl channels (Dulhunty et al. 2001 ; Board et al. 2004; 
Dulhunty et al. 2005; Liu et al. 2009). CLIC2, however is an exception as it inhibits both RyRl 
and RyR2 in bilayer studies (Board et al. 2004). Modulation effects are mild and occur within a 
physiological range of open probabilities. RyR2 inhibition for example does not abolish RyR2 
activity but is reduced 40-60% of control activity, while RyRl activation by GSTs is by a factor 
of about 2 and not to maximal activity. RyRl therefore remains responsive to modulation by 
other agents. 
33 
Chapter 1 
1.5.3 Non-protein modulators of RyR1 function 
Not only is the RyR involved in protein interactions that modulate its function. there are also 
some smaller non-protein molecules that significantly influence RyR function. Some of the 
molecules discussed here are normally present in cells (Ca2+, Mg2+ and ATP). whereas others do 
not occur in muscle cells naturally and are substances commonly used to study RyR function 
( caffeine, ryanodine, ruthenium red). 
Ruthenium red is an inorganic dye used in histology and it completely blocks CICR (Ohnishi 
1979; Miyamoto and Racker 1981; Meissner 1984; Smith et al. 1986; Ma 1993). It is often used 
as a tool to check for RyR-dependent Ca2+ leaks from the SR as well as identifying RyR at the 
end of lipid bilayer experiments. 
1.5.3.1 Ca2+, Mg2+, and ATP 
Ca2+ is thought to be the "physiological" RyR channel activator as other RyR ligands cannot 
activate the channel in the absence of Ca2+, or Ca2+ is necessary for some ligands to have their 
full effect (Zucchi and Ronca-Testani 1997). Cytosolic Ca2+ has a biphasic effect on RyRl 
channel activity (Meissner et al. 1986; Smith et al. 1986; Pessah et al. 1987; Bull and Marengo 
1993; Percival et al. 1994; Meissner et al. 1997). RyRl is activated above l00nM Ca2+ with a 
maximal activation between 10-1 00µM. Millimolar Ca2+ concentrations almost completely 
inhibit RyRl. The bell shaped cytosolic Ca2+-dependence curve suggests the existence of high-
affinity Ca2+-binding sites on RyRl that stimulate the channel and low-affinity inhibitory 
binding sites. Ca2+ alone, however, cannot fully activate the RyRl and other agonists are 
therefore still able to modulate RyRl activity in the presence of Ca2+. It has also been shown 
that RyRl has considerable functional heterogeneity with respect to Ca2+ regulation, which may 
be due to differences in the redox state between individual channels (Ma 1995; Capello et al. 
1997; Marengo et al. 1998). Recombinant RyRl expressed in HEK293 cells showed Ca2+-
dependence properties similar to native channels (Chen et al. 1997) and is therefore a suitable 
model for native channels. 
Lu111inal Ca2+ also has an effect on the RyR as demonstrated by single channel recordings 
(Sitsapesan and Williams 1994b; Sitsapesan and Williams 1995; Tripathy and Meissner 1996· 
Gyorke and Gyorke 1998; Xu and Meissper 1998; Laver et al. 2004) and the rate of Ca2+ release 
fro111 the SR that is sensitive to Ca2+ store content (Donoso et al. 1995; Lamb et al. 2001a). 
Increasing the luminal Ca2+ concentration increases RyRl channel activity by increasing its 
sensitivity to its cytosolic agonists (Ca2+, ATP and caffeine) and by alleviating Mg2+ inhibition 
(Sitsapesan and Williams 1995; Tripathy and Meissner 1996; Xu and Meissner 1998). The 
luminal Ca2+ concentration, however. has a threshold where. if reached. it can cause a decrease 
in channel activity (Tripathy and Meissner 1996). The mechanism of activation by luminal Ca2+ 
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can involve Ca2+ binding on the luminal side of the RyR (Sitsapesan and Williams 1994b; 
Sitsapesan and Williams 1995; Gyorke and Gyorke 1998) and/or the cytosolic Ca2+ regulatory 
sites activated by Ca2+ flowing through the pore from the luminal solution (Tripathy and 
Meissner 1996; Xu and Meissner 1998). Both mechanisms are probably operational with 
luminal Ca2+ altering the cytosolic Ca2+ regulatory sites ' affinity through an allosteric effect if 
only one channel is present. In RyRl arrays, luminal Ca2+ flowing through one channel might 
interact with cytosolic regulatory sites on neighbouring channels (Laver et al. 2004 ). The 
luminal Ca2+ sensor is an intrinsic RyR property (luminal Ca2+ regulatory sites) as purified RyR 
channels that are not associated with CSQ, triadin and junctin are regulated by luminal Ca2+ 
(Ching et al. 2000), but CSQ, triadin and junctin are also involved (Gyorke et al. 2004; Beard et 
al. 2005) in conveying sensitivity to luminal Ca2+ to the RyR, by modifying the intrinsic RyR 
response. 
Mg2+ is a very strong inhibitor of the RyR. It inhibits the RyRl in a dose-dependent manner, 
with complete inhibition occurring at millimolar concentrations of Mg2+ (Meissner et al. 1986; 
Smith et al. 1986; Pessah et al. 1987; Lamb and Stephenson 1994; Laver et al. 1997a; Copello et 
al. 2002; Laver et al. 2004). Since Mg2+ has a cytoplasmic concentration of about lmM, Mg2+ 
inhibition may be a significant mechanism for keeping the RyRl in the closed state until 
activation during EC coupling. Mg2+ inhibits RyRl activity in the absence of Ca2+ (Laver et al. 
2004). It has also been suggested that it competes with Ca2+ for high affinity Ca2+-stimulatory 
sites, having the opposite effect to Ca2+ upon binding to these sites, as well as the low affinity 
inactivation sites (Laver et al. 1997a). Mg2+ has a binding affinity to the Ca2+ binding sites 
comparable to that of Ca2+ (Laver et al. 1997a; Liu et al. 1998; Copello et al. 2002). In skeletal 
muscle, the inhibition of Ca2+ release by Mg2+ seems to be modulated by depolarisation, which 
decreased the affinity of RyRl to Mg2+ (at least the RyRl associated with DHPRs) (Lamb and 
Stephenson 1994; Ritucci and Corbett 1995). 
The adenine nucleotides (ATP, ADP, AMP and cyclic-AMP) as well as adenine (but not 
adenosine) activate RyRl channel activity (Meissner et al. 1986; Smith et al. 1986; Pessah et al. 
1987; Rousseau et al. 1988). ATP is a potent agonist of RyRl at millimolar concentrations 
(Meissner 1984; Meissner et al. 1986; Smith et al. 1986; Pessah et al. 1987; Laver et al. 2001 ). 
RyRl is activated by ATP even at low nanomolar Ca2+ concentrations and a combination of 
micromolar Ca2+ and millimolar ATP concentrations further increase RyRl channel activity. 
ATP has been suggested to increase RyRl sensitivity to Ca2+ activation, decrease RyRl 
sensitivity to Ca2+ inactivation and Mg2+ inhibition (Meissner et al. 1986; Meissner et al. 1997). 
ATP and other adenine nucleotides seems to interact with the RyRl at a molecular site that is 
different from (although interacting with) the Ca2+-binding and Mg2+- binding site. Two 
putative binding sites have been identified in RyRl by sequence analysis. The sites contain the 
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nucleotide binding motif GXGXXG (Takeshima et al. 1989; Zorzato et al. 1990). Labelling the 
putative binding site with a photoaffinity analogue of ATP showed a molar ratio of 1: 1 with the 
subunits of the RyRl(Zarka and Shoshan-Barmatz 1993). 
1.5.3.2 Caffeine 
Millimolar concentrations of caffeine activate the RyR through a ligand binding, and do not 
cause sarcolemmal depolarization. It facilitates CICR in skinned skeletal fibers even at 
inhibiting Mg2+ concentrations (Weber 1968; Weber and Herz 1968; Endo et al. 1970; Delay et 
al. 1986; Rousseau et al. 1986; Meissner and Henderson 1987; Ikemoto et al. 1991 ). RyR 
activation by caffeine is Ca2+ dependent and inhibited by ryanodine (Fabiato 1985; Rousseau et 
al. 1988; Rousseau and Meissner 1989). Caffeine may have two modes of action. At relatively 
low concentrations less than 2mM () the effect of caffeine is dependent on Ca2+ being present 
and therefore its action may be to increase the sensitivity of the Ca2+ activation site. However, 
at higher caffeine concentrations, the RyR channels are activated in the absence of Ca2+ and 
with different kinetics to Ca2+ activation alone or in combination with caffeine, though the 
permeability remains the same (Sitsapesan and Williams 1990). 
1.5.3.3 Ryanodine 
As mentioned before, ryanodine is a plant alkaloid that binds to the RyR with such high 
specificity that it has been used in its initial identification and lends its name to it. Its action on 
the RyR is complex. In the whole animal and when applied to intact muscle, ryanodine can 
produce either intense contracture, which is accelerated by muscle activity, or flaccidity 
(Franzini-Armstrong and Protasi 1997). The reason for this contradictory effect lies in the 
direct dual action ryanodine elicits on RyR that is concentration-dependent (Fairhurst and 
Jenden 1966; Fleischer et al. 1985; Pessah et al. 1985; Sutko et al. 1985; Smith et al. 1988; Lai 
et al. 1989; Zimanyi et al. 1992). Low and high concentrations of ryanodine have opposite 
effects on the RyR. At low concentrations ( <l 0µM), ryanodine locks the RyR into a partially 
open subconductance state (Rousseau et al. 1987; Smith et al. 1988). This effect is strongly 
dependent on the RyR being in its open state as it selectively binds to the RyR in the open state 
(Pessah et al. 1985; Michalak et al. 1988; Lai and Meissner 1989; Chu et al. 1990a). This is 
facilitated by a high affinity binding site for ryanodine that is better accessible in the open 
channel (Zimanyi and Pessah 1991 ). As the concentration of ryanodine is increased, the affinity 
of RyRs for ryanodine decreases (Pessah et al. 1985; Michalak et al. 1988; McGrew et al. 1989) 
through allosteric negative interactions between four binding sites (one per monomer). The first 
ryanodine molecule binds with high affinity to the open channel and reduces the binding affinity 
of ryanodine to the other sites. With each subsequent binding of ryanodine to a binding site. the 
affinities of the remaining sites are lowered. When one ryanodine molecule per monomer is 
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bound, the channel enters a long lived state in which ryanodine is occluded and the channel is 
totally blocked (Carroll et al. 1991 ; Pessah and Zimanyi 1991 ; Buck et al. 1992). 
1.5.4 Post-translational modifications 
As the RyR is such a large protein, it is subject to quite a number of post translational 
modifications such as phosphorylation, oxidation and nitrosylation. 
Both the skeletal and cardiac RyRs are substrates for serine/threonine protein kinases. In 
particular cAMP-dependent protein kinase (PKA), Ca2+/calmodulin-dependent protein kinase II 
(CaMKlI) and to a lesser extent cGMP-dependent protein kinase (PKG) (Takasago et al. 1989; 
Chu et al. 19906; Takasago et al. 1991 ; Witcher et al. 1991 ; Hohenegger and Suko 1993; Suko 
et al. 1993). Dephosphorylation is catalysed mainly by protein phosphatase 1 (PPl) and 2A 
(PP2A) (Marx et al. 2000; Marx et al. 2001 ). CaMKII co-purifies with the RyR though direct 
association (Chu et al. 19906; Hohenegger and Suko 1993; Currie et al. 2004 ). The association 
of PKA, PPl and PP2A with RyR seems take place indirectly through anchoring proteins (Marx 
et al. 2001). Most of the emphasis in the field of phosphorylation has been on RyR2. There is 
therefore not as much information about phosphorylation of RyRl. One site for 
phosphorylation has been identified for RyRl at S2843 and all three kinases phosphorylate this 
site to different degrees, with PKA showing the highest phosphorylation of this site, followed 
by PKG and then CaMKII (Suko et al. 1993). Functionally, the phosphorylation of the RyR 
activates the channel by increasing the sensitivity to Ca2+ activation a12d substantially reduced 
Mg2+ inhibition (Takasago et al. 1989; Takasago et al. 1991 ; Hain et al. 1994; Hain et al. 1995; 
Mayrleitner et al. 1995; Patel et al. 1995; 'Valdivia et al. 1995; Marx et al. 2000; Uehara et al. 
2002; Reiken et al. 2003 ; Carter et al. 2006). 
Oxidative modifications of thiol residues in cysteines, such as S-nitrosylation, S-
glutathionylation and disulphide oxidation, can modulate the skeletal and cardiac RyR (Xu et al. 
1998; Eu et al. 2000; Aracena et al. 2003 ; Aracena et al. 2005; Sanchez et al. 2005; Sun et al. 
2008). Endogenous redox modulators regulate the RyR. Reduced glutathione inhibits the RyR, 
but oxidized glutathione stimulates the RyR (Zable et al. 1997; Xia et al. 2000). Reactive 
o:x.rygen species (ROS) such as hydrogen peroxide and superoxide anion radical activate the RyR 
(Boraso and Williams 1994; Favero et al. 1995; Kawakami and Okabe 1998; Zima et al. 2004) . 
Nitric oxide has also been suggested as an important physiological modulator of RyR function, 
but results are somewhat contradictory (Meszaros et al. 1996; Stoyanovsky et al. 1997; Xu et al. 
1998; Eu et al. 2000; Aracena et al. 2003 ; Cheong et al. 2005). However, most of the studies 
show an activation of the RyR by NO and contradictory results may be due to different 
experimental conditions such as NO donor concentrations. Recently, NO-induced Ca2+ release 
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through RyRl was shown to occur in cerebellar Purkinje cells (Kakizawa et al. 2012: Kakizawa 
2013; Kakizawa et al. 2013) suggesting that, at least in Purkinje cells, the activation of RyRl by 
NO is the more plausible scenario. 
There is evidence for at least three classes of functional cysteines that modulate Ry Rs and the 
activity of the RyR has been correlated to the number of free thiols (Aghdasi et al. 1997: Sun et 
al. 2001). Under physiological conditions, the number of free thiols on the RyRl is high (about 
48 per subunit) and this is associated with low channel activity. Oxidation of about 10 thiols 
did not substantially affect channel activity, but the oxidation of about 15 additional thiols 
increased channel activity reversibly. Further oxidation of approximately 10 additional thiol 
groups caused the channel to be irreversibly inactivated (Sun et al. 2001 ). Oxidation of thiol 
groups the RyR channel's sensitivity to Ca2+ activation (Marengo et al. 1998; Xia et al. 2000; 
Sun et al. 2001; Oba et al. 2002; Bull et al. 2003). It also increases the RyR sensitivity to ATP 
activation and decreases its sensitivity to Mg2+ inhibition (Donoso et al. 2000; Oba et al. 2002; 
Aracena et al. 2003; Bull et al. 2003). Protein-protein interactions are also affected by oxidation 
with the formation of intrasubunit and intersubunit cross-links within the RyRl (Wu et al. 1997) 
as well as complexes with triadin (Liu et al. 1994), CaM (Kawakami and Okabe 1998; Moore et 
al. 1999; Zhang et al. 1999; Eu et al. 2000; Aracena et al. 2005)and FKBP12 (Aracena et al. 
2005) being affected. 
1.5.5 Alternative splicing 
Futatsugi et al (Futatsugi et al. 1995) investigated the possibility that splice variants of the RyR 
exist, as the Inositol triphosphate receptor (IP3R), which shares several structural features with 
the RyR, and had been shown to have splice variants in the N-terminal and modulatory regions 
(Nakagawa et al. 1991; Schell et al. 1993). Futatsugi et al found two alternatively spliced 
regions localized in a modulatory region of the RyRl. They called the two regions ASI and 
ASII. The ASI region contains 15bp that are included in the ASI( + ), or excluded in the ASI(-) 
RyRl variants. ASII involves the inclusion and exclusion of l 8bp and also generated two 
variants ASII( +) and ASII(-). The exclusion of the ASI and ASII base pairs result in the 
absence of 5 or 6 amino acid residues respectively. In the ASI region, this corresponds to 
Ala348 1 -Gln3485 and in the ASII region Va13865 -Asn3870 in rabbit RyRl. Each of the splice 
variants involves the inclusion/exclusion· of an exon. 
Analysis of splicing patterns by Futatsugi et al. revealed a molar ratio of ASI( + ):ASI(-) to be 
roughly 3: 1 in skeletal muscle. Only ASI( +) is found in the cerebrum and cerebellum. They 
also found that during the stages of development, the splicing pattern of ASI in muscle changed 
dramatically. In the e1nbryonic period, only ASI(-) was detected and the proportion of ASI( +) 
38 
Chapter 1 
increased gradually with development. Both ASII( +) and ASII(-) was detected in skeletal 
muscle and cerebrum with molar ratios of ASII( +) :ASII(-) about 10: 1 in skeletal muscle and 
more than 10:1 in the cerebrum. The cerebellum only showed the presence of ASII(+). The 
splicing pattern of ASII in muscle also changed dramatically during development. After birth 
ASII(-) abruptly became predominant. The ratio of ASII( + ):ASII(-) increased gradually until 
three weeks after birth (Futatsugi et al. 1995). 
Kimura et al (Kimura et al. 2005) later found that the ASI splicing pattern is different in 
patients suffering from myotonic dystrophy type 1 (DMl). DMl is a debilitating multisystemic 
disorder caused by a CTG repeat expansion in the DMPK gene. Several genes have been found 
to undergo aberrant splicing and contribute to the symptoms of the disease. Kimura et al 
investigated whether RyRl also undergoes aberrant splicing. In normal subjects, ASI(+)RyRl 
was the major splice variant, while in cultured myotubes, ASI(-)RyRl was the dominant splice 
variant. This is consistent with the findings of Futasugi et al. In patients with DMl , ASI(-) was 
significantly increased compared to age-matched controls, although the degree of aberrant 
splicing was variable. In some patients, the splice pattern was not discemably different from 
control, whereas in other cases, there was 100% ASI(-). ASII(-)RyRl splice variants in DMl 
patients were similar to control. Kimura et al also performed functional studies using 
[3H]ryanodine binding and lipid bilayer techniques. They found the channel activity of 
ASI(-)RyRl to be less than that of ASI(+)RyRl , but that their biphasic Ca2+ dependence of 
ryanodine binding was similar. In lipid bilayers, the open probability of ASI(-)RyRl was lower 
than ASI( + )RyRl. They also showed that caffeine induced Ca2+ release from ASI( + )RyRl and 
ASI(-)RyRl was similar but that there was a significantly higher incidence of Ca2+ oscillations 
in ASI( + )RyRl during the application of 1 0mM caffeine. This is indicative of a less active 
ASI(-)RyRl channel (Kimura et al. 2005). 
In a subsequent study, Kimura et al (Kimura et al. 2007) investigated the possibility that the ASI 
region may be involved an inter-domain interaction. Residues 3495-3502, which are close to 
the ASI region, had been shown to influence binding of the DHPR ~ la subunit, which is 
involved in EC coupling in skeletal myotubes (Cheng et al. 2005). In their investigation, 
Kimura et al made use of peptides corresponding to sequences surrounding the variably spliced 
regions (ASI and ASII). The peptide corresponding to ASI( + )RyRl was called PASI( + ), ASI(-
)RYRl \Nas called PASI(-) and so on. Both PASI peptides significantly increased 
[3H]ryanodine binding to native SR vesicles as well as purified RyRl over a range of Ca2+ 
concentrations (l00nM to l0µM). The increase in [3H]ryanodine binding was significantly 
greater ·with PASI(-) than with PASI(+). The peptides induced the greatest increase in 
[3H]ryanodine binding at 1 00nM Ca2+ with the [3H]ryanodine binding declining with increased 
Ca2+ concentrations. Neither PASII( +) nor PASII(-) had any effect on [3H]ryanodine binding. 
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The P ASI peptides also increased Ca2+ release from SR vesicles in a dose-dependent manner 
with PASI(-) releasing significantly more Ca2+ at concentrations between 1 0 and 50µM than 
PASI( + ). When Kimura et al repeated their [3H]ryanodine binding studies using recombinant 
ASI(+)RyRl and ASI(-)RyRl rather than native RyRl from SR, their results again showed the 
P ASI peptides activating RyRl with PASI(-) inducing the greatest relative activation. P ASI(-) 
activated ASI(-)RyRl at lower concentrations than ASI( + )RyRl. These results together led 
Kimura et al to propose a model in which an inter-domain interaction between the ASI region 
and a binding partner stabilizes the closed state of the R YR 1 and upon binding. The P ASI 
peptides abolish this interaction, resulting in channel activation. They also proposed that 
ASI(-)RyRl interacts more strongly with its binding partner than ASI(+)RyRl, causing ASI(-
)RyRl to dwell more in the closed state. Upon disruption of this interaction, the removal of the 
stronger interaction in ASI(-)RyRl causes a greater relative channel activation. The peptides 
corresponding to ASII had no effect on channel activity which either suggests that this region 
does not participate in an inter-domain interaction, or if it does, the site is not accessible to the 
peptides. 
Kimura et al then went on to investigate the effects of the ASI region on EC coupling (Kimura 
et al. 2009). In recording Ca2+ currents through the DHPR and Ca2+ release from the SR under 
voltage clamp conditions in dyspedic (RyRl-null) myotubes expressing either ASI( + )Ry RI or 
ASI(-)RyRl, Kimura et al found that voltage-induced Ca2+ release during EC coupling was 
significantly increased in ASI(-)RyRl expressing myotubes. The magnitude and voltage 
dependence of the L-type currents were similar in ASI(-)RyRl and ASI(+)RyRl expressing 
myotubes as well as wild type myotubes ( endogenously expressing RyRl ). This indicates that 
DHPR expression and RyRl association are similar for ASI(+)RyRl and ASI(-)RyRl and 
correlates with previous results (Kimura et al. 2005; Kimura et al. 2007). Kimura et al then 
tested SR Ca2+ content and Ca2+ release from the SR in ASI(+)RyRl and ASI(-)RyRl 
expressing dyspedic myotubes. The authors used another RyRl specific agonist 4-choloro-m-
cresol ( 4-cmc) to induce Ca2+ release from the SR. They found that in contrast to voltage-
induced Ca2+ release (EC coupling), but consistent with previous single channel data, 4-cmc 
induced Ca2+ release was significantly reduced in ASI(-)RyRl expressing myotubes. Kimura et 
al then investigated the possibility that the different effects observed during EC coupling with 
the splice variants may be due to the secondary structure of the greater ASI domain (including 
the basic residues that serves as the ~la subunit binding site). The authors therefore compared 
the structure of the PASI peptides using circular dichroism (CD) and nuclear magnetic 
resonance (NMR). They found that their structures are very similar and therefore suggest that 
the functional differences are not due to structural differences between ASI(+)RyRl and 
ASI(-)RyRl. They also showed that the basic residues that were incorporated into the PASI 
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peptides were essential for the activation of RyRl by the P ASI peptides. When three of the 
basic residues were mutated to alanine or lysine, RyRl activation was significantly reduced. 
1.5.6 Mutations of the RyR1 causing disease 
Because the RyR is such a large protein there are many possibilities for mutations and many 
have been associated with three clinically distinct muscle disorders, namely Malignant 
Hyperthermia (MH), Central Core Disease (CCD) and Multi-minicore Disease (MmD) (Treves 
et al. 2005). 
MH is an autosomal dominant pharmacogenetic disorder of skeletal muscle first described by 
Denborough and Lovell in 1960 (Denborough and Lovell 1960). The clinical manifestations are 
triggered in pre-disposed individuals by inhalation of anaesthetics ( e.g. halothane) or by 
depolarising muscle relaxants ( e.g. succinylcholine ). The manifestations include a rapid 
increase in body temperature, muscle rigidity, tachycardia, hypercapnia, cyanosis, 
rhabdomyolisis and myoglobinuria (Denborough and Lovell 1960; MacLennan and Phillips 
1992; Denborough 1998; Miller 2009). MH is a life-threatening disease if not recognised and 
treated shortly after onset with the RyR antagonist, dantrolene (Zhao et al. 2001 ; Paul-Pletzer et 
al. 2002; Krause et al. 2004 ). 
CCD is a congenital myopathy involving structural changes of the muscle fibers (Magee and 
Shy 1956). It is usually inherited as an autosomal dominant disease, b_~t two cases of recessive 
CCD has also been reported (Jungbluth et al. 2002; Romero et al. 2003). CCD is characterized 
by hypotonia during infancy, proximal weakness, delayed motor development and reduced 
muscle bulk (Magee and Shy 1956; Isaacs et al. 1975; Shuaib et al. 1987). CCD is diagnosed 
with histological identification of large, well demarcated, centrally located cores that lack 
mitochondria and do not stain with histological dyes for oxidative enzymes. In longitudinal 
sections, the core area covers a considerable length of mostly the slow-twitch muscle fibers 
(Greenfield et al. 195 8; Shuaib et al. 1987; Hayashi et al. 1989; Sewry et al. 2002) . 
MmD is a non-progressive congenital myopathy and it is inherited autosomal recessively. 
Infants are typical hypotonic at birth, present distal joint laxity, ophtalmoplegia and 
arthrogyposis. Progressive scoliosis and respiratory problems are common, with most patients 
requiring 1nechanical ventilation. Multiple small cores can occur in both slow-twitch and fast-
twitch fibers, but unlike CCD, the cores do not run the entire length of the fiber (Ferreira et al. 
2002; Treves et al. 2005 ; Zissimopoulos and Lai 2007). 
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More than 100 different RyRl mutations have so far been associated with MH. CCD and MmD 
(Treves et al. 2005; Zissimopoulos and Lai 2007; Capes et al. 2011). They are mostly 
associated with RyRl mutations, but also with small, in-frame deletions or out-of-frame 
insertions. The mutations cluster in three regions on RyRl: the N-terminus. the central domain 
and the C-terminal domain containing the channel pore. There are, however. mutations outside 
these regions and they will probably increase as more mutations are found and better sequency 
methods become available. These same three regions are involved in arrythmogenic diseases in 
RyR2, which might suggest common mechanisms of action. Mutations on the R YRl gene are 
the only mutations, so far, linked to CCD. MH mutations are mostly on RYRl , but there are 
also MB-causing mutations in the gene coding for the DHPR a,1s subunit (Ali et al. 2003 ). Only 
a minority of MmD cases are due to RYRl mutations, with the majority of cases caused by a 
mutation on the selenoprotein gene (SEPNl) (Ferreira et al. 2002). MR-linked mutation are 
mostly in the N-terminal and central domains of the RyRl and CCD-linked mutations 
predominate in the C-terminal domain, however, mutations for MH and CCD are found in all 
three regions. Some mutations cause both MH and CCD (Quane et al. 1993; Zhang et al. 1993 ; 
Jurkat-Rott et al. 2000; McCarthy et al. 2000; Treves et al. 2005). 
Studies on the effects ofMH and CCD indicate that RyRl mutations in the N-terminal and 
central domain as well as the C-terminal domain result in higher sensitivity to RyRl agonists 
such as caffeine and halothane, as well as to sarcolemmal depolarisation. The 1nutant channels 
also show reduced sensitivity to inactivation by Mg2+ and Ca2+ (Gallant and Lentz 1992; Otsu et 
al. 1994; Treves et al. 1994; Laver et al. 1997b; Owen et al. 1997; Tong et al. 1997; Censier et 
al. 1998; Dietze et al. 2000; Avila and Dirksen 2001; Yang et al. 2003; Wehner et al. 2004· 
Chelu et al. 2006). Mutant RyRl channels show increased basal activity at rest to a variable 
extent, which can result in higher resting cytoplasmic Ca2+ concentrations and lower Ca2+ store 
content. Lower Ca2+ store content leads to a reduced magnitude of Ca2+ release and therefore 
muscle weakness (Censier et al. 1998; Tong et al. 1999; Avila and Dirksen 2001; Tilgen et al. 
2001; Avila et al. 2003b; Zorzato et al. 2003 ; Dirksen and Avila 2004; Brini et al. 2005: Chelu 
et al. 2006). CCD-linked mutations have the highest effect on Ca2+ store depletion. Disruption 
of interdomain interactions involved in stabilizing the channel in the closed state has also been 
suggested in MH (Yamamoto et al. 2000; Lamb et al. 2001 b; Shtifman et al. 2002: Yamamoto 
and Ikemoto 2002; Kobayashi et al. 2004; Bannister and Ikemoto 2006; Lobo and Van Petegem 
2009). 
1.6 The dihydropyridine receptor (DHPR) 
In muscle. the major Ca2+ currents have a high voltage of activation, large single channel 
conductance, slow voltage-dependent inactivation, marked up-regulation by PK.A 
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phosphorylation pathways and specific inhibition by Ca2+ antagonist drugs such as 
dihydropyridines, phenylalkylamines and benzothiasepines (Reuter 1979; Tsien et al. 1988). 
These Ca2+ currents are known as L-type because they have slow voltage dependent inactivation 
and are therefore long lasting (Tsien et al. 1988; Catterall 2011). Due to the L-type Ca2+ 
channel's specific interaction with dihydropyridines, it is also referred to as the dihydropyridine 
receptor (DHPR). 
The different types of voltage gated Ca2+ channels are primarily defined by different a 1 subunits. 
Ten different a 1 subunits have been characterized by cDNA cloning and functional expression 
in mammalian cell lines and Xenopus oocytes. These can be divided into three structurally and 
functionally related families; Cav 1, Cav2, and Cav3 (Snutch and Reiner 1992; Ertel et al. 2000) 
(See Table 1.1). For the purposes of this thesis, the Cav 1 family of a 1 subunits, in particular the 
skeletal muscle isoform Cav 1.1 ( a 15) and cardiac muscle isoform Cav 1.2 ( a 1c) will be discussed. 
Table 1.1: Subunit composition and function of Ca2+ channel types. Adapted from (Catterall 
20112 
Ca 2+ current a 1 Subunits Specific blocker Principle physiological function 
type 
L 
N 
p 
R 
T 
Cavl.1 
Cavl.2 
Cavl.3 
Cavl.4 
Cav2.1 
Cav2.2 
Cav2.3 
Cav3.1 
Cav3.2 
Cav3.3 
DHPs 
DHPs 
DHPs 
DHPs 
w-CTx-GVIA 
w-Agotoxin 
SNX-482 
None 
EC coupling in skeletal muscle, 
regulation of transcription 
EC coupling in cardiac and smooth 
muscle, endocrine secretion, 
neuronal Ca 2+ transients in cell 
bodies and dendrites, regulation of 
enzyme activity, regulation of 
transcription 
Endocrine secretion, cardiac 
pacemaking, neuronal Ca2+ 
transients in cell bodies and 
dendrites, auditory transduction 
Visual transduction 
Neurotransmitter release, dendritic 
C 2+ . a transients 
Neurotransmitter release, dendritic 
C 2+ . a transients 
Neurotransmitter release, dendritic 
C 2+ . t a trans1en s 
Pacemaking and repetitive firing 
Pacemaking and repetitive firing 
Abbreviations: DHP, dihydropyridine; m-CTx-GVIA, m-conotoxin GVIA from the cone snail Conus geographus; 
SNX-482, a synthetic version of a peptide toxin from the tarantula Hysterocrates gigas. 
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1.6.1 Structure and function 
The skeletal DHPR is heteropentmneric comprising of a 1, a2, ~ ' y, and 8 subunits (Curtis and 
Catterall 1984; Curtis and Catterall 1986; Flockerzi et al. 1986; Hosey et al. 1987; Leung et al. 
1987; Striessnig et al. 1987; Takahashi et al. 1987). A structural model based on analysis of 
biochemical properties, glycosylation and hydrophobicity of the five subunits includes a 
principle transmembrane al subunit of 190kDa in association with a disulphide-linked a28 dimer 
of l 70kDa, an intracellular~ subunit of 55kDa and a trans1nembrane y subunit of 33kDa 
(Takahashi et al. 1987) (see Figure 1.19) 
The a1 subunit contains about 2000 residues and its predicted transmembrane structure is similar 
to the pore-fonning a subunit of voltage-gated sodium and potassium channels (Tanabe et al. 
1987; Tempel et al. 1987; Hille 2001) (see Figure 1.19). The amino acid sequence is organised 
into four repeated domains (I-IV), which each contains six transmembrane seg1nents (S 1-6) and 
a 1nembrane associated loop between transmembrane segment S5 and S6 (Takahashi et al. 
1987). The S5 and S6 helices together with the S5-S6 linker loop from each of the four repeated 
do1nains is believed to fonn the Ca2+ channel pore. The S4 seg1nent of each repeat contains an 
ordered pattern of five to six positively charged residues and is the voltage sensor (Aggarwal 
and MacKinnon 1996; Seoh et al. 1996; Catterall 2010). The ~ subunit has predicted a-helices 
but no trans1ne1nbrane segments (Ruth et al. 1989). They subunit is a glycoprotein with four 
transme1nbrane segments (Jay et al. 1990). The a2 subunit is an extracellular extrinsic 
1nembrane glycoprotein attached to the me1nbrane through disulphide linkage to the 8 subunit 
(Gurnett et al. 1996). The 8 and a2 subunits are coded for by the same gene and the mature 
forms of the two subunits are produced by posttranslational proteolytic processing and 
disulphide linkage (De Jongh et al. 1990). Initially the 8 subunit was assu1ned to be anchored to 
the me1nbrane via a single trans1nembrane seginent, but recent work argues persuasively that 
further posttranslational processing actually cleaves the predicted transmembrane segment and 
replaces it with a glycophosphatidylinostiol 1ne1nbrane anchor (Davies et al. 2010). Ablation of 
either a28 or y subunit expression has only modest effects on channel current density (Freise et 
al. 2000; Held et al. 2002; Ursu et al. 2004; Obermair et al. 2005 ; Gach et al. 2008 ; Obermair et 
al. 2008). The main function of a28 so far identified is to slow activation kinetics of the a 1 s 
subunit (Obermair et al. 2005 ; Gach et al. 2008; Obermair et al. 2008), while that of they 
subunit is to cause a depolarizing shift in the voltage-dependence of channel activation (Freise 
et al. 2000; Held et al. 2002; Ursu et al. 2004). The broader physiological significance of the 
effect of these two subunits is not clear. Although the a 1 subunit carries the characteristic 
pharmacological and functional properties for voltage sensing, ion permeability and drug 
binding of the DHPR, all the subunits are required for complete receptor function (Tanabe et al. 
1988; McDonald et al. 1994; Melzer et al. 1995; Catterall 2000). 
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Figure 1.19: Subunit structure of the DHPR illustrated as transmembrane folding models. Predicted a-helices are 
shown as cylinders. The length of lines correlated approximately to the lengths of the polypeptide segments 
represented. The zigzag line on the 8 subunit illustrates its glycophosphatidyl-inositol anchor. 
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Figure 1.20: 30A resolution 3D structure obtained by cryo-electron microscopy and single particle reconstruction . 
The structure is shown in four different views: (a) top view; (b) front view by 90° rotation along the horizontal axis of 
the top view in (a); (c) and (d) are views obtained by stepwise rotation of the view in (b) along the vertical axis by 
90°. The handle-shaped structure and the upper lobes of the heart-shaped region were proposed to account for the 
extracellular channel region and to include the a2 subunit. Thus the heart shaped region includes the voltage-sensitive 
transmembrane region of the DHPRand the cytoplasmic ~,a subunit.(e) Shows the side view ofRyRl coupled with 
the DHPR tetrad. Horizontal lines indicate the approximate position of the surface and SR membranes. The scale bar 
represents 1 00A. Adapted from (Serysheva et al. 2002; Serysheva 2004) . 
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Apart from the predicted structure of the DHPR discussed above, there are only low resolution 
structural models that have been developed from image reconstitution analys is of electron 
micrographs (Serysheva et al. 2002; Wang et al. 2002; Wolf et al. 2003). Some structural 
features of the 3D model have been associated with the a 1s, ~ l a and a28 subunits (see Figure 
1.20). 
The structure and function of the skeletal a1s and ~l a subunits with specific emphasis on skeletal 
type EC coupling will be discussed in more detail below. 
1.6.1.1 a1s subunit 
Schneider and Chandler demonstrated intramembrane charge movements in the t-tubular 
membrane (Schneider and Chandler 1973) which led to the hypothesis that release of Ca2+ fro1n 
the SR is controlled by a voltage sensor in the t-tubular membrane physically interacting with 
RyRl. The voltage sensor was later identified as the DHPR when it was observed that dysgenic 
myotubes, which lack the DHPR a1s subunit , did not have the DI-IP-sensitive voltage gated Ca2+ 
current, charge movements or EC coupling (Beain et al. 1986) and that charge move1nent and 
EC coupling were inhibited in parallel by the DHPR antagonist nifedipine (Rios and Brum 
1987). Subsequently it was shown that expression of the newly cloned Cav 1.1 gene restored the 
L-type Ca2+ current, charge movement and EC coupling when expressed in dysgenic myotubes 
(Tanabe et al. 1988; Adams et al. 1990; Tanabe et al. 1990a; Garcia et al. 1994 ). Today it is 
universally believed that the DHPR a 1s subunit is the voltage sensor for EC coupling in skeletal 
muscle. 
The skeletal muscle DHPR is the only L-type channel capable of supporting skeletal EC 
coupling (Tanabe et al. 1990b; Garcia et al. 1994; Nakai et al. 1998b; Kasielke et al. 2003) and 
it is believed that one or 1nore of the intracellular regions of the DHPR a 15 subunit (N-terminus, 
C-tenninus, cytoplasn1ic loops I-II, II-II and II-IV) either directly or indirectly interact with the 
cytoplas1nic assembly of the RyRl. 
The II-II loop of the a 15 subunit was first identified as a major contributor to skeletal type EC 
coupling with the use of chimeric DHPRs consisting of the individual a15 cytoplasmic domains 
within the highly conserved background-of the a 1c subunit (Tanabe et al. 1990a). A direct 
interaction between the full length a 15 II-III loop and RyRl was subsequently detected (Lu et al. 
1994). A peptide con-esponding to the a15 II-III loop activated purified RyRl in lipid bilayers 
and increased [3H]ryanodine binding in isolated skeletal SR ves icl es. Two regions of interest on 
the II-III loop were studied intensively. The first corresponds to residues 681-690 and was 
arbitrarily named the A region and the second corresponds to residues 720-765 and was named 
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the C region (El-Hayek et al. 1995). A peptide corresponding to the A region was shown to 
activate RyRl in lipid bilayers and increase [3H]ryanodine binding in SR vesicles (El-Hayek et 
al. 1995; Lu et al. 1995; El-Hayek and Ikemoto 1998; Dulhunty et al. 1999) and that, in vitro, it 
binds to the second of three SPRY domains on RyRl which encompasses residues 1085-1208 
(Cui et al. 2009). Contrastingly, in dysgenic myotubes expressing modified <Xi s subunits 
demonstrated that the A region is not essential for skeletal type EC coupling in situ (Nakai et al. 
1998b; Grabner et al. 1999; Proenza et al. 2000b; Ahem et al. 2001a; Ahem et al. 2001b; 
Wilkens et al. 2001; Flucher et al. 2002; Lorenzon et al. 2004; Papadopoulos et al. 2004). The 
C-region was shown to be essential to produce skeletal type EC coupling in further chimeric 
studies in dysgenic myotubes (Nakai et al. 1998b) and a peptide corresponding to this region 
was shown to modify RyRl activity in lipid bilayer studies and [3H]ryanodine binding assays 
(Saiki et al. 1999; Haarmann et al. 2003; Haarmann et al. 2005). The C region was named the 
"critical domain" and a subsequent study proposed that residues 7 44-7 51 within this domain 
adopt a random coil conformation that enables <Xi s to interact with other junctional proteins. The 
corresponding residues in <Xie form a putative a-helix that inhibits such interactions (Haarmann 
et al. 2003; Kugler et al. 2004; Cui et al. 2009). This study identified four residues to be 
responsible for stopping the formation ofan a-helix in the als II-III loop (A739, F741 , P742 
and D744). It is important at this stage to point out that the <Xi s and <Xie II-III loops share more 
than a considerable sequence similarity (Wilkens et al. 2001) and therefore some conserved 
elements required for conformational coupling may remain masked. Leong and MacLennan 
found that the a 1s II-III loop binds to residues 922-1112 of RyRl (Leong and MacLennan 
1998a) and that this interaction was dependent on positively charged re_sidues K667 and K682 
within the II-III loop. In contrast, residues 719-767 of the critical domain interacts weakly with 
residues 1837-2168 of the RyRl in a yeast two-hybrid assay, while no interaction was found 
with residues 666-709 on the II-III loop in parallel experiments (Proenza et al. 2002). The 
conflicting results from these studies may reflect that a particular conformational state of the II-
III loop, that cannot be replicated in vitro, may be required in order to interact with the RyRl , or 
that the interactions with the RyRl is of very low affinity, as crucial physiological interactions 
frequently are (Bannister 2007). 
Some studies have found that there is some residual EC coupling in dysgenic myotubes 
expressing constructs missing both the A and C regions (Ahem et al. 2001 b) and that a 
co1nponent of EC coupling is lost in chimeras with only the <Xi s II-III loop in a a1e background 
compared to chimeras with all the intracellular <X is domains in a <Xie background (Carbonneau et 
al. 2005). Although the i1nportance of the II-III loop for skeletal type EC coupling is well 
accepted, a broader view of multiple contacts between the DHPR and RyRl might be closer to 
the truth and consistent with studies showing multiple regions of RyRl involved in EC coupling 
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(Nakai et al. 1998a; Proenza et al. 2002; Protasi et al. 2002; Perez et al. 2003a: Perez et al. 
2003 b; Sheridan et al. 2006) . 
The C-terminus of the a 1s subunit is subject to proteolytic cleaving at residue Al664 (De Jongh 
et al. 1989; Hulme et al. 2005) although cleaving at this site does not seem to affect the ability 
of the a 1s subunit to couple to RyRl in dysgenic myotubes (Beam et al. 1992). Deletions 
upstream fro1n this site progressively diminish DHPR surface expression as this region contains 
a PDZ domain (residues 1543-164 7) that is critical for targeting of the a 15 subunit to the triad 
junction (Flucher et al. 2000; Proenza et al. 2000a) . The important role of the C-terrninus is 
clear, but atte1npts to show the role of this region in DHPR trafficking have been unsuccessful 
(Flucher et al. 2002; Wilkens and Beam 2003). Biochemical approaches identified direct 
interactions between RyRl with the a 15 C-terminus in binding directly to Ry RI and in reducing 
[ 3H]ryanodine binding (Slavik et al. 1997; Sencer et al. 2001 ). It also seems that the presence of 
the RyRl puts conformational pressure on the a15 C-terminus (Lorenzon et al. 2004; 
Papadopoulos et al. 2004). 
The a 1s III-IV loop has not drawn so much experimental attention for a possible role in EC 
coupling, despite its identification as the only site for DHPR-linked MH mutations (R 1086H 
and RI 086C) (Monnier et al. 1997). Dysgenic myotubes expressing DHPRs with the Rl 086H 
mutation showed increased sensitivity to pharmacological (caffeine) and physiological 
(membrane depolarization) stimuli, suggesting a negative allosteric contribution of the III-IV 
loop in coupling to RyRl (Weiss et al. 2004). Evidence for binding between the III-IV loop and 
residues 922-1112 on the RyRl is also consistent with a possible role for the a 15 III-IV loop in 
the basic EC coupling mechanism as The II-III and III-IV loops bind to contiguous and possibly 
overlapping sites on the RyRl (Leong and MacLennan 1998b). 
The N-tenninus of the a15 subunit seems not to be involved in EC coupling (Tanabe et al. 1990a; 
Bannister and Beam 2005 ; Carbonneau et al. 2005) . 
1.6.1.2 /11a subunit 
There are fo ur vo ltage-gated Ca2+ channel 0 subunit (Cav0) genes with vari ous spli ce variants 
for each gene (Ruth et al. 1989; Hullin et al. 1992; Perez-Reyes et al. 1992: Castellan o et al. 
1993a; Castellano et al. 1993 b ). The skeletal muscle isoforrn, Cav01a, is uniquely associated 
,vith Cav 1.1. All the Cav0 isofonns possess a com1non structure consisting of fi ve domains (see 
Figure 1.21 ). Homo logy modell ing and X-ray crystallography have shown an Src homology 
domain (SH3) and a guanylate kinase (GK)-l ike domain making up the core of the 0 subunit. 
The core is highly conserved among the fo ur isofonn s (Chen et al. 2004; Opatowsky et al. 2004· 
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Van Petegem et al. 2004), while the connecting region between the core domains (Hook region) 
and the N- and C-termini are unconserved and subject to alternative splicing. The core of the~ 
subunits is similar to the membrane-associated guanylate kinases (MAGUKs ), a group of 
scaffolding proteins containing several protein-protein interaction domains and involved in the 
assembly of multiprotein complexes (Hanlon et al. 1999; Dolphin 2003). 
No published crystal structure for the ~la subunit is available, but the core of other~ subunit 
isoforms that have been crystalized and share significant homology with the ~la subunit core, 
show that the GK domain of the~ subunit interacts with the alpha interaction domain (AID) 
located in the a 1 subunit I-II loop with high affinity (low nanomolar range) (Chen et al. 2004; 
Opatowsky et al. 2004; Richards et al. 2004; Van Petegem et al. 2004 ). Two other lower-
affinity ~ subunit interactions sites have also been identified on the N- and C-terminal domains 
of the a,1 subunit (Qin et al. 1997; Walker et al. 1999; Stephens et al. 2000) 
SH3 GK 
Figure 1.21: A schematic representation of the domain modules of Cav~- The SH3 and GK domains are 
conserved in all~ subunit isoforms with the greatest sequence variability observed in the N- and C 
termini and the Hook region (Karunasekara et al. 2009). 
The ~I a subunit is essential for DHPR function (Gregg et al. 1996; Strube et al. 1996). It 
facilitates trafficking of the a1s subunit to the plasma membrane, but the specific targeting of the 
assembled DHPR to the junctional membrane is dependent on the a1s subunit (Neuhuber et al. 
1998; Bichet et al. 2000; Schredelseker et al. 2005; Leuranguer et al. 2006). In mammals the 
absence of the ~la subunit is fatal at birth due to respiratory failure and myotubes from ~1a-null 
1nice are incapable of EC coupling (Gregg et al. 1996; Strube et al. 1996). The ~la subunit is 
essential for efficient tetrad formation . The ~1a-null zebra fish mutant relaxed embryo displays 
rando1nly positioned a1s subunits at the junctional membranes, whereas the transgenic 
overexpression of ~la in these relaxed mutant embryos restored the tetradic arrays 
(Schredelseker et al. 2005). The rescue of tetrads is unique to the ~la subunit (Schredelseker et 
al. 2009). This suggests that the ~l a subunit may be the molecular "glue" that hold the tetrad 
together by linking the a1s subunit to RyRl (Bannister et al. 2013). 
The functional significance of the ~ subunit SH3 domain remains unclear. SH3 domains are 
typically protein interaction domains that mediate the assembly of protein c01nplexes through 
praline-rich recognition sites such as PXXP or XPPPX (McPherson 1999). Possible binding 
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sites have been identified in the II-III loop and C-terminal of the a.1a subunit (Dubuis et al. 
2006). Interestingly, as discussed above (Section 1.6.1.1) the II-III loop has been shown to be 
important for EC coupling. A recent study using chimeras of the ~l a and ~3 expressed in relaxed 
zebra fish mutants have shown the importance of the SH3 domain and C-terminus of the ~ 1 a 
subunit for charge movement and EC coupling restoration (Dayal et al. 2013) suggesting 
cooperativity between the SH3 and C-terminal domains in inducing a proper conformational 
change in the a. 1a subunit crucial for its voltage sensing function to operate. This resonates with 
the suggestion above that the ~la subunit may be the molecular "glue" that hold the tetrad 
together. The SH3 domain of the ~2a subunit has also been shown to bind to dynamin and 
mediate endocytosis of the DHPR a.1c subunit in Xenopus oocytes (Gonzalez-Gutierrez et al. 
2007). 
In vitro binding studies have shown a possible direct interaction site between the C -terminus of 
the ~la subunit and the RyRl. Specifically, a cluster of positively charged residues (3495-3502) 
on the cytoplasmic assembly of RyRl is close to the ASI region as discussed in Section 1.5 .5 
(Cheng et al. 2005). Peptides corresponding the 35 most distal residues of the ~l a C-terminus 
( 490-524) bind to native RyRl in SR vesicles and the peptides also activate RyRl directly in 
lipid bilayer and [3H]ryanodine binding assays. The full length ~l a subunit was also shown to 
activate the RyRl in lipid bilayers (Rebbeck et al. 2011; Karunasekara et al. 2012). However, 
the ~l a subunit does not seem to bind to the RyRl in dysgenic myotubes (Neuhuber et al. 1998; 
Papadopoulos et al. 2004; Leuranguer et al. 2006) suggesting, not surprisingly, that if an 
association between RyRl and ~la exists in vivo, the presence of a.15 is required (Bannister et al. 
2013). 
1.6.2 Orthograde and retrograde coupling 
The triggering of the release of calcium from the SR though the interaction of the DHPR and 
RyR has been discussed in Section 1.4.2. This coupling (DHPR-to-RyR) is referred to as 
orthograde coupling. Interestingly, the signalling interaction between DHPR and RYR is often 
bi-directional. The calcium conducting properties of the DHPR are strongly influenced bv its 
functional association with RyR. The ability of the RyR to alter DHPR channel behaviour is 
referred to as retrograde coupling (RyR-to-DHPR) (Nakai et al. 1996; Dirksen 2002) . The 
nature of the bi-directional signal can be chemical ( cardiac muscle) or mechanical (skeletal 
muscle). 
In cardiac muscle, retrograde signalling is in the form of calcium-independent inactivation 
(Brehm and Eckert 1978; Kass and Sanguinetti 1984; Lee et al. 1985). Calcium release from 
the SR acts as a negative feedback mechanism for cardiac EC coupling by promoting calcium-
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dependent inactivation of the DHPR and thereby reducing subsequent calciu1n influx and 
release (Sham et al. 1995; Adachi-Akahane et al. 1996). Calmodulin acts as a Ca2+ sensor for 
the DHPR to facilitate calcium-dependent inactivation and interacts with the C-terminal tail of 
the a 1c subunit (Peterson et al. 1999; Zuhlke et al. 1999; Pate et al. 2000; Zuhlke et al. 2000). 
The retrograde signal in skeletal muscle does not occur through chemical feedback, but rather 
involves an allosteric 1nodulation of the DHPR through the DHPR/RyRl mechanical interaction 
involved in orthograde coupling (Nakai et al. 1996; Grabner et al. 1999; Avila and Dirksen 
2000). The calcium conducting properties of the DHPR are strongly dependent on the presence 
of RyRl (Nakai et al. 1996; Avila and Dirksen 2000). RyRl increases the ratio of maxi1nal L-
type channel conductance to charge movement, indicating that DHPRs not associated with 
RyRl function poorly as a Ca2+-permeable L-type channel (Nakai et al. 1996; Dirksen 2002). 
The a15 II-III loop, i1nportant in orthograde coupling (above), is also important for retrograde 
coupling (Grabner et al. 1999). Multiple RyRl regions are involved with retrograde coupling 
(Nakai et al. 1998a) suggesting that two-or more regions from different parts of the RyRl 
primary sequence may come together to form and interaction domain for the DHPR a 15 II-III 
loop when the RyRl is folded. 
1. 7 Muscle fiber type 
Muscles are heterogeneous with respect to a number of characteristics. Whole muscles 
themselves differ in size, shape, anatomical position as well as function.: The fibers that make 
up the muscle are also heterogeneous with different metabolic as well as contraction 
characteristics. In addition, the motor units of the skeletal muscle system are heterogeneous in 
nerve sti1nulus frequency and also in the fiber-type content. 
1.7.1 Four major fiber types 
Since the first half of the 19th century skeletal muscles have been distinguished on the basis of 
their colour (red/white) and their contractile properties (fast/slow). Until around 1968-1970, 
1nammalian skeletal muscle was classified as (Needham 1926): 
• Fast twitch muscles with glycolytic metabolism, specialized for phasic activity 
and identified as white muscle 
• Slow twitch muscles, rich in myoglobin and oxidative enzymes, specialized for 
1nore continuous activity and called red muscles 
At the end of the 1960s and as a result of four different lines of evidence, a more complex 
scheme emerged. The first line of evidence correlated histochemical and physiological studies 
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of individual motor units. The second was electron microscopy of fast and slow skeletal 
muscle . The third was a novel procedure for myosin ATPase histochemistry and lastly 
biochemical studies on oxidative and glycolytic enzymes in different muscles (Schiaffino and 
Reggiani 2011 ). Edstrom and Kugel berg used stimulation of single motor axons in rat fast TA 
muscles to characterize single motor units according to its twitch properties. They then used 
periodic acid-Schiff (PAS) staining (stain for glycogen) to indicate changes in glycogen levels 
after induced glycogen depletion in those fibers thereby identifying the fibers in cryo-sections. 
Subsequently oxidative metabolism of the fibers were assessed by enzy1ne histochemistry for 
succinate dehydrogenase (SDH) (Edstrom and Kugelberg 1968). Their results showed that 
motor units are homogenous in fiber type composition. Motor units composed of small SDH 
negative fibers or large SDH positive fibers were both fast-twitch, but they differed with respect 
to fatigue resistance. A spectrum of motor units with intermediate SDH staining and fatigue 
resistance was detected in TA muscle. Similar results were found in rat extensor digitorum 
longus (EDL ), a muscle known to contain essentially only fast twitch motor units (Close 1967; 
Schiaffino et al. 1970). Enzyme histochemical procedures for myosin A TPase led to the 
identification of two fast twitch fiber populations, type 2A and 2B, abundant in fast-twitch 
muscle , but distinct from type 1 fibers predominant in slow twitch muscle (Guth and Samaha 
1969; Brooke and Kaiser 1970). This was confirmed using both myosin ATPase and SDH 
staining, with the type 2A fibers staining strongly for SDH and being fatigue resistant whereas 
type 2B fibers stained weakly for SDH and was fatigable (Burke et al. 1971). The fatigue 
resistance of type 2A fibers is lower than that of type 1 fibers. It was subsequently shown that 
type 2A and 2B fibers have high levels of glycolytic enzymes, in spite of their differences in 
oxidative enzyme content and this led to the further classification of slow-twitch oxidative (type 
1 ), fast-twitch oxidative glycolytic (type 2A) and fast-twitch glycolytic fibers (type 2B) (Peter et 
al. 1972). The different fiber types each express different myosin heavy chain (MyHC) 
isoforms (see Tablel.2). Due to the central role myos in plays as molecular motor in the muscle 
fibers as well as the existence of several MyHC isoforms that are differentially expressed in the 
fibers , MyHC is the most useful marker available for fiber typing (Schiaffino and Reggiani 
2011 ). 
A third fast fiber type with a MyHC composition different from 2A and 2B fibers was identified 
and named type 2X (Schiaffino et al. 1988; Schiaffino et al. 1989). Type 2X motor units have 
twitch properties similar to 2A and 2B with a fatigue resistance intermediate between type 2A 
and 2B (Larsson et al. 1991 ). Rat skeletal type 2X fibers have moderate to strong SDH staining 
(Schiaffino et al. 1989; Larsson et al. 1991) with a maximal shortening velocity intermediate 
between 2A and 2B fibers (Bottinelli et al. 1991 ; Bottinelli et al. 1994 ). It was also shown that 
there is a spectrum of fiber types with a pure or hybrid MyHC the fo l lowing composition: l 
1/2A. 2A, 2A/2X~ 2X, 2X/2B and 2B (Gorza 1990: Pette and Staron 1990~ DeNardi et al. 1993· 
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Bottinelli et al. 1994). Human muscles do not express the gene for MyHC-2B (although 
MYH4 is present in the genome) and the fibers that were typed 2B according to myosin ATPase 
staining are in fact 2X fibers based on MyHC composition (Smerdu et al. 1994 ). The 2X fibers 
in humans have the lowest level of SDH activity compared to all other fibers types. There are 
therefore important differences to consider in extrapolating results fro1n mice and rats to 
humans. 
Developing muscles express different MyHC isoforms (MyHC-emb and MyHC-neo) but fully 
developed mammal limb and trunk muscles contain the four major fiber types discussed above. 
There are, however, several other muscle groups with specialized functions and fiber types 
different from those seen in limb and trunk muscles. Atypical muscle fibers are present in head 
and neck 1nuscles, particularly the extraocular muscles, jaw muscles, middle ear muscles, 
laryngeal muscles (Schiaffino and Reggiani 2011 ). 
Table 1.2: The co1nplete panel of sarcomeric MyHC isoforms with their corresponding genes 
and expression pattern. Adapted from (Rossi et al. 2010; Schiaffino and Reggiani 
2011) 
Protein Genes Expression 
MyHC-2A MYH2 Fast-twitch 2A fibers 
MyHC-2B MYH4 Fast-twitch 2B fibers 
MyHC-2X MYHl Fast-twitch 2X fibers 
-
MyHC-a MYH6 Heart and jaw muscle 
MyHC-~/slow MYH7 Heart and slow-twitch fibers 
MyHC-Neo MYH8 Developing muscle 
MyHC-e1nb MYH3 Developing muscle 
MyHC-EO MYH13 Extraocular muscle 
MyHC-slow/tonic MYH14/7b Extraocular muscle 
MyHC-15 MYH15 Extraocular muscle 
MyHC-M MYH16 Jaw muscle 
1. 7 .2 Functional significance of fiber type diversity 
The nervous system employs the ability of skeletal muscle to generate force and movement for a 
variety of tasks that for simplicity can be reduced to three main types: postural joint 
stabilization, long-lasting and repetitive activity (respiration, locomotion, chewing) and fast, 
generally powerful action (jumping, kicking, biting). Muscle fibers have adapted to suite each 
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task. Motor units with specific firing patterns must be connected to fibers vvith the correct 
functional properties for proper muscle function. Motor neuron firing patterns can determine 
the properties of the fibres that they innervate and this is also the basis of fiber type remodelling 
discussed in Section 1.7.9 (Schiaffino and Reggiani 2011). 
Three distinct firing patterns in rat motor units have been detected (Hennig and Loma 1985). 
Motor units consisting of slow and fatigue resistant fibers are characterized by a persistent 
activity (300000-500000 impulses/24h) with long lasting trains (300-500s) and relatively low 
frequency of firing ( ~20Hz). Motor units consisting of fast fibers have an intermittent but 
higher frequency of firing and can be divided into two groups. The first has a modest an1ount of 
activity per day (3 00-10000 impulses/24h), high discharge frequency (70-90Hz) and short 
duration of trains (<3s). This group presu1nably corresponds to type 2B fibers. The second 
group has a similar discharge frequency (50-80Hz), but has much greater activity per day 
(90000-250000 impulses/24h) and relatively long train duration (60-240s), which presumably 
corresponds to type 2A and 2X fibers (see Figure 1.22 for su1n1nary). The 1notor neuron and 
1notor unit muscle fiber properties integrate well in terms of firing pattern, contraction 
parameters and fatigue resistance (Kugel berg and Edstrom 1968; Burke et al. 1971 ; Burke et al. 
1973). 
Firing patterns Median firing I Longest train I Impulses per I Time on frequency (Hz) duration (s) 24 hrs per 24 hrs 
'J.Ji~) 
! 'I I _ -
10ms 
69-91 0.8-3.9 2600-11200 0.5--3 min 
EDL-1 
1 11 111111 1 111 1 1 I I I I I I I I I I 48-83 59-141 89500-243100 I 23-72 min 
EDL-2 
1 111 111 I 11 
18-21 290-548 30950Q-495800 I 5.3-8A hrs 
SOL 
Figure 1.22: Fi ring patterns of three classes of motor units identified in rat fast EDL and slow Soleus muscles. EDL-1 and EDL-2 presumably corresponds to motor units consisting of 2B and 2A fibers respectively (Henn ig and Lomo 1985 : Schiaffino and Reggiani 201 1 ). 
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1.7.3 Fiber type differences in EC coupling 
Skeletal muscle fibers are very specialized in their control of intracellular Ca2+. Different fiber 
types are characterized by distinct levels of resting Ca2+ concentration and kinetics of Ca
2
+ 
transients induced by action potentials. Ca2+ transient kinetics are correlated with the dynamic 
properties of muscle fibers. Fast twitch fibers for exainple have a faster Ca2+ transient, faster 
cross-bridge kinetics and thus a shorter time to peak tension and half relaxation (Schiaffino and 
Reggiani 2011). 
1. 7.3.1 Resting Ca2+, Ca2+ transients and Ca2+ release from the SR 
The cytosolic free Ca2+ concentration at rest is higher in slow-twitch than fast-twitch fibers 
(Gailly et al. 1993; Carroll et al. 1997; Carroll et al. 1999; Fraysse et al. 2003 ; Fraysse et al. 
2006). Values of 50-60nM have been reported in rodent slow-twitch fibers , in contrast to 30nM 
in fast-twitch fibers. Sreter et al. first hypothesised that the resting Ca2+ concentration could 
influence fiber phenotype (Sreter et al. 1987). This was subsequently confinned experimentally 
using rabbit myotube cultures to show that an increase of resting Ca2+ concentration induced a 
fast-to-slow fiber type transformation (Kubis et al. 1997). 
Calcium transients reach a higher peak in fast-twitch fibers than slow-twitch fibers (Eusebi et al. 
1980; Fryer and Stephenson 1996; Carroll et al. 1997; Baylor and Hollingworth 2003). The SR 
volume is larger in fast-twitch fibers compared to slow-twitch (Schiaffino et al. 1970; Luff and 
Atwood 1971) and an inverse relation between terminal cisternae fraction volume and time to 
peak tension has been observed in rat motor units (Liu et al. 2005). 
Ca2+ release from slow-twitch fibers is less inhibited by cytosolic Mg2+ (Stephenson et al. 1998) 
and the responsiveness of slow-twitch fibers to caffeine-induced calcium release is greater than 
in fast-twitch fibers (Isaacson et al. 1970; Salviati and Volpe 1988; Fraysse et al. 2003). Ca2+ 
release is first detected with 0.2mM caffeine in rat soleus but requires lmM in EDL (Fryer and 
Stephenson 1996). In fast twitch fibers , the threshold for caffeine response becomes lower 
when the SR is maximally loaded, but this does not occur in slow-twitch fibers (Bartolotto et al. 
2001). Neonatal muscles are also more responsive to caffeine than adult muscles (Bertocchini 
et al. 1997). RyR3 is present in postnatal muscle, and may determine the features of Ca2+ 
release (Bertocchini et al. 1997), but in adult muscle RyRl is the predominant Ca2+ release 
channel. The differences in Ca2+ release from the different adult fiber types therefore, is not due 
to different RyRl isoforms. It might be determined by other factors such as post-translational 
modifications (phosphorylation, oxidative state) (Ruehr et al. 2003 ; Isaeva et al. 2005), 
interactions with other proteins (DHPR, calmodulin, FKBP 12, CSQ) and the amount of Ca2+ 
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available in the terminal cisternae (slow-twitch fiber SR is maximally loaded but fast-twitch 
fiber SR is not) (Schiaffino and Reggiani 2011). 
The amount of Ca2+ release by a single action potential is greater in fast-twitch than in slow-
twitch fibers (Baylor and Hollingworth 2003). This is correlated with the abundance of RyRl 
channels, which in fast-twitch fibers is more than twice that in slow-twitch fibers (Franzini-
Armstrong et al. 1988) and in the different fraction of RyR channels coupled to DHPRs. The 
ratio of DHPR to RyRl is lower in slow-twitch fibers (Delbono and Meissner 1996; Baylor and 
Hollingworth 2003). CICR may play a role in the slow twitch kinetics of slow-twitch fibers. 
Slow-twitch fibers may therefore be partly reminiscent of cardiac muscle. Interestingly, the 
same MyHC isoform expressed in type 1 (slow-twitch) fibers is also expressed in the heart (see 
Table 1.2) and the DHPR a 1c subunit is expressed in soleus and diaphragm but not in EDL 
(Pereon et al. 1998). RyR3 , which is activated by CICR, is also expressed at higher levels in 
soleus and diaphragm (Flucher et al. 1999; Sorrentino and Reggiani 1999; Rossi et al. 2001; 
Conti et al. 2005). 
As discussed in Section 1.5 .2.2, CSQ influences RyRl channel activity, and there are two 
isoforms of CSQ expressed in skeletal muscle. Fast-twitch fibers express CSQ 1, whereas slow-
twitch fibers express CSQl and CSQ2. CSQ content is greater in fast-twitch than in slow-
twitch fibers (Leberer et al. 1988), which is probably related to the larger volume of SR in fast-
twitch muscles. A quantitative analysis of CSQ content in murine fibers showed concentrations 
of 36µM in fast-twitch fibers (CSQl only) and l lµM in slow-twitch fibers (CSQl and CSQ2) 
(Murphy et al. 2009). CSQ plays a role in fiber type diversity. Firstly, CSQ buffers Ca2+ in the 
SR lu1nen and as CSQ 1 binds up to 80 Ca2+ molecules per molecule and CSQ2 binds up to 60, 
CSQ 1 contributes to the fast-twitch SR's greater Ca2+ store content. Secondly, it modulates 
Ca2+ release because of its interaction with RyRl (Beard et al. 2004). 
1. 7.3.2 Cytosolic Ca2 + buffers 
The Ca2+ transient declines faster in fast-twitch fibers compared to slow-twitch. The rate of 
decline of the Ca2+ transient is determined by the Ca2+ removal mechanisms (SERCA etc.) and 
binding of Ca2+ to cytoplasmic buffers . The major cytoplasmic Ca2+ buffers are parvalbumin 
troponin C (TnC) and calmodulin. (Schiaffino and Reggiani 2011 ). 
Parvalbumin is expressed in fast-twitch fibers at concentrations of ~ 1 mM but is virtually absent 
in slow-twitch fibers (Celia and Heizmann 1982; Gundersen et al. 1988; Campbell et al. 2001 ). 
Parvalbumin is specifically expressed in type 2B and 2X fibers but not in type 2A fibers 
(Fuchtbauer et al. 1991 ). Functional ly, parvalbumin quickly lowers the cytoplasmic Ca2+ 
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concentration after the Ca2+ release from the SR (Schwaller et al. 1999) allowing the fiber to 
relax faster. The Ca2+ bound to the parvalbumin dissociates and is returned to the SR slowly 
causing a tail in the Ca2+ transient detectable only in fast-twitch fibers (Klein et al. 1991 ). 
TnC, which is involved in cross-bridge cycling (see Section 1.4.3) is present in the myofibril at 
a concentration of ~60µM with two reported isoforms (Salviati et al. 1984; Schiaffino and 
Reggiani 1996; Schiaffino and Reggiani 2011). TnC-fast expressed in fast-twitch fibers has 
four Ca2+ binding sites (two high affinity and two low affinity), whereas TnC-cardiac-slow, 
expressed in slow twitch fibers , lacks one of the low affinity binding sites. Thus TnC 's 
contribution to Ca2+ buffer capacity is greater in fast-twitch fibers than slow-twitch (240µM vs. 
180µM). 
1. 7.3.3 Ca2+ uptake by the SR 
Early studies suggested that Ca2+ uptake occurs faster in fast-twitch fibers than in slow-twitch 
because of the greater SR surface area, parvalbumin as cytosolic Ca2+ buffer and the presence 
of specific transport proteins, (Sreter and Gergely 1964; Margreth et al. 1972; Salviati et al. 
1982). SERCAl is exclusively expressed in fast-twitch skeletal muscle fibers , whereas 
SERCA2 is expressed in slow-twitch fibers, cardiac muscle, smooth muscle and non-muscle 
tissue (Periasamy and Kalyanasundaram 2007). However, when expressed in COS cells, 
SERCAl and SERCA2 have identical kinetics and transport rate (Lytton et al. 1992), so the 
diversity in Ca2+ uptake rate must be due to other factors such as the density of the pumps, 
presence of SERCA regulatory subunits or free Ca2+ gradient (Schiaff~-o and Reggiani 2011 ). 
The 1nitochondrion might also contribute to the Ca2+ uptake diversity seen in different fiber 
types due to different levels of ATP production and uptake of Ca2+ into the mitochondrion ( see 
Section 1. 7 .3 .4 ). The· oxidation state of SERCA is another factor that could contribute to Ca2+ 
uptake rate as SERCA is vulnerable to redox modification. Oxidation of free-thiol groups on 
SERCA reduces its activity (Hidalgo and Donoso 2008). 
SERCA pump density is greater (5-6 fold) in fast-twitch fibers than slow-twitch (Leberer and 
Pette 1986; Everts et al. 1989; Wu and Lytton 1993). Type 2B fibers have the highest SERCA 
density (Krenacs et al. 1989). This may be due to the SR volume and surface area being larger 
in fast-twitch fibers but could also be due to a greater concentration of SERCA pumps per unit 
area of SR (Dulhunty et al. 1987). Ca2+ uptake by SERCA is affected by extraluminal 
regulatory proteins that are bound to the pump as well as intraluminal proteins. SERCA2 is 
modulated by the phosphorylation state of the regulatory subunit phospholamban (Kirchberber 
et al. 1975; Tada and Kirchberger 1976; Kugelberg and Thornell 1983; Vangheluwe et al. 
2005). As in cardiac muscle, phospholamban probably also inhibits SERCA2 in a 
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phosphorylation-dependent manner in slow-twitch muscle. Sarcol ipin associates with SERCA 1 
in fast-twitch fibers and reduces Ca2+ pump activity, however, its regulatory role is less well 
defined (Vangheluwe et al. 2005). Due to the SR' s larger volume in fast-twitch fibers. and 
greater abundance of CSQ, it is filled only to 3 5% of its capacity at resting cytoplasmic free 
Ca2+. Therefore any increase of cytoplasmic Ca2+ results in fast and effective uptake into the SR 
(Dawson et al. 1987; Fryer and Stephenson 1996). In slow fibers , however, the SR is 
completely saturated with Ca2+ at resting cytoplasmic Ca2+ concentrations (Fryer and 
Stephenson 1996). Therefore the reuptake of cytoplasmic Ca2+ following a Ca2+ transient is 
slowed by a back inhibition of SERCA as SR Ca2+ binding sites become saturated (Inesi and de 
Meis 1989) 
1. 7.3.4 Contribution of mitochondria to Ca2+ homeostasis 
Mitochondria, in addition to their energy supply role, play a role in modulating cytoplasmic free 
Ca2+ concentration. In skeletal muscle fibers, mitochondria are either subsarcole1nmal , 
clustered beneath the sarcolemma, or they are intermyofibrilar and e1nbedded ainong the 
myofibrils, (Ogata and Yamasaki 1985). The intermyofibrilar mitochondria are located in 
transversal rows close to the CRUs at the I-A band edge where they are closely associated with 
terminal cistemae (Vendelin et al. 2005; Dirksen 2009). In type 1 and 2A fibers there is an 
additional longitudinal row of mitochondria. Ca2+ enters the mitochondrion mainly through a 
Ca2+-uniporter (MCU) (De Stefani et al. 2011). MCUs have a low affinity for Ca2+ (1-1 0µM) , 
however they transport Ca2+ into mitochondria that are located near RyRs and are exposed to 
microdomains of high Ca2+ concentration (Rizzuto and Pozzan 2006; Franzini-Armstrong 
2007). Mitochondria take up Ca2+ during contraction and rapidly release it during relaxation 
(Rudolf et al. 2004 ). The increase in 1nitochondrial Ca2+ is delayed by a few milliseconds 
following the cytoplasmic Ca2+ transient. Ca2+ entry into the mitochondrion is an important 
signal for mitochondrial function (Satrustegui et al. 2007; Gellerich et al. 2010), and could also 
help in calcimn homeostasis by providing a calciurn buffer. Indeed, there is some evidence that 
mitochondrial contribute differentially to Ca2+ homeostasis slow- and fast-twitch fibers. 
Inhibition of mitochondrial Ca2+ uptake shows that 1nitochondria do not play an active role in 
promoting relaxation in fast-twitch fibers , but play a significant role in the mitochondria-rich 
slow-twitch fibers (Gillis 1997). There is also some evidence that the protein compliment of 
mitochondria differs between fast- and slow-twitch fibers , which suggests that mitochondria can 
be specialized not just for energy metabolism, but also calcium regulation (Racay et al. 2006). 
1. 7.3.5 Response of myofibrils to Ca2+ 
The troponin subunits and tropomyosin have distinct isoforms expressed in skeletal muscle 
(Schiaffino and Reggiani 1996). The response of the myofibrillar apparatus to Ca2 
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concentration is often expressed as the relation between tension developed and free Ca
2
+ 
concentration as a log value (pCa) giving the tension-pCa curve (see Figure 1.23). The 
threshold for activation is lower in slow-twitch than in fast-twitch fibers , but the steepness of 
the slope is greater in fast-twitch fibers (Schiaffino and Reggiani 2011 ). 
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Figure 1.23: Modulation of active tension and rate of tension development be free calcium concentration 
(expressed as pCa = -log[Ca2+]). The slow fibers were from rat soleus and the fast from rat EDL. The 
slow-twitch fibers have a lower threshold and slope compared to fast-twitch fibers (Schiaffino and 
Reggiani 2011) 
In summary, compared to slow-twitch fibers , fast-twitch fibers are characterized by the 
following: 
• Lower cytoplasmic free Ca2+ concentration due to more powerful cytoplasmic Ca
2
+ 
buffering 
? -'-
• Reduced ca- ' entry from extracellular space 
• Ability to release and take up larger amounts of Ca
2
+ in a shorter time due to a more 
developed SR, more SERCA, RyRl and CSQ and more Ca2+ stored in the SR 
• A steeper tension-pCa curve 
1.7.4 Energy supply 
The energy supply in terms of oxidative or glycolytic metabolism is extensively reviewed by 
Schiaffino and Reggiani (Schiaffino and Reggiani 2011) and only a brief summary is given 
below (see Figure 1.24). 
The metabolic diversity among fibers becomes apparent ·when contractile activity starts. Upon 
activation, the energy consumption in muscle fibers increases roughly 1000-fold due to ATP 
hydrolysed by myofibrillar ATPase as well as SERCA. In human muscle, during high intensity 
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contractions, l .5mM/s of ATP is consumed in slow-twitch muscle (3 7°C) and up to 7mM/s in 
fast-twitch muscle. ATP stores and phosphocreatine provide energy to support contractile 
activity for a few seconds, and for a longer period in slow-twitch fibers than for fast-twitch 
fibers. Therefore, even on a short time scale, fast-twitch fibers can generate 1nore power, but 
contract for a shorter time than slow-twitch fibers. 
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Figure 1.24: Scheme showing some differences in glucose, lactate and fatty metabolism between fat and slow twitch 
musc le fibers. Pathways prevalent in fast twitch muscle are shown in red arrows, whereas pathways prevalent in 
slow-twitch are shown in green arrows. The abbreviations stand for the following: DHAP, dihydroxyaceto ne 
phosphate; GLUT4, flucose transporter 4; F-6-P, fructose-6-phosphate; FAT/CD36, fatty acid translocase; Ff A, free fatty acids; F-1 ,6-P, fructose-1 ,6-bisphosphate; F-2-6-P, fructose-2 ,6-bisphosphate; G-3-P, glyceraldehyde-3-
phosphate; G-6-P. glucose-6-phosphate; GPD I , glycerolphosphate dehydrogenase I ( cytoplasmic) ; GPD2, 
g lycero l phosphate dehydrogenase 2 (mitochondrial) ; HK, hexokinase; LDH, lactate dehydrogenase; MCTl. 
monocarboxy lic acid transporter I ; MCT4, monocarboxylic acid transporter 4; PDH, pyruvate dehydrogenase: PFK. phosphofructokinase; MCT4, monocarboxylic acid transporter 4; PDH, pyru vate deh ydrogenase; PFK. 
phosphofructokinase; PFKFB3 , phosphofructokinase-fructose bisphosphatase 3; TG, triglycerides (Schiaffi no and 
Reggiani 2011 ). 
Creatine kinase supports immediate ATP regeneration with assistance from adenylate kinase. 
Adenylate kinase is more active and leads to more AMP accumulation in fast-twitch fibers 
compared to slow-twitch. AMP deaminase, which is more abundant in fast-twitch fibers 
converts AMP to IMP . IMP causes a greater activation of glycogenolysis. On the other hand 
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AMP activates AMP kinase which is more active in slow-twitch fibers and therefore causes a 
greater glucose uptake and ~-oxidation than in fast-twitch fibers. 
ATP production through glycolysis is more effective in fast-twitch than slow-twitch fibers 
because glycolytic activity is about twice as high in fast-twitch fibers. This, however, is not 
sufficient to cope with maximal ATP consumption in either fiber type and therefore sets a limit 
to pathway glycolysis as an energy source for contractile activity. Pyruvate produced through 
glycolysis can either be converted to lactate and exported, or it can be decarboxylated to acetyl-
CoA. The balance between the two options is shifted towards acetyl-CoA in slow-twitch fibers 
and towards lactate in fast-twitch. Different lactate dehydrogenase isoforms and pyruvate 
dehydrogenase regulation via pyruvate dehydrogenase kinase and pyruvate dehydrogenase 
phosphatase control the switch in the pathway. 
ATP production through the oxidative Krebs-cycle is more effective in slow-twitch fibers than 
in fast. This is due to the greater mitochondrial density in slow-twitch fibers and greater Krebs-
cycle fuelling based on ~-oxidation, which is three time higher in slow-twitch fibers. 
Mitochondrial activity is also regulated differently in slow- and fast-twitch fibers with 
differences in the effects of ADP stimulation (more effective in fast-twitch fibers) and creatine 
stimulation (more effective in slow-twitch fibers). Once mitochondrial respiration and ATP 
production are activated in slow-twitch fibers, they achieve a complete energy balance (ATP 
consumption is covered by ATP production). This never occurs in fast-twitch fibers. 
1.7.5 Variations in muscle fiber types in relation to species, 
gender and individual polymorphism 
1. 7.5.1 Species diversity 
Body size is a major determining factor in muscle fiber type composition. Muscles from small 
mammals like mice consist mainly of type 2X and 2B fibers and they abound in oxidative 
enzymes. Muscle from larger mammals like humans consists mainly of type 1 and 2A fibers but 
they contain lower levels of oxidative enzymes (Schiaffino and Reggiani 2011 ). Energy 
metabolism per unit body mass is inversely related to body size (Kleiber's law) therefore the 
metabolic activity in smaller species is higher than in larger animals (Kleiber 1947). This is 
reflected in the volume of muscle fiber occupied by mitochondria and the density of capillary 
vessels (Hoppeler et al. 1981). For example, in the common shrew, which is the smallest 
mammalian species, muscles are composed of exclusively type 2X and 2B fibers (Savolainen 
and Vomanen 1995) with a mitochondrial volume of35% of the fiber. In humans however, 
mitochondria make up about 2-5 % of fiber volume (Rowald et al. 1985). Muscle fiber diameter 
61 
Chapter 1 
and maximum shortening velocity are also related to body size in that 1nuscles from smaller 
animals are smaller diameter and have a faster shortening velocity (Rome et al. 1990: Seow and 
Ford 1991; Pellegrino et al. 2003; Toniolo et al. 2005; Marx et al. 2006) (Gauthier and Padykula 
1966), although there are exceptions. Tension development is also faster in both in fast-twitch 
and slow-twitch fibers from small animals (Close 1965), and consequently the sti1nulation 
frequency necessary to obtain fused tetanic contraction is higher in smaller animals than in 
larger animals. For example, in humans, a maximal force is attained at about 50Hz. whereas 
rats need more than 1 00Hz for fast motor units and more than 70Hz for slow motor units to 
achieve fused tetanic contraction (Macefield et al. 1996; Piotrkiewicz and Celichowski 2007). 
1. 7.5.2 Gender diversity 
There is obvious gender diversity in skeletal muscle mass when it comes to humans and this is 
dependent on the increased testosterone levels in men after puberty. The MyHC fiber type 
profile, however, is essentially si1nilar in men and women but there is a higher ratio of type 2 to 
type 1 fiber mass in men. This could be because of the hypertrophy of type 2 fibers induced by 
testosterone (Welle et al. 2008; Schiaffino and Reggiani 2011 ). There are also differences in 
metabolic properties such as lipid metabolis1n in muscle from women and men (Kiens 2006). 
Women use more lipids in exercise than men, which could also be because they have a higher 
ratio of type 1 to type 2 fibers. However, the factors responsible for gender differences in 
muscle metabolism are not known. 
1. 7.5.3 Individual diversity 
Human skeletal muscle composition shows significant individual variation. For exa1nple in a 
study on fiber type composition of human vastus lateralis (Simoneau and Bouchard 1989), type 
1 fibers were found to vary fro1n 15-85% in a large cohort of individuals including sedentary 
and physically active individual of both sexes. 25% of individuals had either less than 3 5% or 
more than 65% of type 1 fibers. Muscle biopsies from monozygotic and dizygotic twins have 
shown that ahnost 50% of this variance is associated with genetic factors (Simoneau and 
Bouchard 1995). Muscle biopsies fro1n athletes also show marked variation in fiber type 
profile. Sprint athletes have a tendency towards type 2 dominance and endurance athletes 
towards type 1. However, the extent to which training or genetic endowment influence this is 
not known (Costill et al. 1976; Andersen et al. 2000) . 
1.7.6 Fiber type diversification during muscle development 
Muscle fiber type diversification is observed from the early developmental stages and it is 
initially independent of neural influence (Condon et al. 1990b ). In mouse embryos. before EJ 6 
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all muscle fibers express both MyHC-emb and MyHC-~/slow (Narusawa et al. 1987; Condon et 
al. 1990a; Lyons et al. 1990). At El 6, fiber type diversity is first observed with some of the 
primary fiber generation losing MyHC-~/slow expression for MyHC-neo. The two primary 
generation fiber populations turn into fast-twitch fibers (MyHC-emb and MyHC-neo 
expressing) or slow-twitch fibers (MyHC-emb and MyHC-~/slow) (Condon et al. 1990a). New, 
secondary generation fibers are also formed, expressing MyHC-emb and MyHC-neo. Fiber 
diversification occurs independently of neural influence and during the early stages of 
synaptogenesis. Matching between motor neuron types and muscle fiber types must occur 
because early motor units are largely homogenous in fiber type even during the period when 
they are polyneuronally innervated (Thompson et al. 1984). 
During the first weeks after birth, four major changes take place in fiber type and MyHC 
composition in rat and mouse muscles: 
• The progressive disappearance ofMyHC-emb and MyHC-neo ( lost more slowly in 
type 2A fibers) (Schiaffino et al. 1989). 
• The upregulation of adult MyHC genes and the accumulation of MyHC-2A, -2X and -
2B in fast-twitch fibers (DeNardi et al. 1993). 
• Some fast-twitch muscle in mice (TA, plantaris) contain a proportion of type 1 fibers 
that disappear during postnatal development (Whalen et al. 1984; Agbulut et al. 2003). 
• Some slow-twitch muscle in rats (soleus) have some type 2A fibers which are 
progressively transformed into type 1 fibers with concomitant transformation of type 2 
to type 1 motor units (Kugelberg 1976). 
The developmental MyHCs disappear during the first 2-4 weeks of postnatal development 
staring in type 2B fibers, then type 2X and later type 2A fibers (Schiaffino et al. 1989). 
1.7.7 Fiber type in regenerating skeletal muscle 
The satellite cells (muscle stem cells) responsible for muscle regeneration differ from the 
embryonic muscle precursor cells present at prenatal development. They also differ from the 
satellite cell involved in muscle growth during the early postnatal development stage. At first, 
developmental MyHC isoforms are expressed during regeneration (Sartore et al. 1982; 
Schiaffino et al. 1986; d'Albis et al. 1988). This is switched to adult isoforms under control of 
nerve activity. A widely used model for regeneration is the rat soleus which undergoes rapid 
regeneration after injury. If innervation is present, the regenerating fibers acquire the typical 
slow-twitch profile within a week. The fast-twitch gene program which seems to be the default, 
is activated in denervated regenerating muscle (Whalen et al. 1990; Esser et al. 1993). 
Functional innervation of regenerating fibers starts 3-5 days after injury and causes a rapid 
downregulation in MyHC-2B and -2X with an upregulation in MyHC-slow (J erkovic et al. 
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1997). A slow motor neuron stimulation frequency is the switch in MyHC expression 
(Kalhovde et al. 2005). Satellite cells from adult mammalian muscle tend to form fibers with a 
phenotype reflecting their fiber type of origin, which suggest that there is satellite cell 
heterogeneity (Dusterhoft and Pette 1993; Wehrle et al. 1994; Barjot et al. 1995: Rosenblatt et 
al. 1996; Huang et al. 2006). This might also be because of transcription factors influenced by 
the fiber type milieu they find themselves in. 
1.7.8 Fiber type remodelling 
Skeletal muscle is very adaptable in response to changes in use. Its adaptations include changes 
in fiber size, fiber type as well as changes in muscle force and fatigue resistance (Pette and 
Staron 1997). Adult skeletal muscle can be induced to switch fiber type by changes in nerve 
activity, loading (increasing the force that a muscle must support or overcome e.g. weight 
training) or hormonal influences. 
The effect nerve activity has on fiber type is mediated by specific impulse patterns (Pette and 
Vrbova 1999; Schiaffino and Reggiani 2011; Jorquera et al. 2013). Aphasic high-frequency 
electrical stimulation can induce a slow-to-fast switch. This pattern resembles the firing pattern 
of fast neurons and the direction of fiber type change is 1 --.2A--.2X ---. 2B. Muscle unloading 
caused by hind limb suspension as well as hyperthyroidis1n can also cause a slow-to-fast fiber 
type switch in muscle. A fast-to-slow switch can be induced by electrical stimulation 
resembling the firing pattern of slow 1notor neurons (tonic low frequency). The direction of 
switching is 2B --. 2X --. 2A ---.1. Muscle overloading due to loss of synergistic muscles as well as 
hypothyroidis1n can also cause a fast-to-slow switch. The changes in any given muscle are 
dictated by the original fiber type of the muscle and intrinsic differences between muscles that 
detennine their range of adaptations. Fast muscle has the capacity to adapt mostly in the fast 
range (2B+--+ 2X+--+ 2A) and slow muscles in the range l+--+ 2A+--+ 2X (Ausoni et al. 1990). 
Muscles undergoing fiber type transformation very frequently have hybrid fibers with mixed 
MyHC co1nposition. This is due to the slow turnover of myosin (Schiaffino et al. 1988: Ausoni 
et al. 1990; Caiozzo et al. 1998). In hmnans, endurance-trained individuals have increased l/2A 
hybrid fibers , whereas sedentary individuals have increased 2A/2X fibers (K]itgaard et al. 
1990a). 
During postnatal development and regeneration, a default nerve-activity independent muscle 
fiber differentiation program pathway activates the fast-gene program. However. slow-motor 
neuron activity induces slow gene program during postnatal development (Butler-Browne and 
Whalen 1984; Esser et al. 1993). Once established, the slow gene program is not readily 
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reversed in adult fibers and can persist for a long time even in denervated muscle. Physiological 
adaptation to increased activity, such as endurance exercise, induces a switch to a more 
oxidative fast phenotype (2X--+2A in humans, 2B--+ 2X--+ 2A in rats and mice), but no 
significant switch to type 1 muscle fibers (Ausoni et al. 1990; Allen et al. 2001 ). 
1.8 Sarcopenia 
Sarcopenia is the age related loss of muscle mass and strength. It has also been associated with 
other serious conditions such as insulin resistance, osteoporosis, obesity, arthritis, and metabolic 
syndromes (Boden et al. 1993; Colman et al. 1995; Marcus 1995; Coin et al. 2000; Roubenoff 
2000). In addition, the decay of the neuromuscular system due to age results in diminished 
force production, reduced speed of contraction, problems with maintaining balance, an 
increased risk of accidental falls, struggling to rise from seated positions and slowed walking 
(Lennmarken et al. 1985; Young et al. 1985; Einsiedel and Luff 1992; Hakkinen et al. 1996; 
Lindle et al. 1997; Izquierdo et al. 1999; Vaillancourt et al. 2003). Together, these outcomes 
can have a negative effect on quality and quantity of life. The causes of sarcopenia are 
multidimensional involving alterations in the central and peripheral nervous system, hormonal, 
nutritionaL immunological and physical activity changes (Narici and Maffulli 2010). For the 
purposes of this thesis, the focus will be on structural and functional changes involving and 
affecting EC coupling. 
1.8.1 Structural changes 
Muscle undergoes significant structural changes during aging. From about the age of 50, whole 
muscle size decreases at a rate of roughly 1 % per year. The result is that from the age of 5 0 to 
the age of 80yr, there is a reduction of 30% in whole muscle size (Lexell et al. 1988; Marcell 
2003; Goodpaster et al. 2006). The proportions of protein, collagen and fat also change. As 
protein (contractile tissue) is lost, it is replaced by fat and collagen (Rice et al. 1989; Overend et 
al. 1992). The muscle mass decline with age in humans appears to be primarily due to a loss in 
the number of fibers (Eddinger et al. 1985; Lexell et al. 1988) and although early studies 
suggested that fiber size decreases, especially in type 2 fibers , more recent longitudinal reports 
suggest that fiber size is preserved in humans (Aniansson et al. 1992; Frontera et al. 2008). 
1.8.1.1 Changes in fiber type 
The loss of muscle mass seen with aging is due to atrophy of the muscle fibers and especially of 
fast-twitch fibers. Lexell et al showed that type II fibers experience a 26% decline in cross-
sectional area between 20 and 80yr while the size of type I fibers did not atrophy significantly 
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(Lexell et al. 1988). This fiber type-specific reduction in size is seen in humans as we ll as 
animals (Lexell et al. 1983; Ansved and Larsson 1989; Holloszy et al. 1991 ; Coggan et al. 
1992). However in humans although fiber atrophy contributes to the whole muscle ' s decrease 
in size, the main factor is the decrease in fiber number with age. In humans between the age of 
52 and 77, there is a 3 5% decrease in fiber number within the whole muscle (Lexell et al. 1986). 
There appears to be a difference between species in the fiber specificity of the decrease in in 
muscle fiber nu1nbers. A number of investigations show that humans loose equal amount of 
fast- and slow-twitch fibers during the aging process (Lexell et al. 1983; Lexell et al. 1988· 
Ansved and Larsson 1990). However, there seems to be a selective loss in fast-twitch fibers in 
rodent muscle in aging (Ishihara et al. 1987; Kanda and Hashizume 1989; Ansved and Larsson 
1990). In rodents and humans, aging results in the whole muscle size and mass being 
comprised of a higher percentage of slow-twitch fibers. For rodents this would be the natural 
outflow of selective loss in fast-twitch fibers , but for humans this is unexpected as equal 
numbers of fast- and slow-twitch fibers are lost. The reason for the increase in slow-twitch 
content in aging human muscle is due to the age related atrophy of 1nuscle fibers being 1nore 
severe in fast-twitch fibers, therefore the proportion of muscle mass made up by slow-twitch 
fibers is significantly increased even though the fiber number ratio between fast-and slow does 
not change (Larsson et al. 1978; Essen-Gustavsson and Borges 1986; Lexell et al. 1988). 
1.8.1.2 Changes in CRU structure 
Boncompagni et al (Boncompagni et al. 2006) studied the ultrastructure and geometry of the 
CRUs in hu1nan vastus lateralis and gluteus medius biopsies from male and female subjects 
between the age of 28 and 83. They found that in mature skeletal muscle from young 
individuals, the CRUs were located ahnost exclusively opposite the sarcomere I-A junctions 
one on each side of the Z-line. The CRUs were frequent and fairly evenly distributed, oriented 
transversely with respect to the long axis of the myofibrils. The feet (RyRl) were located in 
two parallel rows on either side of the t-tubule. Dyads as well as longitudinal triads and dyads 
were extre1nely rare. Several differences were observed in aged muscle specimens. The overall 
number of junctions was lower and the average CRU density per unit area significantly 
decreased. While the CRUs were uniformly distributed in fibers from younger muscle. the 
density of the CR Us in fibers from aged muscle was variable with areas completely devoid of 
CRUs. The junctions in the aged muscle were also more variable. The frequency of dyads and 
junctions with a large transverse profile (showing more than two feet on each side of the t-
tubule) were higher in aged muscle. The frequency of longitudinal t-tubules was also increase 
in the aged muscle samples. Significantly, the size of the junctional gap between the SR and t-
tubule, however, remained unchanged. The aged muscle CRUs often appeared disordered 
(although recognizable from their location near the A-I junction), with disordered junctions 
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usually in areas of low CRU density. It was suggested that they might represent a stage in the 
disassembly of CRUs. 
1.8.2 Changes in motor units and neuromuscular junctions 
1.8.2.1 Structural and functional changes in motor units 
The decrease in the number of fibers with age is, as might be expected, directly linked with a 
loss of motor neurons. A number of mechanisms have been proposed to explain age-related 
loss of muscle fibers. One particularly involves the denervation of fibers caused by motor 
neuron cell death (Vandervoort 2002; Jones et al. 2009; Siu and Alway 2009; Deschenes et al. 
2010). There have been reports of fewer of motor neuron axons present in the ventral roots of 
aged spinal cords and a greater number of the remaining axons displaying axonal degeneration. 
One study showed that among humans aged 60 and over, there were 25% fewer motor neurons 
compared to younger individuals (Tomlinson and Irving 1977). The remaining healthy neurons 
were significantly smaller in aged spinal cords. This is important because smaller neurons are 
capable of innervating fewer fibers than larger neurons (Kawamura et al. 1977; Tomlinson and 
Irving 1977; Mittal and Logmani 1987). 
The current understanding of age-related remodelling of the motor units (Deschenes 2011) 
states that, during the degeneration of motor units the fibers innervated by the affected neuron 
become abandoned and no longer receives neural input. This process is compensated for, to 
some degree, by nerve terminal sprouting of the remaining healthy neurons to re-innervate the 
abandoned muscle fibers. Aging, however, also results in a reduced capacity for motor neuron 
sprouting and therefore the capacity for reinnervation of abandoned fibers is reduced (Jacob and 
Robbins 1990; Robbins 1992). This age related denervation/reinnervation process leads to 
greater clustering of reinnervated fibers and the death of fibers that are not successfully 
reinnervated (Larsson et al. 1978; Larsson and Edstrom 1986; Lexell and Downham 1991). 
Another effect of this process is that unlike the motor units of young adults, where all the fibers 
are of the same fiber type, different fiber types are dispersed in aging motor units, although they 
still display one dominant fiber type (Edstrom and Larsson 1987). The presence of more than 
one type of muscle fiber in a motor unit has become the hallmark of aging motor units. 
With age-related remodelling of motor units, the muscle is left with fewer, but larger motor 
units . The innervation ratio of motor units is increased and therefore the remaining motor 
neurons activate a greater number of muscle fibers. Also, whether it is through the selective 
loss of fast motor neurons seen in animals or a greater atrophy of fast-twitch fibers seen in 
humans, the result is a greater portion of the aged muscle being composed of slow-twitch 
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muscle (Brown 1972; Lexell et al. 1983; Lexell et al. 1988; Klitga.ard et al. 1989) . This has 
phys iological and functional implications for the muscle. 
The natural consequence of structural changes in motor units is functional change in the affected 
1nuscles. A number of investigations have found that in humans 60 years and above, there is a 
steady decline in strength, at an annual rate of about 1.5% (Vandervoort and McComas 1986· 
Lindie et al. 1997; Rantanen et al. 1998; Deschenes 2004). This is seen in both men and women 
in muscles of both the upper and lower body (Young et al. 1984; Young et al. 1985 ; Lynch et al. 
1999; Deschenes 2004). One of the main reasons for age-related decrease in muscle strength is 
the decrease in the number of motor units in affected muscles (Brown 1972; Campbell et al. 
1973 ; Stal berg and Fawcett 1982; Galea 1996). Although aging reduces muscle mass, motor 
unit number and specific tension (force produced relative to fiber size) (Frontera et al. 2000; 
Gonzalez et al. 2003 ), the strength of individual motor units seems to increase in aging. It has 
been shown in humans that the age-related decline in the motor unit nu111ber of a muscle 
exceeds that muscle ' s decrease in maximal force production and that the strength expressed by 
surviving motor units is ainplified (Doherty et al. 1993). This provides some compensation for 
the loss of motor units. Another functional implication of the change in motor-units with age is 
that the contractile velocity of the muscle fiber decreases due to more slow-twitch fibers in the 
whole muscle (Krivickas et al. 2001 ; Yu et al. 2007). However, age-induced changes in 1notor 
neuron conduction rate and alterations in the Ca2+ handling during contraction contribute to the 
reduction in contractile velocity and power (Campbell et al. 1973 ; Edstrom and Larsson 1987; 
Ansved and Larsson 1989; Sugiura and Kanda 2004; Deschenes 2011). Increased fatigue 
resistance with aging is another consequence of increased slow-twitch fiber content (Lanza et al. 
2004; Dalton et al. 2010). However the reported effect of aging on fatigue resistance can vary 
due to differences in the way fatigue is measured (Kent-Braun et a.I. 2002; Yoon et al. 2008; 
Callahan et al. 2009). Whether the 111otor units themselves show improved fatigue resistance 
depends on the type of motor unit examined. While aging has no significant impact on slow-
twitch motor units, fast-twitch motor units show decreased resistance to fatigue with aging 
(Kanda and Hashizume 1989; Sugiura and Kanda 2004; Lochynski et al. 2008). Table 1.3 gives 
a sUJnmary of the age related adaptations of whole 1nuscles and their motor units (Deschenes 
2011 ). 
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Table 1.3 Summary of age-related adaptations of whole muscles and their motor units 
(Deschenes 2011) 
Whole Muscle Motor Unit 
Size Decrease Increase 
Number of muscle fibers Decrease Increase 
Maximal force production Decrease Increase 
Specific tension (force/size) No change or decrease Decrease 
Contractile velocity Decrease Decrease 
Fatigue resistance Increase (depending on test No change (slow-twitch) or 
protocol) decrease (fast-twitch 
1.8.2.2 Structural and functional changes in neuromuscular junctions 
There is evidence that remodelling of the NMJ occur throughout our lifetime (Banker et al. 
1983~ Kelly and Robbins 1986; Wigston 1990a; Wigston 1990b; Hill et al. 1991; Robbins 
1992), and that this natural remodelling is amplified "\iVith age and results in significant structural 
synaptic modifications. Reports show that modifications of the NMJ may possibly cause the 
modifications in muscle fibers such as atrophy and fiber type composition (Deschenes et al. 
2010). Age-related modifications of the NMJ include elevations in nerve terminal branching 
(Courtney and Steinbach 1981 ; Oda 1984; Robbins and Fahim 1985; Andonian and Fahim 
1987), and at the same time a sharp dechne in vesicle density resulting in a decrease in stored 
ACh in aged nerve endings (Fahim and Robbins 1982; Deschenes and Wilson 2003). The 
reduced neurotransmitter is associated "\iVith a decrease in the number of active zones (ACh 
release sites) in the presynaptic terminals. Typically, the size of the neural endings and the 
number of branches ·within are related to axon thickness. Ho~rever, even though the nerve 
ten11inal branching is elevated, the axons of the aged motor neurons were no larger in diameter 
(Prakash and Sieck 1998). This suggests that age-related NMJ changes do not originate in the 
spinal cord, but are initiated by changes at the neuromuscular apparatus . In fact there is 
evidence that the expedited denervation/reinnervation process that characterizes aging begins 
the NMJ and progresses in a retrograde (terminal to spinal cord) direction causing the axon to 
degenerate and ultimately resulting in the death of the neuron cell body (Ansved and Larsson 
1990: Dupuis et al. 2009). The NMJ degeneration may be rooted in mitochondrial dysfunction 
in the nerve terminal \Vhich increases ceUular toxicity association with excess ROS production 
(Seo et al. 2008; Dupuis et al. 2009; Jang et aL 2010) and reduced ATP synthesis (Kujoth et al. 
..... 006: Safdar et al. 2010), which is needed for vesicular and neurotransmitter recycling. 
69 
Chapter 1 
Changes in the pre-synaptic nerve terminal are accompanied by alterations at the post-synaptic 
end plate. The overall area of the motor end plate enlarges in aged NMJ with a more dispersed 
AChR distribution (Fahim and Robbins 1982; Rosenheimer and Smith 1985: Prakash and Sieck 
1998; Deschenes et al. 2010). There is also increased architectural uncoupling of pre- and post-
synaptic features (Fahim and Robbins 1982; Prakash and Sieck 1998). This less stable, more 
fragile relationship between pre- and post-synaptic components of the NMJ, leads to a greater 
incidence of neuromuscular transmission failure during continuous stimulation (Smith 1979· 
Smith 1984 ). Table 1.4 gives a summary of the morphological response of the NMJ to aging. 
Table 1.4: Summary of morphological adaptations of the NMJ to aging. Adapted from (Deschenes 2011) 
Pre-synaptic Post-synaptic 
i complexity of nerve terminal branching i incidence of abandoned synaptic gutters 
i nerve terminal branch number i dispersion of ACh receptors 
i total nerve terminal branch length i length of endplate 
i planar area of nerve terminal branching i total area of endplate 
i area of ACh vesicle clusters i perimeter length around endplate 
l total number of ACh vesicles iincidence of pre- and post-synaptic uncoupling 
The structural changes in NMJs related to age are naturally linked to functional changes in 
neurotransmission across the synapse. The larger nerve terminal number and area in aged NMJs 
are accompanied by an increased neurotransmitter release upon stimulation resulting in higher 
sarcole1n1nal endplate potential amplitude (Kelly and Robbins 1986; Bhattacharyya et al. 1994; 
Fahi1n 1997). This, however, leads to an earlier depletion of neurotransmitter and therefore 
increased neurotrans1nission failure. 
1.8.3 Changes in EC coupling (EC uncoupling) 
Although loss of muscle mass would reduce muscle strength, the loss in muscle strength is 
greater than can be accounted for by the loss in mass (Lynch et al. 1999). In vitro studies in 
single hu1nan muscle fibers have also shown a decrease in specific force (force/cross sectional 
area) w ith age (Frontera et al. 2000). This suggests that the intrinsic force-generating capacity 
of skeletal muscle per contractile unit may be impaired in aging mammals. Some of the 
suggested mechanisms involved in this process include alterations to the EC coupling process 
(Delbono et al. 1995 ; Renganathan et al. 1997; Wang et al. 2000) and decreased actin-1nyosin 
cross-bridge stability (Lowe et al. 2002). 
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Delbono et al (Delbono et al. 1995) first investigated the possibility that the reduction in 
specific force seen in aging muscle may be due to alterations in the EC coupling Ca
2
+ release 
process. Their study was specific to fast-twitch fibers as fast-twitch fibers showed the most 
significant degree of hypo-atrophy with aging in mixed fiber type composition muscles (Coggan 
et al. 1992). Delbono et al found that the fast-twitch fibers from the aged human subjects (65-
75yr) had a reduced smaller average fiber diameter than the younger cohort (25-35yr). The 
maximal DHPR charge movement, normalized to membrane capacitance was reduced in the 
aged muscle with no change in voltage dependence or charge distribution. They also found 
DHPR Ca2+ current amplitude was reduced in aged muscle, again with no change in voltage 
dependence. The peak voltage-induce Ca2+ transient from the SR was reduced in aged muscle 
and this was not due to SR store depletion. These results suggested that the DHPR-dependent 
Ca2+ release underlying EC coupling is less in aged fast twitch muscle. This group coined the 
term EC uncoupling to describe the defects in transmission of membrane depolarization to SR 
Ca2+ release that are responsible for decreased specific force (Payne and Delbono 2004 ). 
Reduced DHPR change movement during EC coupling could indicate fewer DHPRs and/or 
dysfunctional DHPR with age. The reduced SR Ca2+ release could be the result of fewer 
DHPRs, dysfunctional DHPR, fewer RyRl and/or dysfunctional RyRl. A number of 
subsequent studies investigated the expression of EC coupling proteins and are discussed below 
in Section 1. 8 .3 .1. 
In addition to the changes discussed above, the cytoplasmic free Ca
2
+ concentration is increased 
in both slow-twitch soleus and fast-twitch EDL muscles from old rats (F!aysse et al. 2006). In 
addition, a population of aging mouse skeletal muscle fibers has an external Ca
2
+ dependent 
component to EC coupling indicated by reduced voltage-induced Ca
2
+ transients in fibers in the 
absence of external Ca2+ (Payne et al. 2004). Interestingly, regenerating skeletal muscle and 
developing muscle go through similar stages in which effective EC coupling and contraction are 
partially dependent on external Ca2+ (Louboutin et al. 1995; Louboutin et al. 1996), and there is 
an accompanying transient expression of the DHPR a 1c subunit (Pereon et al. 1997). The 
expression of the DHPR a 1c diminishes as the expression of DHPR a 1s increases over time as 
muscle regeneration proceeds. As denervation and reinnervation occur in aged muscle with 
accompanying regeneration it is tempting to speculate that there is a shift towards cardiac EC 
coupling in aged muscle. However, one subsequent study found that external Ca
2
+ but not Ca2+ 
influx is needed to maintain force in repetitive fiber electrical stimulation of single fibers from 
aging mouse muscle (Payne et al. 2004 ). It is therefore unlikely that CICR plays a role in EC 
coupling in aged mice. The authors found that the external Ca2+ dependence is due to sodium 
channels modification with age, with the absence of external Ca2+ leading to a failure in in 
action potential generation. 
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Muscle weakness in aged muscle could also be due to modification of the RyRl. Oxidation and 
S-nitrosylation of RyRl in aged muscle dissociates FKBP12 from the RyRl causing an increase 
RyRl activity and therefore " leaky" channels (Andersson et al. 2011 ). Stabilizing the 
RyRl /FKBP12 binding reduced this calcium leak from the SR, enhanced Ca2+ release from the 
SR, increased specific force and increased exercise capacity in aged mice. 
1.8.3.1 DHPR and RyR1 expression in aged muscle tissue 
It seems that there is a general change in protein expression (O'Connell et al. 2007) as well as 
protein turnover (Ferrington et al. 1998) in muscle with age. Changes in expression levels of 
DHPR and RyRl are associated with loss of specific muscle force with age and this underlies 
the EC uncoupling hypothesis. 
1.8.3.1.1 The RyR1 
There are conflicting reports regarding the expression ofRyRl with age. A decrease in RyRl 
levels has been reported in mixed and fast-twitch fibers in rats and mice with age using 
[ 3H]ryanodine binding (Renganathan et al. 1997; Renganathan et al. 1998). However, other 
[ 3H]ryanodine binding and immunoblot studies report no change in RyRl expression in fast-
and slow-twitch muscle from aged rats (Damiani et al. 1996; Margreth et al. 1999; O'Connell et 
al. 2008). In terms of the EC uncoupling hypothesis, the ratio of DHPR to RyRl is likely to be 
more important than absolute expression levels in rodents. 
1.8.3.1.2 The DHPR a1s subunit 
The report by Delbono et al (Delbono et al. 1995) showing reduced DHPR charge movement 
and SR Ca2+ transients in aged hu1nan muscle fast-twitch fibers was subsequently confirmed in 
fast-twitch fibers of aging 1nice (Wang et al. 2000). [3H]PN200-l 10binding to DHPR a1 s in rat 
and mouse muscle shows reduced DHPR a 15 expression with age in mixed, slow-twitch and 
fast-twitch muscles (Renganathan et al. 1997; Renganathan et al. 1998). This was confirmed by 
immunoblot of aging rabbit and rat muscle (Ryan et al. 2000; Ryan et al. 2003 ; O'Connell et al. 
2008). The DHPR/RyR] ratio in adult rat EDL of ~ 1 suggests that every fourth RyR 1 is I inked 
to a DHPR tetrad. In soleus muscle this ratio is lower ( ~0.4) and indicates every 12th RyRl is 
linked to a DHPR tetrad (Delbono and Meissner 1996; Renganathan et al. 1997). In aged 
muscle the ratio decreases to 0.26 in soleus and 0.68 in EDL muscle . This indicates that more 
DHPR uncoupled RyRl s are present in older rat muscle and supports the EC uncoupling 
hypothesis. Significantly, insulin growth factor-I (IGF-1) enhances DHPR a 15 expression and 
prevents the age-related decline in DHPRa15 expression and muscle force (Renganathan et al. 
1998; Delbono 2000; Zheng et al. 2002). 
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In human muscle, however, there is apparently no decrease in DHPR a 1s with age (Ryan et al. 
2003 ). The alterations in CRU structure seen in aged human muscle showed that the total 
number of CRUs was decreased, but that the average size of the RyRl feet arrays are increased 
to compensate for this loss (Boncompagni et al. 2006). In human muscle therefore, it may be 
more a case of altered structure and arrangement of the EC coupling apparatus than the 
expression of the protein that cause the EC uncoupling. 
1.8.3.1.3 The DHPR Jl1a subunit 
As discussed previously in Section 1.6.1.2, the DHPR ~ l a subunit plays an important role in EC 
coupling as it is required for the trafficking of the DHPR a15 subunit to the sarcolemma, 
formation of tetrads as well as regulating L-type Ca2+ current and supporting a fraction of EC 
coupling. In addition, the SH3 domain of the ~2a subunit has been shown to bind to dynamin 
and mediate endocytosis of the DHPR a1c subunit in Xenopus oocytes (Gonzalez-Gutierrez et al. 
2007). The effect of aging on the DHPR ~l a subunit expression was investigated by Taylor et al 
(Taylor et al. 2009). They reported a significant increase in ~l a expression with age in mice 
both in mixed muscles and fast-twitch muscles. They also found that over expression of the ~l a 
subunit in TA muscles of mice caused a decrease in a 15 subunit expression and decline in 
specific force. Introducing siRNA against the ~l a subunit and thereby reducing its expression in 
aged mice showing a decrease in charge movement restored the charge movement levels to 
control. These results suggest a possible role for ~ la in the reduction in a1s subunit expression 
reported in rodents. However, the increased expression of ~ la has not been investigated in 
humans. 
73 
Chapter 2 
Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 List of chemicals and reagents 
All chemicals and reagents used were of analytical grade. 
CHEMICAL MANUFACTURER 
1,2-Bis (2-Aminophenoxy)ethane-N,N,N' ,N' - Sigma-Aldrich, USA 
tetraacetic acid (BAPTA) 
1 0bp DNA ladder Invitrogen, Life Technologies, USA 
1 0mM dNTP Mix Invitrogen, Life Technologies, USA 
2-Mercaptoethano 1 Sigma-Aldrich, USA 
2-Propanol (Isopropanol) AnalaR Normapur, VWR International , USA 
Acetic acid AnalaR Normapur, VWR Inten1ational , USA 
Acetone Univar, USA 
Acrylamide Bio-Rad Laboratories, USA 
Adenosine 5 '-triphosphate disodium salt Sigma-Aldrich, USA 
hydrate (ATP-Na2) 
Agar Difeo Laboratories, USA 
Albumin fro1n bovine seru1n (BSA) Sig1na-Aldrich, USA 
lyophilized powder 
Ammonium persulphate (APS) Sigma-Aldrich, USA 
Ampicillin Sigma-Aldrich, USA 
BCA protein assay Kit Thermo Scientific Pierce Protein Biology 
Products, Thermo Scientific, USA 
Benzamidine Sigma-Aldrich, USA 
Bolt® LDS Sample Buffer ( 4x) Life Technologies, USA 
Bolt® MES SDS running buffer (20x) Life Technologies, USA 
Bolt® MOPS SDS running buffer (20x) Life Technologies, USA 
Bolt® Sample Reducing Agent ( 1 Ox) Life Technologies, USA 
Boric acid AnalaR Nonnapur, VWR International , USA 
Brilliant Blue R Sigma-Aldrich , USA 
Bromophenol blue Sigma-Aldrich , USA 
CaCl2 Univar, USA 
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CHEMICAL MANUFACTURER 
Calpain inhibitor I Sigma-Aldrich, USA 
Calpain inhibitor II Sigma-Aldrich, USA 
Cesium hydroxide (CsOH) Sigma-Aldrich, USA 
Cesium methanesulfonate - CsCH3O3S Sigma-Aldrich, USA 
(CsMS) 
Chloroform Sigma-Aldrich, USA 
CsCl Sigma-Aldrich, USA 
DC Plus Protein Assay Kit Bio-Rad Laboratories, USA 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich, USA 
Dithiothreitol (DTT) Sigma-Aldrich, USA 
Ethanol EMSURE, Merck Millipore, Germany 
Ethidium Bromide Sigma-Aldrich, USA 
Ethylene glycol-bis(2-aminoethylether)- Sigma-Aldrich, USA 
N,N,N ' ,N ' -tetraacetic acid (EGTA) 
Ethylenediaminetetaacetic acid disodium salt Sigma-Aldrich, USA 
dihydrate (EDTA-Na2) 
Foetal Calf Serum (FCS) Sarana Australia Animal Serum 
Manufacturers, Australia 
Glycerol Univar, USA 
Glycine AMRESCO LLC, USA 
Goat a-mouse IgG-HRP antibody Santa Cruz Biotechnolegy Inc, USA 
Goat a-rabbit IgG-HRP antibody Santa Cruz Biotechnology Inc, USA 
Guanidine hydrochloride (GuHCl) AMRESCO LLC, USA 
HiSpeed Plamid Maxi Kit QLA.GEN, Netherlands 
Imidazole Sigma-Aldrich, USA 
Isopropyl ~-D-1-thiogalactopyranoside (IPTG) Sigma-Aldrich, USA 
KCl Chem-Supply, Australia 
KOD Hotstart DNA polymerase Novagen, Merck Millipore, Germany 
Leupeptin Sigma-Aldrich, USA 
Luria Broth JCSMR media, Australia 
Luria Broth (LB) JCSMR media, Australia 
Methanol EMSURE, Merck Millipore, Germany 
Minimum Essential Medium (MEM) Invitrogen, Life Technologies, USA 
N,N,N ' ,N ' ,-Tetramethylethylenediamine Bio-Rad Laboratories, USA 
(TEMED) 
N,N,N ' ,N ' -Tetraethylsulfamide (TES) Sigma-Aldrich, USA 
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CHEMICAL MANUFACTURER 
Na2HPO4 AnalaR Normapur, VWR International, USA 
NaCl Merck Milli pore, Gennany 
NaH2PO4 AnalaR Normapur, VWR International , USA 
n-Decane Sigma-Aldrich, USA 
Oligo dT 12-18 primer Invitrogen, Life Technologies, USA 
Pepstatin A Sigma-Aldrich, USA 
Phosphate Buffered Saline (PBS) JCSMR media, Australia 
Phosphatidylcholine (PC) A vanti polar lipids, USA 
Phosphatidylethanolamine (PE) Avanti polar lipids, USA 
Phosphatidylserine (PS) Avanti polar lipids, USA 
Phynylmethylsulfonylfluoride (PMSF) Sigma-Aldrich, USA 
Pierce ECL Western Blotting Substrate Thermo Scientific Pierce Protein Biology 
Products, Thermo Scientific, USA 
Precast 4-12% Novex® Bolt® Bis-Tris gels Life Technologies, USA 
Precast 4-15% Bio-Rad Tris-Gly gels Bio-Rad Laboratories, USA 
Precision Plus Protein Dual Colour Prestained Bio-Rad Laboratories, USA 
Standard 
Primers for PCR (hu1nan) Gene Works, Australia 
Pri1ners for PCR (mouse and rat) Integrated DNA Technologies, USA 
Protease inhibitor cocktail, EDTA free Roche, Switzerland 
PSN 1 000x antibiotic cocktail JCSMR media, Australia 
QIAprep spin Miniprep Kit QIAGEN, Netherlands 
RNaseOUT 1M Invitrogen, Life Technologies, USA 
RN easy 1nin i Kit QIAGEN, Netherlands 
Ruthenimn red Sigma-Aldrich, USA 
Silver Stain Plus Kit Bio-Rad Laboratories, USA 
Skim milk powder Woolworths, Australia 
Sodimn dodecyl sulphate (SDS) Sigma-Aldrich, USA 
Sucrose Chem-Supply, Australia 
SuperScript®III Reverse Transcriptase Kit Invitrogen, Life Technologies, USA 
Tris Sigma-Aldrich, USA 
Tris- HCl Sig1na-Aldrich, USA 
TRizo l® Invitrogen, Life Technologies, USA 
TWEEN®20 AMRESCO LLC, USA . 
Urea Sigma-Aldrich, USA 
a-Cav 1 .2 ACC-003 polyclonal antibody Alemone Jabs, Israel 
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CHEMICAL MANUFACTURER 
a-DHPR a 1a IIID5El monoclonal antibody Developmental Studies Hybridoma Bank, 
USA 
a-DHPR ~ la VD2(l)B12 monoclonal antibody Developmental Studies Hybridoma Bank, 
USA 
a-FKBP12 (H-5) monoclonal antibody Santa Cruz Biotechnology Inc, USA 
a-RyRl 34C monoclonal antibody Developmental Studies Hybridoma Bank, 
USA 
2.1.2 Buffers and Solutions 
All buffers and solutions were made up using water that has been sequentially passed through a 
1 0mU filter, 5mU filter, activated carbon and a reverse osmosis (RO) system. The water from 
the RO system was then filtered through a MilliQ unit (Merck Millipore, Germany). This 
process produces water at 18.2 mO. 
Some buffers were made up at higher concentrations to serve as stock solutions. The dilution 
factor is indicated in front of the buffers affected e.g 1 Ox Buffer A has to be diluted 1 in 10 to 
make lx Buffer A. 
2.1.2.1 Buffers and solutions used in expression and purification of the full 
length DHPR Pia-subunit 
2.1.2.1.1 10x Buffer A 
0.5M sodium phosphate pH8, 3M NaCl. 
2.1.2.1.2 DHPR JJ1a Resuspension Buffer 
8M Urea, 5mM Imidazole, 12mM 2-Mercaptoethanol, lx Buffer A pH 8.0, 10% Glycerol. 
2.1.2.1.3 DHPR JJ1a Elution Buffer 
8M Urea, 500mM Imidazole, 12mM 2-Meraptoethanol, l x Buffer A pH8, 10% Glycerol. 
2.1.2.1.4 Sample Buffer for DHPR JJ1a Purification 
0.06M Tris-HCl pH 6.8, 2% (w/v) SDS, 5% (v/v) 2-Mercaptoethanol, 10% (v/v) 
Glycerol, 0,025% (w/v) Bromophenol blue. 
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2.1.2.1.5 10x Electrophoresis Running Buffer 
0.25M Tris, 1.95M Glycine, 1 % (w/v) SDS. 
2.1.2.1.6 DHPR fl1a Purification Prepcell Gel Recipe 
Resolving gel: 25% (v/v) 1.5M Tris-HCl pH 8.8 stock 
7% (v/v) Acrylainide/Bis-acrylamide (37.5: 1) 
0.5% (w/v) APS 
0.125% (v/v) TEMED 
Stacking gel: 25% (v/v) 0.5M Tris-HCl pH 6.8 stock 
2.1.2.2 
6% (v/v) Acrylamide/Bis-acrylamide (37.5:1) 
0.5% (w/v) APS 
0.125% (v/v) TEMED 
Buffers and solutions used in MyHC analysis 
2.1.2.2.1 MyHC Homogenizing Buffer 
20mM Imidazole pH7.2, 150mM KCl, 0.21nM EDTA-Na2 
2.1.2.2.2 MyHC Resuspending Buffer 
501nM Tris-HCL pH7.4, 150mM NaCl. 
2.1.2.2.3 5x MyHC Resolving Gel Buffer 
lM Tris-HCl pH 8.8, 0.5M Glycine. 
2.1.2.2.4 5x MyHC Stacking Gel Buffer 
0.35M Tris-HCl pH 6.7, 20mM EDTA-Na2. 
2.1.2.2.5 20x MyHC Electrophoresis Running Buffer 
lM Tris, 1 .SM Glycine, 1 % (w/v) SDS. 
2.1.2.2.6 3x MyHC Sample buffer 
78 
0.24M Tris-HC pH 6.8, 60% (v/v) Glycerol , 6% (w/v) SDS, 150mM DTT, 0.01 % 
(w/v) Bromophenol blue. 
2.1.2.2.7 MyHC Gel Recipe 
Resolving gel: 35% (v/v) Glycerol 
8% (v/v) Acrylamide/Bis-acrylamide (99: 1) 
0.4% (w/v) SDS 
20% (v/v) 5xMyHC Resolving gel buffer 
0.1 % (w/v) APS 
0.05% (v/v) TEMED 
Stacking gel: 30% (v/v) Glycerol 
2.1.2.3 
2.1.2.4 
4% (v/v) Acrylamide/Bis-acrylamide ( 49: 1) 
0.4% (w/v) SDS 
20% (v/v) 5x MyHC Stacking gel buffer 
0.01 % (w/v) APS 
0.05% (v/v) TEMED 
Microsomal vesicle homogenizing buffer 
300mM Sucrose, 5mM Imidazole pH 7.4. 
2xHBS 
140mM NaCl, 1.5mM Na2HP04 5mM HEPES. 
' 
2.1.2.5 Bilayer solutions 
2.1.2.5.1 Trans Solution 
20mM CsCl, 30mM CsCH30 3S, lmM CaCb, l0mM TES. 
2.1.2.5.2 Cis Solution 
20mM CsCl, 230mM CsCH30 3S, lmM CaCb, l0mM TES. 
2.1.2.5.3 Perfusion Solution 
20mM CsCl, 230mM CsCH30 3S, l0µM CaCb, l0mM TES 
2.1.2.6 Buffers and solutions used in SDS-PAGE and Immunoblot 
2.1.2.6.1 10x Electrophoresis Running Buffer 
0.25M Tris, 1.95M Glycine, 1 % (w/v) SDS. 
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2.1.2.6.2 4x Sample Buffer 
200mM Tris-HCl pH 6.8, 8% (w/v) SDS, 0.05M EDTA-Na2, 40% (v/v) glycerol 
0.588M 2-Mercaptoethanol, 0.08% (w/v) Bromophenol Blue. 
2.1.2.6.3 Immunoblot Transfer Buffer 
37mM Tris, 140mM Glycine, 20% (v/v) Methanol. 
2.1.2.6.4 Coomassie Brilliant Blue stain 
0.1 % (w/v) Brilliant Blue R, 10% (v/v) Acetic acid, 40% (v/v) Ethanol. 
2.1.2.6.S Destain Solution 
5% (v/v) Acetic acid, 20% (v/v) Ethanol. 
2.1.2. 7 Buffers and solutions used for vertical DNA gels 
2.1.2.7.1 10x TBE Buffer 
0.89M Tris pH 8.2, 0.91M Boric acid, 0.025M EDTA-Na2. 
2.1.2.7.2 DNA Gel Recipe 
Resolving gel: 10% (v/v) Acrylamide / Bis acrylamide (29:1) 
0.4% (w/v) SDS 
10% (v/v) 1 Ox TBE buffer 
0.075% (w/v) APS 
0.05% (v/v) TEMED 
No stacking gel used 
2.1.2.7.3 2x Sucrose DNA Loading Dye 
60% (w/v) sucrose, l 51nM EDTA-Na2, 0.025 % (w/v) Bromophenol Blue. 
2.1.2.8 Buffers and Solutions from JCSMR Media 
2.1.2.8.1 1000x PSN Antibiotic Cocktail 
30.072g/L Penicillin G, 50g/L Streptomycin Sulphate, 50g/L Neomycin Sulphate 
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2.1.2.8.2 Luria Broth (LB) 
10g/L Tryptone, 5g/L Yeast Extract, 10g/L NaCl 
2.1.2.8.3 Minimum Essential Medium F15 Eagles 
9.61g/L F15 MEM powder (Gibco, LifTechnologies, USA), 2.2g/L NaHCO3, pH6.8-
7.5 
2.1.2.8.4 Phosphate Buffered Saline (PBS) 
8g/L NaCl, 1.25g/L Na2HPO4.2H2O, 0.3535g/L NaH2PO4.H2O 
2.2 Methods 
2.2.1 DNA extraction 
2.2.1.1 DNA extraction for transformation of bacterial cells 
5ml of Luria Broth (LB) (JCSMR Media, Australia) containing l00µg/ml ampicillin was 
inoculated with BL21 (DE3) Escherichia coli (E. coli) cells containing the plasmid of interest 
and incubated overnight at 3 7°C with agitation. Plasmid DNA was extracted using the QIAprep 
spin Miniprep Kit (QIAGEN, Netherlands) following manufacturer' s instructions and quantified 
using a Nanodrop ND-1000 (Thermo Scientific, USA) spectrophotometer. 
2.2.1.2 DNA extraction/or transfection of mammalian cells 
A starter culture was prepared by inoculating 5ml of LB (JCSMR Media, Australia) containing 
1 00µg/ml ampicillin with DH5a E. coli cells containing the plasmid of interest and incubated 
for 8-9hr at 3 7°C with agitation. The 5ml starter culture was then added to 200ml LB 
containing l00µg/ml ampicillin and incubated overnight at 37°C with agitation. Plasmid DNA 
was extracted using the HiSpeed Plamid Maxi Kit (QIAGEN, Netherlands) following 
manufacturer' s instructions and quantified using a Nanodrop ND-1000 (Thermo Scientific, 
USA) spectrophotometer. 
2.2.2 Transformation of competent cells 
Competent cells were prepared using the calcium chloride method (Sambrook and Russell 
2001 ), and 100µ1 aliquots were snap frozen on dry ice. Cells were stored at -70°C until further 
use. 
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Competent cells were transformed by adding lng of plasmid DNA to l 00µ 1 of competent cells 
mix ing by carefully pipetting up and down on ice. The mixture was then incubated on ice for 
3 0min. The plasmid/competent cell mixture was then exposed to a heat shock by spreading the 
mixture onto a pre-heated (3 7°C) LB agar plate containing 1 00µg/ml ampicillin and the plate 
was incubated over night at 3 7°C. 
2.2.3 Protein expression in bacterial cells 
The full length murine DHPR ~la-subunit was expressed in a pHUE vector (Figure 2.1) (Baker 
et al. 1994; Karunasekara 2011 ; Rebbeck et al. 2011) which attaches a 6xHis-ubiquitin tag to 
the protein. 
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Figure 2.1 DHPR ~1) pHUE construct (Karunasekara 2011 ; Rebbeck et a l. 2011 ). The murine sequence of the 
DHPR ~,a-subunit was used. 
An LB agar plate containing 1 00µg/ml ampicillin was streaked with DHPR ~1/ pHUE in 
BL2 l (DE3) E. coli and incubated overnight at 3 7°C. A single colony fr0111 thi s plate was then 
inoculated into 40ml of LB containing 1 00µg/ml ampicillin and incubated with agitation at 
3 7°C overnight. 5ml of the starter culture was then inoculated into 400ml of LB containing 
1 00µg/ml in a 2 litre flask. 6 such flasks were prepared and incubated w ith agitation at 37°C 
unti I OD600 ( optical density at 600nm) reached approximately 0. 8-1. 0 (Cary 100 UV-vis 
spectrophotometer). Protein expression was initiated with the addition of 0. 1 mM IPTG to each 
flask. The flasks were then incubated at 3 7°C with agitation for 2hr. The culture was then 
centrifuged in 500m l Drypin bott les (Du Pont Instruments, USA) at 5000rpm ( 4400g) at 4 °C for 
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20min. A Sorval RC-SB Refrigerated Superspeed Centrifuge, (Du Pont Instruments, USA) was 
used with a SLA-3000 rotor. The pellets were stored at -20°C until further use. 
The initial purification steps of the expressed ~1a-subunit was carried out by immobilized metal 
affinity chromatography (IMAC) using a Ni-NT A agarose resin produced in-house according to 
(Hochuli 1990). 
2.2.4 Protein purification by IMAC (immobilized metal affinity 
chromatography) 
As this is a denaturing purification, all steps were carried out at room temperature unless 
otherwise specified because proteases will be denatured and risk of protein breakdown at room 
temperature is minimal. The E. coli pellet obtained from the procedure described in section 
2.2.3 was thawed on ice and resuspended in 40ml of DHPR ~la resuspension buffer (Section 
2.1.2.1.2). Cells were lysed by sonication on ice using 5 bursts of 30s at 300W with a 30s 
cooling period between bursts (Branson Sonifier, USA). The cell lysate was centrifuged in 
50ml polycarbonate tubes (Du Pont Instruments, USA), using a SS34 rotor (Sorval RC-SB 
Refrigerated Superspeed Centrifuge, Du Pont Instruments, USA) at 15 000rpm ( 10000g) for 
40min at 4 °C. 
The supernatant was added to 50% slurry ofNi-NTA agarose resin pre-equilibrated in 
resuspension buffer. A Ni-NTA agarose bed volume of2ml was used. The mixture of agarose 
and supernatant was incubated on a rotating wheel at 4 °C for 1hr. Subsequently, the mixture 
was centrifuged at l 500rpm ( 453 g) in a benchtop centrifuge (Eppendorf Centrifuge Model 
5810R, Eppendorf, USA) for 5min at 4°C to spin down the resin. The supernatant was 
discarded and the resin washed three times by centrifugation with 50ml of resuspension buffer. 
After the final wash, the resin was transferred to a 10ml polypropylene column and the protein 
eluted with DHPR ~l a elution buffer (Section 2.1.2.1.3). 15ml of eluate was collected and 
diluted to a final volume of 45ml with lx Buffer A (Section 2.1.2.1.1) in order to dilute the urea 
concentration to 2.6M to preserve the activity ubiquitin protease cleaving enzyme. 
The 6xHis-ubiquitin tag was removed by digesting the expressed ~la with an ubiquitin-specific 
protease, Usp2cc, in the presence of lmM DTT. The protease was added at a ratio of 1 :200 
(v/v) and incubated at 30°C overnight. 
The digested sample was concentrated to approximately 2ml using a 1 0kDa cutoff AMI CON® 
Ultra filter concentrator (Merck Millipore, Germany) following the manufacturer ' s instructions. 
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2.2.5 Protein purification by preparative denaturing 
polyacrylamide gel electrophoresis (SOS-PAGE) 
After the initial purification of the expressed DHPR 01a-subunit the protein was purified by 
preparative denaturing polyacrylamide gel electrophoresis (PAGE) using the Bio-Rad Prep Cell 
model 491 (Bio-Rad laboratories, USA). 
A 10cm, 7% Tris-glycine resolving gel and a 2cm, 6% stacking gel (Section 2.1.2.1.6) was 
poured on to the 2.8cm diameter assembly tube of the Prep Cell apparatus according to the 
manufacturer ' s instructions. 
The partially purified concentrated 2ml DHPR 01a sample obtained at the end of the protocol 
described in the previous section (2.2.4) was mixed with ltnl sample buffer (2.1.2.1.4) and 
boiled for 5min. The sample was then loaded onto the preparative gel. The Prep Cell 
apparatus was assembled according to the manufacturer ' s instructions and electrophoresis was 
carried out at 4 °C at a constant current of 40mA and lx Electrophoresis Running buffer 
(2.1.2 .1.5) was used both as the running buffer and as the elution buffer. 41nl fractions were 
collected after the dye front eluted (Bio-Rad Model 2128 Fraction Collector, Bio-Rad 
Laboratories, USA). 
The collected fractions were analysed on 4-15% Precast Tris-glycine polyacrylamide gels 
(Section 2.2.12) and the fractions containing the band of interest pooled. Ice cold acetone was 
added to the pooled fraction at a ratio of 4: 1 (v/v) to precipitate the protein from the buffer 
containing SDS. The proteins were precipitated overnight at -20°C. Subsequently the protein 
was centrifuged at 4000rpm (Eppendorf Centrifuge Model 5 81 OR, Eppendorf, USA) at 4 °C for 
30min and the supernatant removed. A vacuum desiccator was used to remove excess acetone. 
The dried protein sample was then dissolved in lx Buffer A (Section 2.1.2.1 .1) containing 6M 
guanidine hydrochloride. The sample was then refolded to its native form by dialysis into lx 
Buffer A at 4 °C overnight. The refolded protein was quantified and aliquots were stored at -
70°C until further use. 
2.2.6 Protein Quantitation 
2.2.6.1 BCA assay 
The concentration of the expressed full length DHPR 01a-subunit was determined using the 
BCA assay (Smith et al. 1985) according to the manufacturer ' s instructions for microplates 
(Thenno Sc ientific Pierce BCA protein assay kit, Thermo Scientific, USA). The assay 
measures the fo rmation of Cu - fonn Cu2- by the Biuret complex in alkaline solutions of proteins 
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using bicinchonic acid (BCA). The absorbance at 562nm was measured as primary wavelength 
with a reference wavelength of 750nm using an EL 800 Universal Microplate Reader (Bio-Tek 
Instruments, USA). 
2.2.6.2 DC protein assay 
The total protein concentration in muscle homogenates and in microsomal vesicles was 
determined using the Bio-Rad DC Protein assay (Bio-Rad Laboratories, USA). This assay is 
similar to the Lowry assay (Lowry et al. 1951 ). It is based on the reaction of protein with an 
alkaline copper tartrate solution and Folin reagent, which produces reduced species that have a 
characteristic blue colour. The assay was conducted according to the manufacturer ' s 
instructions for microplates. The absorbance at 650nm was measured as primary wavelength 
with a reference wavelength at 405nm using an EL 800 Universal Microplate Reader (Bio-Tek 
Instruments, USA). 
2.2.7 Protein expression in mammalian cells 
The full length splice variants of the rabbit RyRl , ASI(+)RyRl and ASI(-)RyRl were expressed 
in a pCineo vector (Figure 2.2) in HEK.293 cells which do not naturally express RyRl in levels 
detectable by standard immunoblot analysis (Querfurth et aL 1998). The recombinant 
constructs were kindly donated by Prof R. T. Dirksen (Kimura et al. 2007). 
HEK.293 cells were grown in minimum essential medium (MEM) (JCSMR Media, Australia) 
with 10% foetal calf serum (FCS) and 0.1 % PSN antibiotic cocktail (JCSMR Media, Australia) 
at 3 7°C with 5% CO2. HEK293 cells were transfected using the calcium-phosphate method 
(Sambrook and Russell 2001). Tl 75 flasks (cell culture flasks with a surface area of l 75cm2 for 
cell adhesion) were plated at 50% confluency 24h before transfection. The cells were given 
fresh growth medium 3 h before transfection. For each T 175 flask, the calcium phosphate 
precipitate was prepared in the following manner. All dropping was done using a P 1000 
Pipettnan®, Gilson Inc. , USA. One drop from 0.75ml 2M CaCb was added to a volume of 
sterile MilliQ (Merck Millipore, Germany) water. The volume of water is determined by the 
concentration of the plasmid DNA. As the final volume of plasmid DNA and water must be 
1.2825ml per flask and 80µg of plasmid DNA is needed per flask, the volume of water used is 
1.2825 minus the volume of plasmid DNA that contains 80µg of DNA. The plasmid DNA 
(80µg per flask) was then added to the water drop for drop. The remaining 2M CaCb was then 
added to the mixture drop for drop. The CaCb/plasmid DNA/water mixture was subsequently 
added to 1.5ml 2x HBS (Section 2.1.2.4) drop for drop, while agitating the 2x HBS with a 
motorised pipette (Eppendorf Easypet, Eppendorf, USA). The resulting mixture was incubated 
for 45min at room temperature to allow the formation of the calcium phosphate precipitate. The 
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mixture was then added to the 175c1n2 flask containing the HEK293 cells and incubated at 37°C 
in 5% CO2 for 24h. The mediu1n containing the DNA calcium phosphate precipitate was then 
removed and replaced with fresh mediu1n after which the cells were incubated for another 24h 
and then harvested. 
The transfected HEK293 cells were removed from the 175cm
2 flask using cell scrapers and the 
growth medium with the suspended cells were centrifuged at 1 000rpm ( 169g) for 20min at 
room temperature using a Hettich Universal 16 Centrifuge (Hettich Lab technology, Gennany) 
with a model 1617 swing-out rotor. The supernatant was removed and the cell pellet stored at -
70°C until further processed. 
2.2.8 Preparation of microsomal vesicles from HEK 293 cells 
As this is a native preparation, all steps were carried out at 4 ° C, so as to reduce the activity of 
proteases. The transfected cell pellet was resuspended in microsomal vesicle homogenizing 
buffer (Section 2.1.2.3) with a protease inhibitor cocktail (Roche, Switzerland). The cells were 
homogenized using a 1notorised homogenizer (IKA® TIO basic ULTRA-TURRAX®, IKA 
Works, Germany) on setting 2, using the plastic probe. The cells were homogenised twice for 
5 s. The homogenate was then transferred to a 2ml eppendorf tube and centrifuged at 12000rpm 
(11752g) for 20min at 4 °C (Eppendorf 5415C Microcentrifuge, Eppendorf, USA). The 
supernatant was discarded and an equal volume of homogenizing buffer added to the pellet. 
The pellet was then homogenized again three times for 5 s and the homogenate transferred to 
-
Beckinan Coulter ultracentrifuge tubes for use with Beckman Coulter TLA 120 .2 rotor 
(Beckinan Coulter, USA). The homogenate was then centrifuged at 46000rpm (75126g) for 2hr 
at 4 °C (Beckinan Coulter Optima MAX ultracentrifuge, Beckman Coulter, USA). The 
supernatant was removed and the pellet resuspended in 3 00 µl of homogenising buffer using a 
potter homogenizer. The homogenate was then sonicated for 2 bursts of 5s at 300W (Branson 
Sonifier, USA). Aliquots were snap frozen in liquid nitrogen and stored at -70°C until further 
use. 
2.2. 9 Collection of muscle tissue 
2.2. 9.1 Rabbit muscle 
New Zealand White Rabbits were euthanized with Pentobarbitone Sodium (325mg/ml) 
administered intravenously at a dose rate of 1 ml/2kg using Lignonocaine to pre-load the wing 
infusion set according to the ethically approved protocol A2012/01 ( ethical approval obtained 
fro1n The Australian National University Animal Experimentation Ethics Committee) . The 
back and leg fast twitch muscles were removed and immediately rinsed in PBS containing 2mM 
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EGT A. Subsequently, excess fat and connective tissue was removed and the muscle diced into 
approximately 50g pieces. The muscle was then snap-frozen in liquid nitrogen and stored at -
70°C until further processed. 
2.2.9.2 Human muscle 
Human muscle was collected at John James Calvary Hospital theatre, Deakin, ACT, Australia 
with ethical approval ETH.9/07.865 obtained from ACT Health Hu1nan Research Ethics 
Committee and Protocol 2013/307 obtained from the ANU Human Ethics Committee. Muscle 
tissue samples were collected in collaboration with Prof P .N. Smith fro1n patients undergoing 
knee and hip replacements. Vastus medialis tissue samples were from patients undergoing knee 
replace1nents. Gluteus medius and gluteus minimus samples were from patients undergoing hip 
replacements. The muscle tissue sample was rinsed in PBS containing 2mM EGT A, excess fat 
and connective tissue was removed and cut into approximately 80mg pieces. The muscle was 
then snap-frozen in liquid nitrogen and stored at -70°C until further processed 
2.2.9.3 Rat muscle 
5 week old and 1 year old male Wistar rats were euthanized with CO2 gas according to the 
ethically approved protocol A2011/022 ( ethical approval obtained from The Australian National 
University Animal Experimentation Ethics Committee). Soleus and extensor digitorum longus 
(EDL) 111uscles were re1noved from both hind legs of the rats, briefly rinsed in PBS containing 
2mM EGTA and snap frozen in liquid nitrogen. Muscle was stored at -70°C until further 
processed. 
2.2.10 Homogenization of muscle tissue 
2.2.10.1 For MyHC analysis 
All steps in this protocol were performed at 4 °C. Muscle was thawed on ice in 1ml of cold 
MyHC homogenizing buffer (Section 2.1.2.2.1) with protease inhibitor cocktail (Roche 
Switzerland). Muscle was homogenized 3 ti111es for 5s with a motorized homogenizer (IKA® 
TIO basic ULTRA-TURRAX®, I.KA Works, Germany) on setting 5, using the metal probe. 
The homogenate was transferred to 2ml· eppendorf tu bes and centrifuged at 12000 rpm (117 52 
g) for 20min at 4 °C (Eppendorf 541 SC Microcentrifuge, Eppendorf, USA). The supernatant 
was discarded and the pellet resuspended in 100-200µ1 MyHC resuspending buffer (Section 
2.1.2 .2 .2) using a potter homogenizer. The protein concentration of the homogenates was 
determined using the DC protein assay (Bio-Rad Laboratories, U SA) as described in section 
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2.2.6.2. The concentration of the homogenates was then adjusted to 0.4mg/ml and aliquots were 
snap-frozen in liquid nitrogen until further use. 
2.2.10.2 For Immunoblot 
All steps in this protocol were performed at 4 °C. Muscle was thawed on ice in 1ml of cold 
Microsomal vesicle homogenizing buffer (Section 2.1.2.3) with protease inhibitors ( 1 µM 
pepstatin A, lµM leupeptin, lµM benzamidine, 0.7mM PMSF, 3µM calpain inhibitor I, 3µM 
calpain inhibitor II). Muscle was homogenized 3 times for 5s with a motorized homogenizer 
(IKA® TIO basic ULTRA-TURRAX®, IKA Works, Germany) on setting 5, using the metal 
probe. The protein concentration of the homogenates was determined using the DC protein 
assay (Bio-Rad Laboratories, USA) as described in section 2.2.6.2. Aliquots were snap frozen 
in liquid nitrogen and stored at -70°C until further use. 
2.2.11 Isolation of SR microsomal vesicles from muscle tissue 
(rabbit) 
Native skeletal muscle SR vesicles were isolated fro1n back and leg muscles of New Zealand 
white rabbits. Muscle was collected as described in Section 2.2.9.1. The isolation procedure 
was carried out by Ms Suzy Pace and Joan Stivala from the JCSMR Muscle Research Group, 
based on the method described by (Inui et al. 1987a), with modifications (Ahem et al. 1994; 
Ahern et al. 1997). 
Muscle was homogenized in a Waring co1nmercial blender (Waring Products, USA) in 
Microsomal vesicle homogenizing buffer (Section 2.1.2.3) with protease inhibitors ( 1 µM 
pepstatin A, lµM leupeptin, lµM benzamidine, 0.7mM PMSF, 3µM calpain inhibitor I, 3µM 
calpain inhibitor II) using a muscle to buffer ratio of 1 :5 (w/v). The muscle was homogenized 
for lmin and then centrifuged at 9000rpm (12296g) for 20min at 4°C using a SLA1500 rotor 
(Sorval RC-SB Refrigerated Superspeed Centrifuge, Du Pont Instruments, USA). The 
supernatant was discarded and the pellet resuspended in the same volume of ho1nogenizing 
buffer with protease inhibitors. The sample was then homogenized again for lmin followed by 
the centrifugation step described above. 
The supernatant from the second centrifugation step was then filtered through four layers of 
cotton gauze and centrifuged at 30000rpm (70409g) using a Type 45 Ti rotor (Beckman Coulter 
Opti1na XE-100 Ultracentrifuge, Beckman Coulter, USA) for 1-2hr. The pellet was collected 
and resuspended in 45ml hmnogenizing buffer with protease inhibitors using a Dounce Teflon 
homogenizer (Edwards Instruments, Australia). Several millilitres of the sample was loaded 
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onto a discontinuous sucrose density gradient consisting of the following sucrose layers: 4ml 
45% (w/v), 7ml 38% (w/v), 7ml 34% (w/v), 7ml 32% (w/v) and 4ml 27% (w/v). The sucrose 
solutions were prepared in a diluting buffer containing 20mM imidazole, pH 7.4 and the 
protease inhibitors stipulated above. The sucrose gradient was centrifuged at 20000rpm 
( 49123 g) overnight at 4 °C using a SW 32 rotor (Beckman Coulter Optima XE-100 
U ltracentrifuge, Beckman Coulter, USA). Sucrose density bands at the 34-3 8% interface (band 
3) and the 38-45% interface (band 4) were collected and di luted with two volumes of diluting 
buffer. The diluted fractions were then centrifuged at 32000rpm (8011 0g) for 1 hr at 4 °C using a 
Type 45 Ti rotor (Beckman Coulter Optima XE-100 Ultracentrifuge, Beckman Coulter, USA). 
The pellet was resuspended in homogenizing buffer with protease inhibitors to a final 
concentration of about 20mghnl and aliquots were snap-frozen in liquid nitrogen and stored at -
70°C until further use. 
2.2.12 Preparation of microsomal vesicles from muscle tissue 
(human and rat) 
All steps in this protocol were performed at 4 °C. Muscle was thawed on ice in 1.8ml cold 
Microso1nal vesicle ho1nogenizing buffer (Section 2.1.2.3) with protease inhibitors (1 µM 
pepstatin A, lµM leupeptin, lµM benzamidine, 0.7mM PMSF, 3µM calpain inhibitor I, 3µM 
calpain inhibitor II). Muscle was homogenized 3 times for 5s with a motorized homogenizer 
(IKA® TIO basic ULTRA-TURRAX®, IKA Works, Germany) on setting 5, using the metal 
probe. The homogenate was transferred to 2ml eppendorf tubes and centrifuged at 12000rpm 
(11752g) for 20min at 4 °C (Eppendorf 54 l 5C Microcentrifuge, Eppendorf, USA). The 
supernatant was removed and an equal volume of homogenizing buffer with protease inhibitors 
added to the pellet. The pellet was then homogenized on setting 3 of the motorized 
ho1nogenizer for 5s and the resulting homogenate centrifuged at 12000 rpm (11752 g) for 20min 
at 4 °C (Eppendorf 5415C Microcentrifuge, Eppendorf, USA). The supernatant was then 
transferred to Beckinan Coulter ultracentrifuge tubes for use with Beckman Coulter TLA 100.3 
rotor (Beckman Coulter, USA) and centrifuged at 43000rpm (78486g) for 2hr at 4 °C (Beckman 
Cou lter Optima MAX ultracentrifuge, Beckman Coulter, USA). The supernatant was removed 
and the pellet resuspended in 15 0µ1 homogenizing buffer with protease inhibitors with a potter 
homogenizer which was used to resuspend the pellet. The protein concentration of the 
microsomal vesic les was determined using the DC protein assay (Bio-Rad Laboratories, USA 
as described in section 2.2.6.2. Aliquots were snap-frozen in liquid nitrogen and stored at -70°C 
until further use. 
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2.2.13 Denaturing (SDS) Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
2.2.13.1 General 
One-dimensional SDS-PAGE was used to resolve proteins in muscle homogenate and 
microsomal vesicle samples. SDS-P AGE was performed using either 4-15% Tris-Glycine 
precast Bio-Rad gels in a Mini-PROTEAN® Tetra Cell syste1n (Bio-Rad Laboratories, USA) or 
4-12% Bis-Tris precast Novex® Bolt® gels in a Bolt® Mini Gel Tank system (Life 
Technologies, USA). Sample preparation for each system is described below (Sections 
2.2.13 .1.1 and 2.2.13 .1.2). Precision Plus Protein Dual Colour Prestained Standard (Bio-Rad 
Laboratories, USA) was used as protein marker. Upon completion of electrophoresis, gels were 
either used in immunoblotting or stained using Coomassie Brilliant Blue stain (Section 
2.1 .2.6.4) for at least 40min with gentle agitation on a platform shaker followed by destaining in 
Destain Solution (Section 2.1.2.6.4) with gentle agitation on a platform shaker until the 
background was clear and protein bands visable. Stained gels were dried between cellophane 
sheets in a gel drying solution containing 20% (v/v) ethanol and 2% (v/v) glycerol. Gels were 
documented by digital imaging using a Gel Doc XR System (Bio-Rad Laboratories, USA) with 
Quantity One 1-D analysis Software (Bio-Rad Laboratories, USA). 
2.2.13.1.1 Sample preparation for use on 4-15% Tris-Glycine precast Bio-Rad gels 
Samples were mixed with 4x Sample Buffer (Section 2.1.2.6.2) and heated at 60°C for 1 0min. 
-
Samples were then loaded onto the gel and the gel run at 200V in 1 x Electrophoresis Running 
Buffer (Section 2.1.2.6.1) until the dye front reached the bottom of the gel. 
2.2.13.1.2 Sample preparation for use on 4-12% Bis-Tris precast Novex® Bolt® gels 
Samples were mixed with 1 Ox Bolt® Sample Reducing Agent and 4x Bolt® LDS Sample 
Buffer and heated at 70°C for 1 0min. Samples were loaded onto the gel and the gel run at 165V 
in lx Bolt® MOPS SDS running buffer (Life Technologies, USA) until the dye front reached 
the bottom of the gel. 
2.2.13.2 MyHC analysis 
One-dimensional SDS-P AGE was used to analyse MyHC isoforms present in muscle. The 
method has been modified from (Talmadge and Roy 1993; Mizunoya et al. 2008). 0.75 mm and 
1.5mm thick 8% polyacrylamide MyHC gels were cast (Section 2.1.2.2.7) allowing lh for 
polymerization of the resolving gel before the stacking gel was cast. The gels were stored in 1 x 
MyHC Electrophoresis Running Buffer (Section 2.1.2.2.5) overnight to allow for complete 
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polymerization. Homogenate prepared according to method described in Section 2.2.10.1 was 
mixed with 3x MyHC Sample Buffer (Section2. l .2.2 .6) and boiled for 2min. 3 µg of protein 
was loaded onto the gel and gels were run for at 140V for 20hr at 4 °C using a Mini-PROTEAN 
3 cell (Bio-Rad Laboratories, USA). Precision Plus Protein Dual Colour Prestained Standard 
(Bio-Rad Laboratories, USA) was used as a protein marker. lx MyHC Electrophoresis Running 
buffer was used in the outer buffer dam, whereas 8x MyHC Electrophoresis Running buffer 
with 0.12% (v/v) 2-Mercaptoethanol was used in the inner buffer dam. After completion of 
electrophoresis, the gels were stained using a Silver Stain Plus Kit (Bio-Rad Laboratories, USA) 
according to manufacturer ' s instructions. Stained gels were dried between cellophane sheets in 
a gel drying solution containing 20% (v/v) ethanol and 2% (v/v) glycerol. Gels were 
documented by digital imaging using a Gel Doc XR System (Bio-Rad Laboratories, USA) with 
Quantity One 1-D analysis Software (Bio-Rad Laboratories, USA). 
2.2.14 Immunoblot 
After electrophoresis, gels were equilibrated in cold Immunoblot Transfer Buffer (Section 
2.1.2.6.3) for 15min. Proteins were transferred onto a 0.45µm pore PVDF membrane (Merck 
Millipore, USA or Thermo Scientific, USA) using a Mini Trans-Blot® Electrophoretic Transfer 
Cell (Bio-Rad Laboratories, USA). The 1nembrane was prepared by soaking it sequentially for 
at least lmin in methanol, MilliQ water and then cold Transfer Buffer. The membrane was left 
in cold Transfer Buffer until used. The 1nembrane was placed on the gel containing the proteins 
to be transferred and sandwiched between Extra Thick Western Blotting Filter Paper (Thermo 
Scientific, USA) and fiber pads and secured in the plastic gel holder cassette. The assembled 
cassette was the placed in the gel tank containing cold Transfer buffer in such a way that the 
membrane was placed on the anode side of the gel. Transfer was performed at 1 00V for 1 h at 
roo1n te1nperature with continuous stirring of the buffer. After 1 h, the voltage was increased till 
a current of about 0.5A was reached and the protein transferred for another 30min or until the 
current reached 0.8A (which ever occur first). 
Following transfer, the membrane was washed twice for 5min with PBS (JCSMR Media 
Australia) and blocked for 1hr at room temperature in either 5% (w/v) skim milk in PBS or 
3%BSA (w/v) in PBS (depending on the primary antibody used) with agitation on a platforrn 
shaker. After blocking, the membrane was washed 4 times for 1 0min with 0.05% (v/v) 
TWEEN® 20 in PBS (TPBS). The membrane was then cut into appropriate sections and 
incubated with the appropriate primary antibody overnight at 4 °C. A list of primary antibodies 
with the blocking agent for each one used is listed in Table 2.1. 
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Antibody 
a-Cavl.2 ACC-003 polyclonal antibody 
a-DHPR a1a IIIDSE1 monoclonal antibody 
a-DHPR ~1a VD2{1)B12 monoclonal antibody 
a-FKBP12 {H-5) monoclonal antibody 
a-RyRl 34C monoclonal antibody 
~ 
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Section 2.1.1 for manufacturer) 
Blocking solution used 
3% BSA {w/v) in PBS 
5% skim milk (w/v) in PBS 
5% skim milk (w/v) in PBS 
5% skim milk (w/v) in PBS 
5% skim milk (w/v) in PBS 
After this incubation, the membrane was washed again 4 times for 1 0min in TPBS and then 
incubated with the appropriate secondary antibody for 2h at roo1n temperature. Upon 
completion of the incubation, the membrane was washed 4 times for l0min in TPBS and then 
once in PBS for 5min before treating it with Pierce ECL Western Blotting Substrate (Thermo 
Scientific Pierce Protein Biology Products, USA) for 5min. The treated me1nbrane was exposed 
to X-ray film (FUTI Medical X-ray Film, FUnFILM Corporation, Japan) and manually 
developed. Developed films were documented by digital imaging using a Gel Doc XR System 
(Bio-Rad Laboratories, USA) with Quantity One 1-D analysis Software (Bio-Rad Laboratories, 
USA). 
2.2.14.1 Reprobing of Immunoblot 
The membrane was rehydrated for lmin in methanol and then rinsed with MilliQ water before it 
was placed in 501nl of stripping solution (40ml PBS, 350µ12-Mercaptoethanol, 10ml 10% (w/v) 
SDS) and heated at 50°C for lh. The membrane was then washed 3-5x in PBS until the 2-
Mercaptoethanol could no longer be smelled, and then blocked in either 5% (w/v) skim milk in 
PBS or 3%BSA (w/v) in PBS (depending on the primary antibody used) for lh at room 
temperature with agitation on a platform shaker. 
After blocking, the membrane was washed 6 times for 1 0min with 0.05% (v/v) TWEEN® 20 in 
PBS (TPBS) and then incubated with the appropriate primary antibody overnight at 4 °C. After 
this incubation, the membrane was washed again 6 times for 1 0min in TPBS and then incubated 
with the appropriate secondary antibody for 2h at room temperature. Upon completion of the 
incubation, the membrane was washed 6 times for 1 0min in TPBS and then once in PBS for 
5min before treating it with Pierce ECL Western Blotting Substrate (Thermo Scientific Pierce 
Protein Biology Products, USA) for 51nin. The treated membrane was exposed to X-ray film 
(FUTI Medical X-ray Film, FUJIFILM Corporation, Japan) and manually developed. 
Developed films were documented by digital imaging using a Gel Doc XR System (Bio-Rad 
Laboratories, USA) with Quantity One 1-D analysis Software (Bio-Rad Laboratories, USA). 
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2.2.15 Planar lipid bilayer studies 
2.2.15.1 Lipid mixture 
Bilayers were made using an artificial phospholipid mixture consisting of 
phosphatidylethanolamine, phosphatidylserine and phosphatidylcholine at a ratio of 5 :3 :2 
respectively. The lipids were obtained in chloroform and the lipid mixture is dried under a 
stream of nitrogen gas. The mixture is then redissolved in n-decane at a final concentration of 
50mg/ml. 
2.2.15.2 Bilayer solutions 
The solutions used in bilayer experiments are described in Section 2.1.2.5. Each solution was 
adjusted to a pH of 7.4 with 4M CsOH. BAPTA is a Ca2+ chelator and was used to accurately 
control the Ca2+ concentrations <l00µM. The purity of BAPTA as well as Ca2+ concentrations 
of solutions was accessed using a Ca2+ electrode. 
Cs+ rather than Ca2+ was used as current carrier for a number of reasons. Firstly, the Ca2+ 
conductance of 100-200mM Ca2+ through the RyRl is much lower than that for 100-200mM 
Cs+, so that use of Ca2+ as the current carrier and would reduce the signal to noise level 5 fold 
(Sitsapesan and Williams 1994a). Secondly, Ca2+ has a physiological modulatory effect on 
RyRl activity at concentrations between ~ 1 00nM and lmM, and is varied experimentally 
within this range (Meissner et al. 1986). Cs+ does not have a modulatory action (Laver 2001 ). 
Thirdly, Cs+ has a low conductance through SR K+ channels and therefore effectively blocks 
them by dominantly competing with other cations (Cukierman et al. 1985). CH30 3S- is used as 
the major anion because it blocks SR er channels, due to their low permeability to the anion 
(Laver 2001 ). 
2.2.15.3 Bilayer apparatus setup 
Miller and Racker (Miller and Racker 1976) discovered that SR vesicles isolated from muscle 
could be fused with artificial lipid bilayers thereby incorporating ion channels into artificial 
membranes. The bilayer apparatus consists of two interconnected solution filled chambers 
formed when of a lipophilic Delrin cup is fitted snugly into the back compartment of a two 
compartment Teflon mould (Figure 2.3). The Delrin cup contains an aperture of 150-200µm. 
The chamber to which the microsomal vesicles are added is referred to as the cis chamber and 
the other cha1nber is the trans chamber. 
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Figure 2.3 Bilayer apparatus setup showing the Delrin cup (A) inside the Teflon mould (B) with the electrodes (C) 
on either side of the aperture. The perfusion tubes for the cis chamber (front chamber - D) can be seen in front of the 
mould (F) and those for the trans chamber (back chamber - E) is located behind the mould (G). The electrodes are 
attached to the head stage (H) with the grounding wire (green - I) attached to the cis electrode visible. 
The cis chamber was filled with 0.85ml cis solution (Section 2.1.2.5.2) and the trans chamber 
with 0.85ml trans solution (Section 2.1.2.5 .1 ). The lipid mixture describe in Section 2.2.15 .1 is 
painted over the aperture with a flame polished glass rod and the bilayers forms spontaneously 
as the surface active lipids aggregate into monolayers at the oil-water interfaces and then-
decane drains away from the two monolayers thus allowing the formation of the bilayer (Laver 
2001 ). At times it was necessary to apply gentle pressure on the side of the aperture to induce 
the draining of the n-decane. The thickness of the bilayer was monitored by observing changes 
in the bilayer capacitive current amplitude when a 1 V /s triangular voltage ramp is applied across 
the bilayer. The voltage ramp was generated by a custom built ramp generator (JCSMR 
workshop, Canberra, Australia). Due to the bilayer's ability to separate ions across an electrical 
insulator (bilayer), it has capacitive properties (Hille 2001 ). The relationship between 
capacitance of the lipid bilayer and membrane areas is described by Equation 2.1. 
Equation 2.1 
A 
C==E xd 
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Where C is the capacitance, E is the dielectric constant of n-decane between the lipid 
monolayers, A is the area of the lipid bilayer and dis the distance between the lipid monolayers. 
The amount of charge stored by the lipid bilayer as a capacitor is directly proportional to the 
voltage across the bilayer indicated by Equation 2.2 below. 
Equation 2.2 
Q=CxV 
Where Q is the charge stored on the lipid bilayer, C is the capacitance and V is the 
voltage across the bilayer. 
When the area and distance between the lipid monolayers are constant, the capacitance of the 
lipid bilayer is constant (see Equation 2.1). If the voltage across the bilayer is altered, the 
resulting capacitive current is described by Equation 2.3 below. 
Equation 2.3 
dQ dV 
-=:.J ==-CX-dt C dt 
Where dQ/dt is the change in charge over time, le is the capacitive current, C is the 
capcitance, and dV/dt is the change in voltage over time. 
When Equation 2.1 and Equation 2.3 are combined, the resulting equation is Equation 2.4 
(below). 
Equation 2.4 
A dV 
J ==-EX-X-
c d dt 
Where le is the capacitive current, E is the dielectric constant of n-decane. A is the area 
of the lipid bilayer, d is the distance between the lipid monolayers and dV /dt is the 
change in voltage over time. 
Therefore if the thickness of the bilayer ( d) is decreased when a triangular voltage ramp is 
applied across it, the size of the capacitve current Cie) increases due to the fact that the capacitive 
current is inversely proportional to the thickness of the bilayer as seen in Equation 2.4. 
The Teflon mould fits snugly into a custom built bilayer box (JCSMR Workshop. Canberra 
Australia) that also holds the CV 201A headstage (Axon Instruments, USA) that connects the 
two silver chloride coated silver electrodes immersed in the cis and trans solutions to the bi layer 
amplifier (Axon In struments, USA) (Figure 2.3). To reduce the junction potential between the 
solutions and the electrodes, the ends of the electrodes were immersed in salt agar bridges . 
Agar bridges were made form a mixture of 2% (w/v) agar powder and 250mM CsCl injected 
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into 3 0cm lengths of 1.4 7mm laboratory tubing (Dow Coming Corporation, USA). Once the 
agar set, the tubing was cut into 1.5-2cm lengths and stored in 250mM CsCl at 4 °C. 
The cis chamber was grounded and the trans chamber was voltage clamped at +40m V or -
40m V with the help of an Axopatch 200A Integrated Patch Clamp (Axon Instruments, USA). 
The potentials are expressed according to standard physiological convention V cis - Y irans· 
Microsomal vesicles containing RyRl were added to the cis chamber at a concentration of 
about 20µg/ml. In order to promote vesicle incorporation the following steps were taken. 
Firstly, an osmotic gradient was created across the bilayer by having different Cs+ 
concentrations on either side of the bilayer (250mM Cs+ in cis chamber vs. 50mM Cs+ in the 
trans chamber). Secondly, the cis solution contained a high Ca2+ concentration (lmM) as fusion 
of the vesicles with the bilayer is dependent on a Ca2+ concentration greater than 0.5mM (Miller 
and Racker 1976) . Thirdly, the cis solutions was vigorously stirred thereby increasing the 
probability that vesicles could come into contact with the bilayer to fuse (Laver 2001 ). 
Generally channels incorporate with their cytoplasmic surface facing the cis solution. This was 
confinned by the addition of 2mM ATP-Na2 to the cis chamber, which, if the RyRl is 
incorporated in the correct way, would increase channel activity (see Section 1.5 .4.1) and by 
decreasing the Ca2+ in the cis chamber from lmM to l0µM which will also cause an increase in 
RyRl channel activity (see Section 1.5 .4.3). 
2.2.15.4 Channel recordings 
The current across the bilayer, indicating channel incorporation into the lipid bilayer, and 
channel activity was recorded using an in-house acquisition program BLMl. Activity was 
recorded throughout the experiment at 5kHz and the current was filtered with a low pass 8-pole 
Bessel filter at lkHz integrated in the Axopatch 200A Integrated Patch Clamp (Axon 
Instruments, USA). The bilayer box is surrounded by a grounded faraday cage on an air table to 
reduce electrical noise. 
After the commencement of recording, 200mM CsCH30 3S was added to the trans chamber in 
order to have symmetrical solutions on either side of the bilayer with respect to Cs+, er and 
CH30 3S-. The voltage across the bilayer was alterated between +40mV and -40mV every 30s 
thoughout the experiment. The solutions were stirred for 15-20s after which 4min of activity () 
was recorded. The Ca2+ concentration was then lowered to l0µM by perfusing the cis chamber 
with 5ml cis solution containing l0µM Ca2+ (Section 2.1.2.5.3). Control activity was recorded 
for 8min. 1 0nM full length DHPR ~ la in dialysis buffer ( or an equal volume of dialysis buffer 
alone in buffer control experiments) was added to the cis chamber and stirred for 15-20s. 
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Activity was recorded for 8min alternating between +40m V and -40m V every 3 Os. The 
concentration of full length ~ 1 a was then increased to 50nM ( or an equal volume of dialysis 
buffer alone in buffer control experiments) in the cis chamber and stirred for 15-20s. Activity 
was recorded for 8min. 2rnM ATP-Na2 was then added to the cis chamber and stirred for 15-
20s . Activity was recorded for 4min. Lastly, 20µM Ruthenium Red was added to the cis 
chamber and stirred for 15-20s. Activity was recorded for 4min. The recording was then 
terminated. Experiments were conducted at 20±2 °C. 
2.2.15.5 Data analysis 
Single and multiple channel parameters were obtained using an in-house software program 
Channel 2 (developed by P.W. Gage and M. Smith, John Curtin School of Medical Research 
Canberra, Australia). The channel parameters were measured from 90s of channel activity at 
each potential for each experimental condition. 
The following parameters were determined: 
Open probability (P 0 ) 
Fractional Mean Current (I'f) 
Mean open time (T 0 ; ms) 
Mean closed time (Tc; ms) 
Open frequency (F0 ) 
T open/T total time 
I ' /Imax 
Topenfn 
Tclosein 
n/TtotaJ time 
Where Topen is the total channel open time; TtotaJ time is the total duration of the analysed record ; I' 
is the mean current; Imax is the maximal current of channel openings in the analysed record; 
Tc1osed is the total channel closed time; and n is the total number of channel openings. 
I'f is approximately equal to PO and it has been shown that PO and I'f values obtained from a 
single channel record with a high open probability these values are very similar (Beard et al. 
2008). PO most accurately quantifies RyRl activity when only a single channel is present in the 
recording, however, when more than one channel is present I'f is the more accurate 
quantification method. Since these quantification methods yield approximately equal values, all 
channel activity (I'f and P 0 ) is expressed as PO in this thesis. To measure P 0 , a threshold was set 
outside baseline noise level at about 20% of the maximum open conductance, currents 
exceeding this threshold was perceived as open. Imax was measured from the baseline which 
was the mean of the baseline noise . The close threshold was placed above baseline noise. Slow 
baseline variation was corrected for using an in-house program Baseline2 (developed bv D .R. 
Laver). 
Statistical analysis was done with paired and unpaired student's t-tests as appropriate and a 
P$0 .05 was deemed stati stically significant 
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2.2.16 .RNA extraction from muscle tissue 
Muscle was thawed in 1ml TRizol® reagent (Invitrogen, Life Technologies, USA) and 
homogenized using a motorised homogenizer (IKA® T25 ULTRA-TURRAX®, IKA Works, 
Germany). The homogenate was incubated for 5min at room temperature to permit complete 
dissociation of the nucleoprotein complex. 200µ1 of chloroform was added and the samples 
shaken vigorously by hand for 15s. The samples were then incubated for 3min at room 
temperature and subsequently centrifuged at 12126rpm (12000g) for 15min at 4°C (Eppendorf 
541 SC Microcentrifuge, Eppendorf, USA). The mixture separates into a lower red phenol-
chloroform phase, an interphase and a colourless upper aqueous phase. The aqueous phase, 
containing the extracted RNA, was removed and the RN easy Mini Kit (QIAGEN, Netherlands) 
according manufacturer' s instructions, used to clean the RNA. The resultant RNA was then 
treated with the TURBO DNA-free™ Kit (Ambion, Life Technologies, USA) according to 
manufacturer' s instructions to remove any DNA contamination. The RNA concentration was 
determined using a Nanodrop ND-1000 (Thenno Scientific, USA) spectrophotometer. 
2.2.17 Production of cDNA 
RT-PCR was performed using the SuperScript™ ill Reverse Transcriptase Kit (Invitrogen, Life 
Technologies, USA) according to manufacturer' s instructions. Oligo( dT)12_18 primers 
(Invitrogen, Life Technologies) were used and the reaction was performed at 50°C for 60min, 
followed by a 15min incubation at 70°C (PTC-200 DNA Engine , MJ Research, USA) 
2.2.18 PCR 
PCR was performed using KOD Hot start DNA Polymerase Kit (Novagen, Merck Millipore, 
Germany) according to manufacturer' s instructions. The mixture was cycled 35 times in a PTC-
200 DNA Engine (MJ Research, USA). The following cycling parameters were used: 
Parameter Time {s) Temperature {°C) 
Initialization 120 95 
Denaturation 20 95 
Annealing 10 62 
Extension 10 70 
The sequences for human and mouse primers were the same as the primers used by Kimura et al 
(Kimura et al. 2005) to amplify the ASI region on the RyRl. The rat primers were designed 
with thanks by Dr Angelo Theodoratos of the Molecular Genetics Group, John Curtin School of 
Medical Research, The Australian National University. The sequences for primers used were: 
Human (forward): 5 ' -GACAACAAAAGCAAAA TGGC-3 ' 
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Human (reverse): 
Mouse (forward): 
Mouse (reverse): 
Rat (forward): 
Rat (reverse): 
5 ' -CTTGGTGCGTTCCTGGTCCG-3 ' 
5 ' -GA CAA T AAGAGCAAAA TGGC-3 
5 ' -CTTGGTGCGTTCCTGATCTG-3 
5 ' -ACTGGAT AA TGCAGCCTTCC-3 ' 
5 ' -CTTGGTGCGTTCCTGGTC-3 ' 
2.2.19 Visualization of DNA on vertical polyacrylamide gels 
As the PCR product had a maximum length of 69bp, vertical polyacrylamide gels were used to 
visualize the DNA. 10% Polyacrylamide gels were cast (Section 2.1.2. 7 .2) and left to 
polymerise for 60min. 15µ1 of PCR product was mixed with 2x Sucrose DNA loading dye 
(Section 2.1.2.7.3) and loaded onto the gel. The gel was run at l00V at 4°C in lx TBE buffer 
(Section 2.1.2.7.1) till the dye reached ¾ down the gel using a Mini-PROTEAN 3 cell (Bio-Rad 
Laboratories, USA). The gel was subsequently stained with 0.5µg/ml Ethidium Bromide in lx 
TBE buffer for 30min. DNA bands were visualized under UV light using a Gel Doc XR System 
(Bio-Rad Laboratories, USA) with Quantity One 1-D analysis Software (Bio-Rad Laboratories, 
USA). 
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Chapter 3: Fiber type distribution of muscle 
salllples 
3.1 Introduction 
Muscles differ in regard to their fiber type distribution. This is part of the muscle ' s adaption to 
its function (see Chapter 1, for a detailed description). Muscles used for short bursts of large 
1novements tend to have more type II fibers than muscles involved mostly in stabilizing joints 
and posture, which have more type I fibers. Humans have only muscles containing a mixture of 
fiber types. Rats on the other hand have fiber type specific muscles. Rat soleus is often used as 
a representative of slow twitch muscle whereas rat EDL is used as a representative fast twitch 
muscle (Schiaffino and Reggiani 2011). The developmental MyHC isoforms disappear during 
the first 2-4 weeks of postnatal development in rodents (Schiaffino et al. 1989). Although rats 
are sexually mature from about 6wk they reach musculoskeletal maturity by about 7mo and are 
considered senecent from l 8-20mo (Quinn 2005). In humans, changes related to sarcopenia 
occur from about 50-60yr of age (Larsson et al. 1979; Hakkinen et al. 1995). 
Muscle fiber type distribution can shift towards a more oxidative fiber type distribution or a 
1nore glycolytic fiber type depending on its use. Certain exercise training regimes, or 
stimulating muscle with rates of electrical stimulation that mimic the motor neuron firing 
patterns during exercise can facilitate these fiber type shifts (Pette and Vrbova 1999; Schiaffino 
and Reggiani 2011 ; Jorquera et al. 2013). Muscle wasting conditions can also cause fiber type 
shifts. Some are from slow-to-fast ( e.g. Spinal cord injury, denervation, microgravity) and 
others are from fast-to-slow ( e.g. fasting, glucocorticoid administration, type 1 diabetes, 
cachexia) (Schiaffino et al. 2013). Sarcopenia has also been suggested to be accompanied by a 
fast-to-slow fiber type switch. In the majority of studies investigating changes in size fibers of 
specific types, (usually in the vastus lateralis), the conclusion is that type 2 fiber size is reduced 
with increasing age, whereas the size of type 1 fibers is much less, if at all, affected (Lexell 
1995; Porter et al. 1995). When examining the proportions of each fiber type with age in human 
vastus lateralis, both type 1 and type 2 fibers appear to be reduced to a similar extent. When the 
proportion of type 2 fibers and their mean area were expressed as the relative type 2 area, the 
negative correlation between age and type 2 fiber contribution was much stronger (Lexell 1995; 
Porter et al. 1995). In other words, the cross sectional area of the muscle occupied by type 2 
fibers was significantly reduced with increasing age due to a combined effect of reduced fiber 
size and fewer fibers. In rodents, however, there seems to be a selective loss in fast-twitch 
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fibers during aging (Ishihara et al. 1987; Kanda and Hashizume 1989; Ansved and Larsson 
1990). In both rodent and humans, aging results in the muscle mass being comprised of a 
higher percentage of slow-twitch muscle. For rodents this would be the natural outflow of 
selective loss in fast-twitch fibers . Conversely, for humans this is, as discussed above, due to 
the age related atrophy of muscle fibers being more severe in fast-twitch fibers , so that the 
proportion of muscle mass made up of slow-twitch fibers is significantly increased even though 
the ratio between the numbers of fast- and slow-twitch fibers does not change (Larsson et al. 
1978; Essen-Gustavsson and Borges 1986; Lexell et al. 1988; Lexell 1995). 
As mentioned above, most of the studies involving fiber type distribution in humans have been 
done on the vastus lateralis muscle (Lexell 1995). The fiber type distribution of this muscle (as 
well as most other muscles in humans) varies depending on the depth within the muscle, with 
the surface of the muscle having fewer type 1 fibers present than deeper in the 111uscle (Johnson 
et al. 1973 ). Less information is available regarding fiber type distribution shifts in other 
muscles with age, with some data available about biceps brachii (Klitgaard et al. 1990b; Grim by 
1995). There are no reports of the effect of aging on the gluteus medius, gluteus minim us or 
vastus medialis which are examined in the work reported in this thesis. 
3.2 Aim 
To determine the fiber type distribution of the muscle samples obtained from human gluteus 
medius, gluteus minimus and vastus medialis as well as muscle obtained from rat soleus and 
EDL as positive controls. This work was done in order to investigate any changes that might 
occur during aging, as well as to facilitate correlations between fiber type distribution and the 
results of analyses of other aspects of the muscles presented in later chapters of this thesis. 
3.3 Quantitative and statisctical analysis 
Quantitative analysis was done after digital images of gels were made by determining the 
density of each MyHC band with the use of Quantity One software from Bio-Rad Laboratories 
USA. Statistical analysis of differences in fiber type distribution was done with ANOV A using 
Fisher ' s post-hoc test where differences were deemed significant when P<0.05. The Pearson 
correlation coefficient was used to determine significant correlations between fiber type and 
age. Correlations were deen1ed significant when the coefficient differed significantly from 0 
w ith a P< 0.05. 
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3.4 Results 
3.4.1 Human muscle 
Muscle samples were obtained from human donors and were fiber typed in terms of MyHC 
isoform using SDS-PAGE (as described in Sections 2.2.10.1 and 2.2.13.2). This was done in 
order to investigate whether there is a fiber type shift with age in humans and in order to 
correlate fiber type with all other analysis done on the muscle. Representative examples of the 
silver stained gels are shown in Figure 3.lA. A breakdown of the human samples received is 
given in Table 3.1. 
Table 3.1: Breakdown of the hu1nan samples received from 40 donors 
-
Gluteus medius Gluteus minimus Vastus medialis 
Female 51 Female 51 Female 54 
Female 52 Female 52 Female 56 
Female 76 Female 58 Female 57 
Female 84 Female 61 Female 62 
Female 66 Female 64 
Female 70 Female 64 
Female 71 Female 65 
Female 74 Female 74 
Female 79 
Female 82 
Female 85 
Male 72 Male 45 Male 59 
Male 47 Male 66 
Male 52 Male 69 
Male 56 Male 71 
Male 59 Male 73 
Male 60 Male 77 
Male 61 
Male 69 
Male 70 
Male 72 
3.4.1.1 Densitometry results 
The density of each of the MyHC bands were determined and expressed as a percentage of the 
total amount of MyHC present. There were 40 donors in total and 4 repeats were done for each 
muscle sa1nple. The average percentage of each fiber type for female and male donors <60yr 
and >60yr are given in Table 3.2 and are represented graphically in Figure 3.2. 
103 
Chapter 3 
Human 
250 
150 
Rat 
250 
150 
~ ~ 
"' 'l::t' 
It 
0 
' '-'>o 
* ' V)s 
~ ~ ~ ~ 
~ ' ~ ' 
'l::t' c:-' 
q, t 
.::,.~ 0 
c:( 
~ ' t,? 
* ' V)s * ' V)s 
~ ~ 
"' 
. c:-' ~ 
0 
MyHC 2X 
MyHC 2A 
MyHC slow 
c:( 
~ 
* ' 
'-0.s 
' t,? 
'' ~ 
c:( 
~ ' t,? ,, 
~ 
,, 
~ 
c:( 
~ 
,, 
~ 
MyHC2A 
MyHC 2X 
MyHC 28 
MyHC slow 
Figure 3.1: Examples of silver stained MyHC SDS-PAGE with the 250 and l 50kDa markers indicated. 
(A) Human muscle from four different donors (G med - gluteus medius, V med - vastus medialis, 
G min - gluteus minimus, F - female, M - male, yr - years) . (B) Rat soleus and EDL muscle 
(So - soleus, wk - weeks, yr - years). 
Table 3.2: Fiber type distribution for each human muscle sample per age group. Values are 
averages of the fiber type as a percentage of the total MyHC present (n - number of 
observations, sem - standard error of the mean, * significantly different to <60yr 
P<0.05 , # significantly different to female P<0.05). 
Type 1 Type 2A Type 2X 
n mean ±sem mean ± sem mean ±sem 
<60yr 8 41 .9 2.2 31.8 2.1 26 .2 3.4 female 
~60yr 8 72.6* 5.4 16 .0* 3.4 11.4* 2.2 Gluteus medius 
<60yr 0 ---- - - - - - - -- ---- ----
----
male 
~60yr 4 78 .2 4.4 15 .3 4.2 6.5 0.5 
<60yr 12 63 .9 4 .8 28 .1 3.8 8 .1 2.6 female 
~60yr 32 61 .5 3.3 24.1 1.8 14.4* 1.9 Gluteus minimus 
<60yr 19 55 .9 3.5 30.7 2.2 13.4 1.8 
male 
32.4# ~ 60yr 19 57 .0 3.1 1.5 10.6 2.0 
<60yr 12 25 .1 2.1 35 .8 1.9 39.2 3.6 fema le 
~60yr 17 33 .9 2.7 41 .9 1.9 24.2* 2.1 Vastus medialis 
28 .2# <60yr 4 31 .0 1.6 40 .8 2.2 2.2 
ma le 
35.l1 ~60yr 20 26 .0 1.7 38 .7 1.1 1.9 
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3.4.1.2 Fiber type vs. muscle 
The three source muscles differed significantly from each other with regards to fiber type 
distribution when age and gender groups are compared, with four exceptions. 1) The percentage 
of type 2A fibers in gluteus minim us and gluteus medius from females <60yr did not differ 
significantly. 2) The percentage of type 2A fibers did not differ significantly between vastus 
medialis and gluteus medius from females <60yr. 3) In females >60 yr there was no significant 
difference in the percentage of type 2X fibers between gluteus minimus and gluteus medius. 4) 
The percentage of type 2X fibers did not differ significantly in males >60yr between gluteus 
minimus and gluteus medius (see Table 3.3). Muscle samples taken from the vastus medialis 
had the highest percentage of type 2 fibers with type 2A and 2X contributing to varying degrees 
in the different age and gender groups (see Table 3.2). Gluteus medius and gluteus minimus 
had a higher percentage type 1 fibers, with gluteus medius having the highest percentage of type 
1 fibers , with the exception of the <60yr female group, which has a lower percentage type 1 
fibers than gluteus minimus. 
3.4.1.3 Fiber type vs. age 
The fiber type distribution of donors <60yr and >60yr of age within each muscle were compared 
(see Table 3.2 and Figure 3.2). As there was only one male donor of gluteus medius muscle, 
no age group comparison could be made for male gluteus medius subjects. In the gluteus 
medius 1nuscle, there was a significant difference in all three fiber types_in between female 
donors <60 and >60 years of age. The percentage of type 1 fibers were significantly higher in 
the older age group (72.6±5.4%) compared to the younger age group (41.9±2.15%). The type 
2A and 2X fiber percentages were significantly lower in the older age group (16.0±3.4 and 
11.4±2.2% respectively) compared to the younger age group (31.8±2.1 % and 26.2±3 .4% 
respectively). Gluteus minitnus muscle showed less change with age, with the only significant 
difference in fiber type distribution between age groups being the percentage 2X fibers in the 
>60 yr female group that is significantly larger (14.4±1.9%) than the younger age group 
(8.1±2.6% ). There were no significant differences in fiber type distribution with age in muscle 
from male gluteus minimus donors. In vastus medialis there was also only one significant 
difference between the different age groups for each gender. The type 2X fiber percentage was 
significantly lower in females >60yr (24.2±2.1 % ) compared to the younger age group 
(39.2±3.6%). There was again no difference between the male age groups for vastus medialis 
donors. However, there was only one donor younger than 60yr and he was 59yr old. 
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Table 3.3: Comparison matrix to show significant difference (P<0.05) between fiber type 
distribution in muscle obtained from gluteus medius, gluteus minimus and vastus 
medialis. Red shading indicates the muscle indicated in the column heading is 
significantly lower than the muscle indicated in the row heading, whereas green 
shading indicates the muscle indicated in the column heading is significantly greater 
than the muscle indicated in the row heading. No shading indicates no significant 
difference. 
Female <60yr Gluteus medius Vastus medialis 
I 
Gluteus minimus 1 2A 2X 1 2A 2X 
I ~ Vastus medialis 1 2A ' 2X 
Female ~60yr Gluteus medius Vastus medialis 
I 
Gluteus minimus 1 2A 2X 1 2A 2X 
Vastus medialis 1 2A 2X ~ 
Male <60yr Gluteus medius Vastus medialis 
Gluteus minimus ~ 1 2A 2X 
. 
Male ~60yr Gluteus medius Vastus medialis 
I 
Gluteus minimus 1 2A 2X 1 2A 2X 
Vastus medialis 1 2A 2X ~ 
The fiber type distribution was correlated with age for each of the three muscles separated 
according to gender. The Pearson correlation coefficient was determined and used as an 
indicator for correlation. Correlations were regarded as significant if they differed significantly 
(P<0.05) from 0 (see Figure 3.3). Again, due to the presence of only one male donor of gluteus 
rnedius muscle, only a correlation between female subjects and age was done in this muscle. 
There was a strong positive correlation between age and type 1 fibers with the accompanying 
negative correlation for both type 2X and 2A fibers in female gluteus medius donors (Figure 
3.3A, F). Among g luteus minimus muscle donors, there was no significant correlation with 
fiber type distribution and age in females (Figure 3.3 B, F) or males (Figure 3.3 C, F). In 
female vastus medial is donors a significant positive correlation between age and type 1 fiber 
percentage and the accompanying s ignificant negative correlation between type 2X fiber 
percentage and age was found No s ignificant correlation between the percentage of type 2A 
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fibers and age was seen (Figure 3.3 D, F). In male donors of vastus medialis muscle, there was 
a significant negative correlation between age and type 1 fiber percentage with an 
accompanying significant positive correlation between age and type 2X fiber percentage. The 
type 2A fiber percentage showed no significant correlation with age (Figure 3.3 E, F). 
3.4.1.4 Fiber type vs. gender 
The fiber type distribution of each gender age group was co1npared in the three muscle groups. 
Although there was only one male gluteus medius donor (72 yr old), his fiber type distribution 
did not differ significantly from the female gluteus medius donors in the >60yr age group 
(Figure 3.2A). Among gluteus mini1nus muscle donors, a significant difference was found in 
the average percentage of type 2A fibers in the >60yr female group (24.1±1.8%) compared to 
the >60yr male group (32.4±1.5%) (Figure 3.2B). The vastus medialis donors showed a 
significant difference in average type 2X percentage between male and female donors for each 
age group. In the <60yr age group, the male donors had a lower average percentage of type 2X 
fibers (28.2±2.2%) compared to the female donors (39.2±3.6%) and in the >60yr age group, the 
male donors had a larger percentage type 2X fibers (35.2±1.9%) compared to the female donors 
(24.2±2.1 % ) (Figure 3.2C). 
The correlations of individual fiber type distributions with age were compared between the two 
gender groups for each muscle. In gluteus minimus donor muscle, there was no significant 
correlation between fiber type distribution and age in either of the two gender groups (Figure 
3.3 B, C, and F). In muscle from vastus medialis donors, the fiber type distribution in the two 
gender groups showed opposing patterns with regards to age. The female donors showed a 
significant positive correlation in type 1 fiber percentage with age, an accompanying significant 
negative correlation between type 2X fiber percentage and age, but no significant correlation 
between age and type 2A fiber percentage (Figure3.3 D, F). Male donors showed a significant 
positive correlation in type 2X fiber percentage with age, an accompanying significant negative 
correlation between type 1 fiber percentage and age, and no significant correlation between age 
and type 2A fiber percentage (Figure3.3 E, F). Comparison between gender groups in gluteus 
medius donors could not be done as there was only one male donor. 
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Gluteus minimus fiber type distribution 
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Figure 3.2: Fiber type distribution of musc le samples [gluteus medius (A), gluteus minimus (B) and vastus medi al is (C)] obtained from human donors. The donors have been grouped into youn ger th an 
60yr or 60yr and over fo r each gender. Type l fib er percentage is given in blue whereas the red hues represent th e percentage type 2 fibers (2A in red, 2X in pink). * Signifi cant di ffe rence between age 
groups of same gender P<0.05. # Signifi cant di ffe rence between genders of same age group P<0.05 
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Figure 3.3: Correlati on between age and fiber type fo r each musc le group obtained from human donors separated by gender [(A) gluteus medius, (B-C) gluteus minimus, and (D-E) vastus mecl iali s). 
Signifi cant correlations are indicated by a so lid line, whereas co rrelations that are not significant are indicated by clashed lines. The Pearson correlation coeffici ent fo r each 
correlati on between fiber 
type and age is given in (F) with number in bold signifi cantly di ffe rent from O (P<0.05 
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3.4.2 Rat muscle 
Soleus and EDL muscle obtained from three Swk old and three lyr old male Wistar rats were 
al so fiber-typed in terms of MyHC isoform using SDS-PAGE (as described in Sections 2.2.10. 1 
and 2.2. 13.2). This was done as a positive control in order to confim1 that the methods used 
here would reproduce the fiber type shifts reported for rats during maturation and aging of 
skeletal muscle. The decision to use rats in this study was made in the latter stages of the study. 
As a result the rats used here could not be maintained for sufficient time to fall into the 
senescent age group and only reached an age of about lyr, however other rats have been 
retained for a further 6 to 8 months and will be studied in the next year. The choice of using 
Swk old rats was made based on availability at the time. The Swk old rats are not adult rats and 
therefore represent a juvenile age group, whereas the 1 year old rats would be consistent with 
111iddle aged hutnans (Quinn 2005) but 111erely an adult group. The changes occurring in rats 
during Swk and lyr of age are therefore not considered here as age-related changes, but as 
developmental changes and are compared as such to developmental changes reported in the 
literature. Examples of the silver stained gels are shown in Figure 3.lB. 
3.4.2.1 Densitometry results 
In rats , the soleus muscle contains type 1 and 2A fibers whereas, the EDL muscle contains type 
2A, 2X and 2B fibers (Schiaffino and Reggiani 2011). Soleus and EDL 111uscle from of three 
Swk old and three lyr old 111ale rats were used and the fiber typing was repeated 4 times for 
each rat. The density of each of the MyHC bands were determined and depicted as a percentage 
of the total amount of MyHC present. The average percentage of each fiber type of the soleus 
and EDL muscles is given in Table 3.4 and shown graphically in Figure 3.4. 
Table 3.4: Fiber type distribution for each rat muscle sample per age group . Values are 
averages of the fiber type as a percentage of the total MyHC present (n - number of 
observati ons, sem - standard error of the mean, * significantly different to Swk old of the same 
u 
le P<0.05. " significantly different to soleus of the same age grouo} 
-
- -
Type 1 Type 2A Type 2X Type 28 
n 
mean ±sem mean ±sem mean +sem mean ±sem 
Swk 12 83 .8 2.9 16.3 2.9 Soleus 
lyr 12 90 .2 3.2 9 .8 3 .2 
Swk 12 20 .3 1.3 29 .7 0 .9 46 .0 3.1 EDL 
lyr 12 29 .6* 11 1.4 43 .7* 1.2 18 .9* 2.0 
3.4.2.2 Fiber type vs. muscle 
As di scussed above in Secti on 3 .4.2 .1 , rat soleus muscle con s ists of type I and 2A fibers 
w hereas rat EDL consist only of type 2 fibers in the form of 2A. 2X and 2B. Therefore, on! 
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type 2A fibers are common to the two muscles. A comparison of the percentage of type 2A 
fibers in soleus and EDL muscle for each age group reveals that there was a significant 
difference between lyr old rats with the soleus muscle containing 9.8±3.2% and the EDL 
muscle containing 29.6±1.4%. There was no significant difference in type 2A fiber percentages 
between soleus and EDL muscle in 5wk old rats. 
3.4.2.3 Fiber type vs. age 
The fiber type distribution for each muscle was compared between age groups. No significant 
difference was found in fiber type distribution in soleus muscle of 5wk old rats compared to lyr 
old rats. In marked contrast, the EDL muscle fiber type distribution was significantly different 
for each fiber type. The lyr old rats had a higher percentage of type 2A and 2X fibers 
(29.6±1.4% and 43.7±1.2% respectively) than 5wk old rats (20.3±1.3% and 29.7±0.9% 
respectively). In contrast, lyr old EDL has a relatively fewer type 2B fibers (18.9±2.0%) 
compared to 5wk old rats (46.0±3.1%) (see Figure 3.4) 
3.5 Discussion 
3.5.1 Human muscle 
Obtaining human samples for muscle research is always a challenge and the samples mostly 
consist of muscle biopsies or autopsies. The human muscle obtained for the work done in this 
thesis namely, vastus medialis, gluteus minimus and gluteus medius-has not been the subject of 
studies of fiber type distribution as a function of age. Therefore the work described in this 
chapter provides new insight into fiber type distribution changes with age in different muscle 
groups. Because the muscles samples were obtained from hip and knee replacement operations, 
the age distribution available for sampling was limited as it is more likely that a knee or hip 
replacement will be needed later in life than in younger subjects. The youngest donor was 45yr 
and the lack of young donors could influence the results as the difference in age between 
sa1nples was small. Although an atte1npt was made to obtain equal numbers of samples from 
each muscle for every age group this was not always possible. Consequently there was only one 
1nale gluteus medius donor and also only one male younger than 60 who donated vastus 
1nedialis 1nuscle. The results, although insightful, have to be regarded in the light of small 
sample numbers and large individual variation. Although it can be assumed that all the subjects 
were sedentary because a knee or hip replacement was necessary, no information about their 
activity during the course of their lives was available, and this could have contributed to 
individual variation. 
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Figure 3.4: The fiber type distribution using MyHC isoform as indication for so leus and EDL muscle of Swk and l yr old male Wistar rats. The different fiber types are represen ted as a percentage of the total MyHC present on the ge l with (A) showing the fiber type di stribution for so leus muscle and (B) the fiber type distribution fo r EDL muscle. Type I fibers percentage is shown in blue. whereas the percentage type 2 fiber types arc shown in red hues with 2A in red, 2X in dark pink en 2B in li ght pink. * Significantly different to Swk (P<0.05) . 
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3.5.1.1 Fiber type vs. muscle 
Most of the studies by others on human muscle have been done on biopsies from the vastus 
lateralis muscle. Consequently, much of the available data on human muscle changes with age 
are based on results from this muscle. The vastus lateralis muscle is responsible for extending 
and stabilizing the knee. Muscles that are involved in short bursts of large movement, e.g. 
gluteus maxim us, tend to have roughly an equal distribution of type 1 and type 2 fibers. The 
gluteus maximus, is the most powerful muscle in the human body for example (Marieb and 
Hoehn 2010), and it has 52% type 1 fibers and 47% type 2 fibers in young (l 7-30yr) male adult 
subjects (Johnson et al. 1973). The vastus lateralis and vastus medialis are also muscles that fall 
in this short burst/large movement group and have a similar fiber type distribution. Although 
samples from the surface contained less type 1 fibers (37.8% vastus lateralis and 43.7% vastus 
medialis) than from deeper in the muscle (46.9% vastus lateralis and 61.5% vastus medialis) in 
the study by Johnson et al (Johnson et al. 1973). The results from the work done in this thesis 
showed a lower percentage (25.1-33.9%) of type 1 fibers in general (see Table 3.2) for vastus 
medialis than the study by Johnson et al. However, Johnson et al used autopsy samples and 
myosin A TPase staining to determine the fiber type of their muscle samples, which could 
account for the variation in results. Johnson et al stained cross-sections of musle samples, 
selected three areas at random and counted a total of 200 fibers which were then classified as 
type 1 or type 2 according to their level of staining. The percentages of different fiber types 
reported by Johnson et al were therefore a reflection of the number of fibers of each fiber type. 
The results discussed in this chapter were obtained through the homogenization of muscle 
samples and the determination of the fraction of each fiber type based on separation of the 
MyHC isofonns on SDS-P AGE. There is therefore no information about single fibers, but the 
results reflect what fraction of the whole muscle could be attributed to each fiber type. In 
hu1nan vastus lateralis it has been shown that the number of fibers of each fiber type were 
reduced to a similar extent with age but that the mean cross sectional area of the type 2 fibers 
were reduced more than type 1 fibers (Lexell 1995; Porter et al. 1995). In other words, aging 
results in the 1nuscle mass being comprised of a higher percentage of slow-twitch muscle. As 
the work discussed in this thesis investigates fiber type distribution changes with age, the use of 
MyHC isoforms separated on SOS-PAGE in determining fiber type distribution would be more 
useful than counting the amount of fibers on a cross-section. 
The gluteus minimus and gluteus medius samples in general contained more type 1 fibers than 
type two fibers with the exception of the <60yr of age female group of gluteus medius donors, 
which contained 41 .9% type 1 fibres. In general the three muscles studied here differed 
significantly from each other in terms of fiber type distribution with some exceptions (see Table 
3.3). Gluteus minim us and gluteus medius are both involved in the stabilization of the pelvis 
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during wa lking, pointing the toes inwards and lifting the leg sideways (Marieb and Hoehn 
2010). They are mostl y used in their pelvis stabilizing function and thi s is consistent with th 
higher percentage type 1 fibers seen in these muscles. 
3.5.1.2 Fiber type vs. age 
As mentioned above, most of the work done on changes in fiber type distribution with age has 
involved the vastus lateralis and I have been unable to find any studies thus far on changes in 
fiber type di stribution in gluteus minimus and gluteus medius muscle with age. Although the 
gluteus medius and gluteus minimus have a similar function in the pelvic stabilization during 
walking, their fiber type distribution is significantly different from each other and the 
correlation between fiber type distribution and age is also significantly different between the 
two 111uscles. The female gluteus medius muscle donors <60yr age group had a lower 
percentage type 1 fibers (41.9%) than the corresponding group in gluteus n1inimus donors 
(63.9%). However, in the >60yr age group of gluteus 1nedius donors, the percentage type 1 
fibers was significantly higher and was also significantly higher than the corresponding gluteus 
minimus donor group (see Table 3.2 and Figure 3.2). The percentage of type 1 fibers was not 
significantly different in the two age groups of the female gluteus minimus donors. Therefore, 
the female gluteus medius showed a very strong positive correlation with age and the percentage 
of type 1 fibers , whereas the female gluteus 1ninimus showed no correlation in this regard (see 
Figure 3.3) . The male gluteus 1ninimus also did not have a correlation between age and fiber 
type di stribution . It is interesting to note that two muscles that have similar functions have a 
very different response to age. It is unfortunate that there were not enough male donors of 
gluteus medius to correlate fiber type distribution with age. 
Although there was no correlation between fiber type distribution and age in gluteus minim us 
from female donors, there was a significant difference in percentage type 2X fibers between the 
<60yr age group (8.1 %) and the >60yr age group (14.4%), but the percentage of type 1 fibers 
was not significantly different (see Table 3.2 and Figure 3.2) . Although one would expect the 
percentage of type 2A fibers to be lower because the percentage of type 2X fibers is larger and 
there was no change in percentage of type l fibers , this is not the case. However. there is a 
trend towards a lower type 2A fiber percentage in female gluteus m inimus donors of the >60yr 
age group (28.1 % vs. 24 .1 %), although the difference is not significant. Thi s lack of significant 
change in type 2A fibers may be a conseq uence of the low sample size . 
The vastus mediali s results showed a significant difference between percentage of type 2X 
fibers in the female <60yr age gro up (39.2%) and the >60yr age group (24.2%), again with no 
significant difference in the percentage of type 2A or type 1 fiber (see Table 3.2 and Figure 
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3.2). However, there is a strong trend towards a higher percentage of type 1 fibers in the older 
age group. In correlating age with fiber type distribution, there is a significant positive 
correlation between age and type 1 fiber percentage with an accompanying negative correlation 
between age and type 2X fiber percentage (see Figure 3.3). With regard to the vastus medialis 
muscle from male donors, there was no significant difference between the age groups. 
However, there was a significant positive correlation between age and type 2X fiber percentage 
with a corresponding negative correlation in type 1 fiber percentage. The fact that there was 
only one male vastus medialis donor below the age of 60yr, could contribute to the lack 
significance between the younger and older age group as the mean value for the younger age 
group (28.18%) was lower than that of the older age group (35.24%). The decrease in the 
percentage of type 1 fibers and the increase in the percentage of type 2X fibers in male vastus 
medialis is unexpected as most previous studies on vastus lateralis have shown a reduced 
contribution of type 2 fibers to muscle mass due to atrophy, resulting in a higher type 1 fiber 
content in the muscle (Lexell 1995; Porter et al. 1995). The increased percentage of type 2X 
fibers found here is therefore surprising and in contrast to female vastus medialis donors. 
Together with the gluteus minimus and gluteus medius muscle results, the vastus medialis 
results regarding fiber type distribution and age points to a diverse response from different 
muscles to aging. Importantly the results emphasise the importance of taking care when 
extrapolating results obtained in vastus lateralis muscle to all muscles in the human body. 
3.5.1.3 Fiber type vs. gender 
A compariso.n of gender and fiber type distribution in gluteus medius was not possible due to 
the limited sample size. The percentage of type 2A fibres in gluteus minimus muscles from 
donors in the >60yr age group was significantly less than in the muscle from male donors 
(24.1 % and 32.4% respectively) (see Table 3.2 and Figure 3.2). Again, there was no 
significant difference in the other fiber types although there was a trend towards lower values 
for type 1 fibers in muscle from males ( 61.5% female and 56.1 % male) and type 2X fibers 
(14.4% female vs. 10.6% male). The younger age group of gluteus minimus donors showed no 
significant difference between fiber type distribution in male and female donors and there was 
no correlation between age and fiber type distribution in gluteus minimus from male and female 
donors (see Figure 3.3). 
Vastus medialis muscle showed significant differences in the percentage of type 2X fibers 
between male and female donors in both age groups (see Table 3.2 and Figure 3.2). In the 
younger age group, male donors had lower percentage of type 2X fibers (28 .18% vs. 39.17%) 
and in the older age group the male donors had a larger percentage of type 2X fibers (35.24% 
vs. 24.24%). There were no significant age-related differences in the other fiber types to 
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account for the different fraction of type 2Xfibers. The correlation between age and fiber type 
di stribution among vastus medial is muscles showed opposing patten1s in male and female 
donors (see Figure 3.3) with muscles from female donors having the expected significant 
positive correlation between percentage of type 1 fibers and age with a corresponding negative 
correlation between type 2X fiber percentage and age. Muscles from male donors however 
showed exactly the opposite trend with a significant positive correlation between the percentage 
of type 2X fibers and age and a corresponding negative correlation between the percentage of 
type 1 fibers and age. 
The lack of clear pattern in fiber type distribution when comparing the corresponding age 
groups in the different sexes could be attributed to the high degree of individual variability 
present in human muscle apparent in Figures 3.2 and 3.3 and also reported by others (Lexel I 
1995 ; Schiaffino and Reggiani 2011 ). The muscles discussed responded differently not just 
with age but also between male and female donors. This may be due individual variability, but 
might suggest a more complex response to age than commonly reported for vastus lateral is. 
3.5.2 Rat muscle 
As explained in Section 3 .4.2, the 5wk old rats are not adult rats and represent a juvenile age 
group, whereas the lyr old rats would be consistent with middle age humans (Quinn 2005) and 
do not represent an aged group. They represent an adult group. The changes occurring in rats 
during 5wk and lyr of age are therefore developmental changes and are compared as such to 
developmental changes reported in the literature. 
3.5.2.1 Fiber type vs. muscle 
The fiber type distributions found for soleus and EDL muscles fro111 the rats where consistent 
w ith earlier reports of fiber type distributions, reviewed in (Schiaffino and Reggiani 2011). The 
so leus mu scle consisted of type 1 and 2A fibers and the EDL muscle consisted of type 2A, 2X 
and 2B fibers. The percentage of typel fibers in soleus 111uscle (83 .8% in 5wk old and 90.2% in 
1 yr o ld rats) (see Table 3.4) is very similar to the percentage of type 1 fibers reported for soleus 
musc le in young adult(] 7-30yr) male human subjects (86.4% on the surface and 89% deeper in 
the musc le) (Johnson et al. 1973). Unfortunately the study by Johnson et al did not include data 
for EDL musc le fo r comparison and no other reports for human EDL could be found . 
3.5.2.2 Fiber type vs. age 
No developmental MyHC isoform s were present in the 5wk old rat muscle, indicating that the 
transiti on to adult MyHC isoform s was complete. Although the skeletal muscle from 5wk old 
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rats contains the adult MyHC isoforms, the muscle will still continue to grow and mature until 
they reach musculoskeletal maturity at an age of about 7mo. 
No significant difference was found in soleus fiber type distribution between Swk old rats and 
lyr old rats. The EDL muscle fiber type distribution showed significant differences between the 
Swk and lyr old rats for each of the three type 2 fiber types with a lower percentage of type 2B 
fibers in the lyr old rats (18.9% lyr vs. 46.0% Swk) and a higher percentage of type 2X (43.7% 
lyr vs. 29.7% Swk) and and 2A fibers (29.6% lyr vs. 20.3% Swk) (see Table 3.4 and Figure 
3.4). This indicates a shift towards more a oxidative type 2 profile in the lyr old rats compared 
to the Swk old rats and is consistent with previous reports reviewed in (Schiaffino and Reggiani 
2011). 
3.6 Conclusion 
Very little data regarding the response of hu1nan muscles other than vastus lateral is to age is 
available in the literature due to the accessibility of vastus lateralis for muscle biopsies. The 
work presented here has contributed to this gap in our kno~1ledge base. The findings point to a 
rather complex and varied response of the different human muscles studied with regards to age 
with no clear pattern emerging across the muscle. This suggests that it is necessary to be 
cautious in extrapolating data obtained from vastus lateralis to all other muscles in the human 
body. Humans show large variability between individuals regarding fiber type distribution as 
well as muscle response to aging which makes establishing patterns !llore difficult and point to 
the need of large subject numbers in order to obtain significant data. However, significant 
correlations between age and fiber type distribution were found for female gluteus medius, 
female vastus medialis and male vastus medialis . The fiber type distribution of the rat soleus 
and EDL muscle was consistent with previous reports and the rat results therefore validate the 
measurements in humans (i.e. human results do not reflect experimental errors). 
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Chapter 4: ASI splice variant ratio in Inuscle 
4.1 Introduction 
Zorzato et al reported in 1994 that they found two RyRl transcripts present in rabbit skeletal 
muscle (Zorzato et al. 1994). The two RyRl transcripts differed with 5 amino acids and seemed 
to be due to the alternative splicing of a l 5bp exon. The different transcripts were present in 
slow- and fast-twitch 1nuscle and in different stages of fast-twitch muscle development and it 
suggested that there are two RyRl isoforms present in mammalian skeletal muscle. This was 
followed up by a study from Futatsugi et al in 1995 showing two alternatively spliced regions in 
the RyRl which they called alternatively spliced region I (ASI) and alternative spliced region II 
(ASII) respectively (Futatsugi et al. 1995). The region they called ASI corresponded to the 
alternative spliced region described by Zorzato et al. Futatsugi et al used the muscle of the hind 
limbs of mice to show that there is more RyRl splice variants containing the 5 amino acid 
residues (ASI(+)RyRl) than RyRl that does not have the 5 amino acid residues (ASI(-)RyRl) 
in adult skeletal muscle of mice (ratio of about 3: 1) and suggested that ASI is a developmentally 
spliced area. In juvenile and embryonic muscle, the ASI(-)RyRl splice variant predominated. 
In 1998, Bastide and Mounier showed that there is no difference in the properties of the Ca2 
release channels from slow-and fast-twitch muscle in terms of conductance, sensitivity to 
caffeine and the bell shaped Ca2+ activation curve between a pCa of 7 to 3 in muscle from 
Rhesus monkeys (Bastide and Mounier 1998). Interestingly, they found that about 18% of the 
RyRl from slow-twitch preparations showed a very high activity level. They concluded that the 
differences seen in Ca2+ release kinetics in fast- and slow-twitch muscle is not due to different 
intrinsic properties of the RyRl Ca2+ release channel, but due to the co-expression of RyR 
isofonns and the relative amounts of the RyRl expressed in slow- and fast-twitch muscle, but 
did not mention ASI. 
Kimura et al did a series of studies involving the ASI region of the RyR 1 (Kimura et al. 2005: 
Kimura et al. 2007: Kimura et al. 2009). Their main findings were firstly, that there was a 
change in the ASI( + )RyR 1 :ASI(-)RyR 1 ratio in musc le from humans suffering from myoton ic 
dystrophy type l. \vith there being an increase in the leve l of ASI(-)RyR 1 transcripts (Kimura et 
al. 2005) . Secondly. they found that peptides corresponding the ASI region activate RvR 1 
possibly by interrupting an inhibitory interdomain interaction and with ASI(-)RyR l being 
actiYated the most by its corresponding peptide (Kimu ra et al. 2007). Thirdly. thev found that 
the AS I splice variants showed different levels of activation during EC coupling. with 
ASI(-)RyR l being activated more than ASI(+)RyR] during EC coupling (Kimu ra et al. 2009). 
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With the ASI region being close to a binding site for the DHPR ~l a subunit on the RyRl 
(Sections 1.5 .5 and 1.6.1 above), and the necessity for the ~l a subunit to be present for 
successful EC coupling, it was suggested that the ASI region may be involved in EC coupling 
through influencing ~l a subunit binding. 
A characteristic of aging 1nuscle is the increased denervation and reinnervation of 1nuscle fibers 
(Deschenes 2011 ). During long-term denervation of skeletal muscles, the regenerated muscle 
fibers do not undergo complete maturation, and morphologically resemble myotubes (Dedkov et 
al. 2001) with juvenile isoforms of proteins. Therefore the starting hypothesis for the work in 
this chapter was that the juvenile splice variant (ASI(-)RyRl) may be upregulated in aged 
1nuscle. 
4.2 Aim 
To investigate the splice variant transcript levels of the ASI region (ASI( + )RYRl vs. 
ASI(-)RyRl) in 1nuscle from human and rat subjects and correlate it with age and fiber type 
distribution. 
4.3 Quantitative and statistical analysis 
The density of the visualized PCR product bands were determined using Quantity One 1-D 
analysis Software (Bio-Rad Laboratories, USA) and represented as _a percentage of the total 
PCR product for the ASI region present. Statistical analysis was done using ANOV A with 
Fisher' s post hoc test (P<0.05) and Pearson correlations. Correlations were deemed significant 
if the correlation coefficient (R) differed significantly from O (P<0.05). 
4.4 Results 
4.4.1 Human muscle 
To investigate splice variant ratio of RyRl ASI region, RT-PCR analysis of spliced transcripts 
was perfonned on each of the skeletal muscle samples from 40 human donors (see Table 3.1 for 
breakdown of donors). The total RNA was extracted from the muscle samples (as described in 
Section 2.2.16). Two of the samples had too low a yield of RNA to merit its further use and it 
was decided to continue without these samples due to the limited quantity of muscle received 
fro1n each donor. RT-PCR was performed on all samples at the same time in the same 
apparatus to ensure the same conditions for all samples (as described in Sections 2.2.17 -
2.2.19). The ASI region of the RYRl gene was amplified using primers specific for this region 
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(Kimura et al. 2005). The RT-PCR products were 69bp and 54bp for ASI(+)RyR 1 and 
ASI(-)RyRl respectively An example of the visualized RT-PCR product for some of the human 
donors is represented in Figure 4.1. 
A 
lOO bp 
70bp 
60bp 
50bp 
B 
lOO bp 
70bp 
60bp 
SObp 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
tane Muscle Sex Age 
1 Gluteus minimus F 51 
2 Vastus medialis F 54 
3 Vastus medialis M 71 
4 Gluteus medius F 76 
5 Gluteus minimus M 60 
6 Gluteus minimus F 74 
7 Gluteus minimus F 58 
8 Vastus medialis M 59 
9 Vastus medialis M 73 
10 Gluteus minimus F 52 
11 Gluteus medius F 52 
12 Gluteus minimus F 61 
13 Gluteus minimus F 66 
14 Gluteus minimus F 79 
ASI(+) 
ASI( -) 
PCR 
Figure 4.1: Examples of the RT-PCR product of the spli ce vari ant analysis of th e RyR I AST reg ion. (A) RT-PCR 
product from 14 of the human muscle donor samples . The ASI(+)RyRI and ASI(-) RyRI RT-PCR produ cts are 69bp 
and 54bp respecti vely. (B) Negative contro ls of the RT-PCR reaction fo r each of the samples in (A) PCR - negative 
co ntrol for th e PCR reaction conta in ing no cONA templ ate. 
To en sure that the band intensity for each sample was a true reflection of the ASI(+):ASI(-) 
rati o and that the PCR reacti on was not saturated , two representative samples of a high 
ASI (+)RyRl leve l. equa l ASI (+RyR1 ) and ASI(-)RyRl levels as well as a high ASI(-) level 
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were selected and the PCR repeated. The reaction was allowed to run for 28 cycles, 32 cycles 
and 35 cycles for each sample. The visualized PCR product is shown in Figure 4.2. 
A 
lOObp 
70bp 
GObp 
SObp 
B 
lOObp 
70bp 
GObp 
SObp 
Lan,e 
1 
2 
3 
4 
5 
6 
7 
,g 
9 
Lan,e 
1 
2 
3 
4 
5 
6 
7 
,g 
9 
1 2 3 4 5 6 7 8 9 
Muscle Sex Age PCR Cycles 
G. med F 85 28 
32 
35 
G. min F 6.6 28 
32 
35 
G. med F 76, 28 
32 
35 
1 2 3 4 5 6 7 8 9 
Muscle Sex 
G. min M 
V. me-d M 
V. med F 
Age 
61 
77 
57 
PCR Cycle·s 
28 
32 
35 
28 
32 
35 
28 
32 
35 
ASI(+) 
ASI(-) 
ASI(+) 
ASI(-) 
Figure 4.2: Experiment to show that PCR reaction was not saturated at 35 cycles and that differences seen in band 
density is a true reflection of ratio of ASI(+)RyRl and ASI(-)RyRl mRNA present in the muscle. ASI(+)RyRl PCR 
poduct is 69bp and ASI(-)RyRl PCR product is 54bp. (A) Lanes 1-3 and 4-6 shows the PCR product at 28, 32 and 
35 PCR cycles for two samples with a higher ASI(-)RyRl product level. Lanes 7-9 shows the PCR product at 28, 32 
and 35 PCR cycles of a sample with roughly equal levels of ASI(+)RyRl and ASI(-)RyRl product. (B) Lanes 1-3 
shows the PCR product at 28, 32 and 35 cycles of a sample with roughly equal levels of ASI( + )RyRl and 
ASI(-)RyRl product. Lanes 4-6 and 7-9 shows the PCR product at 28, 32 and 35 cycles of two samples with a higher 
level of ASI(+)RyRl product. 
4.4.1.1 Densitometry results 
The density of the visualized R T-PCR product was determined and expressed as a percentage of 
the total RT-PCR product of the RyRl ASI region present for each sample. The densitometry 
result for each sample as well as their corresponding fiber type distribution is shown in Table 
4.1. 
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Table 4.1: Densitometry results of the PCR product of the amp lified AS] region fo r the human 
donors with their corresponding fiber type distribution. Values are averages of the 
fiber type as a percentage of the total MyHC present. The values for type 2A and 2X 
are given separately (grey fill) as we ll as together as type 2. Blue fi ll highlights 
muscle having high percentages of type 1 fibers and ASI(-) RyRl. Pink fi ll 
highlights muscle having high percentages of Type 2 fibers and ASI(+) RyRl. 
Muscle Sex Age Type 1 Type 2A Type 2X Type 2 %ASI(+) %ASI(-) 
52 42 .82 35.91 21.27 57 .18 23.16 76 .84 
Gluteus F 76 59.65 24.15 16.20 40 .35 47 .16 52.84 
medius 84 85 .64 7.82 6.54 14.36 14.99 85 .01 
M 72 78 .25 15.29 6.46 21.75 30.43 69.57 
51 58.04 32.00 9.95 41 .96 29.22 70.78 
52 81 .77 13.33 4.90 18.23 24 .93 75.07 
58 52.95 39.44 7.61 47.05 25 .10 74.90 
61 58.16 26.68 15 .15 41 .84 31.25 68 .75 
66 89.22 9.31 1.47 10.78 17.50 82.50 
F 70 44.11 31.51 24.38 55 .89 22.35 77.65 
71 44 .60 30.79 24.61 55.40 36 .82 63.18 
74 67.88 22.26 9.86 32.12 41.89 58.11 
79 42.93 31.07 26.00 57.07 31.90 68 .10 
82 58.10 31.80 10.10 41 .90 20 .93 79 .07 
Gluteus 85 87.05 9.28 3.67 12 .95 33.44 66.56 
minimus 
45 49.96 36.30 13.74 50.04 42.54 57.46 
47 78.41 14.93 6.66 21.59 54.37 45 .63 
52 41 .76 34.31 23.93 58 .24 33 .05 66.95 
56 58 .34 35.03 6.63 41 .66 33 .81 66 .19 
59 49.46 33.63 16.90 50.54 20 .71 79.29 
M 
60 75 .77 23 .03 1.20 24.23 32.74 67.26 
61 52.91 38.60 8.49 47 .09 51.75 48 .25 
69 62.05 29 .26 8.69 37.95 30.44 69 .56 
70 45 .27 37.84 16.89 54.73 37 .72 62 .28 
72 46.20 33.54 20 .25 53.80 45 .34 54.66 
54 25.14 35.15 39.72 74.86 70.84 29 .16 
56 29.93 42.97 27 .09 70.07 57.53 42.47 
57 20.14 29.16 50.70 79.86 82.77 17 .23 
F 62 25 .02 46.58 28.40 74.98 61.25 38 .75 
64 33.42 41 .18 25 .40 66.58 53.04 46 .96 
64 31.99 46 .96 21 .05 68.01 53.97 46.03 
Vast us 
74 44 .66 42 .11 13 .23 55 .34 42.24 57 .76 medial is 
59 31.00 .40.82 28.18 69.00 57.58 42.42 
66 24.78 45.33 29.89 75.22 62.40 37 .60 
69 27 .66 33 .55 38.79 72.34 78.26 21 .74 M 
71 28 .88 35 .16 35.95 71.12 69.57 30.43 
73 34.99 40.76 24.25 65.01 59.03 40 .97 
77 13.80 38.87 47 .33 86.20 80.19 19.81 
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4.4.1.2 RyR1 AS/ splice variant levels vs. age 
The percentage of ASI( + )RyRl transcript present was correlated with the ages of the donors and 
the Pearson correlation coefficient determined to establish correlation. As the percentage 
ASI(-)RyRl transcript correlation is just the reciprocal of the ASI( + )RyRl correlation, only the 
ASI(+)RyRl transcript correlation is shown. No significant correlation between age and 
percentage ASl(+)RyRl transcript was found (see Figure 4.3A). When the data was sorted 
according to muscle and gender and then correlated with age, the only significant correlation 
between age and the percentage ASI(+)RyRl transcript was found in muscle from female vastus 
medialis donors (R =0. 791 ). No significant correlation between age and the percentage 
ASI( + )RyRl transcript was found in muscle from gluteus 1nedius, gluteus minimus or male 
vastus medialis donors (see Figure 4.3B-D). 
4.4.1.3 RyR1 AS/ splice variant levels vs. muscle and fiber type 
distribution 
The percentage of ASI(+)RyRl transcript was then correlated with the different fiber type 
percentages of the muscle from each of the donors. A strong positive correlation (R=0.781) was 
found when the percentage ASI( + )RyRl transcript was plotted against the percentage type 2X 
fibers in the muscle of each of the donors (see Figure 4.4A). The correlation between 
percentage ASI(+)RyRl transcript and percentage type 2A fibers (R=0.461) was not as strong 
as in the case of type 2X fibers, but still a significant positive correlation (see Figure 4.4B). 
When the type 2X and 2A fiber components were combined into a type 2 fiber group and 
plotted against the percentage of ASI( + )RyRl transcript, a strong positive correlation was found 
(R=0.725) with a corresponding strong negative correlation between percentage ASI(+)RyRl 
transcript and type 1 fiber percentage (R=-0.725) (see Figure 4.4C&D). Comparison of the 
mean ASI( + )RyRl transcript percentage of the three different muscles samples were taken 
from, showed a significant difference (P<0.01) between vastus medialis and both gluteus 
1nedius and gluteus minimus (see Figure 4.5B). 
4.4.1.4 RyR1 AS/ splice variant levels vs. gender 
The percentage of ASI( + )RyRl transcript was separated into gender groups and the means for 
each group compared. There was no significant difference in the percentage of ASI( + )RyRl 
transcript between fe1nale and male donors (see Figure 4.5A). When the percentage of 
ASI( + )RyRl transcript was separated according to muscle and gender and the means of each 
group compared, the only significant difference found was between the male and female donors 
of gluteus 1ninimus (see Figure 4.5C-E). No significant difference was found between the 
gender groups of the vastus medialis muscle donors. A mean comparison between gluteus 
medius gender groups was not possible as there was only one male donor. 
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Figure 4.3: Correlation between age and percentage of AS J(+)RyR I transcript in muscle from human gluteus medius, gluteus minimus and vastus medial is muscle. (A) Correlation between age and percentage or AS l(+)RyR I transc ript for all th e donors. (B) Correlation between age and percentage of ASI(+)RyRl transcripts of gluteus medius donors sorted according to gender. (C) Correlation between age and percentage of AS l(+)RyR I transcript of gluteus minimus donors sorted according to gender. (D) Correlation between age and percentage of ASI(+)RyR I transcript ofvastus mediali rted according to gender. N.S. = Correlation not significant. R = Pearson correlation coefficient 
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Figure 4.4: Correlation between fiber type percentage and percentage of ASI(+)RyRl transcript present. (A) Correlation between percentage of ASI(+)RyRl transcript and type 2X fiber percentage for 
all the donors. (B) Correlation between percentage of ASI(+)RyRI transcript and percentage of type 2A fiber for all the donors. (C) Correlation between percentage ASI(+)RyRI transcript and 
percentage of type 2 fiber for all donors. (D) Correlation between percentage of ASI(+)RyRl transcript and percentage of type I fiber for all donors. N.S. = No significant correlation, R = Pearson 
correlation coefficient. 
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4.4.2 Rat muscle 
In contrast to human muscles that mostly contain a mixture of fiber types, rats have fiber type 
specific muscles such as the EDL, which consists of only type 2 fibers and soleus, which is 
mostly type 1 fibers with some type 2A fibers. It is therefore useful to determine whether 
muscles consisting of only type 2 fibers would express only ASI( + )RyRl. The complete 
sequence of the rat RYRl gene is not available on the NCBI databases. It was therefore decided 
to use the mouse primer sequence used by Kimura et al (Kimura et al. 2005) instead. The PCR 
using these mouse primers, however, was unsuccessful. The RNA was checked for degradation 
and found to be intact. A rat sequence for RYRl was found on the Ensembl Genome Browser 
database, but the sequence was quite different from rabbit, human and mouse sequences. 
Primers using that rat sequence were designed but the PCR was again unsuccessful. It was 
decided due to time constraints not to pursue this further. 
4.5 Discussion 
4.5.1 RyR1 ASI splice variant levels vs. age 
The hypothesis underlying the investigation of ASI splice variant transcript levels in muscle was 
there would be an increased level of the juvenile splice variant in aged muscle. This was based 
on observations that denervation and reinnervation occur at higher frequencies in aged muscle 
(Deschenes 2011) and the fact that the regenerated muscle fibers do not always completely 
mature (Dedkov et al. 2001). However this hypothesis was not proven. When the percentage 
ASI( + )RyRl transcript of all the muscles was plotted against donor age, there was no significant 
correlation (see Figure 4.3A). When the data was separated according to muscle type and 
donor gender and the percentage of ASI( + )RyRl transcript plotted against age , the only 
significant correlation was found in female vastus medialis muscle (see Figure 4.3B-D) with 
the percentage of ASI( + )RyRl transcript showing a negative correlation with age (R = -0. 791 ). 
The coefficient of determination (R2) for this correlation is 0.626 which indicates that 62.6% of 
the variance in the percentage of ASI( + )RyRl transcript could be explained by variance in age. 
This is interesting as there was also a negative correlation found between female vastus medialis 
donors and percentage of type 2X fiber type with a correlation coefficient (R) of -0 .669 and R2 
value of 0.447 (see Figure 3.3D&F). However, in female gluteus medius, where a similar 
strong negative correlation between type 2X fibers and age was seen, no significant correlation 
between age and the percentage of ASI( + )RyRl transcript was found (see Figure 4.3B and 
Figure 3.3A&F). There is also no significant correlation between the percentage of 
ASI( + )RyRl transcript and age in male vastus medialis donors. Interestingly, a positive 
correlation between the percentage of type 2X fiber type and age was found in male vastus 
127 
Chapter 4 
medial is donors (R = 0.5 03 , R2 = 0.253) (see Figure 3.3E&F). One can therefore not say that a 
higher percentage of type 2X fiber is necessary to see the negative correlation between age and 
ASI(+)RyRl transcript and age seen in female vastus mediali s donors. as the male donors of 
this muscle do not show the same correlation. This result once aga in speaks of a more complex 
mechanism with multiple factors contributing to age related changes in musc le. 
4.5.2 RyRl ASI splice variant level vs. muscle and fiber type 
When Zorzato et al showed the presence of two splice variants in both slow- and fast-twitch 
muscle they did not indicate the proportion or ratio of the transcript levels in either, as they used 
different primers and PCR reaction for the different splice variants (Zorzato et al. 1994 ). 
Futsasugi et al used the hind limb muscles of mice which is mostly fast-twitch muscle to show 
their adult ASI splice variant ratio of 3: 1 ASI( + )RyRl to ASI(-)RyRl (Futatsugi et al. 1995). 
Kimura et al used vastus lateralis muscle biopsies to show that the same 3: 1 ratio of 
ASI( + )RyRl to ASI(-)RyR 1 in normal adult human skeletal muscle (Kimura et al. 2005). Here 
I have shown for the first time that the levels of ASI(+)RyRl and ASI(-)RyRl transcripts are 
consistently influenced by fiber type with a strong positive correlation between ASI( + )RyR 1 
and the percentage of type 2 fibers in muscle from human donors (R=0.725 , R2=0.525) with a 
corresponding strong negative correlation between the percentages of ASI( + )RyRl transcript 
and type 1 fibers (R=-0.725, R2=0.525) (see Figure 4.4C&D). When the type 2 fibers were 
separated into type 2X and type 2A fibers , the correlation with the percentage of ASI( + )RyR 1 
transcript was the strongest with the percentage of type 2X fibers (R=0.781 , R2=0.610) with a 
weaker correlation between the percentages of type 2A fibers and ASI( + )RyR 1 transcript 
(R=0.461 , R2=0.212) (see Figure 4.4A&B). This result points to a muscle fiber type specific 
distribution of the RyRl splice variants with ASI(+)RyRl being the type 2 fiber splice variant 
and ASI(-)RyRl being the ASI(-)RyRl splice variant. The use of vastus laterali s as muscle 
source by Kimura et al therefore becomes sign ificant in interpreting the shift of ASI splice 
variant ratio observed in DMl patients (Kimura et al. 2005) as it has been shown that vastus 
lateralis muscle from DMl patients has a type 1 fiber dominance (64%) (Andersen et al. 2013) 
whereas vastus lateral is from healthy subjects show type 1 fibers constituting only 37. 8 - 46.9% 
and therefore these muscle have a type 2 fiber type dominance (Johnson et al. 1973). The 
higher level of ASI(-)RyRl transcript observed by Kimura et al may therefore be due to a 
fiber type shift rather than a perturbed RyRl splicing in the ASI region. In the DM 1 
disease mechanism. RN As with expanded CUG repeats bind to Muscleblind-like 1 (MBNL]) 
protein v.·ith hi gh affinity. resulting in its sequestration in nuclear foci. MBNLl acts as a 
regulator of splicing and microRNAs (miRNAs) processing and its sequestration leads to a loss 
of its activity (Mi ller et al. 2000: Warf and Berglund 2007: Yuan et al. 2007: Rau et al. 2011 · 
Tang et al.2012). This leads to misregulated alternative sp licing and other changes of the 
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muscle transcriptome, which could in fact affect one of several steps in fiber type regulation 
signalling pathways causing this change in fiber type distribution observed in vastus lateralis of 
DMl patiens. In fact, one of the mechanisms involved in coordinated fast and slow gene 
programs makes use of muscle specific miRNAs (Schiaffino and Reggiani 2011) and could 
possibly be one of the mechanisms affected in DMl. 
In the results discussed in this chapter, the gluteus medius and gluteus minimus, which have a 
higher % of type 1 fibers , shows a significantly lower level of ASI( + )RyRl transcript than 
vastus medialis which has a higher percentage of type 2 fibers (see Figure 4.5B). This result 
supports the hypothesis that ASI splice variants are fiber type specific. In this regard it would 
have been interesting to have determined the ASI splice variant levels in rat EDL muscle, as it 
contains no type 1 fibers. The concept of having different RyRl isoforms in slow- and fast-
twitch fibers is not novel, as it has been shown in skeletal muscle of fish that there are two 
RyRl isoforms specific to fast- and slow-twitch 1nuscle (Franck et al. 1998; Morrissette et al. 
2000). However, the presence of fiber type specific RyRl isoforms in amphibian, avian and 
1nammalian skeletal muscle has not been shown and therefore the presence of fiber-type specific 
RyRl splice variants in humans is a novel finding. The physiological significance of 
ASI( + )RyRl in type 2 fibers and ASI(-)RyRl in type 1 fibers will be discussed in the general 
discussion chapter ( Chapter 7). 
It remains to be determined whether individual fibers express only one splice variant, or 
whether ( as with myosin isoforms ), regions of the multinucleate fibe~ can express different 
isoforms, so that an individual fiber may have a higher percentage of one or the other isoform. 
It is also not known whether a fiber that contains both splice variants would have 
homotetrameric or heteroterameric RyRls containing just one splice variant per RyRl or a 
various hybrids consisting of different combination of the two splice variants. The latter is 1nost 
probably the case as have been de1nonstrated with co-expression of WT and mutant RyRls in 
HEK cells (Xu et al. 2008). This will be discussed more in the general discussion chapter 
(Chapter 7). 
4.5.3 RyR1 ASI splice variant level vs. gender 
No significant difference was found in the percentage of ASI( + )RyRl transcript between the 
1nuscles of male and female donors, (see Figure 4.5A) . When the donors were separated 
according to muscle and then gender, the only significant difference in ASI( + )RyRl transcript 
found was between female (28.67%) and male donors (30.43%) of gluteus minimus (see 
Figure 4.5 C-E) (P<0.05). This was probably due to the significant difference (P<0.01) in type 
129 
Chapter 4 
2A fiber type percentage between the gender groups in gluteus minim us muscle (female 25. 17% 
vs. male 31.55%) rather than gender differences in the percentage of ASI(+)RyRl transcript. 
4.6 Conclusion 
T he level of RyR 1 ASI splice variants in human muscle is not affected by age as was originally 
hypothesised. However, a novel finding is that the levels of ASI splice variant in human muscle 
co rrelates with fiber type distribution. It seems therefore that the splice variants are fiber type 
specific isoforms of the RyRl. Different RyRl isoforms in slow-twitch and fast-twitch fibers 
have been shown in fish , but this is the first ti1ne that this is shown in ma1nmalian skeletal 
muscle. 
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Chapter 5: EC coupling protein expression 
\\Tith age 
5.1 Introduction 
Sarcopenia is the age related loss of muscle mass and strength. Although loss of muscle mass 
would reduce muscle strength, the loss in muscle strength is greater than can be accounted for 
by the loss in mass (Lynch et al. 1999). One of the suggested mechanis1ns involved in the loss 
of 1nuscle strength is alterations to the EC coupling process (Delbono et al. 1995; Renganathan 
et al. 1997; Wang et al. 2000). 
Delbono et al (Delbono et al. 1995) first investigated the possibility that the reduction in 
specific force seen in aging muscle may be due to alterations in the EC coupling Ca
2
+ release 
process. Delbono et al coined the term "EC uncoupling" to describe the defects in trans1nission 
of membrane depolarization to SR Ca2+ release that are responsible for decreased specific force 
with aging (Payne and Delbono 2004). The observed reduction in DHPR charge move1nent 
during EC coupling could indicate fewer DHPRs and/or dysfunctional DHPRs with age. The 
reduced SR Ca2+ release observed could be the result of fewer DHPRs, dysfunctional DHPR, 
fewer RyRl and/or dysfunctional RyRl. It seems that there is a general change in protein 
expression (O'Connell et al. 2007) as well as protein turnover (Ferrington et al. 1998) in muscle 
with age. Changes in expression levels of the DHPR and RyRl are associated with loss of 
specific muscle force with age and this could underlie the EC uncoupling hypothesis. 
There are conflicting reports regarding the expression of RyRl in aging muscle. A decrease in 
RyRl levels has been reported in mixed and fast-twitch fibers in rats and mice with age based 
on [3H]ryanodine binding (Renganathan et al. 1997; Renganathan et al. 1998). However, other 
[3H]ryanodine binding and immunoblot studies report no change in RyRl expression in fast-
and slow-twitch 1nuscle from aged rats (Damiani et al. 1996; Margreth et al. 1999; O'Connell et 
al. 2008). In tenns of the EC uncoupling hypothesis, the ratio of DHPR to RyRl is likely to be 
1nore i1nportant than absolute expression levels in rodents because it is the increase in RyRl 
unassociated with DHPR that is the basis for this hypothesis. In the work discussed in this 
chapter both RyRl expression and the DHPR a 1/ RyRl expression ratio are investigated with 
respect to age and sex. 
The results reported by Delbono et al (Delbono et al. 1995) showing reduced DHPR charge 
1novement and SR Ca2+ transients in aged human fast-twitch fibers were subsequently 
confirmed in fast-twitch fibers of aging mice (Wang et al. 2000). [3H]PN200-1 l O binding to 
131 
Chapter 5 
DHPR a 15 in rat and mouse muscle indicates reduced DHPR a 15 expression with age in mixed 
s low-twitch and fast-twitch muscles (Renganathan et al. 1997; Renganathan et al. 1998). This 
was confirmed by immunoblot of aging rabbit and rat 1nuscle (Ryan et al. 2000; Ryan et al. 
2003 ; O'Connell et al. 2008). The DHPR/RyRl ratio in adult rat EDL of ~ 1 suggests that every 
fourth RyRl may be linked to a DHPR tetrad. In soleus muscle this ratio is lower (~0.4) and 
could mean that every 12th RyRl is linked to a DHPR tetrad (Delbono and Meissner 1996· 
Renganathan et al. 1997). In aged muscle the ratio decreases to 0.26 in soleus and 0.68 in EDL 
muscle. Therefore more DHPR uncoupled RyRls may be present in older rat muscle and this 
would support the EC uncoupling hypothesis. In human muscle, however, there is apparently 
no decrease in DHPR a 15 with age (Ryan et al. 2003). The alterations in CRU structure seen in 
aged human muscle showed that the total number of CRUs decrease, but that the average size of 
the RyRl feet arrays increase to compensate for the loss of CRUs (Boncompagni et al. 2006). 
In human muscle therefore, it may be more a case of altered structure and arrangement of the 
EC coupling apparatus than the expression of the protein that cause the EC uncoupling. In the 
work discussed in this chapter, the level of a 15 expression is also investigated. 
The DHPR ~l a subunit plays an important role in EC coupling as it is required for the trafficking 
of the DHPR a 15 subunit to the sarcolemma (Neuhuber et al. 1998; Bichet et al. 2000; 
Schredelseker et al. 2005 ; Leuranguer et al. 2006), formation of tetrads (Schredelseker et al. 
2005) as well as regulating L-type Ca2+ current and supporting a fraction of EC coupling (Gregg 
et al. 1996; Strube et al. 1996). In addition, the SH3 domain of the ~2a subunit has been shown 
to bind to dynamin and mediate endocytosis of the DHPR a 1c subunit in Xenopus oocytes 
(Gonzalez-Gutierrez et al. 2007). The effect of aging on the DHPR ~ la subunit expression was 
investigated by Taylor et al (Taylor et al. 2009). They reported a significant increase in ~ la 
expression with age in mice both in mixed muscles and fast-twitch muscles (TA and EDL). 
They also found that over expression of the ~l a subunit in TA muscles of mice caused a decrease 
in a 15 subunit expression and decline in specific force. Introducing siRNA against the ~ la 
subunit and thereby reducing its expression in aged mice showing a decrease in charge 
movement restored the charge movement to control levels. These results suggest a poss ible role 
for ~l a in the reduction in a 15 subunit expression reported in rodents. However, the increased 
expression of ~ la has not been investigated in humans and has been attempted in the work 
discussed in this chapter. 
The C\1op lasmic free Ca2- concentration is increased in both s low-twitch so leus (22%) and fast-
t\Yitch EDL muscles (7 6%) from old rats (F raysse et al. 2006). A population of aging mouse 
skeletal muscle fibers demonstrates an external Ca2- dependent component to EC coupling 
indicated by reduced Yoltage-induced Ca2- transients in fibers in the absence of external Ca2~ 
(Payne et al. 2004). Interestingly. regenerating muscle and developing skeletal muscle go 
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through similar stages in which effective EC coupling and contraction are partially dependent 
on external Ca2+ (Louboutin et al. 1995; Louboutin et al. 1996), and there is an accompanied 
transient expression of the DHPR a1c subunit (Pereon et al. 1997). The expression of the DHPR 
a1c diminishes as the expression of DHPR a 15 increases over time as muscle regeneration 
proceeds. As aged muscle show increased denervation and reinnervation and therefore also 
undergo regeneration, it could be possible that there may a shift towards cardiac EC coupling in 
aged muscle. However, a subsequent study found that external Ca2+ but not Ca2+ influx is 
required to maintain force in repetitive fiber electrical stimulation of single fibers from aging 
mouse muscle (Payne et al. 2004 ). If this is generally true, it is unlikely that CICR plays a role 
in EC coupling in aged mice. In fact, the authors contributed the external Ca2+ dependence to 
sodiu1n channel modification with age that leads to a failure in action potential generation in the 
absence of external Ca2+. However, the expression of the DHPR a 1c in aging hu1nan skeletal 
muscle has not been investigated. In the work discussed in this chapter the a 1cfRyRl expression 
ratio is examined in human skeletal muscle. 
Muscle weakness in aged muscle could also be due to the modification of RyRl. Oxidation and 
S-nitrosylation of RyRl in aged muscle dissociates FKBP12 from the RyRl causing an increase 
RyRl activity and therefore "leaky" channels (Andersson et al. 2011 ). Stabilizing 
RyRl/FKBP12 binding reduced this calcium leak from the SR, enhanced Ca2+ release from the 
SR, increased specific force and increased exercise capacity in aged mice. In the results 
discussed in this chapter, the expression of FKBP12 with age in humans as well as the 
FKBP12/RyRl ratio has been investigated. 
5.2 Aim 
To investigate the expression levels of RyRl , DHPR a 1s, DHPR ~l a and FKBP12 as well as the 
DHPR a 1/ RyR1 , DHPR a1c /RyRl , and FKBP12/RyR1 expression ratios in muscle obtained 
from human and rat subjects. 
5.3 Quantitative and statistical analysis 
Stained gels and developed films were documented by digital imaging using a Gel Doc XR 
Syste1n (Bio-Rad Laboratories, USA) and band intensity measured using Quantity One 1-D 
analysis Software (Bio-Rad Laboratories, USA). For muscle homogenate immunoblots, the 
band density was normalised to the density of the total protein in the same sample on a 
Coomassie stained gel (see Figure 5.1) . This was done as most proteins used as loading 
standards in muscle immunoblot ( e.g. actin, MyHC and glyceraldehyde 3-phophate 
dehydrogenase - GAPDH) show a change in expression in humans with age (Gelfi et al. 2006). 
For microsomal vesicle immunoblots, the protein band intensity was normalised to that of the 
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RyRl because the ratio of the expression of the specific proteins relative to that of the RyR l 
was of interest. 
Statistical analysis was done using ANOVA, student's t-test (P~0.05) and Pearson correlations. 
Correlations were deemed significant if the correlation coefficient (R) differed significantly 
from O (P~0.05). 
5.4 Results 
In order to detennine if all the proteins of interest were present in microsomal vesicles, the 
different fractions obtained during the preparation of microsomal vesicles for a human muscle 
sample were probed for RyRl , DHPR a 1s, DHPR 01a, and FKBP12. The results showed that 
most of the 01a subunit is lost during with the first centrifugation step (see Figure 5.2) and that 
there is very little 0ia present in the final microsomal vesicles. It was therefore decided to use 
the muscle homogenate in the investigation of the expression levels of the proteins. 
Figu re 5.1: Example of muscle homogenate SDS-PAGE showing areas used to determine den sity of total protein ( U 1-U 1-l ). U 15 \\·as used as background (in each case the whole lane was scan ned including bands and regions 
between bands?) 
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H 51 Pl 52 P2 53 V 
RyRl 
DHPR als 
DHPR ~la 
FKBP12 
Figure 5.2: Immunoblot of human muscle microsomal vesicle preparation fractions, probed for RyRl , DHPR a 15, 
DHPR ~la and FKBP12. H- homogenate, Sl - supernatant from first centrifugation step , Pl - pellet from first 
centrifugation step, S2 - supernatant from second centrifugation step, P2 - pellet from second centrifugation step, S3 
supernatant from final centrifugation step and V - microsomal vesicles. 
The expression levels ofRyRl , DHPR a 1s, DHPR ~la and FKBP12 was investigated in human 
(gluteus medius, gluteus minimus and vastus medialis) and rat (soleus and EDL) muscle 
homogenate using immunoblot and densitometry ( as described in Sections 2.2.9 - 2.2.14 ). At 
least four repeats on two different immunoblots (two per blot) were done for each muscle 
homogenate sample. The density for the resulting bands was determined and normalised to total 
protein as described in section 5 .1.5. Figure 5.3 gives an example of the 1nuscle homogenate 
immunoblots for the human and rat muscle samples. As not all the FKBP12 present in the 
muscle ho1nogenate will be associated with RyRl , microsomal vesicles were used to investigate 
the FKBP12/RyR1 level for the different muscle samples. The a 1/RyR1 and a 1/ RyR1 levels 
were also investigated in 1nicrosomal vesicles. The expression levels of DHPR a 1s, DHPR a 1c, 
and FKBP 12 were determined in microsomal vesicles prepared from human (gluteus medius, 
gluteus minimus and vastus medialis) and rat (soleus and EDL) muscle. As the DHPR a 1 
subunits are of similar molecular weight, the membrane was first probed for a 15 and then 
stripped and reprobed for a 1c in cases where both proteins were probed for on one blot. At least 
four repeats on two different immunoblots (two per blot) were done for each microsomal vesicle 
sample and the density of the resulting bands determined. The density was normalised to the 
RyRl density. Figure 5.4 gives an example of the microsomal vesicle immunoblots for the 
human and rat muscle samples. 
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5.4.1 Human muscle 
A breakdown of the human donors has been given in Table 3.1 of Chapter 3. 
5.4.1.1 Densitometry results 
The human muscle results were grouped according to muscle, and donor gender and age ( <60yr 
or ~60yr) . As most of the changes in muscle associated with age seem to occur after the 6th 
decade (Vandervoort and McComas 1986; Lindle et al. 1997; Rantanen et al. 1998; Deschenes 
2004), the donors younger than 60yr were considered as the control group. The average density 
of the protein bands relative to total protein determined in muscle homogenate for each group is 
given in Table 5.2 and the average density of the protein bands relative to RyR 1 determined in 
microsomal ves icles for each group is given in Table 5.3. 
The expression level of the DHPR a 1 s subunit was then plotted as a function of the expression 
levels of RyRl (both normalised to total protein) in the muscle homogenate for all the muscle 
donors (Figure 5.5A). The same was done for the DHPR ~l a subunit and then the expression 
levels of the two DHPR subunits were also correlated (Figure 5.5B&C). There was a 
significant positive correlation (P<0.01) between the DHPR a 15 density and that of the RyRl 
with a correlation coefficient of 0.889 . The DHPR ~l a subunit density also showed a significant 
positive correlation (P<0.01) with that of the RyRl , although the correlation coefficient was 
lower (R=0.435). The two DHPR subunits also showed a significant (P<0.01) positive 
correlation with R=0.542. 
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Table 5.1: The average density of the protein bands relative to total protein in human muscle homogenate. Donors were grouped according to muscle, gender and age (<60yr or 
~60yr) (sem - standard error of the mean, n - number of observations, * significantly different from <60yr age group of same muscle,# significantly different from 
female of same muscle, + significantly different from female of same age group and muscle, t significantly different from gluteus medius, t significantly different from 
gluteus minimus) 
RyRl DHPR a 1s DHPR J31a FKBP12 
n mean ±sem mean ±sem mean ±sem mean ±sem 
gluteus medius female <60 8 0.57 0.09 0.58 0.11 0.81 0.13 1.00 0.09 
~60 8 1.23* 0.14 0.95* 0.12 1.09 0.19 1.31 * 0.06 
combined 16 0.90 0.12 0.77 0.09 0.95 0.12 1.15 0.07 
male <60 0 - - - - - - - -
~60 4 1.02 0.09 0.55+ 0.11 0.63+ 0.07 1.21 0.13 
combined 4 1.02 0 .09 0.55 0.11 0.63# 0.07 1.21 0.13 
f and m combined 20 0.92 0.10 0.72 0.08 0.89 0.10 1.16 0.06 
gluteus minimus female <60 12 0.73 0.05 0.91 0.10 0.78 0.13 1.01 0.10 
~60 32 0.88 0.08 0.92 0.08 0.96 0.06 1.28* 0.08 
combined 44 0.84 0.06 0 .91 0.06 0.91 0 .06 1.21 0.07 
male <60 20 1.16+ 0.12 1.17 0.12 1.24+ 0.08 1.02 0.10 
~60 20 0.81 * 0.11 0.95 0.10 1.18 0.13 1.19 0.10 
combined 40 0.99 0.09 1.06 0.08 1.21# 0.08 1.11 0.07 
f and m combined 84 0.91 0.05 0.98* 0.05 1.05 0.05 1.16 0.05 
vastus medialis female <60 12 1.31 0.10 1.12 0.06 0.63 0.09 0.97 0.09 
~60 20 1.44 0.15 1.44 0.17 0.92* 0.10 1.21 0 .15 
combined 32 1.39 0.10 1.32 0.11 0.81 0.08 0.70 0.10 
male <60 4 1.64 0 .12 1.41+ 0.07 0.79 0.07 0.84 0.12 
~60 20 1.91 0.32 1.93 0.34 1.04 0.14 1.30 0.36 
combined 24 1.91 0.27 1.93 0.29 1.04 0 .12 1.30 0.30 
f and m combined 56 l.62*t 0.13 1.58*t 0.14 0.91 0.07 1.20 0.14 
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Table 5.2: The average density of the protein bands relative to that ofRyRl in microsomal vesicles from human muscle donors. Donors were grouped according to musc le, gender 
and age ( <60yr or ~60yr) (sem - standard error of the mean, n - number of observations, * significantly different from <60yr age group of same musc le, #significantly different from female of same musc le. + significantly different from female of same age group and muscle. t significantly different from gluteus minimus). ~ ~ . < ~ , 
DHPR a 1s/RyR1 DH PR a 1JRyR1 FKBP12/RyR1 
mean ±sem n mean ±sem n mean ±sem n 
gluteus medius female <60 0.94 0.23 10 1.07 0 .51 8 2.01 0.22 10 
~60 0.69 0 .10 8 0 .51 0 .06 8 0.82 * 0 .12 10 
combined 0.83 0.14 18 0.79 0.26 16 1.07 0 .14 20 
male <60 - - - -
- - -
- -
~60 0.51 0 .10 4 1.03+ 0.13 4 0 .59 0 .11 4 
combined 0.51 0.10 4 1.03 0.13 4 0 .59# 0 .11 4 
f and m combined 0.77 0.12 22 0.83 0.21 20 0.99 0.12 24 
gluteus minimus female <60 1.05 0 .15 12 0.74 0 .19 12 1.08 0 .10 14 
~60 0.73 0 .12 39 0 .36 0.04 37 0 .81 * 0 .04 51 
combined 0 .81 0 .10 51 0.45 0.06 49 0 .86 0.04 65 
male <60 1.09 0 .13 25 0.65 0.15 26 1.04 0.10 28 
~60 1.27+ 0 .12 19 0 .51 0 .14 20 1.00+ 0 .06 24 
combined 1.17# 0.09 44 0 .59 0.10 47 1.02 0.06 53 
f and m combined 0.98 0.07 95 0 .52 0 .06 96 0 .94 0 .04 118 
vastus medialis female <60 1.10 0 .13 12 0 .91 0 .13 12 0 .94 0 .02 12 
~60 0 .89 0 .11 20 1.02 0 .12 26 0 .76* 0 .05 36 
combined 0.97 0.08 32 0.99 0 .09 38 0 .80 0 .04 48 
male <60 1.12 0 .11 4 0 .35+ 0.07 5 0 .96 0 .09 6 
~60 1.01 0 .12 19 0 .77* 0 .16 20 0 .83 0 .05 22 
combined 1.03 0 .10 23 0 .67# 0.13 26 0.86 0 .05 28 
f and m combined 1.00 0 .06 55 0 .86t 0.08 64 0 .82t 0 .03 76 
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Figure 5.5: Correlation between the expression levels of the DHPR subunits and RyRl in the human muscle homogenates, normalized to total protein. (A) Express ion levels of the DI-IPR a 15 subunit 
plotted against that of RyRl . (B) Expression levels of the DHPR ~l a subunit plotted against that of Ry RI . (C) Expression levels of the DI-IPR ~l a subunit plotted against th at of the a 15 subunit. 
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5.4.1.2 The effect of age on protein expression levels 
5.4.1.2.1 Comparing the means 
In order to investigate the effect of age on the expression levels of RyRl , DHPR a. 15, 01a, and 
FKBP12 as well as the expression ratios ofa. 1/ RyRl, a.1/ RyRl and FKBP12/RyRL the 
den sitometry data obtained from the immunoblots were grouped into donors <60yr and ~60yr. 
The mean was determined for each group (Table 5.2 and 5.3). 
There was no significant difference in RyRl , a. 15, and 0i a expression between the age groups 
when the data for all three muscles were combined (Figure 5.6A) . There was however_ a 
significantly higher expression of FKBP12 in the ~60yr age group (P~0.05). When the data for 
the different muscles was plotted separately (Figure 5.6 B-D), significantly greater expression 
levels of RyRl and FKBP12 (P~0.05) were observed in the ~60yr age group in gluteus medius 
muscle homogenates. No significant differences were found in a. 15 and 0ia expression levels in 
this muscle (Figure 5.6B). In gluteus minimus muscle homogenates, there was also a 
significantly greater FKBP12 expression level (P~0.05) in the ~60yr age group, but no 
difference in RyRl , a. 15 or 01a expression levels (Figure 5.6C). Vastus medialis homogenates 
showed a significantly higher a. 15 and 0i a expression (P~0.05) in ~60yr age group, but no 
difference in RyRl and FKBP 12 expression (Figure 5.6D). 
Combining the microsomal immunoblot densitometry data of the three muscles showed a 
significantly lower (P~0.05) a. 1/ RyRl and FKBP12/RyR1 expression ratio in the ~60yr age 
group (Figure 5.7 A) but no difference in the a.1/ RyRl expression ratio. 
When the data from the three muscles were separated, a significantly lower (P~0.05) 
FKBP 12/RyRl ratio was observed in gluteus medius microsomal vesicles, but no significant 
difference in the a. 1/ RyRl or a 1c!RyR1 ratios (Figure 5.7B). In the gluteus minimus 
microsomal ves icles significantly lower ratios ofFKBP12/RyR1 and a 1c /RyR] (P~0.05) were 
observed in ~60yr donors with no significant difference in the a. 1/ RyRl ratio (Figure 5.7C). 
The vastus medial is microsomal vesicles showed a significantly lower FKBP 12/RyR 1 ratio 
(P~0 .05) in the ~60yr age group with no significant difference in the a 1/ RyR1 and a. 1/ RyR] e 
ratios (Figure 5.7D). 
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Figure 5.6: A compari son of express ion leve ls of RyRl , DI-IPR a 15, DI-IPR ~l a and FKBP12 in muscle homogenate of human donors <60yr and ~60yr. (A) The prote in express ion levels in muscle 
homogenate where data fro m all three musc les were combined. (B) The protein express ion leve ls in gluteus medius muscle homogenate. (C) The prote in expression levels in gluteus min imus muscle 
homogenate. (D) The prote in express ion leve ls in vastus mediali s musc le homogenate. 
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Figure 5.7: A comparison or DHPR a 15 / RyR I, Dll PR a 1c / RyR I and FKBP 12 / R 
pro tein express ion ra ti os in mi crosomal ves icles where data fro m all three muse! 
rati os in gluteus minimus microsoma l ves icles. (D) The protein express ion rat ios in 
R I express ion rati os in mi crosomal ves icles prepared from muscle of human donors <60yr and ~60yr. (A) The 
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re combined. (B) The protein express ion ratios in gluteus medius microsomal ves icles. (C) The protei n express ion 
astus medi al is mi croso mal ves icles. 
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In order to determine if the effect of age on the expression levels are different between male and 
female donors, the densitometry results for the muscle homogenate and microsomal vesicle 
immunoblots were grouped firstly into the <60yr and ~60yr age groups and then each age 
group was separated into male and female donors (see Table 5.2 and 5.3). As there was only 
one male gluteus medius donor, only the fe1nale gluteus medius donors are considered. 
The muscle homogenates from female gluteus medius showed a significantly greater (P~0.05) 
expression level of RyRl , a1s and FKBP12 in the ~60yr age group. No difference was seen in 
~l a expression levels between the age groups (Figure 5.8A). In female gluteus minimus muscle 
homogenate a significantly greater level (P~0.05) of FKBP12 was observed in the ~60yr age 
group with no significant difference in the expression levels of RyRl , a 1s and ~1a (Figure 5.8B). 
However, in the male gluteus minimus muscle homogenate, there was a significantly lower 
expression (P~0.05) of RyRl in the ~60yr age group with no difference in the a 1s, ~la and 
FKBP12 expression levels (Figure 5.8D). The female vastus medialis muscle homogenates a 
significantly greater expression level (P~0.05) of ~1a was observed in the ~60yr age group 
whereas there was no difference in the RyRl , a 1s and FKBP12 expression levels (Figure 5.8C). 
No significant difference in any of the proteins' expression levels were observed in male vastus 
1nedialis muscle ho1nogenate (Figure 5.8E). 
The data obtained from female gluteus medius microsomal vesicles showed a significantly 
lower (P~0.05) FKBP12/RyR1 ratio in the ~60yr age group. No difference was observed in the 
a 1/RyR1 and a 1cfRyR1 expression ratios (Figure 5.9A). Female gluteus minimus 1nicrosomal 
vesicles showed similar results with only the FKBP12/RyR1 being significantly lower (P~0.05) 
in the ~60yr age group (Figure 5.9B). The male gluteus mini1nus microsomal vesicles showed 
no difference in any of the ratios investigated (Figure 5.9D). The female vastus medial is 
n1icrosomal vesicles also showed a significantly lower (P~0.05) FKBP12/RyR1 ratio with no 
difference in the a 1/ RyR1 and a 1cfRyR1 ratios (Figure 5.9C). The male vastus medialis 
microsomal vesicles, however, showed a significantly higher a1cfRyR1 ratio (P~0.05) with no 
difference in a1/ RyR1 or FKBP12/RyR1 ratios (Figure 5.9E). 
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Figure 5.9: A comparison of DI-IPR a 15 / RyRl , DHPR a,c I RyRl and FKBP12 I Ry RI expression ratios in microsomal ves icles prepared from muscle of male and female human donors <60yr and 
~60yr. (A) The protein expression ratios in female g luteus med ius microsomal vesicles. (B) The protein expression ratios in female gluteus minimus microsomal vesic les. (C) The protein expression 
ratios in fema le vastus medialis microsomal ves icl es. (D) The protein express ion ratios in male gluteus minimus microsomal ves icles. (E) The protein expression ratios in male vastus mediali s 
microso mal vesicles. 
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5.4.1.2.2 Correlations 
To further investigate the effect of age on the expression leve ls of RyR1 , a 15, ~ Ia• FKBP 12 as 
we ll as the expression rati os of a 1/ RyR 1, a, cfRyRl and FKBP 12/RyR 1, the average dens ity for 
each protein was plotted against the age of their respective donors. In each case. the data from 
the three different muscles was first combined and the correlated with age, after which the data 
for each muscle was correlated separately with age as well. No significant correlation w ith age 
was found either in the combined data or separated data for RyRl (Figure 5.10), DHPR a 15 
(Figure 5.11 ), DHPR ~ Ia (Figure 5.12) of FKBP12 (Figure 5.13). There was also no 
significant correlation with age in the combined or separated 1nuscle data for the a 1/ RyR1 
(Figure 5.14), a 1/ RyR (Figure 5.15) or FKBP12/RyRl (Figure 5.16) expression ratios. 
148 
A 
3.5 
C: 
ai 3 
t5 
... 
c. 2.5 
"' ~ 2 
' .-1 ~ 1.5 
a: 
~ 1 
~ 
C1I ~ 0.5 
0 
C 
3.5 
C: 
ai 3 
t5 
... 
c. 2.5 
~ 2 
' .-1 a: > 1.5 
a: 
~ 1 
~ 
C1I ~ 0 .5 
0 
RyRl vs. age in muscle homogenate {combined data} 
♦ 
♦ 
♦ 
♦ •• ♦ ♦ ♦ 
--------:!--~~-•---•+-!------~ ♦ ~t ♦ •• ♦♦ ♦ ♦♦ 
r ++ ••• ♦ 
N.S. 
40 so 60 70 80 90 
Age (yr) 
RyRl vs. age in gluteus minimus homogenate 
♦ ♦ ♦ · ♦ N.S . 
I 
-----.--~---i------t--♦-----~--♦ ♦ ••• ♦ ••• ♦ 
40 so 60 70 80 90 
Age (yr) 
B 
3.5 
C: 
C1I 3 
0 
... 
c. 2.5 
, 
2 2 
' .-1 ~ 1.5 
a: 
~ 1 
"' ... C1I 
~ 0 .5 
RyRl vs. age in gluteus medius homogenate 
N.S . 
♦ 
♦ ""--------------♦---------
0 -'--------------------------------
40 
D 
3 .5 
C: 
ai 3 
0 
... 
c. 2.5 
, 
2 2 -
' .-1 ~ 1.5 -
a: 
C1I 
?a° 1 
... 
C1I 
~ 0 .5 
0 
40 
so 60 70 80 
Age (yr) 
RyRl vs. age in vastus medialis homogenate 
♦ 
♦ 
♦ N.S. ♦ ~~--
,.,.-- ... --- ♦ 
► ------♦ --♦ ♦ ♦ 
♦ 
♦ 
•• 
so 60 70 80 
Age (yr) 
Chapter 5 
90 
90 
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Figure 5.14: The co rrelati on between the DHPR a 15 /RyRl express ion ratio and the age of the human donors. (A) DHPR a 15 /RyRl expression rati o in microsomal ves icles plotted against age with the 
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Figure 5.16: The correlat ion between the FKBP 12 /RyRl express ion ratio and the age of the human donors. (A) FKBP12 /RyRl expression ratio in microsomal vesicles plotted against age with the 
data of all three muscles combined. (H) FKBP12 /RyRI expression ratio plotted against age in gluteus medius in microsomal vesicles. (C) FKBP12 /RyRl expression ratio plotted against age in 
gluteus minimus microsomal vesicles. (D) FKBP12 /RyRl expression ratio plotted against age in vastus medialis microsomal vesicles. (Dashed line indicates no sign ificant correlation and is also 
indicated by N .S, R - correlation coefficient) . 
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5.4.1.3 The effect of gender on protein expression levels 
In order to investigate whether the donor ' s gender influenced the protein expression levels and 
ratios of the proteins under investigation, the donors were grouped into male and female bins 
and the mean density (Tables 5.2 and 5.3) for each protein compared . 
When the data obtained from the muscle homogenates of all three muscles were combined 
there was a significantly greater expression (P~0.05) of RyRl , a 15 and 0ia in male donors than in 
female donors with no difference in FKBP 12 expression (Figure 5.17 A). The data from each 
muscle was then c01npared separately. In the muscle homogenates from gluteus medius muscle 
there was a significantly lower expression of 01a (P~0.05) in the male donors compared to the 
female . There was, however, no difference in the RyRl , a 1a and FKBP12 expression levels 
between male and female donors (Figure 5.17B). The gluteus 1nini1nus 1nuscle homogenate 
showed a significantly higher expression level of 01a (P~0.05) in male donors compared to 
female, again with no difference in RyRl, a 1a or FKBP12 expression levels between the genders 
(Figure 5.l 7C). The muscle homogenate from vastus medialis showed no significant 
difference between male and female donors in any of the protein expression levels investigated 
(Figure 5.17D). 
In the combined muscle data from the microsomal vesicles there was a significantly larger 
a 1afRyR1 expression ratio (P~0.05) in male donors than female donors with no difference in the 
alc/RyRl or FKBP12/RyR1 ratios (Figure 5.18A). When the data for each 1nuscle was 
compared separately, the microsomal vesicles from gluteus medius muscle showed a 
significantly smaller FKBP12/RyR1 ratio (P~0.05) in male donors compared to female donors. 
No difference was observed in the a 1/ RyR1 or a 1cfRyR1 ratios (Figure 5.18B). The gluteus 
minimus microsomal vesicles showed a significantly greater a 1/ RyRl ratio in male donors 
(P~0.05) but no difference in the a 1J RyRl or FKBP12/RyRl ratios (Figure 5.18C). And 
finally, the microsomal vesicles of the vastus medialis donors showed a significantly lower 
alc/RyRl ratio in male donors with no difference in a 1/ RyR1 or FKBP12/RyR1 ratios (Figure 
5.18D) . 
156 
A 
2.5 
C: 
·a:; 
+-~ 2 
c.. 
"' 0 
+- 1.5 
........ 
~ 
-~ 1 
QJ 
"C 
QJ 
~ 0.5 
... 
QJ 
:::, 
<( 
0 
The effect of gender on protein expression in muscle 
homogenate (combined data) 
* * 
RyRl a l s ~l a FKBP12 
* Significantly different from fema le (P:50.05) 
C The effect of gender on protein expression in human gluteus minimus homogenate 
C: 
QJ 
2.5 l 
0 
... 2.0 
c.. 
~ 
+- 1.5 
........ 
~ 
-~ 1.0 
QJ 
"C 
QJ 
~ 0 .5 
... 
QJ 
:::, 
<( 
0 .0 
* 
RyRl als 131a FKBP12 
■ fema le 
■ ma le 
■ fema l e 
■ ma le 
B 
2.5 
C: 
QJ 
0 -
... 2.0 
c.. 
~ 
+- 1.5 
........ 
~ 
'iii 
~ 1.0 
"C 
QJ 
b.l) 
~ 0 .5 -
QJ 
:::, 
<( 
D 
C: 
QJ 
0.0 
2.5 
~ 2.0 -
c.. 
"' 0 
+- 1.5 
........ 
~ 
"iii 
~ 1.0 
"C 
QJ 
b.l) 
~ 0 .5 -
QJ 
:::, 
<( 
0.0 
The effect of gender on protein expression in human 
gluteus medius homogenate 
RyRl a l s ~la FKB P12 
The effect of gender on protein expression in human 
vastus medialis homogenate 
RyRl als ~la FKBP12 
Chapter 5 
■ female 
■ male 
■ female 
■ male 
Figure 5.17: A compari son of express ion leve ls of RyRl , DI-IPR a ,s, DI-IPR ~I a and FKBP12 in muscle homogenate of female and male human donors. (A) The protein express ion levels in muscle 
homogenate where data fro m all three n,usc les were combined. (B) The protein expression levels in gluteus medius muscle homogenate. (C) The protein express ion levels in glu teus minimus muscle 
homogenate. (D) The prote in express ion leve ls in vastus medi ali s muscle homogenate. 
157 
A 
1.4 
1.2 I 
~ 1.0 
·;;; 
C 
~ 0.8 
Cl) 
bO ~ 0 .6 I 
Cl) 
::, 
<! 0.4 I 
0.2 
0 .0 .1 
The effect of gender on protein expression in human 
muscle microsomal vesicles {combined) 
* 
als/RyRl alc/RyRl FKB P12/RyR 1 
* Significantly different from female (P~0.05) 
C 
1.4 
1 .2 I 
~ 1.0 I 
·v; 
C 
~ 0.8 
Cl) 
bO ~ 0 .6 
Cl) 
::, 
<! 0.4 
0.2 
0.0 
The effect of gender on protein expression in human 
gluteus minimus microsomal vesicles 
* 
als/RyRl alc/RyRl FKBP12/RyR1 
■ female 
■ male 
■ female 
■ male 
B 
1.4 
1.2 I 
~ 1.0 7 
·;;; 
C ~ o.8 1 
~ 0.6 i 
Cl) 
:::, 
<! 0.4 -I 
0.2 
The effect of gender on protein expression in human 
gluteus medius microsomal vesicles 
- -
~ 
-
I 
0.0 .1___ 
D 
1.4 7 
1.2 
~ 1.0 -· 
'iii 
C: 
GJ O 8 ~ 
"C . 
Cl) 
~ 0 .6 
... 
Cl) 
:::, 
<! 0 .4 I 
0 .2 1 
0.0 
als/RyRl alc/RyRl FKB P1 2/RyR 1 
The effect of gender on protein expression in human 
vastus medialis microsomal vesicles 
als/RyRl alc/RyRl FKB P12/RyR 1 
Chapter 5 
■ female 
■ male 
■ female 
■ male 
Figure 5.18: A comparison of DHPR a 15 / R..yR I. DHPR a, c / RyR I and FKBP 12 / RyR I expression ratios in microsomal ves icles prepared from muscle of female and male human donors. (A) The protein express ion ratios in microsomal ves icles where data from all three muscles were co mbined . (B) The protein exp ression ratios in gluteus medius microsomal vesicles. (C) The protein exp ression ratios in gluteus minimus microsomal vesicles . (D) The protein expression ratios in vastus mediali s mi crosomal vesicles. 
158 
Chapter 5 
The data for each muscle was then further grouped according to the age of the donors into <60yr 
or 2::60yr old (Tables 5.2 and 5.3). As the single gluteus medius male donor was >60yr, only 
the 2::60yr donors were considered for this muscle. A significantly lower level of a 15 and ~l a 
expression was observed in the male donor compared to the female donors (P$0.05). No 
difference was observed in RyRl or FKBP12 expression levels (Figure 5.19A). The muscle 
homogenate from gluteus minimus donors <60yr showed a significantly greater RyRl and ~l a 
expression level in male donors c01npared to female (P$0.05) with no significant difference in 
a 15 or FKBP12 levels (Figure 5.19B). The 2::60yr gluteus minimus muscle homogenate showed 
no significant difference between male and female donors in any of the protein expression levels 
investigated (Figure 5.19C). The muscle homogenate from vastus medialis donors <60yr 
showed a significantly greater a15 expression level (P$0.05) in male donors with no difference in 
RyRl , ~la or FKBP12 levels (Figure 5.19D). However, there was no significant difference in 
expression levels between 2::60yr female and male vastus medialis donors for any of the proteins 
investigated (Figure 5.19E). 
When the microsomal immunoblot data from each muscle was similarly grouped into age 
groups to compare the expression ratios in male and female donors of each age group, the 2::60yr 
gluteus medius group showed a significantly larger a 1J RyRl ratio in the male donor compared 
to the female donors (P$0.05) and no significant difference in the a 1/ RyRl or FKBP12/RyRl 
ratios (Figure 5.20A). The microsomal vesicles from <60yr gluteus minimus donors showed no 
difference between male and female donors in any of the expression ratios investigated (Figure 
5.20B), however the 2::60yr group showed significantly larger a1/ RyRl and FKBP12/RyRl 
ratios (P$0.05) with no difference in the a1J RyRl ratio (Figure 5.20C). Finally, a significantly 
smaller a 1/ RyRl expression ratio was observed in male vastus medialis microsomal vesicles 
from <60yr donors (P$0.05) with no difference in a1/ RyRl or FKBP12/RyRl ratios (Figure 
5.20D). There was also no difference in any of the expression ratios investigated in 2::60yr 
vastus medialis donors (Figure 5.20E). 
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Figure 5.20: A compari son of D I-I PR a 1s / RyR I , DI-IPR a 1c I RyR I and FKBP 12 / RyR I expression rat ios in microsomal vesic les prepared from muscle of <60yr and ~60
yr male and female human 
donors. (A) T he prote in expression rat ios in ~60yr gluteus medius microsomal ves icles. (B) The prote in express ion rat ios in <60yr gluteus minimus microsomal vesic les. (C) The prote in expression 
ratios in ~60yr gluteus min imus mi crosomal ves icles. (D) The protei n express ion rat ios in <60yr vastus medial is microsomal ves icles. (E) The prote in expression ratios in ~60yr vastus medial is 
microsomal ves icles. 
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5.4.1.4 Protein expression levels and ratios in the different human muscles 
The mean expression leve l of RyR 1, DHPR a1 s, DHPR Pia and FKBP 12 for each musc le was 
detennined (Table 5.2) as well as the mean expression ratio of a 1/ RyR1 , a 1cfRyR1 and 
FKBP 12/RyR 1 (Table 5.3). The means for each muscle were then compared (Figure 5.21A-
B). 
RyRl and a 15 expression in vastus medial is were significantly greater (P~0.01) compared to 
their express ion in gluteus medius and gluteus 1ninimus. There was no difference in RyRl 
expression between gluteus medius and gluteus minimus muscle homogenates, however, 
gluteus minimus muscle homogenates showed a significantly larger a 15 expression level than 
gluteus medius. There was also no significant difference in the mean expression of Pia or 
FKBP12 between the three muscles (Figure 5.21A). 
There was no significant difference between the mean a 1/ RyRl ratio between the muscles, . 
The a 1cfRyRl ratio was significantly larger (P~0.05) in vastus medial is microsomal vesicles 
than gluteus minimus, however, there was no significant difference between the ratio in gluteus 
medius and vastus medialis microso1nal vesicles. The FKBP12/RyRl expression ratio was 
significantly smaller (P~0.05) in vastus 1nedialis microsomal vesicles compared to gluteus 
rninimus. No significant difference was observed between gluteus medius and gluteus minim us, 
neither between gluteus medius and vastus medialis (Figure 5.21B). 
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5.4.1.5 The effect of fiber type on protein expression levels 
Because the mean expression level of RyR 1 and a 15 were higher in vastus medial is compared to 
the gluteal musc les, and vastus medial is muscles have a greater percentage type 2 fibers, the 
average density of each protein was correlated with the average percentage of type l, 2A and 
2X fibers in the muscle for each respective donor. 
The RyRl expression showed a significant negative correlation (R=-0.442, P~0.0 1) with the 
percentage type 1 fibers in the muscle from the respective donors (Figure 5.22A) with an 
accompanying significant positive correlation between RyRl expression and percentage of type 
2X fibers (R=0.521, P~0.01) (Figure 5.22C). No significant correlation was observed between 
RyRl expression level and the percentage type 2A fibers in the respective muscle (Figure 
5.22B). 
DHPR a 15 expression levels also showed a significant negative correlation with the percentage 
type 1 fibers in the respective muscle (R=-0.325 , P~0.05) (Figure 5.23A) and a significant 
positive correlation with the percentage type 2X fibers in the respective muscle (R=0.382, 
P~0 .05) (Figure 5.23C). No significant correlation was observed between a 15 expression level 
and the percentage type 2A fibers of the respective muscle (Figure 5.23B). 
No significant correlation between DHPR ~I a expression and fiber type was found (Figure 5.24 
A-C). There was also no significant correlation between FKBP 12 expression (Figure 5.25), or 
the als/RyRl (Figure 5.26), alc/RyRl (Figure 5.27) or FKBP12/RyR1 (Figure 5.28) ratios 
and fiber type. 
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Figure 5.24: The corre lation between DHPR ~la express ion leve ls and the fiber type of the human donor muscle. (A) DHPR ~l a express ion levels plotted against the percentage type 1 fibers in the 
respective muscle. (B) DHPR ~l a express ion leve ls plotted against the percentage type 2A muscle fibers in the respective muscle. (C) DHPR ~l a expression levels plotted against the percentage type 2X 
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Figure 5.26: The correlat ion between a 1/ RyR I ex press ion rat io and the fiber type of the human donor muscle. (A) DHPR a 1/ RyR 1 expression ratio plotted against the percentage type 1 fibers in the 
respective muscle. (8 ) DHPR a 1/ RyR 1 express ion ratio plotted against the percentage type 2A muscle fibers in the respective muscle. (C) Df-IPR a 1/ RyR 1 expression ratio plotted against the 
percentage type 2X fibers in the respective musc le. (Dashed line indicates no significant correlat ion and is also indicated by N.S, R - correlation coefficient). 
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Figure 5.27: The corre lation between a 1/ RyR I expression ratio and the fiber type of th e human donor muscl e. (A) DHPR a 1/ RyR I express ion rati o plotted agai nst the percentage type I fi bers in th e 
respec ti ve musc le. (8 ) DHPR a 1/ RyR I ex press ion rati o plotted against th e percentage type 2A muscle fibers in th e respecti ve muscle. (C) DHPR a 1/ RyR I express ion rati o pl otted aga inst the percentage type 2X fi bers in the respecti ve musc le. (Dashed line ind icates no signifi cant co rrelation and is also indicated by N.S , R - co rrelation coeffic ient). 
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Figure 5.28: The correlat ion between FKBP 12/RyR 1 expression ratio and the fiber type of the human donor muscle. (A) FKBP 12/RyR 1 express ion rat io plotted against the percentage type 1 fibers in 
the respective muscle. (B) FKBP 12/RyR I express ion ratio plotted against the percentage type 2A musc le fibers in the respective muscle. (C) FKBP 12/RyR I expression ratio plotted against the 
percentage type 2X fibers in the respective muscle. (Dashed line indicates no signifi cant correlat ion and is also indicated by N.S, R - correlat ion coefficient). 
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5.4.2 Rat muscle 
5.4.2.1 Densitometry results 
Rat muscles were examined as a positive contro l due to the variabi li ty observed in the human 
data . The average density of the protein bands obtained from muscle homogenate immunoblots 
relative to total protein were determined for each muscle of the two rat age groups. The results 
are given in Table 5.4 . The average density of the protein bands relative to RyRl determined 
in microsomal vesicles for each muscle from the two rat age groups were also determined and 
the results are given in Table 5.5. 
Table 5.3: The average density of the protein bands relative to total protein in rat soleus and 
EDL muscle homogenate from 5wk and lyr old rats. (sem - standard error of the 
mean, n - number of observations, * significantly different from Swk o ld of same 
le P<0.05, # significantly different from Sol of sa1ne age group P<0.05} 
-
RyRl DHPR a 1s DHPR '31a FKBP12 
n mean +sem mean ±sem mean ±sem mean ±sem 
Swk Sole us 12 0.59 0 .05 0.38 0.07 0.91 0.04 1.21 0 .09 
EDL 12 1.23# 0.05 0.93# 0.13 0 .67# 0.03 1.23 0.11 
Soleus 12 0 .68 0 .05 0.77* 0 .07 0.64* 0.07 1.09 0 .08 lyr 
EDL 12 1.40# 0.07 1.89*# 0.12 0 .38*# 0.05 0 .87* 0 .06 
Table 5.4: The average density of the protein bands relative to that of Ry RI in microsomal 
vesic les from rat soleus and EDL muscle obtained from 5k and 1 yr old rats. (sem -
standard error of the mean, n - number of observations, * s ignificantly different from 
5wk old of same muscle P<0.05 , # significantly different from Sol of same age group 
P<0.05). 
DHPR a 1s/ RyRl DHPR a 1c/ RyRl FKBP12/RyR1 
mean ±sem n mean ±sem n mean ±sem n 
Swk Sole us 0.84 0 .14 12 0 .05 0 .02 6 0 .72 0 .26 12 
EDL 1.33# 0.07 12 0.32 0 .67 6 0 .12 0 .06 12 
Soleus 2.25* 0 .36 12 0 .14* 0 .03 12 0.36 0 .05 12 lyr 
1.67* 0.35# 0.47* EDL 0 .07 12 0.04 12 0.03 12 
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The expression level of the DHPR a 1s subunit was correlated with the expression levels of RyRl 
in the rat muscle homogenate to validate the results obtained from the immunoblots (Figure 
5.29A). The data obtained from the two age groups as well as the two muscles types were 
combined in this correlation. The DHPR ~l a subunit was also correlated with RyRl expression 
in a similar fashion (Figure 5.29B) and then the expression levels of the two DHPR subunits 
were correlated (Figure 5.29C). There was a significant positive correlation (P<0.01) between 
the DHPR a 1s density and that of the RyRl with a correlation coefficient of 0.710. The DHPR 
~l a subunit density showed a significant negative correlation (P<0.01) with that of the RyRl 
(R = -0.395). The two DHPR subunits also showed a significant (P<0.01) negative correlation 
with R = -0.420. 
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Figure 5.29: The correlation between the expression leve ls of the DHPR subunits and RyR I in the rat muscle homogenates. (A) DHPR a 15 subunit expression levels plotted against that of the R vR I. (B 
DHPR P,a subunit expression leve ls plotted against that of the RyR I. (C) DHPR Pia subunit ex pression leve ls plotted against that of the a 15 subunit. 
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5.4.2.2 The effect of age on protein expression levels 
In order to investigate the change in protein expression with the age of the rat, the average 
expression levels of RyRl , DHPR a 15, DHPR ~la and FKBP12 in rat muscle homogenate as well 
as the a 1/ RyRl , a 1/ RyRl and FKBP12/RyRl ratios in microsomal vesicles were compared 
between the Swk old and lyr old rats. 
In the muscle homogenate from soleus, a significantly greater a 15 expression was observed in 
the lyr old rats (P~0 .05). However, the ~la expression was significantly lower in the lyr old 
rats (P~0.05) . No significant age difference was found in RyRl or FKBP12 expression (Figure 
5.30A). When the protein levels between the rat age groups were compared in EDL, a 
significantly greater a 15 expression was observed in lyr old rats (P~0.05). The ~la and FKBP12 
expression levels, however, where significantly lower (P~0.05) in lyr old rats. No significant 
difference between Swk and lyr old rats RyRl expression was found in EDL muscle (Figure 
5.30B). 
The soleus microsomal vesicles showed a significantly larger a 1/ RyRl and a 1/ RyRl ratios in 
lyr old rats compared to the Swk old rats (P~0.05 ) but no significant difference in FKBP12 
expression (Figure 5.30C). In EDL microsomal vesicles, there was a significantly larger 
a 1/ RyRl expression ratio in lyr old rats but a significantly lower FKBP12/RyRl ratio 
compared to Swk old rats (P~0.05). No difference was found in the a 1c/RyR1 eratio (Figure 
5.30D). 
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5.4.2.3 The effect of muscle type on protein expression levels 
In order to investigate differences in protein expression as a result of the rat muscle used, the 
average levels of RyRl , DHPR a 1s, DHPR ~l a and FKBP12 in rat muscle homogenate as well as 
the a 1/ RyRl , a 1/ RyRl and FKBP12/RyRl ratios in microsomal vesicles were compared 
between the Swk old rat soleus and EDL muscle as well as the lyr old rat soleus and EDL 
muscle. 
The Swk old rat EDL muscle homogenate showed significantly greater RyRl and a 1s expression 
compared to the soleus muscle (P~0.05). The ~l a expression was significantly lower in EDL 
muscle homogenate compared to soleus in Swk old rats. No difference in FKBP12 expression 
was observed (Figure 5.31A). In lyr old rat muscle homogenate, similar results were observed. 
RyRl and a 15 expression were significantly higher in EDL (P~0.05), ~la expression 
significantly lower (P~0.05) and there was no difference in FKBP12 expression (Figure 5.31B). 
Comparing the soleus and EDL microsomal vesicle data in Swk rats showed a significantly 
larger a 15/RyRl expression ratio in EDL muscle (P~0 .05) with no difference in the a1c/RyRl or 
FKBP12/RyRl ratios (Figure5.31C). In lyr old rats, there was a significantly larger a 1c/RyRl 
expression ratio in EDL (P~0.05) with no difference in a 15/RyRl or FKBP12/RyRl ratios 
(Figure 5.31D). 
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5.5 Discussion 
5.5.1 Human muscle 
5.5.1.1 Muscle samples 
Chapter 5 
Obtaining samples is a limiting factor to any study involving humans. In the work described in 
this chapter, all the possible human samples that became available in the allotted time frame 
were collected without a filtering system. In total 40 muscle samples were collected, however, 
they were sourced from three different muscles with the donor cohort consisting of males and 
females. The sample number for each muscle was not ideal, especially the gluteus medius 
muscle which were donated by only five individuals, one of which was male. Due to the nature 
of the sample collection, which was during hip and knee replacements, the age of the donors are 
also skewed towards older people, the youngest sample being from a 45yr old. There are 
therefore no donors in the 20-30 year age range which is normally considered to be the control 
age group for studies involving aged muscle. However, as most of the changes in muscle 
associated with age seem to occur after the 6th decade (Vandervoort and McComas 1986; Lindle 
et al. 1997; Rantanen et al. 1998; Deschenes 2004), the donors younger than 60yr were 
considered as the control group. 
5.5.1.2 Correlations between RyR1, DHPR a1s and DHPR /31a 
The expression levels ofRyRl , a 15 and ~ la in human muscle homogenate (measured as the 
average density of the protein bands obtained with immunoblots nonpalised to total protein) 
were correlated with each other. The significant positive correlation between a 15 and RyRl 
expression (R= 0.889) is consistent with a close association between the DHPR and RyRl in the 
skeletal muscle CRUs. In fact most of the DHPR is found in the junctional t-tubules (Yuan et 
al. 1991 ; Carl et al. 1995b; Jorgensen 1998), which would imply that the a 15 and RyRl 
expression levels should correlate positively. When the correlation coefficient is squared to 
obtain the coefficient of determination (R2) , a value of 0.79 is obtained which indicates a strong 
correlation in expression between these two proteins. 
The significant positive correlation (R=0.435) between ~ la and RyRl is also to be expected as 
the ~la subunit forms part of the DHPR that is closely associated with the RyRl. However, 
what is surprising is that the correlation is not as strong. The R2 for this correlation is 0.19 
which indicates a moderate correlation. Therefore the variance in the RyRl expression level 
can only account for 19% of the variance in ~ la expression level whereas it could account for 
79% of the variance of the a 15 expression level. 
The significant positive correlation between the two DHPR subunits (R=0 .542) is also to be 
expected as they form part of the complete DHPR subunit complex. Again the strength of the 
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corre latio n is interesting as one wou ld a lso expect it to be as strong as that of the RyR 1 and a. 15. 
However, the R2 va lue fo r this corre lati on is 0.29 and although statistically this indi cates a 
strong corre lation, only 29% of the variance in 01a expression can be accounted for by the 
variance in a. 15 and might indicate that there is a cohort of 0ia not associated with a.15 in the 
musc le homogenate. This is also consistent with the observation that the 01a subunit is lost 
during the first centrifugation step in the preparation of microsomal vesicles, although the 
imidazole in the homogenizing buffer could also cause a dissociation of the 0ia subunit from the 
a. 15 subun it. Witcher et al (Witcher et al. 1995) described the presence of non-assoc iated 0ia 
subun its in ske letal muscle ho1nogenate which is consistent with the lower than expected 
correlation between a. 15 and 01a subunits in muscle homogenate described in this chapter. 
5.5.1.3 Effect of age on protein expression levels and ratios 
5.5.1.3.1 RyR1 
The general pattern emerging when the RyRl expression levels between the <60yr and >60yr 
age groups are compared is that there is no difference in its expression between these age 
groups. There are three exceptions to this. The first is in gluteus medius homogenate where a 
significantly larger RyRl expression level was observed in the >60yr age group (Figure 5.6B) . 
However, as the sample size for this 1nuscle in particular is very small (n=2 for <60yr and n=3 
for >60yr) caution should be applied when interpreting this data. Secondly, when the n1ale and 
female 1nuscle donors are considered separately, the female gluteus medius shows the same 
larger RyRl expression level in the >60yr age group as when the genders were combined 
(Figure5.8B). As only one of the 5 gluteus rriedius donors were male, the Ry RI expression 
leve ls for the combined gender gluteus medius and the female only gluteus medius musc le 
homogenate are essentially the same result and again reflect the small sample size. 
T hirdly, male gluteus minimus 111uscle homogenate showed a significantly lower RyR 1 
expression leve l in the >60yr age group (Figure 5.8D). However, the male gluteus minimus 
group was the only human musc le group that showed this result and therefore an exception to 
the general RyR 1 express ion pattern observed in most of the 111usc le homogenate data. 
When RyR 1 express ion leve ls were plotted over the entire range of ages. the correlation w ith 
the age of the respective donors confirms the general pattern observed when the mean valu es for 
the age groups were compared . There was no signifi cant correlation between RyRl express ion 
and the age of the respective donors when the data from all the musc le combined were 
cons idered . There was also no significant correlat ion when the data from the three muscles 
were considered separately. Even the g luteus medius, w hich showed a signifi cantly higher 
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RyRl expression in the >60yr age group when comparing the means of the age groups, showed 
no significant correlation between RyRl expression and age. 
These results together suggest that in human muscle, there is no change in RyRl expression 
with age, which is consistent with previous [3H]ryanodine binding and immunoblot studies 
showing no change in RyRl expression in aged rats (Damiani et al. 1996; Margreth et al. 1999; 
O'Connell et al. 2008). 
5.5.1.3.2 DHPR a1s 
As with RyRl expression discussed above, the general pattern emerging when comparing the 
mean a.15 expression level in <60yr and >60yr donors is that there is no difference in the 
expression of a.15 between the age groups. In this case there are two exceptions to the general 
pattern. 
Firstly, muscle homogenate from vastus medialis showed a significantly larger a.15 expression 
level in the >60yr age group (Figure 5.6D). When the male and female data for this muscle is 
separated, the significance of the difference is lost (Figure 5.8C&E) although there are trends 
in both cases towards a higher expression level in the older age group. It seems that combining 
the data from the two genders provided a large enough observation number to make the 
difference significant. The higher a.15 expression is similar to the higher RyRl expression in 
older vastus medialis (above). However, the larger expression level observed in the older age 
-
group is in contrast to all previous studies regarding a.15 expression which have shown a 
decrease in a.15 expression if a change was observed at all (Delbono et al. 1995; Renganathan et 
al. 1997; Renganathan et al. 1998; Ryan et al. 2000; Wang et al. 2000; Ryan et al. 2003 ; 
O'Connell et al. 2008). It is also difficult to explain the higher a.15 expression in terms of the 
structural changes that aging muscle undergoes with age as if anything, there are less CRU s in 
aging muscle and the t-tubular network is less orderly structured (Boncompagni et al. 2006). As 
there were only 4 vastus medialis donors younger than 60yr, the higher expression seen in the 
older age group could be attributed again to insufficient sampling. 
Secondly, when the mean expression level of a.15 was compared between the age groups in 
males and females separately, a significantly greater expression of a.15 was also observed in the 
female gluteus medius muscle homogenate (Figure 5.8A). However, the addition of the data 
from the single male gluteus medius donor removes the significance of the difference observed 
in the female gluteus medius alone (Figure 5.6B). This suggests that the small sample size of 
the gluteus medius muscle cohort may be causing this anomalous result. 
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When a 15 expression was plotted over the entire range of ages, the correlation of a 15 expression 
with the age of the respective donors is consistent with the general pattern observed when the 
means of the age groups were compared. No significant correlation was found between a 15 
expression and the age of the respective donors when the data from all three muscles were 
combined or correlated separately (Figure 5.11). Specifically, the vastus medial is muscle 
homogenate that showed a significantly larger a 15 expression in >60yr age group compared to 
the <60yr age group, showed no significant correlation with age. 
These results together suggest that in human muscle, there is no change in DHPR a 15 expression 
in aging muscle, which is consistent with the study by Ryan et al (Ryan et al. 2003). 
5.5.1.3.3 The a1s/RyR1 ratio 
The principal underlying the EC uncoupling hypothesis of reduced muscle strength in aging 
muscle is the ratio of the DHPR a 15 subunit to RyRl that is reduced in aging muscle, leading to 
an increased number ofRyRls not associated with DHPR and an " uncoupling" between the 
voltage sensor and Ca2+ release channel of EC coupling (Payne and Delbono 2004 ). 
The investigation into the a 1/ RyR1 expression ratio in microsomal vesicles prepared from 
human muscle described in this chapter showed a lower a 1/ RyR1 expression in the >60yr age 
group when the data from all three muscles are con1bined (Figure 5.7 A). However, when the 
data from the three muscles are considered separately, there is no significant difference between 
the two age groups, although a trend towards a lower mean in the >60 age group is observed 
(Figure 5.7B-D). Similarly when the data from the male and female donors of each muscle is 
considered separately, a trend towards a lower mean in the >60yr age group is observed in all 
the groups except the male gluteus minim us. These results together may once again suggest 
that only when the data from all the donors are combined, the observation number is large 
enough to 1nake the difference between the means of the two age groups significant. 
However, when the a 1/ RyR 1 expression ratio is plotted against the age of each donor, there is 
no s ignificant correlation between this ratio and age in the combined data from all three muscles 
(Figure 5.14A) , or in the muscles separately (Figure 5.14B-D). It may well be that an increased 
samples size may lead to a significant correlation, but this is speculation . Together with the 
results from mu scle homogenates showing no change in RyR l or a 15 expression with age, the 
microsomal ves icle data suggest that there is no change in the a 1/ RyR 1 expression ratio with 
age in human muscle . This confirms the suggestion that the reduced muscle strength observed 
in ag ing human muscle may be more a case of altered structure and arrangement of the EC 
couplin g apparatu s than the express ion of the protein. 
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5.5.1.3.4 The a1c/RyR1 ratio 
The cardiac DHPR a 1c subunit has been shown to be expressed in adult rat soleus, EDL and 
diaphragm of rats and developing muscle from mice (Chaudhari and Beam 1993 ; Pereon et al. 
1997; Pereon et al. 1998). The work described in this chapter also shows for the first time 
cardiac DHPR expression in adult human skeletal muscle. The DHPR a 1J RyR1 ratio did not 
seem to change with age as the general pattern observed in results from microsomal vesicle 
immunoblots shows no significant difference between the <60 yr and >60yr age groups of 
human donors. This is the case when the data from all three muscles are combined (Figure 
5. 7 A), when the data from the muscles are considered separately (Figure 5. 7B-D) as well as 
when the male and female donor data for each muscle is considered separately (Figure 5.9). 
There are two exceptions to this general pattern. The first is a significantly lower a 1J RyR1 ratio 
in the >60yr age group of gluteus minimus microsomal vesicles (Figure 5.7C). The second is a 
significantly larger a1J RyR1 ratio in the >60yr age group in male vastus medialis vesicles 
(Figure 5.9E). In both cases there is no apparent explanation for the significant differences. 
The fact that there was no significant correlation between the a1J RyR1 and the age of the 
respective donors in either the combined muscle data or the data from the muscles considered 
separately suggests that the two exceptions discussed above might be due to the large variation 
observed between humans in combination with sample size and that generally the data suggests 
that there is no change in the a1J RyR1 ration with age in humans. 
5.5.1.3.5 DHPR (31a 
As with RyRl and a 1s expression discussed above, the ~la subunit expression shows a general 
pattern of no difference between the age groups of human donors (Figures 5.6 and 5.8) with 
one exception. The muscle homogenate from vastus medialis showed a larger ~I a expression in 
the >60yr age group (Figure 5.6D). When the female and male donors for this muscle are 
considered separately, the female muscle homogenate shows a similar significantly larger ~ la 
expression in the older age group (Figure 5.8C) and the although the male muscle homogenate 
showed no significant difference, there was a trend toward a higher expression in the older age 
group (Figure 5.8E). As the vastus medialis was the only muscle showing this increase in ~ Ia 
expression, and it contains higher percentage fast-twitch fibers , it may be that the increase in ~ la 
expression seen in this muscle with age is fiber type related. However, the study by Taylor et al 
(Taylor et al. 2009) showing an increase in ~ Ia expression with age in mice found the increase in 
expression less pronounced in tibialis anterior and EDL muscles which contain only fast twitch 
muscle. When ~l a expression was correlated with age in the work described in this thesis, there 
was no significant correlation found when the muscle data was combined (Figure 5.12A) or 
when the data from different muscles were correlated separately (Figure 5.12B-D). Even in the 
vastus medialis there was no significant correlation between age and ~ Ia expression (Figure 
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5.12D) . T hese results together suggest that in contrast to the results found in mice by Tay lor et 
al , there is no change in ~I a expression with age in humans. However, further invest igation into 
this matter involving larger sample sizes is warranted because the vastus medial is results 
indicate possible diffe rences between fiber types in ~ Ia expression with age. 
5.5.1.3.6 FKBP12 
FKBP 12 express ion in muscle homogenates shows a general pattern of increased express ion in 
the >60yr age group (Figure 5.6 and 5.8). The vastus 1nedialis musc le homogenate does not 
show a significant difference between the <60 and >60yr age groups, but there is a trend 
towards a larger FKBP12 expression in the older age group (Figure 5.6D). The standard error 
of the mean (se1n) is larger for this data set showing more variability in the data and may be 
why the difference is not significant. When the male and female donors are considered 
separate ly, there is again a loss in significance in the difference between the age groups in male 
gluteus minimus and male vastus 1nedialis donors (Figure 5.8D&E), but both these groups 
show a trend towards a larger FKBP12 expression and the small sample size in addition to the 
larger sem may be why the difference is not significant in these two groups. Interest ingly, 
FKBP12 inhibits the mTOR signalling pathway in muscle, which is involved in muscle growth 
(Kang et al. 2008 ; Schiaffino et al. 2013). An increased FKBP12 expression in aging 1nusc le 
1nay therefore contribute to the reduction in muscle mass observed in aging muscle . 
However, the when FKBP 12 expression is considered over the individual ages, in the combined 
muscle data as well as the data from the muscles considered individually, there is no significant 
correlation between FKBP 12 expression and age (Figure 5.13). Again thi s may be due to the 
variabi lity in the data. However, the significant differences in the average data suggest that the 
question merit further investigation with a larger sample size to determine the effect of aging on 
FKBP 12 expression. 
5.5.1.3.7 The FKBP12/RyR1 ratio 
Not all of the FKBP 12 present in muscle homogenate is associated with the RyR l as FKBP 12 is 
invo lved in various ce llular pathways (Kang et al. 2008). In an attempt to investigate the level 
of FKBP 12 assoc iated with RyR l , the leve l of FKBP l 2 expression in microsomal vesicles 
relative to the expression of RyR l in microsomal vesicles was investigated . As there is an 
increase in oxidation and S-nitrosylation of RyR l in aging musc le which cou ld lead to 
di ssoc iati on ofFKBPI2 from RyR l (Andersson et al. 2011), a decreased FKBPl2/RyRl ratio 
might be expected in ag ing mu scle. 
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When the average FKBP 12/RyRl expression ratio in human muscle microsomal vesicles were 
compared between <60yr aged donors and >60yr old donors, a general pattern of a smaller 
FKBP12/RyRl ratio in the older age group emerged. This was the case when the data from the 
three muscles were combined as well as considered separately (Figure 5.7). Separating the data 
from male and female donors for each muscle showed similar results when the <60yr old donors 
were compared with >60yr old donors (Figure 5.9). Although the microsomal vesicles from 
male gluteus minimus and male vastus 1nedialis showed no significant difference, the male 
vastus medialis data also showed a trend towards a lower FKBP12/RyR1 ratio in the older age 
group. These results are consistent with the hypothesis that there is less FKBP12 associated 
with RyRl in aging muscle. However, when the FKBP12/RyRl ratio was plotted against the 
age of the respective donors, no significant correlation was observed either in the co1nbined data 
from all three muscles or when the data fro1n each muscle was correlated separately (Figure 
5.16). However the significant differences between the average data for the two age groups 
again point towards a need for further investigation into this matter. 
5.5.1.4 Gender differences in protein expression levels and ratios 
The data obtained from the 1nuscle homogenate and microsomal vesicle immunoblots were also 
compared between 1nale and female donors to investigate whether there was a difference in 
protein expression between the genders. 
In the combined data from all three muscles, the male donor muscle homogenate showed a 
significantly larger RyRl , DHPR a 1s, and DHPR ~la expression level compared to the female 
muscle homogenates (Figure 5.17). However, when the data from the three muscles were 
considered separately, no significant difference was observed between male and fe1nale donors 
with the exception of the ~la subunit expression level in gluteus medius and gluteus minimus. 
In the gluteus medius muscle homogenate there was a significantly lower expression of ~l a in 
the male donor compared to the female donors (Figure 5.17B). Seeing that there is only one 
male donor of gluteus medius muscle, the sample size is not large enough for the differences in 
protein expression between male and female donors of gluteus medius to be significant. The 
gluteus minimus muscle homogenate showed the same significantly larger ~l a expression in 
1nale donors that was observed when the data from all three muscles were combined (Figure 
5.17C). 
When the data from each muscle were separated into <60yr old donors and >60yr old donors 
and the expression levels of the proteins compared between the male and female donors (Figure 
5.19), the sample sizes become too s1nall for most of the differences seen in the combine muscle 
data to be significant. Once again the gluteus medius sample size is too small to contribute 
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significantly to the question of whether there is a difference in male and female donor protein 
express ion. 
In comparing male and female donor expression ratios in microsomal vesicles, a significantly 
larger a 1/ RyR 1 ratio is observed in male donors when the data from all three muscles are 
combi ned (Figure 5.18A). When the muscles are considered separately, the gluteus minimus 
donor microsomal vesicles show a similar greater a 1/ RyRl ratio in male donors (Figure 5.18C) 
and although the difference isn ' t significant, the a 1/ RyRl ratio in male vastus medialis 
microsomal vesicles showed a trend towards a higher expression ratio (Figure 5.18D). Once 
more the gluteus medius muscle sainple size was too small to be included gender differences in 
protein expression in this muscle. When the data from the microsomal vesicles of each 1nuscle 
were grouped into <60yr and >60yr old donors and the expression ratios compared between 
male and fe1nale donors (Figure 5.21), the sample size of each group once more was too small 
to provide meaningful information. 
5.5.1 .. 5 Muscle differences in protein expression levels and ratios 
The average expression levels of each of the proteins investigated were compared between the 
three muscles to investigate whether the muscle source would have an effect on the observed 
expression level of each protein. This was done for the data obtained from muscle homogenates 
as well as microsomal vesicles. 
In the muscle homogenates, the vastus 1nedialis muscle exhibited a significantly greater RyR 1 
and al s expression level compared to the gluteal muscles (Figure 5.21A). Seeing that vastus 
medial is has a larger percentage fast-twitch fibers than slow-twitch, and that fast-twitch fibers 
generally have a larger and more developed SR and t-tubular network (Schiaffino and Reggiani 
2011 ), the larger RyRl and a 15 expression levels in vastus med ialis is probably due to the fiber 
type composition of the muscle . Interestingly, there was no difference in the ~l a expression 
levels between the muscles even though it forms part of the DHPR in the skeletal muscle CRU 
and is essential for the fonnation of tetrads. This is consistent with the lower than expected 
corre lati on between the a 15 and ~l a expression levels discussed in section 5 .3 .1.2. The fact that 
there is no significant difference in ~l a and FKBP 12 expression levels between the three muscles 
also suggests that the expression of these proteins are not fiber type dependent. 
In the microsomal vesic les, there was no significant difference in the a 1/ RyR] expression ratio 
between the three muscles (Figure 5.21B). The higher fast-twitch content in vastus medial is 
therefore did not show a larger a 1/ RyR 1 ratio compared to the gluteal mu sc les which have a 
higher slow-tvvitch content. This is in contrast to the Renganathan et al study on rat muscle 
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(Renganathan et al. 1997) in which they found a higher als/RyRl ratio in fast twitch muscle 
(EDL) compared to slow twitch muscle (soleus). 
The microsomal vesicles from vastus medialis did, however, show a significantly larger 
a 1cfRyR1 ratio and significantly lower FKBP12/RyR1 ratio compared to gluteus minimus 
(Figure 5.21B). This may also be attributed to the fiber type composition difference between 
the muscles. The effect of fiber type on protein expression will be discussed further in section 
5 .3 .1.6 below. 
5.5.1.6 The effect of fiber type distribution on protein expression levels and 
ratios 
In order to investigate whether the fiber type composition of the samples from the donors had an 
effect on the protein expression levels and ratios investigated, the average RyRl , DHPR a 15, 
DHPR Bl and FKBP12 expression level as well as the a 1/ RyR1 , a 1c/RyR1 and FKBP12/RyR1 
expression ratios for each donor sample were correlated to the percentage type 1, type 2A and 
type 2X fibers present in the sample. 
The significant positive correlation between the RyRl (R=0.521) and a 15 (R=0.382) expression 
levels and the percentage type 2X fibers in the muscle samples (Figures 5.22 and 5.23) is 
consistent with the suggestion that the greater expression of these two proteins seen in vastus 
medialis is related to fiber type composition. The lack of significant correlation with Bia and 
FKBP 12 expression levels and fiber type (Figures 5.24 and 5.25) is also consistent with the 
suggestion that the Bi a and FKBP12 expression levels are not related to fiber type. 
There was no significant correlation between the fiber type composition of the muscle samples 
and the a 15/RyR1 or FKBP12/RyR1 expression ratios in microsomal vesicles (Figures 5.26 and 
28). The significantly lower FKBP12/RyR1 ratio seen in vastus medialis compared to gluteus 
1ninimus therefore is not due to fiber type composition. However, there was a moderate 
significant positive correlation (R-0.316, R2=0.10) between the percentage type 2X fibers in the 
1nuscle samples and the a 1clRyR1 ratio (Figure 5.27), which indicates that the larger a 1cfRyR1 
ratio observed in vastus medialis microsomal vesicles compared to gluteus minimus may also be 
due to the fiber type composition of the muscle. This in contrast to a study by Pereon et al 
showing a less intense immunohistochemical a 1c response in rat EDL compared to soleus and 
diaphragm (Pereon et al. 1998). Fast-twitch muscle has a more developed t-tubular network 
than slow-twitch muscle and has more DHPR as a result. It may be that if a certain percentage 
of the DHPR present in muscle is of the cardiac type, it may result in the fast-tv1itch fibers 
having a larger level of a 1c present due it having more DHPR to begin with. 
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5.5.2 Rat muscle 
5.5.2.1 Muscle samples 
In the time constraints for the work described in this chapter, there was not time for rats to be 
maintained for sufficient time to fall into the senescent age group. The decision to use rats in 
thi s study was made in the light of the variability in the human data and was thus made in the 
latter stages of the study. As a result the rats used here only reached an age of about 1 yr, 
however other rats have been retained for a further 6 to 8 months and wi II be studied in the next 
year. The choice of 5wk old rats was made based on availability at the time. All the rats used 
in this study were male . 
The 5wk old rats are not adult rats and therefore represent a juvenile age group, whereas the 
lyear old rats would be consistent with middle aged hun1ans (Quinn 2005) and therefore 
represent an adult age group and not a senescent age group. 
5.5.2.2 Correlations between RyR1, DHPR a1s and DHPR P1a 
The expression levels ofRyRl , a 15 and ~l a in rat 1nuscle homogenate (indicated by the average 
density of the protein bands obtained with i1n1nunoblots normalised to total protein) were 
correlated with each other. 
As with human muscle h01nogenate, the expected strong significant positive correlation 
between the DHPR a 15 expression level and that of the RyRl (R=0.710, R2=0.50) was observed 
in rat muscle homogenate. However, the DHPR ~l a expression level showed a 
surprizingly1noderate significant negative correlation with the RyRI (R=-0.395 , R2=0. I 6) and 
DHPR a, 15 (R=-0.420, R2=0. l 8) expression levels. This indicates that the more a 15 is present in 
the muscle homogenate, the less ~l a is present and vice versa. Although this result is in contrast 
to the correlation found between the DHPR subunits in hrnnan muscle discussed in section 
5.3. 1.2, a study by Taylor et al showed a similar inverse relationship between a 15 and ~l a in mice 
(Tay lor et al. 2009). When the ~l a subunit was overexpressed, the a 15 expression decreased . 
C learly, the express ion of the DHPR subunits show different patterns in human s and rodents 
indi cating again that caution is required ·when extrapolating results obtained in rodents to 
humans. 
5.5.2.3 The effect of age on protein expression levels and ratios 
As th ere is no senescent age group in the rats the muscle was sourced from , thi s section will not 
be about the changes in prote in express ion w ithin ag ing muscle. However, the results show 
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differences in expression between juvenile rat muscle and "middle aged" adult rat muscle. The 
protein expression levels and ratios in soleus and EDL muscle homogenates and microsomal 
vesicles were compared between the 5wk and lyr old rats. 
There was no difference in RyRl expression levels between the age groups in either soleus or 
EDL but both muscles showed a trend towards a higher RyRl expression in lyr old rats. The 
a 15 expression level was significantly larger in the lyr old rats in both these muscles (Figure 
5.30A-B). The a1/ RyR1 expression ratio in the microsomal vesicles prepared from the soleus 
and EDL muscles also show a significantly larger ratio in lyr old rats compared to 5wk (Figure 
5.31A-B). The larger in a 15 expression in lyr old rats is probably due to the more developed t-
tubular network in adult muscle (Luff and Atwood 1971 ; Baldwin 1984; Takekura et al. 1994). 
Interestingly, the ~l a expression level in muscle homogenate from soleus and EDL muscle was 
significantly lower in lyr old rats compared to 5wk. This is in contrast with the findings of the 
study by Taylor et al that showed an increase in ~l a expression across the lifespan of mice 
(Taylor et al. 2009). The study does not investigate the a 15 expression in these mice over the 
same time period so it is not known whether the expression of the a 15 decreased as the ~l a 
expression increased across the lifespan of the mice. They do, however, show that the over 
expression of ~l a decreases a 15 expression in adult mice. The exact relationship between a 15 and 
~I a expression levels in different mammalian species remains unclear and suggests that there 
may be significant differences even among rodents. 
The FKBP12 expression levels remained unchanged in the soleus muscle between 5wk and lyr 
old rats (Figure 5.30A), however, FKBP12 expression was significantly lower in lyr old EDL 
muscle homogenate (Figure 5.30B). The implications of the lower FKBP12 expression in the 
adult EDL muscle remains unclear as FKBP 12 is involved in a number of cellular signalling 
pathways. The FKBP 12 associated with RyRl seems to be reduced as well as the 
FKBP12/RyR1 ratio in lyr old EDL is significantly lower than 5wk old EDL (Figure 5.31B) . 
Although there was no significant difference in the soleus FKBP12/RyR1 ratio between the age 
groups, there was a trend towards a lower ratio in the lyr old rats (Figure 5.31A). This may 
suggests that the RyRl in the lyr old rats are already more oxidized and S-nitrosylated than the 
RyRl in 5wk old rats causing a dissociation of some of the FKBP 12 from RyRl. 
5.5.2.4 Muscle differences in protein expression levels and ratios 
The protein expression levels and ratios in the 5wk and l yr old rats muscle homogenates and 
microsomal vesicles were compared between soleus and EDL. 
189 
Chapter 5 
As expected there were significantly larger levels of RyRl and a 15 in the EDL of both age 
groups compared to the soleus (Figure 5.30C-D). This is consistent with the larger and more 
developed SR and t-tubular network present in fast-twitch fibers compared to slow-twitch fibers 
(Flucher 1992; Schiaffino and Reggiani 2011). The Swk old rats showed a significantly larger 
a 1/ RyRl ratio in EDL muscle, but that difference is no longer present in the 1 yr old rats 
(Figure 5.31C-D). 
The higher level of a 1c present in EDL muscle of lyr old rats (Figure 5.31D) is in contrast to a 
study by Pereon et al showing a less intense immunohistochemical a1c response in adult rat EDL 
compared to soleus and diaphragm (Pereon et al. 1998). As discussed in section 5.3.1.6, it may 
be that if a certain percentage of the DHPR present in muscle is of the cardiac type, the more 
developed t-tubular network present in fast-twitch 1nuscle with a larger amount of DHPR 
present may therefore have a larger level of a1c present than slow-twitch which has less DHPR 
to begin with. 
The significantly lower ~l a expression level observed in the EDL muscle homogenates from 
both age groups (Figure 5.30C-D) seems to be consistent with the increased a 15 expression 
observed in the EDL of both age groups as well as the negative correlation between the a 15 and 
~Ia expression levels. Therefore the higher a 15 expression in EDL coincides with a lower 
expression of ~la in this muscle. 
There was no difference in the FKBP 12 expression levels or FKBP 12/RyRl expression ratio 
between soleus and EDL muscle in either age group (Figure 5.30C-D and 5.31C-D). This 
see1ns to suggest that FKBP12 expression and association with RyRl is not affected by the fiber 
type or source of the muscle in rats and is consistent with the correlations between FKBP 12 
expression and FKBP 12/RyRl ratio with fiber type composition done on human muscle 
discussed in section 5 .3 .1.6 that found no correlation. 
5.6 Conclusion 
The investigation into changes of EC coupling proteins with age in human muscle has shown no 
change in expression of the proteins with age in humans. Differences in protein expression in 
rodents and humans that came to light in this study emphasises once more the importance of 
caution in extrapolating data obtained in studies with rodent to humans. 
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Chapter 6: The response of RyR1 ASI splice 
variants to DHPR (31a in lipid bilayers 
6.1 Introduction 
The RyRl undergoes alternative splicing in two regions, namely alternatively spliced region I 
(ASI) and alternative spliced region II (ASII) (Zorzato et al. 1994; Futatsugi et al. 1995) as 
discussed in Chapter 4. The ASI region is of interest as it is located close to a cluster of 
positively charged residues (3495-3502) identified as a possible direct interaction site between 
the C -terminus of the ~la subunit and the RyRl see (Cheng et al. 2005). Peptides 
corresponding the 35 most distal residues of the ~la C-terminus (490-524) bind to native RyRl 
in SR vesicles and the peptides as well as the full length ~la subunit also activate RyRl directly 
in lipid bilayer and [3H]ryanodine binding assays (Rebbeck et al. 2011; Karunasekara et al. 
2012). 
The ASI splice variants differ with respect to 5 amino acids, Ala3481 -Gln3485 , that are either 
present (ASI( + )RyRl) or absent (ASI(-)RyRl) (Futatsugi et al. 1995). Analysis of splicing 
patterns by Futatsugi et al. revealed a molar ratio of ASI( + ):ASI(-) to be roughly 3: 1 in adult 
1nouse skeletal muscle (Futatsugi et al. 1995). Kimura et al perfonJ?ed functional studies on 
the ASI splice variants using [3H]ryanodine binding and lipid bilayer techniques (Ki1nura et al. 
2005). They found the channel activity of ASI(-)RyRl to be less than that of ASI(+)RyRl , but 
that their biphasic Ca2+ dependence of ryanodine binding was similar. In lipid bilayers, the open 
probability of ASI(-)RyRl was lower than ASI( + )RyRl. They also showed, in RyRl-null 
myotubes expressing ASI(-) or ASI( +) RyRl , that caffeine induced Ca2+ release through 
ASI( + )RyRl and ASI(-)RyRl was similar but that there was a significantly higher incidence of 
Ca2+ oscillations in ASI( + )RyRl during the application of 1 0mM caffeine. These results are 
indicative of a less active ASI(-)RyRl channel (Ki1nura et al. 2005). 
In a subsequent study, Kimura et al investigated the effects of the ASI region on EC coupling. 
Recording Ca2+ currents through the DHPR and Ca2+ release from the SR under voltage clamp 
conditions in dyspedic (RyRl-null) myotubes expressing either ASI( + )RyRl or ASI(-)RyRl 
(Kimura et al. 2009). They found that voltage-induced Ca2+ release during EC coupling was 
significantly increased in the ASI(-)RyRl expressing myotubes. The magnitude and voltage 
dependence of the L-type currents were similar in ASI(-)RyRl and ASI( + )RyRl expressing 
1nyotubes as well as wild type myotubes (endogenously expressing RyRl). This result indicates 
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that DHPR express ion and RyRl association are similar for ASl(+)RyRl and ASI(-)RyRl. 
Kimura et al then tested SR Ca2T content and Ca2+ release from the SR in ASI( + )Ry R 1 and 
ASI(-)RyR1 expressing dys pedic myotubes. The authors used another RyR1 specific agonist 
4-cho loro-m-creso l ( 4-cmc) to induce Ca2+ release from the SR. They found that in contrast to 
voltage-induced Ca2+ release (EC coupling), 4-cmc induced Ca2+ release was s ignificantly 
reduced in ASI(-)RyRl expressing myotubes. Together these results suggest that the two splice 
variants respond differently to two types of triggers. Exogenous triggers ( caffeine and 4-cmc) 
elicit a decreased response from ASI(-)RyRl compared to ASI(+)RyRl , whereas the 
endogenous DHPR-mediated depolarization-dependent trigger evoked an increased response in 
ASI(-)RyRl compared to ASI( + )RyRl. 
Because the ~l a subunit activates RyRl in lipid bilayer studies, and the possible ~l a binding s ite 
close to the ASI region on the RyRl it was interesting to see whether there is a difference in 
activation of the RyRl ASI splice variants by the ~l a subunit in lipid bilayers. 
6.2 Aim 
To investigate the response of ASI( + )RyRl and ASI(-)RyRl recombinant channels to 1 OnM 
and 50nM full length recombinant DHPR ~l a subunit in the presence of 1 OµM Ca2+ (see 
Sections 2.1 - 2.8 for preparation of recombinant proteins). 
6.3 Results 
6.3.1 Establishing that an ion channel is a RyR1 
The response of RyRl to Ca2+ concentration, ATP and ruthenium red have been well established 
and can be used to confirm of the identity and orientation of channels in lipid bilayers (Meissner 
1994). In the work described in thi s chapter, the response of channel activity to the change of 
the free Ca2+ concentration of the cis solution from 1 mM to 1 OµM was used to confirm that the 
channel was a RyR] as we ll as its correct orientation in the bilayer. When the cis ca2-"-
concentration is reduced from 1 mM to 1 OµM an increase in channel activity is expected as 1 
mM Ca2-'- inhibits RyR 1, whi le 1 OµM Ca2+ is a max imally activating concentration (Meissner et 
al. 1986; Smith et al. 1986; Smith et al. 1988) (also see Section 1 .5.4.1). At the end of the 
experiment, the seq uential addition of ATP and ruthenium red further confirmed the identity 
and orientation of the channe l. T he addition of ATP to the c;s soluti on shoul d increase RyR 1 
channel activity if the cytop lasmic side of the channel faces the cis so luti on (Meissner et al. 
1986; Smith et al. 1986; Smith et al. 1988) (a lso see Section 1.5.4.1) and ruthenium red added to 
the ds solution shou ld inhibit the RyRl channel activity (Smith et al. 1988; Ma 1993) (a lso see 
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Section 1.5 .4 ). If ruthenium red is added to the cytoplasmic side of the RyRl it causes a fast 
flicker block of the channel, whereas its addition to the luminal side of the RyRl causes a 
reduction in single channel amplitude (Ma 1993). As ruthenium red irreversibly inhibits the 
RyRl , it is added at the end of the experiment. Figure 6.1 shows the representative channel 
traces for each condition described above. 
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Figure 6.1: Representative channel traces showing RyRl activity in conditions used to confirm the identity of the 
channel. (C - indicates level when channel is closed, 0 - indicates level when channel is fully open) 
6.3.2 Response of RyR1 to buffer solution 
Previous studies involving the response of RyRl to the full length recombinant DHPR ~l a 
subunit (Karunasekara 2011 ; Rebbeck et al. 2011) used a buffer exchange protocol in order to 
change the ~l a phosphate buffer to the cis solution, as high concentrations of ~ la requiring 
significant volumes of stock solution were tested. As very small volumes of ~l a solution were 
added to the cis solution in this study, the buffer was not changed. To ensure that the buffer 
solution alone did not affect RyRl channel activity, volumes of buffer equivalent to the volumes 
added with ~l a were added to the cis solution and RyRl channel activity recorded and analysed 
(as described in Section 2.2.15). Due to the difficulty experienced in getting recombinant 
channel incorporation, native RyRl (SR microsomal vesicles) isolated from rabbit muscle (as 
described in Section 2.2.11) were used for these control experiments. Representative traces of 
each condition as well as the mean PO for each condition is shown in Figure 6.2A-B and Table 
6.1. 
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Figure 6.2: The addition of equivalent volumes of the Bia buffer alone has no effect on RyR 1 channel activity. (A ) 
Representative channel traces of ctr! acti \·ity. activity after the addition of 3.36µ1 buffer (volume of Bia solution added 
to cis chan1ber \\·hen I OnM Bia is added). and activity after the addition of a total volume of 16.8µ1 buffer (total 
\'Olume of Bia solution added to cis chamber after the concentration of Bia is increased to 50nM). (8 ) The mean open 
probability for each condition (n= l 0) . (C) The control channel acti\'ity of native RyR I is not different from that of 
the recombinant RyR I control channel activity. 
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Table 6.1: Mean RyRl open probability after the addition of ~I a buffer to the cis chamber 
(Il_. 10). (sem - standard error of the mean}. 
Volume Buffer added OµI 3.36µ1 16.8µ1 
Channel open probability 
mean ±sem mean ±sem mean ±sem 
0.082 0.014 0.077 0.016 0.080 0.014 
In the 5 experiments performed, there was no statistically significant difference in PO between 
+4Om V and -4O1n V for any of the conditions and therefore the PO data obtained at +4Om V and -
4OmV were combined for each condition respectively giving n=lO observations. The mean 
control PO of native RyRl was compared to the mean control PO of the recombinant RyRl s and 
found to be similar (Figure 6.2C). 
6.3.3 Response of Recombinant channels to the DHPR Pia-
subunit 
6.3.3.1 Effect of the DHPR P1asubunit on Po 
In order to investigate the response of the RyRl ASI splice variants to ~la added to the 
cytoplasmic side of the RyRl in lipid bilayers, recombinant ASI(+)RyRl or ASI(-)RyRl was 
incorporated into lipid bilayers and exposed to 1 OnM and 5OnM ~la in the cis solution. These 
particular ~1 a concentrations were used as they have previously been shown to maximally 
activate native RyRl in lipid bilayers (Rebbeck et al. 2011 ). The respective channel activities 
were analysed and PO determined (as described in Section 2.2.15). There was no difference in 
activity recorded between +4Om V and -4Om V at any stage of the experiment and the data 
obtained at the +4Om V and -4Om V were combined for each experiment, giving n= 10-12 
observations for each condition. The mean PO values for each condition are given in Table 6.2 
for the two splice variants respectively and representative traces for each condition are given in 
Figure 6.3A. 
Table 6.2: The mean PO of ASI( + )RyRl and ASI(-)RyRl before and after the addition of DI-IPR 
~l a to the cis solution (n=lO-12). (sem - standard error of the mean, * significantly 
different to control} 
Ctrl lOnM '31a Ctrl SOnM '31a 
mean ±sem mean ±sem mean ±sem mean ±sem 
ASl(+)RyRl 0.085 0.211 0.295 * 0.065 0.111 0.026 0.311 * 0.071 
ASl(-)RyRl 0.091 0.019 0.204 * 0.044 0.097 0.022 0.239 * 0.049 
lOnM and 5OnM ~la increased the channel activity of ASI(+)RyRl as well as ASI(-)RyRl 
significantly (P<O.O5) compared to control activity. 
The mean relative PO for each condition was determined as a log value. The mean log10 relative 
P0 is the average of the differences between the log10 P0 after the addition of~1a and the log10 Po 
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before the addit ion of ~I a· The mean relative PO fo r each conditi on is g iven in Table 6.3 fo r the 
two splice variants respectively and shown graphically in Figure 6.3B . 
Table 6.3: T he mean re lative P0 (log re l P0 ) of A SI(+)RyRl and ASI(-)RyR l after the additi on 
of l OnM and 50nM ~la to the cis solution (n=l 0-1 2). (sem - standard error of the 
* (' ; r,--n ;ficantlv different from ASI(-)RyR l) 
- -
lOnM '31a SOnM '31a 
mean ±sem mean ±sem 
ASl(+)RyRl 0.646 * 0.083 0.520 0 .114 
ASl(-)RyRl 0.369 0.063 0.433 0.084 
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Figure 6.3: The effect of addi ng DHPR Bia to the recombinant RyR I AST splice variants. (A) Representati ve traces 
of AS I(+ )RyR I (l eft) and AST(-)RyR I (ri ght) showi ng control activity. activity aft.er the add ition of I 0nM Bl a and 
activity after the addition of 50nM BI a. (0 - level at \\·hi ch channel is full y open. C- level at which chann el is 
closed) . (8 ) The mean relative open probability of AST(+)RyRl and AST(-)RyRI treated with I0nM and 50nM Bi a 
given as the log value. Log relative P0 is the average of differences between the log10 of P0 in the presence of the Bia 
subunit (logP0 8 ) and log10 of the control P0 (logP0 c) fo r each channel. with P0 measured over 90s. (* signifi cant!) 
different Ps;0.05) . 
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The activation due to the addition of 1 OnM ~la was significantly larger in ASI( + )RyRl 
compared to ASI(-)RyRl. However, this difference in activation is not seen with the addition of 
50nM ~la to the splice variants respectively. There was also no difference in the relative P 0 
between lOnM and 50nM ~la added in either ASI(+)RyRl or ASI(-)RyRl. More concentrations 
were not tested due to time constraints. However, the smaller increase in activity at 1 OnM ~la 
could indicate a shift in the activation curve for ASI(-)RyRl to slightly higher ~l a 
concentrations. 
6.3.3.2 Effect of the DHPR P1a-subunit on To and Tc 
Channels from both the recombinant RyRl ASI splice variants showed sitnple gating and 
· complex gating (Figure 6.4). The mean TO and Tc can be determined meaningfully for channels 
showing simple gating, however in the channels showing complex gating with long periods of 
sub-conductance openings, determining mean T0 and Tc does not give meaningful results. The 
analysis of the gating properties of these reco1nbinant channels therefore was not possible and is 
discussed further in Section 7 .5 .3. 
ASl(+)RyRl 
········· 0 Simple gdtj ng ......... ;w].· ~--·r·1r, ··:w·i,··;1~~)"ji~.~WJ1J C 
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Figure 6.4: Representative traces of ASI( + )RyRl and ASI(-)RyR 1 showing simple and complex gating occurring in 
both splice variants (0 - level at which channel is fully open, C- level at which channel is fully closed). 
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6.4 Discussion 
6.4.1 Control channel activity of recombinant channels 
The control channel activity of the recombinant channels was similar to the control activity of 
native RyRl under similar conditions (Figure 6.2C) . There was no difference between the 
average control open probability of ASI( + )RyRl and ASI(-)RyRl (Table 6.2 and Figure 6.2C). 
This is in contrast to lipid bilayer studies by Kimura et al showing a higher PO for ASI( + )RyRl 
channels than for ASI(-)RyRl (Kimura et al. 2005). There are several possible reasons for the 
discrepancy in findings between Ki1nura et al and the work described in this chapter including 
the following. Kimura et al recorded channel activity in the presence of 1 00µM free Ca2+ in 
their cis solution, whereas 1 0µM Ca2+ was used in the worked describe in this chapter. The 
preparation of microsomal vesicles was also different. Kimura et al solubilized the microsomal 
protein obtained after homogenisation under reducing conditions (with linM DTT) using 1.5% 
CHAPS and purified the RyRl using sucrose gradient centrifugation after which they 
reconstituted the RyRl into proteoliposomes by removing CHAPS through dialysis. In the 
work described in this chapter, RyRl was not solubilized or purified and no reducing agent was 
present in any of the steps. After two centrifugation steps the pellet was resuspended and 
sonicated briefly. Any or all of these differences in preparation methods as well as differences 
in free Ca2+ concentrations used bilayer experiments could contribute to the difference between 
findings of Kimura et al and the results discussed in this chapter. Due to the difficulty 
experienced in incorporation of recombinant channels and time constraints, these differences 
could not be explored further. 
6.4.2 DHPR JJ1a activation of recombinant channels 
The DHPR ~1a subunit activated the ASI( + )RyRl and ASI(-)RyRl significantly at 1 0nM and 
50nM ~ l a concentrations with no difference in the level of activation between the two ~l a 
concentrations (Table 6.2, 6.3 and Figure 6.3B). This is consistent with previous findings by 
Rebbeck et al with native RyRl showing maximal activation of the channel by the full length 
~ l a subunit as well as a peptide corresponding to the last 35 amino acids of the C-terminal tail of 
~ l a at concentrations ranging from 10-1 00nM (Rebbeck et al. 201 1 ). The authors suggested that 
the ~ l a subunit may contribute to an EC-:-coupling pathway. Kimura et al showed that 
ASI(-)RyRl was activated more during EC coupling than ASJ(+)RyRl (Kimura et al. 2009) . 
Due to the cl ose proximity of a possible ~ l a binding site to the ASI region , the work in this study 
was done to investi gate a possible difference in activation of ASI(+)RyRl and ASI(-)RyRl b 
the ~ la subunit. There was indeed a difference in the level of activation of the ASI splice 
variants by ~ la at a concentration of 1 0nM w ith ASI( + )RyRl activated significantly more than 
ASI(-)RyR 1 (Table 6.3 and Figure 6.3B). The difference in activation level between 
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ASI(+)RyRl and ASI(-)RyRl is not significant at 50nM ~la although there is a trends towards a 
higher ASI(+)RyRl relative P0 • Although the higher activation of ASI(+)RyRl by l0nM ~i a is 
consistent with other agonists of RyRl , caffeine and 4-cmc (Kimura et al. 2005 ; Ki1nura et al. 
2009), it does not support the hypothesis that the increased activation during EC coupling seen 
in ASl(-)RyRl compared to ASI( + )RyRl may be due to the contribution of the ~l a subunit to 
EC coupling. The sequence difference between ASI( + )RyRl and ASI(-)RyRl is 5 residues. 
This suggests that the direct activation of RyRl through agonists occurs through a si1nilar 
mechanism that is different from the mechanisms involved during EC coupling and which 
causes ASI(+)RyRl to be activated more than ASI(-)RyRl. In the case of the DHPR mediated 
activation of the RyRl during EC coupling it has been suggested that multiple regions of the 
RyRl and DHPR are involved, and it 1nay be that the combination of all the sites can produce a 
different outco1ne with the ASI splice variants so that the ASI(-)RyRl is activated more. 
Kimura et al investigated the possibility that the ASI region was involved in an inhibitory 
interdomain interaction with the use of peptides corresponding to the ASI region from 347 1T -
G3500 (Kimura et al. 2007). In that study it was found that the peptide corresponding to the 
ASI(-)RyRl sequence were more effective in activating both splice variants, but that ASI(-
)RyRl was activated the most. This together with other findings showing a less active ASI(-
)RyRl suggests that the ASI(-)RyRl has a stronger inhibitory inter domain interaction than 
ASI( + )RyRl. It seems possible then that the mechanism involved in EC coupling disrupts this 
inhibitory interdomain interaction giving rise to the higher activation of the ASI(-)RyRl , but 
that the 1nechanis1n involving activation by agonists does not disrupt this inhibitory interaction 
and activates the RyRl differently, giving rise to the ASI( + )RyRl being activated more. 
Due to time constraints, 1nore concentrations of ~l a were not tested here. However, the smaller 
increase in activity at 1 0nM ~l a could indicate a shift in the activation curve for ASl(-)RyRl to 
slightly higher ~l a concentrations. However the difference may be due to the fact that there was 
also a trend towards reduced activation of ASI(+) with 50nM ~la· It is notable that higher 
concentrations of ~l a tend to produce less activation of native RyRl under some circumstances 
(R. Rebbeck, personal com1nunication). Therefore this possible difference in activation by ~l a 
observed between the ASI RyRl splice variants in vitro merits further investigation. 
It is important to note that it is not known whether RyRl s in vivo consists of only ASI( + )RyRl 
or ASI(-)RyRl subunits or whether they are hybrids of both splice variants to different degrees. 
The latter however seems the most likely in the light of results obtained in a study by Xu et al in 
which they co-expressed a 1nutant and WT RyRl in HEK cells (Xu et al. 2008) resulting in 
heterotetrainers RyRl s consisting of WT and mutant subunits. The implications of this will be 
discussed further in the final discussion chapter (Chapter 7). 
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6.4.3 Recombinant channel gating 
The analysis of the gating properties (T0 and Tc) of the recombinant ASI(+)RyRl and 
ASI(-)RyRl was hindered by the presence of very long substate openings with brief openings to 
the fully open state in both splice variants (Figure 6.4). In vivo the Ca2+ flux through the 
channel during Ca2+ release is what is of importance and therefore the fractional mean current 
(I ' f) was used as a measure for channel activity in channels exhibiting this type of gating. An 
increased conductance due to channels opening more to the fully open state would be reflected 
in the I'f value whereas the PO would show only that the channel is open or closed. A more 
sophisticated analysis of channel gating such as that provided by HMM (Hidden Markov 
Model) (Chung and Gage 1998) was not considered to be warranted given the small differences 
observed between the two channel types and time restraints. The substate openings may be due 
to the absence ofFKBP12 associated with the RyRl and although some FKBP12 expression 
was detected by i1rununoblot in transfected HEK cells, it not known whether the FKBP is 
associated with the RyRl. RyRl in muscle fibers is also associated with a number of other 
proteins e.g. CSQ, triadin and junctin, whereas the RyRl s expressed in HEK cells lack these 
associated proteins and could also contribute to the complex gating observed. Again due to 
time constraints, this could not be fully investigated and merits further investigation. 
6.5 Conclusion 
The DHPR ~l a subunit activated the recombinant ASI RyRl splice variants significantly in lipid 
bilayer studies with the ASI(+)RyRl isoform showing a higher activation by l0nM ~] a than 
ASI(-)RyRl isoform. The implications of this difference in ASI RyRl splice variant activation 
by ~l a observed in vitro to differences between activation of ASI splice variants during EC 
coupling remains unclear and merits further investigation. 
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Chapter 7: Discussion 
7.1 Summary 
The work presented in this thesis was performed in an attempt to investigate factors associated 
with changes in human and rat muscle function with age. Several properties of muscle samples 
obtained from hu1nan and rat donors were analysed. Firstly expression of proteins essential in 
skeletal muscle type EC coupling was investigated with respect to age. Secondly fiber type 
distribution in muscles from donors of different ages was investigated, as well as ASI RyRl 
splice variant ratios. Finally, the reco1nbinant ASI RyRl splice variants were expressed in HEK 
cells and their single channel properties assessed, as well as their response to activation by the 
recombinant ~l a subunit of the DHPR. The principle findings were as follows: 
1. Fiber type distribution with age. 
a. Human: The human muscles investigated responded differently to age in regard to 
their fiber type distribution. The gluteus medius and gluteus minimus samples, 
although both containing a high percentage type 1 fibers, displayed different 
changes with age. Gluteus 1nedius muscle samples showed an increase in the 
percentage type 1 fibers with age, whereas there was no change in fiber type 
distribution with age in gluteus minimus muscle samples. Vastus medialis samples, 
containing more type 2 fibers than type 1, showed opposite age-related changes in 
male and female donors to age, with female samples showing an increase in the 
percentage type 1 fibers in samples from older donors whereas samples from 1nale 
donors showed a decrease in the percentage type 1 fibers with age. 
b. Rat: Not unexpectedly, a general shift towards a more oxidative fiber type 
distribution was observed in EDL muscles from the 1 year old rats relative to the 
juvenile 5 week old rats. No change in fiber type distribution was observed in 
soleus n1uscles. 
2. EC coupling protein expression with age. 
The expression of RyRl , DHPR a 15, DHPR a 1c, DHPR ~l a and FKBP12 proteins was 
investigated. 
a. Human: No change in expression levels with age was observed in any of the 
proteins examined in any of the human muscle samples. Differences in the means 
of a1/ RyR1 and FKBP12/RyRl ratios were observed between donors <60yr and 
~60yr. Although, no significant correlation was found when these ratios were 
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plotted against age, the difference between the <60yr and 2:'.60yr ratios indicates that 
these aspects merit further investigation. An age-independent positive correlation 
between the level of RyRl and U1 s, RyRl and ~l a as well as a 15 and ~l a expression 
levels were observed. Also independent of age, the level of RyRl and a 15 
expression as well as the a 1cfRyRl ratio correlated positively with the percentage 
type 2X fiber in the muscle samples. In contrast there was no correlation between 
the ~l a and FKBP12 levels or the a 1afRyRl and FKBP12/RyR1 ratios and fiber type 
distribution. Notably, the presence of DHPR a 1c in adult human skeletal muscle was 
shown for the first time. 
b. Rat: Contrary to what has been reported in mice, the level of ~l a expression was not 
higher in lyr old rats compared to the juvenile 5wk old rats, but was in fact, lower. 
A positive correlation between the levels of RyRl and a 15 was observed, and 
negative correlations between RyRl and ~la as well as a 1s and ~l a were observed. 
3. ASI RyRl splice variant analysis. 
a. Human: There was no correlation between the ASI RyRl splice variants and age. 
However, a novel and important finding was that there was a positive correlation 
between the percentage ASI(+)RyRl and the percentage type 2 fibers in the human 
muscle samples as well as a positive correlation between amounts of ASI(-) and 
fraction of type 1 fibres. 
b. Rat: Unfortunately the RYRl sequence of rat is not known and the primers 
designed and used in the RT-PCR analysis were unsuccessful. Thus the generality 
of splice variant distribution across species and in muscle with dominant fiber types 
could not be examined. 
4. Recombinant ASI RyRl splice variant activation by DHPR Bia-
Both ASI(+)RyRl and ASI(-)RYRl channels were activated significantly by 1 OnM and 
50nM DHPR ~l a · No significant difference in activation was observed between 1 OnM and 
50nM ~ la for the same splice variant, however, when ASI(+)RyRl and ASI(-)RyRl 
channels were compared, 1 OnM ~1 a activated ASI( + )RyRl channels significantly more than 
ASI(-)RyR 1 channels. 
7.2 Muscle diversity 
Human s. unlike inbred laboratory animals. show a high level of genetic variation and this 
necess itates large sample numbers in order to identify differences due to environmental or other 
factors apart from genetic variation. Most of the prev ious work involving changes in human 
muscle \\·ith age was performed on vastus lateral is muscle biopsies due to easy access for 
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voluntary biopsy. In contrast, in the work presented in this thesis, gluteus medius, gluteus 
minimus and vastus medialis were investigated and the results showed that the different muscles 
respond differently to age in regard to fiber type distribution. This indicates therefore that not 
only is there variability between individuals, there is also variability depending on the particular 
muscle studied. It is therefore important to investigate muscles other than the vastus lateralis 
when investigating changes in function and strength with age. This could give more insight into 
the extent to which a muscle ' s function might influence the level of atrophy and functional loss 
that may be associated with aging. 
7 .3 EC coupling protein expression with age 
EC uncoupling has been proposed to be one process that contributes to the decay in skeletal 
muscle force with aging (Delbono et al. 1995). It was suggested from levels of dihydropyridine 
and ryanodine binding, that the number of RyRl that were not physically coupled to DHPRs 
increased with age in rats (Renganathan et al. 1997), and this is consistent with the changes in 
DHPR activity and Ca2+ release from the SR observed in aged human muscle (Delbono et al. 
1995). The decrease in DHPR a 15 expression with age in rodents has also been confirmed in 
several other studies (Ryan et al. 2000; Ryan et al. 2003; O'Connell et al. 2008). However, this 
reduction in DHPR a 15 with age was not seen in humans by Ryan et al (Ryan et al. 2003) or 1n 
the work described in Chapter 5, where no change in DHPR a 15 expression in aged human 
muscle was found. The changes reported by Delbono et al in DHPR activity and SR Ca2+ 
release in aged human muscle therefore is likely not to be due to r~duced expression of DHPR 
a 1s and possibly not due to changes in RyRl /DHPR coupling as RyRl expression was also 
unaltered in the aged human muscle examined in the present study and described in Chapter 5. 
It is possible that different methods used in studying the levels ofDHPR and RyRl could 
contribute to differences in findings. Ryanodine binding to RyRl is subject to the activity level 
of the channel (Chu et al. 1990a) and could influence results. The determination of protein 
levels by binding of radio ligands or immunoblots does not directly measure DHPR/RyRl 
coupling and the assumption that all the DHPR detected by these methods are associated with 
RyRl could be an overestimation of the actual numbers of coupled Ry Rs. Whatever the case 
1nay be, the mechanism of EC uncoupling cannot be translated from rodents to humans without 
modification. It may be that in humans other factors such as post-translational modifications of 
proteins, and also changes in muscle and CRU structure observed in aged muscle 
(Boncompagni et al. 2006) could account for the changes in DHPR activity and Ca2+ release 
observed by Delbono et al in aged human muscle. In fact the FKBP12/RyR1 disassociation due 
to oxidation of RyRl shown by Andersson et al (Andersson et al. 2011), could account for at 
least some of the reduced Ca2+ release observed in aged human muscle. Results discussed in 
Chapter 5 showed that although there was no significant correlation between age and the 
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FKBP 12/RyRl ratio in microsomal vesicles from human muscle, there was a significantly lower 
FKBP 12/RyRl ratio in donors >60yr compared to <60yr in all three muscles studied. This 
suggests that there might be a reduction in the amount of FKBP12 associated with RyRl in aged 
muscle, so that this aspect of the RyR macromolecular complex merits further investigation . 
The increase in ~l a expression over the lifetime of mice shown by Taylor et al (Taylor et al. 
2009) was not observed here in hu1nans or rats (Chapter 5). In the human muscle investigated 
in the work described in this thesis , there was a positive correlation between the expression 
level of a. 15 and ~l a, which is in contrast to the findings in mice where increased expressions of 
~la lead to a decreased a.1a level (Taylor et al. 2009). Curiously, a negative correlation between 
a. 15 and ~ la expression levels was observed in the rat muscle studied here and this is consistent 
with the mice studied by Taylor et al. The rat results however, differ from the mouse findings 
in that a decrease in ~l a expression was observed in the lyr old rats compared to the 5wk old 
rats, whereas Taylor et al found an increase in ~la expression as the mice aged. They found a 
twofold increase in ~l a expression in TA and EDL of 6mo old mice compared to 2mo and a 
threefold increase in 14 mo compared to 6mo old mice. It seems therefore that the expression of 
DHPR subunits differs even among rodents and also between rodents and humans, emphasising 
the importance of caution in applying findings from rodents to human muscle. 
7 .4 ASI RyRl splice variant distribution and function 
The ASI region has, since its description and characterisation by Futatsugi et al and 
subsequently by Kimura et al , been thought of as a developmentally spliced region with the 
ASI(-)RyRl splice variant being the juvenile isoform and ASI( + )RyRl being the adult isoform 
(Futatsugi et al. 1995 ; Kimura et al. 2005; Kimura et al. 2007; Kimura et al. 2009). The 
hypothesis in this thesis was that there might be a higher level of ASI(-)RyRl present in aged 
1nuscle. Formulation of this hypothesis was based on the Futatsugi/Kimura observations 
together with the fact that increased denervation and reinnervation associated with aged muscle 
leads to higher leve ls of juvenile isoforms of muscle proteins . The presence of the juvenile 
isoforms has been attributed to incomplete maturation of regenerated muscle (Dedkov et al. 
2001 ). As shovvn in Chapter 4, this hypothesis proved to be incorrect. There was no correlation 
between the percentage ASI(-)RyRl mRNA present and the age of the human musc le donors. 
Neyer-the-less the study led to important in sights into the expression of the ASI splice variants. 
The in\·estigations by Futatsugi et al and Kimura et al involved muscles consisting 
predominantly of fast-h\ ·itch fibers. These musc les were human vastus lateral is and hindlimb 
muscle from mice . In these muscles there \.Vas a ASI(+)RyR l:ASI(-)RvR1 ratio of3:1 in adult 
muscle. In Chapter 4. it \.Vas shown for the first time that the levels of ASI(+)RvRl and 
20-l 
Chapter 7 
ASI(-)RyRl transcripts are influenced by the fiber type distribution of three human 1nuscles that 
had not previously been investigated and having various percentages of fibers of each type. A 
strong positive correlation was found between the percentage ASI( + )RyRl transcripts and the 
percentage type 2 fibers present in the muscle. In the muscle having the highest percentage of 
fast-twitch fibers (vastus medialis ), the correlation with the percentage ASI( + )RyRl transcripts 
was the strongest with type 2X fibers , which in humans are the fast glycolytic fibers. This 
strongly suggests a fiber type specific distribution of the ASI RyRl splice variants rather than a 
develop1nentally spliced region. This was reinforced by the gluteus medius and gluteus 
minimus muscles, which have predominantly slow-twitch fibers , found to have the highest level 
of ASI(-)RyRl transcripts. 
It is not known at this stage whether individual muscle fibers contain both splice variants or 
whether the post transcriptional splicing is regulated in such a way that only one splice variant 
is present per fibre. It has been shown that some muscle fibres co-express MyHC isoforms and 
that these fibres show contractile properties intermediate to fibers expressing only one MyHC 
isoforms (Rivero et al. 1998; Rhee et al. 2004; Cvetko et al. 2012; Lamboley et al. 2013). 
Individual slow twitch fibers express both isoforms of CSQ while fast twitch fibers express only 
CSQ 1 and it has been suggested that the differential expression of CSQ in fast-and slow-twitch 
fibers probably facilitates optimal contractile function in the individual fiber types (Lamboley et 
al. 2013 ). This could also be true for the ASI RyRl splice variants. It may also be that the 
fibers always contain both splice variants, but that it is the ratio between the two that is 
regulated to facilitate optimal contractile function in the individual fibers. A further level of 
complexity is added when one considers that the RyRl is a tetramer and that if both splice 
variants are present in the fiber, the RyRl s would most likely be a heterotetramer consisting of 
various combinations of the splice variants. Xu et al showed that the co-expression of WT 
RyRl and a mutant RyRl in HEK cells produced RyRl s that exhibited a range of phenotypes 
intermediate between the WT phenotype and the mutant, and developed a model in which the 
detailed characteristics depended on the ratio of WT to mutant subunit present in each tetramer 
(Xu et al. 2008). This would suggest that if both ASI( + )RyRl and ASI(-)RyRl are present in a 
fiber, that the RyRl s would be heterogeneous with regards to its subunit composition and RyRl 
channels would exhibit a range of functional characteristics between that of ASI( + )RyRl only 
and ASI(-)RyRl only. 
Kimura et al showed a lower open probability in recombinant ASI(-)RyRl c01npared to 
ASI( + )RyRl in lipid bilayers in the presence of 1 00µM Ca2+ (Kimura et al. 2005). However the 
results discussed in Chapter 6 showed no difference in the open probability of the recombinant 
splice variant channels and the open probability was also similar with the open probability of 
native RyRl under similar experimental conditions (1 0µM Ca2+). In both instances, the Ca2+ 
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concentration reflects the concentration during muscle contraction and not the resting 
cytoplasmic Ca2-,- concentration in 1nuscle fibers. In vivo, the low resting cytoplasmic Ca2-
concentration of 50-lOOnM, together with the presence of 1mM Mg2-,- (Konishi 1998: Hall and 
Guyton 2011 ), which strongly inhibits RyRl , would result in the RyR 1 having a very low open 
probability under resting conditions (Meissner et al. 1986; Smith et al. 1986). During EC 
coupling, RyRl is activated through a physical interaction with the DHPR. Kimura et al have 
shown that ASI(-)RyRl expressing dyspedic myotubes are activated to a greater extent than 
ASI(+)RyRl expressing myotubes during EC coupling (Kimura et al. 2009). The cytoplasmic 
Ca2- concentration rises to levels as high as 20µM during muscle contraction (Hall and Guyton 
2011 ). This is within the Ca2+ concentration range used in the experiments discussed in Chapter 
6. It is possible that the mechanism involved in activation of the RyRl during EC coupling 
causes an increased activation in the ASI(-)RyRl compared to ASI( + )RyRl. In contrast in the 
isolated bilayer situation, a different mechanism dominates and determines the greater activation 
of ASI( + )RyRl by ~1a than ASI(-)RyRl. It is relevant that Rebbeck et al showed that the ~1a C-
tail peptide containing the last 35 residues of the C-terminal region of ~l a had no effect on the 
RyRl at 1 OOnM Ca2+ and its maximum activation effect on the RyRl occurred at 1-1 OµM Ca2+ 
(Rebbeck et al.2011). If we assume that the ~la subunit plays a role in EC coupling, these 
findings could be taken together to suggests an initial activation of RyRl through the EC 
coupling mechanism when cytoplasmic Ca2+ concentration is initially low (1 OOnM) with a 
subsequent modulation by the ~l a as the concentrations of Ca2T increases to micromolar levels. 
In the initial activation by the EC coupling mechanism, ASI(-)RyRl is activated more than 
ASI( + )RyRl , whereas as Ca2- concentration increases the second mechanism dominates so that 
the ASI( + )RyRl is activated more than ASI(-)RyRl. Kimura et al suggested a mechanism by 
which the ASI(-)RyRl could be activated more during EC coupling. Based on the results of 
their single channel studies, they hypothesised that the ASI region is involved in an inhibitory 
interdomain interaction and that the ASI(-)RyRl inhibitory interaction is stronger than the 
ASI( + )RyRl (Kimura et al. 2007; Kimura et al. 2009). A peptide corresponding to the ASI 
region (including the 5 basic residues thought to interact with ~ta) was used to disrupt this inter 
domain interaction and it was found that the activation by the peptide was strongest in the 
ASI(-)RyRl . This suggests that the EC coupling activation mechanism could work through a 
disruption of this stronger interdomain interaction, allowing ASI(-)RyRl to be activated more 
during EC coupling when expressed in dyspedic myotubes (Kim ura et al. 2009). 
There is a significant phys iological importance of the ASI(-)RyR I being activated more through 
the EC coupling mechanism and the ASI(+)RyR l activated more through the subsequent 
modulation mechanism . This is in their differential presence in fast- and slow-twitch fiber as 
discussed in Chapter 4. Slow-twitch fibers have a less developed and smaller SR than fast 
t\\·itch fibers (Schiaffino and Reggiani 2011) therefore also have less RyRl (Renganathan et al. 
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1997). The increased activation of ASI(-)RyRl , which is present in slow-twitch fibers, during 
EC coupling may be an adaptation by the muscle to compensate for the reduced Ca2+ release 
capacity. The late EC coupling modulation mechanism that kicks in at micromolar 
concentrations may be a way that fast-twitch fibers , in which ASI( + )RyRl is dominantly 
present, could allow for increased Ca2+ release if necessary, when stronger contraction is 
needed. If individual fibers were to express both splice variants, with the accompanying 
heterotetrameric RyRl s, this could produce an intermediate response allowing for muscles to be 
more adaptable to changes in contraction demands. As the correlation between the percentage 
ASI(+)RyRl transcripts and type 2X fibers were the strongest (as discussed in Chapter 4), it 
could also be that the type 2A fibers , which have a metabolism and contractile properties 
intermediate between type 1 and 2X fibers, have both the splice variants present in various 
degrees of RyRl heterotetramers which facilitates its intermediate contractile properties. 
7 .5 Future directions 
7.5.1 Sample selection 
Throughout the discussion of results in this thesis, the limited number of samples has been 
mentioned as a possible cause for statistically insignificant or anomalous results. It would 
therefore be beneficial for future studies involving human muscle to have larger sample 
numbers. Not only is sample number a factor to consider, but also the age range of these 
donors. In the investigation of the effect of age on muscle, an age _group that of 20-3 0yr old 
donors would serve as a better control group as the <60yr age group used in this thesis. 
In addition, a selective screening of donors in terms of their medical history would help in 
reducing variation in data. For example, anthracyclines, which is a commonly used treatment 
for various types of cancers can cause muscle fatigue that is not alleviated by a period of rest 
and is associated with impairment in skeletal muscle function (Morrow et al. 2002; Gilliam and 
St Clair 2011; Hayward et al. 2013 ). Muscle fatigue could have many contributing factors , one 
of which is oxidative stress (Allen et al. 2008) and the RyRl is susceptible to oxidative 
modifications (Aracena-Parks et al. 2006) and could potentially be a mechanism whereby 
anthracyclines could cause muscle fatigue. Due to the fact that the RyRl is affected by this 
family of drugs, it would be beneficial to analyse muscle from donors with a history of 
anthracycline treatment as a separate cohort. 
Statins (3-hydroxy-3methylglutaryl coenzyme-A (HMG-CoA) reductase inhibitors) are 
cholesterol-lowering drugs effective in decreasing low-density lipoprotein (Evans and Rees 
2002; Joy and Hegele 2009). They are commonly used and the majority of patients tolerate 
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statins well, however, up to 10% of patients display muscle-related symptoms including 
soreness, fatigue , and an increase in circulating levels of muscle specific proteins such as 
creatine kinase that results in statin-induced myopathy (SIM) (Evans and Rees 2002· 
Sathasivam and Lecky 2008 ; Venero and Thompson 2009). The mechanism underlying this 
condition is still unclear. One theory centres on the potential of statins to modulate intracellular 
Ca2+ homeostasis (Sirvent et al. 2008; Ghatak et al. 2010; Sirvent et al. 2012). The application 
of statins to healthy human fibers triggers a significant increase in cytoplasmic Ca2+ and it has 
been suggested that the Ca2+ release can be from both mitochondria and the SR (Inoue et al. 
2003; Sirvent et al. 2005a; Sirvent et al. 2005b; Guis et al. 2006; Metterlein et al. 201 O; Sirvent 
et al. 2012). Mutations in RyRl have been found to underlie some instances of SIM, 
specifically malignant hypothermia related mutations (Guis et al. 2006; Metterlein et al. 2010). 
It would therefore be interesting to analyse muscle from donors treated with statins as a separate 
cohort. 
Exercise history is another example of a factor which could be used in screening for donors. 
Donors that did extensive training for sport should also be analysed as a separate cohort because 
training alters muscle composition and physiology (Schiaffino and Reggiani 2011 ). 
7.5.2 FKBP12/RyR1 
The results of FKBP 12/RyRl expression ratio in 1nuscle frmn human donors discussed in 
Chapter 5 showed some interesting inconsistencies. The comparison of the means of the <60yr 
and >60yr old age groups showed a significantly lower FKBP 12/RyRl ratio in the >60yr group 
when the data from the three muscles were combined as well as when the data from each muscle 
was considered separately. However, when the FKBP12/RyR1 ratio was plotted against the age 
of the donors, there was no significant correlation. A repeat of this investigation with a larger 
donor cohort is merited as the association of FKBP12 with the RyRl is important for normal 
RyR activity, Ca2+ release and presumably for muscle function (Brillantes et al. 1994; Lamb and 
Stephenson 1996; Marx et al. 1998; Avila et al. 2003a; Tang et al. 2004). If more RyR] are not 
associated with FKBP12 in aged muscle they would have a higher open probability with more 
substate opening levels. This would lead to an increased cytoplasmic resting Ca2+ 
concentration that could activate Ca2+ sensitive proteases such as µ-cal pain (Murphy et al. 
2012). It could also lead to a reduction i-n the Ca2+ released from the SR during EC coupling 
due to a reduction in the Ca2_,_ stored in the SR causing reduced muscle function (Andersson et 
a l. 2011). The di ssoc iation ofFKBP12 from RyRl has been implicated in muscle disease. 
Bellinger et al found an age-dependent increase in S-nitrosylation of RyRl in a mouse model of 
Ouchenne muscular dystrophy (mdx) that correlated with depletion of FKBP 12 from RyR 1 and 
the onset of muscular dystrophy in the mdx mice (Bellinger et al. 2009). They found that the 
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stabilization of the FKBP12-RyRl co1nplex improved grip strength and reduced muscle da1nage 
in the mdx mice. The FKBP12-RyRl complex is therefore an important interaction for normal 
muscle function and dissociation of these proteins has deleterious effects on 1nuscle. 
7.5.3 ASI RyR1 splice variants 
The level of ASI(+)RyRl and ASI(-)RyRl splice variant transcripts has been shown to be 
correlated with fiber type in Chapter 4. The distribution of ASI splice variants could not be 
confirmed in rat muscle as the rat sequence for RYRl was not available on the NCBI databases. 
Unlike humans, rats have muscles that are fiber type specific such as the EDL, which contains 
only type 2 fibers. Unfortunately, attempts at splice variant analysis in rats were unsuccessful in 
the time constraints associated with this project. However, the determination of the rat sequence 
for RYRl and RT-PCR of the ASI region in order to determine the ratio of ASI splice variant 
transcripts in a muscle containing only fast-twitch fibers would be valuable in the confirmation 
of the results discussed in Chapter 4. Investigating the splice variant transcript ratio in single 
fibers would shed light on whether a single fiber contains both splice variants or if only one of 
the two is present. 
The activation of the recombinant ASI RyR splice variant channels by the DHPR ~l a subunit 
was investigated in Chapter 6 using lipid bilayer techniques. Concentrations of 1 0nM and 
50nM ~l a were added to the cham1els. A difference in activation at 1 0nM ~Ia between the splice 
variants could possibly suggest a shift in the activation curve for ASI(-)RyRl by ~la to slightly 
higher ~l a · Repeating these experiments using ~la concentrations lower than 10111\1 and higher 
than 50nM would elucidate whether this is the case. The open probability of the recombinant 
channels before the addition of ~l a as shown in chapter 6, was much lower than that reported by 
Kimura et al (Kimura et al. 2005). There was also no difference in open probability between the 
splice variants in the results discussed in Chapter 6, in contrast to Kimura et al who reported 
that ASI(-)RyRl had a significantly lower open probability than ASI(-)RyRl. A possible 
reason for the contradicting findings could be the Ca2+ concentration at which the investigations 
were done. Kimura et al used a cis free Ca2+ concentration of 1 00µM in their bilayer 
experiments whereas the experiments discussed in Chapter 6 used a cis free Ca2+ concentration 
of 1 0µM. A repeat of experiments using different Ca2+ concentrations would shed some light as 
to whether the difference in Ca2+ concentration was indeed the cause of the different findings by 
the work discussed in this thesis and Kimura et al. As Mg2+ and ATP are both present in the 
muscle fiber cytoplasm in vivo and 1nodulate RyRl activity (Meissner 1984; Smith et al. 1986; 
Konishi 1998), it would also be i1nportant to repeat the addition of ~ la to the recombinant 
channels under increased physiological ionic conditions with MgATP present. RyRl is also 
sensitive to redox potential (Xia et al. 2000; Aracena et al. 2003) and therefore experiments in 
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which the redox potentials are regulated, as can be achieved with reduced glutathione and 
oxidized glutathione (GSH:GSSG) ratios , would also be prudent. 
Although the bilayer method is the only method to reveal basic mechanisms, it will never be 
able to mimic the intracellular environment exactly or even remotely. It is therefore important 
to investigate mechanisms revealed through bilayer experiments in whole cells. It is not 
possible for example to study EC coupling directly in bilayer experiments as only the SR 
membrane is represented in the bilayer with an incorporated RyRl. The t-tubular membrane 
with the DHPR tetrad that would associate with the RyRl in the triads of skeletal muscle is not 
present in bilayers. However, the direct effect of ionic conditions, associated proteins and 
phannacological agents on RyRl activity could be determined using the bilayer technique, 
which could then be further investigated in whole cells. The bilayer technique therefore allows 
for the simplification of a system in order to facilitate its investigation. If the limitations of this 
technique is kept in mind and combined with other investigative techniques it is a useful and 
informative technique for the study of RyR 1. It would therefore be important to investigate the 
role of the DHPR ~Ia subunit in the modulation of the ASI RyRl splice variant activity in whole 
cells. An example of a possible way this could be atte1npted lies in a study by Garcia et al in 
which the effect of the ~t a subunit on single fibers from mouse flexor digitorum brevis (FDB) 
was investigated (Garcia et al. 2005). They found that the acute application of ~l a subunits 
increased the amount of Ca2+ released by an action potential. FDB is a predominantly fast-
twitch muscle, and from the results discussed in Chapter 4, it would probably have 
predo1ninantly ASI(+)RyRl , however this is still to be confirmed. Si1nilar investigations into 
the effect of ~,a on fibers containing predominantly ASI(-)RyRI could be attempted. 
7.6 Conclusion 
In this project an atte1npt was 1nade to investigate changes in EC coupling protein expression in 
human muscle with aging . No changes in expression with age was found in the proteins 
investigated which is in contrast with findings in rodents (Renganathan et al. 1997; Taylor et al. 
2009), but consi stent with other studies done in humans (Ryan et al. 2003). A novel finding 
was that the ASI RyRl splice variants show a fiber type specific distribution . Different RyRl 
isoforn1s in slow and fast-twitch 1nuscle have been shown in fish but not in amphibians, birds or 
mammals (Franck et al. 1998; Morrissette et al. 2000). Another novel finding was the 
express ion of the cardiac DHPR a ,c in adult human skeletal muscle. The expression of the 
cardiac isoform has been shown in developing and regenerating muscle as well as adult rat 
so leus and diaphragm (Pereon et al. l 998) 
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